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ABSTRACT
The Igf2 and H I 9 genes are tightly linked and oppositely imprinted. Both genes are 
situated at the distal region of mouse chromosome 7 and display conserved linkage in 
humans on chromosome 1 l p l 5.5, a region strongly implicated in the paediatric 
overgrowth disorder Beckwith-Weidemann Syndrome (BWS). Loss of imprinting, 
leading to biallelic expression of Igf2, is the most frequent molecular defect associated 
with BWS and is observed in the majority of all tumours. Igf2 and H19 are widely 
expressed in mesodermal and endodermal lineages during embryogenesis, with 
monoallelic expression of the two genes primarily dependent upon a differentially 
methylated domain (DMD) situated immediately 5’ of H I P. The DMD exists in two 
epigenetic states, dependent upon its parental origin, functioning on the maternal 
allele as a chromatin insulator to prevent access of 3’ enhancers to Igf2, and on the 
paternal allele as a silencer that confers a heterochromatic state upon H I 9 in cis. 
Differential methylation at sites proximal to Igf2, is established by interaction with the 
DMD, in hierarchical fashion, and provides additional imprinting control at this locus. 
Igf2 escapes imprinted regulation and is biallelically expressed in the choroid plexus 
and leptomeninges o f the brain. An enhancer that confers Ig/2 expression in the 
choroid plexus, identified within a central conserved domain (CCD) situated 5’ of the 
DMD, and therefore unaffected by insulator activity, provides one mechanism for 
biallelic expression in this tissue. This work aimed to further elucidate this atypical 
imprinting, by study o f gene expression during choroid plexus development and 
functional analysis of the critical cw-elements. It was found that Igf2 is biallelically 
expressed in the developing choroid plexus epithelium, but imprinted in the stroma, 
thus suggesting that epigenetic modifications are established differently in the two 
components of this organ. Immortalised choroid plexus epithelial cell lines were 
derived to test this hypothesis in a homogenous system. The cell lines proliferated 
rapidly in culture and presented morphological and biochemical features o f choroid 
plexus epithelium. Epigenetic analysis o f the cells revealed that DMRs proximal to 
Igf2 were uncharacteristically methylated upon both alleles, yet differential 
methylation at the DMD was preserved, implicating a DMD-independent mechanism 
in this process. The data argues that the long-range DMR interactions that occur in 
imprinted tissues are potentially decoupled in the choroid plexus epithelium, thus 
providing an additional mechanism for biallelic Igf2 expression in this tissue.
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Embryogenesis in mammals requires a contribution of paternal and maternal genomes 
for development to term. Nuclear transplantation experiments in the mouse have 
demonstrated that reconstituted diploid embryos, derived from two paternal, or two 
maternal pronuclei, are not viable (McGrath 1984; Surani et al. 1986). Such 
uniparental embryos exhibit reciprocal developmental abnormalities, where those of 
entirely paternal derivation display overabundance of the extraembryonic tissues and 
severe growth retardation in embryonic lineages, whilst in embryos of maternal 
derivation the converse situation is seen (Barton et al. 1984; Barton et al. 1985). 
Similarly, in humans hydatidaform moles, which are derived entirely from paternal 
chromosomes generate placental tissue, whilst maternally derived ovarian dermoid 
cysts have a predominant embryonic component (Jirtle 1999)(and references therein). 
The parental genomes are therefore functionally nonequivalent. Genetic studies 
utilising mice in which individual chromosomes or chromosomal regions were 
inherited uniparentally demonstrated that this functional non-complementation is not 
manifested by the entire genome, but resides within specific chromosomal domains 
(Cattanach and Kirk 1985).
The breakthrough in understanding this phenomenon came with the discovery of 
imprinted genes, that is those genes differentially activated or silenced dependent 
upon the sex of the transmitting parent (Barlow et al. 1991; Bartolomei et al. 1991; 
DeChiara et al. 1991). It is thought that imprinted genes acquire their parent-of-origin 
specific mode of expression by means of heritable epigenetic marks established in the 
respective parental germlines. This marking discriminates the alleles as being of 
maternal or paternal origin and determines which copy will be active in the embryo. 
Imprinted genes play fundamental roles during development with particular emphasis 
upon the regulation of foetal and placental growth/viability and influence of postnatal 
behaviour. More than 70 genes with this mode of non-Mendelian expression have 
been identified in the mouse, although it is postulated the total number could be far 
greater (Falls 1999; Beechey et al. 2003). Both the genomic organisation and parental 
origin-specific expression of many imprinted genes are conserved in humans. Non­
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compliance with Mendelian inheritance, it has been suggested, may render imprinted 
genes particularly susceptible to the effects of mutation and consistent with this 
proposal their misregulation is frequently observed in many human cancers and the 
congenital disorders Prader-Willi/Angelman Syndrome (PWS/AS) and Beckwith 
Weidemann Syndrome (BWS), which causes pre- and postnatal overgrowth and 
childhood tumour susceptibility (Nicholls et al. 1998; Jirtle 1999; Pulford et al. 1999; 
Maher 2000; Walter 2003).
Epigenetic Modifications
The nucleotide sequence of autosomal DNA is identical between the paternal and 
maternal genomes. The parental-origin specific mode of expression exhibited by 
imprinted genes must therefore be a consequence of epigenetic marking, or 
‘imprinting’ of DNA in a manner that allows the parental alleles to be distinguished. 
The imprinting mark must be heritable (and stable) through successive cell divisions, 
such that it is retained in cell progeny, but must also be able to alter the transcriptional 
activity of the genes that it regulates. Importantly, an imprinting mark must be 
reversible such that upon germline passage it may be erased and reset in a manner 
appropriate to the sex o f the transmitting parent.
DNA methylation
In mammals, DNA methylation occurs principally by the covalent attachment of a 
methyl group to the 5’carbon of the cytosine residue within symmetrical 
cytosine/guanine (CpG) dinucleotides. This symmetry together with the preference of 
the principle mammalian methyltransferase, Dnm tl, for hemimethylated DNA as a 
substrate provides a basis by which methylation patterns are stably inherited through 
successive cell generations. In general, DNA methylation is thought to regulate 
specific genes by the recruitment of methyl-CpG binding domain (MBD) proteins and 
histone deacetylases (HDACs), which confer transcriptional repression by induction 
o f the heterochromatic state (Bird 1999). Methylation is also thought to be necessary 
for silencing of CpG-rich retrotransposons, the activity of which can lead to genome 
instability (Greally 2002; Bourc'his and Bestor 2004). DNA methylation therefore 
maintains normal genome functioning, by modulating gene expression and 
influencing structural integrity.
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Manipulation of the D nmtl gene in loss- and gain-of-function studies has 
demonstrated an essential role for correct genome methylation in both embryonic 
development and genomic imprinting. Inactivation of D nmtl in mice results in growth 
arrest and embryonic lethality at the 8-somite stage (Li et al. 1992). Deregulation of 
imprinted gene expression also occurs in Dnmtl-deficient embryos, with reactivation 
of the normally silent paternal H I 9 allele and silencing of both alleles at the Igf2 and 
Igf2r loci (Li 1993). Similarly, embryonic lethality and the inappropriate expression 
of several imprinted genes results from the overexpression of D nmtl in mice 
(Biniszkiewicz 2002). These experiments provide unequivocal evidence that DNA 
methylation is required for the imprinting process. An exception is provided by the 
Mash2 gene, whose imprinted expression persists in D nm tl'1' embryos despite 
extensive genome demethylation (Tanaka 1999). Therefore, the imprinting of Mash2 
is probably dependent upon modifications other than DNA methylation.
How does methylation upon CpG dinucleotides convey parental identity such that 
differential expression o f the alleles arises in somatic cells? CpGs occur in vertebrate 
genomes at less than one quarter of the expected frequency. Exceptions to this gross 
underrepresentation are short CpG-rich regions termed CpG islands. The term CpG 
island defines genomic regions that are greater than 200 bp in length, with a GC 
content greater than 50% and a CpG dinucleotide observed to expected ratio (based on 
GC content) greater than 0.6 (Gardiner-Garden 1987; Strichman-Almashanu 2002). It 
is generally thought that CpG islands are not methylated, however exceptions are 
provided by the existence of CpG islands that map to the inactive X-chromosome and 
imprinted regions (Yen 1984; Mann 2000)(and references therein). In support of a 
role for DNA methylation in the imprinting process, CpG islands located within the 
vicinity o f most, but not all imprinted genes are overlapped by regions of parent- 
specific differential methylation (DMRs) and it is generally accepted that this 
modification constitutes at least part of the marking process that discriminates the 
parental origin o f the alleles (Reik 2001b)(and references therein). Additionally, 
consistent with a methylation independent mechanism of imprinting implicated by 
Dnmtl knockout studies, Mash2 does not appear to be differentially methylated or 
associated with a DMR (Tanaka 1999).
17
As already discussed, DNA methylation is generally thought to be a stable and 
heritable epigenetic mark that regulates key aspects of genome function. There are, 
however, two principal developmental stages, primordial germ cells (PGCs) and the 
pre-implantation embryo, in which DNA methylation levels are highly variable, with 
major differences apparent between the parental genomes (reviewed in (Reik 2001a)). 
Functional imprinting requires that differential methylation marks are correctly 
established in germ cells and stably maintained postzygotically, a seemingly 
unremarkable process, if  it were not for successive waves of demethylation and 
subsequent de novo methylation that sweep the genome at pre-implantation stages. 
Specific mechanisms must then exist which protect parental origin-specific 
methylation marks during these early stages of development.
The genomes of the egg and sperm become highly methylated during maturation, 
however both become demethylated following fertilisation by both active and passive 
mechanisms (Reik 2001a)(and references therein). Demethylation is initially confined 
to the paternal genome, which commences following sperm entry to the egg 
cytoplasm and is completed prior to the first zygotic division, providing strong 
evidence o f an active demethylation mechanism. Intriguingly, the maternal genome is 
not itself affected by this ‘demethylase’ activity and remains highly methylated, even 
at syngamy (Santos 2002). The paternal genome is therefore targeted for active 
demethylation, with factors in the egg environment potentially mediating this process. 
In vitro work has implicated the methyl-CpG binding protein, MBD2, in this process 
(Bhattacharya et a l 1999), however demethylation occurs normally in MBD2- 
deficient oocytes, demonstrating that MBD2 is not required for demethylation in vivo 
(Santos 2002).
During subsequent cleavage divisions methylation levels steadily decline in the 
embryo, reaching their lowest point at the blastocyst stage. This represents the passive 
phase of demethylation, probably mediated by the exclusion of the maintenance 
methyltransferase, Dnm tl, from the nucleus in embryos at preimplantation stages 
(Howell et al. 2001). Intriguingly, many imprinted genes and some direct repeat 
sequences are not demethylated during this phase. For example, paternal-specific 
methylation imprints are maintained at both Rasgrfl and H I 9, but not at Igf2, 
suggesting a mechanism that confers specific protection of some loci but not others
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(Brandeis et al. 1993; Tremblay et al. 1997; Reik 2001a). Genetic studies implicate 
the oocyte and preimplantation Dnmtl variant, Dnmtl o, in this process (Howell et al.
2001). Dnm tlo is expressed at high levels in the oocyte and preimplantation embryo 
and replaces the somatic Dnmtl variant at these stages. Though excluded from the 
nucleus prior to fertilization, in 8-cell embryos, Dnm tlo transiently relocates to the 
nucleus for a single replication cycle. Analysis of embryos deficient in this 
preimplantation form of Dnmtl revealed that the methylated alleles o f imprinted 
genes had lost 50% of their methylation at later stages, demonstrating that the 
maintenance methylation function of Dnmtlo, possibly acting at the 8-cell stage, is 
crucial for the preservation of methylation imprints (Howell et al. 2001). That only 
50% methylation is lost at imprinted loci, suggests that additional methylation 
protective mechanisms are also likely to be involved.
By the blastocyst stage of development and unlike earlier stages where gross 
differences are apparent, the parental genomes cannot be distinguished on the basis of 
their methylation levels, with both being almost completely demethylated. Genome 
remethylation commences shortly after implantation and levels gradually increase as 
development proceeds (Monk 1987). This occurs in a lineage-specific manner, where 
de novo methylation is restricted to the inner cell mass (ICM) appear, whilst the 
trophoectoderm remains almost devoid of methylation (Santos 2002). Rising genome 
methylation levels mount a further challenge to the perpetuation o f imprinting marks, 
as unmethylated alleles within DMRs must be protected from de novo methylation. 
Studies at the H I9 locus, which bears a paternal methylation imprint (Tremblay et al.
1997) implicate the local chromatin conformation in the exclusion of methylation 
from the unmethylated maternal allele (Khosla et al. 1999; Kanduri 2000a). More 
recent evidence indicates, that this specific protection against de novo methylation 
may be conferred upon H I 9, entirely by binding of the chromatin insulator protein, 
CTCF (Schoenherr et al. 2003; Fedoriw et al. 2004; Pant 2004). Therefore, it seems 
likely that imprinted genes require additional epigenetic marks and the recruitment of 
/ratts-imprinting factors, in order to attract, or to be protected against de novo 
methylation during postimplantation development.
Precisely how methylation imprints are established de novo is not clearly understood, 
principally because the DNA methyltransferases have little or no sequence specificity
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other than for CpG dinucleotides. Genome wide demethylation takes place at an early 
stage of PGC development in mice and reaches completion by e l3-14 in both male 
and female germlines, though prior to this stage PGCs in both sexes are methylated 
and display monoallelic expression at imprinted loci (Reik 2001a) (and references 
therein). De novo methylation o f both parental germlines is initiated several days 
later, though the process in males occurring in prospermatogonia between e l 5-16 
(Kafri 1992; Brandeis et a l  1993) precedes that in females, which is initiated after 
birth during oocyte growth (Kafri 1992).
Current evidence assigns the function of maintenance methylation to the protein 
Dnmtl and its oocyte variant, Dnmtlo, and whilst there is some evidence that Dnmtl 
can perform de novo methylation in vitro, it seems unlikely that this enzyme can 
initiate de novo methylation in vivo. De novo methyltransferase activity for the 
variant, Dnm tlo has also been excluded (Howell et al. 2001).
The activity of de novo methylation in vivo is thought to be a property of Dnmt3 
family proteins, consisting of Dnmt3a, Dnmt3b and Dnmt3L (Bestor 2000). Targeted 
mutagenesis o f the Dnmt3a and Dnmt3b genes led to embryonic (Dnmt3b) and 
postnatal (.Dnmt3a) lethality, thus both are required for normal development. 
Compound (Dnmt3a'/'/Dnmt3b~/~) mutants did not undergo genome remethylation 
during postimplantation development and were subject to growth arrest at the 
presomite stage. Therefore, these proteins are required for de novo methylation during 
early embryogenesis. Imprinted gene expression was maintained in the compound 
mutants, providing clear evidence that de novo activity o f Dnmt3a and 3b is not 
required to maintain imprinting at post-zygotic stages (Okano 1999). The lethal 
effects of these mutations prevented further analysis in the germline context.
In a recent study, germline-specific deletions of Dnmt3a and Dnmt3b were created by 
cre-loxP mediated conditional mutagenesis, to address the question o f whether these 
proteins are required to establish methylation imprints. Females homozygous for the 
conditional Dnmt3a mutation were viable and normal, however heterozygous progeny 
of these females died at, or prior to e l0.5 of gestation, with disruption of maternal 
methylation imprints and misexpression of several imprinted genes. The role of 
Dnmt3a in the context of the male germline could not be directly addressed, as male
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mice homozygous for the Dnmt3a mutation were azoospermic. However analysis of 
spermatogonia dissected from these mice revealed that paternal methylation imprints 
had similarly been disrupted. By contrast, the conditional Dnmt3b mutation had no 
effect upon methylation in either germline (Kaneda et al. 2004). Therefore, Dnmt3a, 
but not Dnmt3b is required for establishment o f methylation imprints in both male and 
female germlines.
Dnmt3L (for Dnmt3-like) shares homology with Dnmt3 methyltransferases, but lacks 
the catalytic methyltransferase domain, setting it apart from the other Dnmt3 family 
members and suggesting that it does not possess intrinsic methyltransferase activity 
(Bourc'his et al. 2001). Disruption o f Dnmt3L in mice resulted in a matemal-effect 
phenotype that was indistinguishable from that of the conditional Dnmt3a mutation 
(Bourc'his et al. 2001; Hata 2002). Intriguingly, Dnmt3L has also been shown to 
interact and colocalise with both Dnmt3a and Dnmt3b in tissue culture cells (Hata 
2002). Therefore, whilst Dnmt3L is unlikely itself to mediate de novo methylation in 
the germline, it appears to co-operate with the other Dnmt3 proteins in this process 
imprint establishment. Taken with the findings o f other studies, this indicates that 
Dnmt3 family proteins (Dnmt3a and Dnmt3L) are the major factors responsible for 
the establishment of germline methylation marks essential to genomic imprinting.
Features of imprinted genes
Parental origin-specific expression or silencing of the alleles is the defining feature of 
an imprinted gene. It is now generally accepted that most imprinted genes are 
characterised by a number of other distinguishing features that sets them apart from 
autosomal genes not subject to this unusual form of regulation. These features are 
discussed below.
Differential methylation
As discussed above, genome methylation is essential for correct imprinted gene 
expression (Li 1993) and most imprinted genes or their flanking sequences are 
marked by regions o f parental origin-specific differential methylation (DMRs). The 
function o f DMRs with respect to the mechanism of imprinted gene expression will be 
later discussed in detail in the context of the Igf2/H19 locus, upon which this study is 
based.
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Clustering of Imprinted genes
One of the most striking properties of imprinted genes is that, in most cases, other 
imprinted genes are located in close proximity. A significant proportion of known 
imprinted genes are organised in clusters, which argues for the existence of region- 
wide regulatory mechanisms such as c/s-acting imprinting control regions or local 
chromatin structure. An intensively studied imprinted gene cluster is situated within 
the Beckwith-Weidemann Syndrome (BWS) region, which lies on chromosome 
1 l p l 5.5 in humans and shows conserved linkage on distal chromosome 7 in the 
mouse (Beechey 2003). The cluster spans approximately 1Mb in both species. In the 
mouse, this region contains at least 15 imprinted genes, which display both paternal- 
specific (Igf2, Igf2AS/Peg8, Ins2, KvlqtlAS/Lit 1) and maternal-specific {H I9, Cd81, 
Ascl2/Mash2, Tssc4, K vlq tl, p57KIP2ICdknlc, Msuit, Ipl/Tssc3, Slc22all, Obphl, 
Napll4) monoallelic expression (Paulsen 2000; Beechey 2003). The genomic 
arrangement and transcriptional orientation of this cluster is largely conserved in 
humans, although not all o f the human orthologues demonstrate imprinting, with 
CD81 and TSSC4 biallelically expressed. Conversely, the LTRPC5/Ltrpc5 gene is 
imprinted in humans, but not in mice (Paulsen 2000)(and references therein). In 
humans and mice, the proximal and distal extent of the cluster is respectively defined 
by the flanking genes NAP1L4/Napll4 and RRPL23L/Rrpl23l, which are biallelically 
expressed in both species (Paulsen 1998). A further difference between the species 
occurs in the orientation of the cluster with respect to the centromere, with H I9 
representing the most telomeric imprinted gene in humans and the most centromeric 
gene in mice (Caspary et al. 1998).
Paternal uniparental disomy (UPD) of 1 lp l  5.5 is observed in a small number o f BWS 
cases and loss o f maternal 1 l p l 5.5 is a frequent occurrence in the tumours, most 
commonly Wilms tumour, to which BWS predisposes (Jirtle 1999)(and references 
therein). The most frequently observed defect in cases of BWS (where no cytogenetic 
rearrangements are detected) is biallelic expression caused by loss of imprinting (LOI) 
at the IGF2 locus. This is often associated with aberrant epigenetic modification and 
silencing o f the neighbouring H I 9 gene, although in many other cases no modification 
of H19 is apparent (Reik et al. 1995; Catchpoole et al. 1997). Mutations in KvLQTl 
and the overlapping LIT1 antisense transcript are also prominent in BWS and have 
been associated with biallelic IGF2 expression in some cases (Smilinich et al. 1999).
22
Two imprinting control regions (ICR) that confer imprinting upon distinct 
subdomains within this cluster have been formally identified by gene targeting studies 
in mice. One of these is located in the 5’ flank of the H I9 gene and regulates the 
imprinting o f Ins2, Ig/2, and H I 9 by functioning, in part, as a chromatin insulator that 
prevents access to shared enhancers (Thorvaldsen et al. 1998; Bell 2000; Hark et al. 
2000). The function of this ICR and its implications for Igf2/H19 imprinting is 
discussed at length in a later section of this chapter. A second ICR is located within 
the body o f the Kvlqtl gene and is overlapped by the L itl antisense transcript 
(Smilinich et a l 1999). Deletion of this region leads to loss of imprinting o f several 
genes including lp l, p57KIP2 and Ascl2, again with chromatin insulator activity 
possibly mediating at least part o f this function (Fitzpatrick 2002; Kanduri 2002). 
Therefore, this region (and possibly the Litl transcript) is required to imprint a subset 
o f genes within this cluster. Regional imprinting control conferred by two ICR 
elements thus partitions the BWS cluster into Igf2/H19 and p57KIP2/Litl regulatory 
subdomains.
Another example o f regional imprinting control has been revealed by studies of the 
Prader-Willi Syndrome/Angelman Syndrome (AS/PWS) imprinted region, which 
maps to human chromosome 15ql l-q l3 . The cluster is characterised by the paternally 
expressed SNRPN/SNURF, ZNF127, NDN, IPW  genes and the maternally expressed 
UBE3A gene. The homologous region in the mouse is located on proximal 
chromosome 7 with conservation o f gene order and imprinted features (Nicholls
1998). The most frequent event in the pathogenesis o f PWS/AS is a 4Mb deletion at 
15ql 1 -q l3, which removes the entire cluster. The deletion is paternal in origin for 
PWS, and results in loss of expression of several paternally expressed genes, and 
maternal in origin for AS, resulting in loss of UBE3A expression, which it is 
proposed, is the single cause o f this disorder. Mutational studies in PWS and AS 
families, have defined a bipartite ICR element that occupies a 4kb region spanning the 
5’promoter region and exon 1 of the bicistronic SNRPN/SNURF locus and a second 
880bp region situated 40kb further proximal. Microdeletions that disrupt the 5’ region 
of the SNRPN/SNURF locus have been observed in a subset o f PWS patients that 
present biparental inheritance of 15ql 1 -q l3, but display an abnormal epigenotype 
(Ohta 1999). Moreover, deletion of this region in mice leads to the loss of expression 
of the paternally expressed Znfl27 , Ndn and Ipw genes and manifestation of the PWS
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phenotype (Yang 1998). Deletions affecting the second and more proximal of the two 
ICR elements are frequently observed in AS families (Buiting et al. 1999). Analysis 
of this region in a transgenic context demonstrated that this element was required for 
imprinting of mouse Snrpn minitransgenes including the 5’ promoter element, 
providing formal evidence in support of a functional imprinting role (Kantor 2004).
Repeat elements
Mounting evidence indicates that DNA methylation constitutes a primary imprinting 
mark and therefore the processes establishing this modification putatively represent 
the primary imprinting mechanisms. Whilst major toms-imprinting factors (DNA 
methyltransferases) have been discovered, proteins that target the establishment of 
parental-origin specific methylation patterns in a sequence-specific manner have not 
been identified. GC-rich tandem repeats are often observed in association with regions 
of differential methylation (DMRs) of imprinted genes and have been proposed to 
play a role in the imprinting mechanism by attracting methylation to DMRs (Szebenyi 
1994; Neumann 1995). Trans-imprinting factors expressed in the germ line o f one sex 
but not the other are likely to be involved, and their ability to methylate in primary 
DMRs may be mediated, in part, through interactions with the repeat elements 
themselves. Consistent with this proposal, a tandem repeat region located 5’ of the 
Rasgrfl locus has been shown to function in such a role. While not itself differentially 
methylated, this region is required in cis to direct differential methylation within an 
adjacent DMR and for imprinted expression of Rasgrfl (Yoon 2002). By contrast, at 
the Igf2/H19 locus the deletion of two regions containing tandem repeats respectively 
situated 5’ and 3’ o f the H I 9 DMD had no effect upon either differential methylation 
within the DMD or the imprinted expression of H I 9 (or Igf2) (Thorvaldsen et al. 
2002; Lewis 2004). Whilst a definitive role for direct repeat elements in imprinting 
has yet to be established, current evidence (Rasgrfl) supports their participation in 
establishment of parental-origin expression and epigenetic modifications at some 
imprinted loci.
Imprinted chromosomal domains have also been found to be associated with 
significantly reduced numbers of short interspersed transposable elements (SINEs) a 
characteristic that is conserved between humans and mice (Engemann 2000; Greally 
2002; Ke 2002). This correlate supports the hypotheses that there is either active
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selection against SINE elements in imprinted regions or alternatively, that there is a 
lower rate of insertion o f these elements. SINE elements have been reported to attract 
DNA methylation and mediate its spread into adjacent flanking sequence (Hasse
1994). The methylation-nucleating effect mediated by SINEs could have severe 
consequences at imprinted loci where aberrant methylation could lead to the ectopic 
expression or silencing o f imprinted genes. This suggests a possible mechanism by 
which SINE insertion events could be selected against at imprinted loci (Greally
2002). In support o f this hypothesis, a paucity of SINE elements has also been 
observed on the X-chromosome, another region of the genome where monoallelic 
expression is regulated by methylation (Boissinot 2001). Whilst the precise functional 
significance of SINEs, if  any, remains unclear, these elements may provide genomic 
markers for the discrimination of imprinted and non-imprinted regions.
Antisense transcripts
Natural antisense transcripts that overlap imprinted protein coding transcripts have 
been identified at numerous imprinted loci, examples of which are Igf2, Igf2r, K vlqtl, 
Ube3a, W tl, Xist and Gnas (Malik 1995; Moore et al. 1997; Rougeulle 1998; Lee 
1999; Smilinich et al. 1999; Lyle et a l  2000; Wroe 2000) with conservation between 
humans and mice in many cases. These antisense transcripts are always imprinted, in 
most cases oppositely to the protein-coding transcripts with which they overlap. In 
addition, antisense transcripts usually co-localise with the overlapping protein coding 
transcript in a tissue-specific manner. Antisense RNA expression from one parental 
allele therefore correlates with silencing of the protein-coding gene in cis. 
Transcriptional overlap occurring in the same nucleus, it is proposed, may constitute 
one mechanism by which antisense RNA could confer silencing of coding genes in cis 
(Barlow 1997). However, studies at the murine Igf2r locus establish that such a 
mechanism may not mediate silencing in all cases. The antisense to Igf2r (Air) 
transcript is paternally expressed and emanates from a CpG island located within 
intron 2 o f the maternally expressed Igf2r gene, with which it exhibits overlap (Wutz 
1997). Paternal-specific expression of Air correlates with paternal-specific silencing at 
Igf2r and at the flanking Slc22a2 and Slc22a3 loci (Zwart 2001). Disruption of Air in 
mice, by insertion of a polyadenylation sequence thereby truncating 96% of the 
mature transcript, led to reactivation in cis o f the normally repressed, overlapping 
paternal allele o f Ig/2r and that of the neighbouring Slc22a2 and Slc22a3 genes, with
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which it does not overlap. The Air transcript is therefore required to imprint the Igf2r, 
Slc22a2 and Slc22a3 genes (Sleutels et a l 2002). The mechanism by which this 
occurs is currently unknown, but does not appear to involve overlap between the Igf2r 
promoter and Air (Sleutels 2003).
DNA replication timing
The timing o f DNA replication of S-phase nuclei is strongly correlated with 
chromatin structure and transcriptional activity, with active euchromatic regions 
typically replicating earlier than inactive heterochromatin blocks (Kitsberg et al. 
1991; Selig et al. 1992). Many imprinted regions are characterised by asynchronous 
DNA replication timing of the parental alleles. Parental-origin specific differences in 
replication timing have been observed at Snrpn, Tg/2, H I 9 and Igf2r in humans and 
mice, with the paternal allele replicating early in each case (Kitsberg 1993). 
Asynchronous replication is also consistently associated with non-imprinted modes of 
monoallelic expression in immunoglobulin genes, olfactory receptor genes and (in 
females) X-linked genes (Takagi 1980; Chess et a l  1994; Mostoslavsky et a l  2001). 
Asynchronous replication at imprinted loci is established in the gametes, maintained 
postzygotically and is apparent in a number o f differentiated cell types, which argues 
for its functioning as a primary imprint that distinguishes the parental alleles (Simon
1999). Consistent with this proposal, deletion of the H19 gene and its 5’ flank 
(containing the Igf2/H19 ICR), led to synchronous replication of the alleles at this 
locus (Greally 1998). The ICR is therefore required for asynchronous replication at 
the Igf2/H19 locus. However a recent study in the mouse mutant, Minute (.Mnt), found 
that paternal methylation imprints can be established within the ICR, whilst 
maintaining asynchronous replication timing of the alleles (Cerrato et a l  2003). This 
suggests that asynchronous replication o f the alleles is probably independent of DNA 
methylation at Igf2IH19. This also appears to be the case at other imprinted loci. 
Asynchronous replication o f the alleles has been demonstrated in Dnm tl or DnmtSL 
deficient ES-cells that exhibited genome hypomethylation and widespread loss of 
imprinted gene expression (Gribnau 2003). It appears that replication timing is neither 
a determinant, nor a consequence of the epigenetic modifications (DNA methylation) 
likely to directly mediate imprinting. It is possible that asynchronous replication 
timing of the alleles could reflect heritable differences in chromatin structure that 
exist between the alleles of some imprinted loci. Indeed, experimental interference
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with chromatin structure by treatment of cultured cells with histone deacetylase 
inhibitors results in synchronous replication timing o f imprinted regions (Bickmore
1995).
Genetic conflict and the evolution of imprinting
The existence of genomic imprinting was first implied by the observation that 
parthenogenetic embryos do not survive to term (McGrath et al. 1984; Surani et al. 
1986). Subsequently, the observation of reciprocal phenotypes in embryos with either 
paternal or maternal uniparental disomy (UPD) o f certain chromosome regions and in 
gynogenetic and androgenetic embryos, suggested that maternal or paternal 
duplications lead to reduced or increased growth respectively (Barton et al. 1984; 
Barton et al. 1985). These early observations led to the proposal of the widely 
documented and accepted genetic conflict theory of imprinting (Moore and Haig 
1991). The theory proposes that imprinted genes will arise as a consequence of 
conflicting interests between males and females in a mammalian polyandrous species, 
that is where the occurrence o f mixed paternity in reproduction reduces the likelihood 
that paternal alleles in a given fetus will be related to paternal alleles in future 
siblings. Since the female is equally related to all her offspring, she will try to allocate 
resources sufficient for the survival of the current brood without compromising her 
ability to meet the demands of future pregnancies. However, the male has no interest 
in future offspring produced by a mate, as they are unlikely to be sired by him, rather 
he will seek maximum investment o f the females limited resources in his offspring, 
even at the expense of that females future reproductive fitness. The conflict theory 
therefore predicts that paternal alleles will function to increase maternal investment in 
offspring and promote growth, whilst maternal alleles will act in an opposite manner 
and limit maternal investment, thus functioning in growth restraint. That is, growth 
promoting genes will be selected for paternal-specific monoallelic expression and 
growth inhibitory genes, maternal specific expression. Those genes that do not 
influence maternal investment or that are expressed exclusively at adult stages would, 
according to genetic conflict, not be expected to undergo selection for imprinting 
(Moore and Haig 1991). The first imprinted genes to be identified in the mouse, the 
oppositely imprinted Ig/2 (DeChiara et al. 1991) and Igf2r (Barlow et al. 1991) genes, 
the products of which interact antagonistically in the embryo and confer directly 
opposing effects upon growth, support the prediction.
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This is perhaps unsurprising, given that most of what is known about embryonic 
growth relates to insulin/insulin like growth factor (Ins/Igf) signalling (reviewed in 
(Efstratiadis 1998)), though on the other hand if  the genetic conflict theory is correct, 
then genes participating in other embryonic growth control pathways would also be 
expected to undergo selection for imprinting. Consistent with this assertion, in recent 
work targeted mutagenesis of the maternally expressed GrblO gene resulted in 
significant embryonic and placental overgrowth that, intriguingly, was also shown to 
be independent o f Igf2 signalling (Charalambous et a l 2003). Therefore disruption of 
GrblO in mice provides evidence of the existence of a second, Ins/Igf independent, 
major growth axis that has also been selected for genomic imprinting. Taken together, 
these and other studies (reviewed in (Reik et al. 2001)), provide compelling 
experimental evidence o f a strong correlation between preferential paternal-specific 
expression of imprinted genes that promote growth and preferential maternal-specific 
expression o f those involved in growth restraint.
The placenta is the site o f nutrient exchange between the mother and fetus, thus it has 
been argued that this tissue should therefore constitute a principal site for parental 
conflict and imprinted gene function (Moore and Haig 1991). If the conflict theory 
holds, then imprinted genes expressed in the placenta should function to appropriately 
enhance or restrict the availability o f maternal resources to the developing embryo. 
Consistent with this expectation, recent work has shown that a paternal deletion of an 
Igf2 (P0) transcript, specifically expressed in the labyrinthine trophoblast o f the 
placenta, led to placental and embryonic growth restriction, with an associated failure 
of active and passive transport mechanisms (Constancia et al. 2002), providing 
evidence for imprinted gene function in the placenta that directly regulates the supply 
of maternal nutrients to the fetus.
The argument for genetic conflict is not as straightforward as the previous examples 
would suggest, as there exists a gene, Mash2, which encodes a maternally expressed 
transcription factor that promotes placental growth. Targeted deletion of Mash2 in 
mice led to placental failure, severe embryonic growth retardation and early lethality 
(Guillemot et al. 1995). Therefore the directionality of Mash2 imprinting and its 
effect upon growth appear to contradict the conflict hypothesis. However, it may be 
naive to assume that a large placenta will always make a large embryo, as illustrated
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by some paternal UPD embryos, which are smaller than normal embryos, yet have 
larger than normal placentae (Hurst 1997). The implication is that placental 
overgrowth may negatively affect placental function and nutrient flux between mother 
and fetus, possibly limiting rather than promoting embryonic growth. These 
considerations do not necessarily exclude genetic conflict as a determinant of 
imprinted gene evolution but rather suggest it may operate in a more complex manner 
than previously thought.
As a further cautionary note, it seems likely that many hundreds or possibly thousands 
of genes regulate embryonic growth, yet the number of imprinted genes is small with 
around 70 examples identified to date (Efstratiadis 1998; Moore 2001; Beechey 
2003). A perceived inconsistency of genetic conflict, questions why most embryonic 
growth factors are not selected for imprinting as exemplified by the Ig fl gene, which 
encodes a potent embryonic and postnatal growth factor yet is not imprinted (Liu 
1993; Hurst 1997; Efstratiadis 1998). Proponents of genetic conflict explain this 
problem in terms of a cost/benefit argument. For example, when a new imprinted 
paternal allele arises, it will be exposed to severe negative selection and will only 
persist if  it receives a pay-off in terms of increased investment o f maternal resources 
in offspring that exceeds the cost of effectively being functionally haploid (Moore and 
Haig 1991; Moore 2001). In other words, the benefits conferred by changes in 
maternal resource allocation may not be sufficient to select for imprinting in all cases.
Genetic conflict predicts that imprinted genes will arise only in those species where 
the nutritional requirements of the developing embryo are provisioned by direct 
contact with maternal tissues, an assertion supported by the occurrence o f imprinted 
genes in placental mammals, marsupials and angiosperm plants (Moore and Haig 
1991). However, recent studies have revealed the existence of imprinting in 
Drosophila (reviewed in (Lloyd 2000)), a finding inconsistent with genetic conflict in 
its current form. Whilst other theories have been proposed to account for the evolution 
o f imprinting (reviewed in (Hurst 1997)) and despite some inconsistencies, the theory 





Insulin-like growth factor 2 (IGF2) is an embryonic growth factor structurally related 
to insulin (Milner 1984). The Igf2 gene is widely expressed in the mesoderm and 
endoderm lineages at postimplantation stages of development, with expression 
predominantly occurring from the paternally inherited allele (DeChiara et al. 1991). 
Germline knockout experiments demonstrate that Igf2 is required for embryonic 
growth, such that mice inheriting a paternal deletion in the Igf2 gene display severe 
embryonic growth retardation, with only 60% of the bodyweight of wild type 
littermates at birth (DeChiara et a l 1990; DeChiara et al. 1991). An identical 
phenotype was observed in mice homozygous for the deletion, though consistent with 
the imprinted status o f the endogenous gene, animals that inherited the Igf2 deletion 
maternally were phenotypically indistinguishable from wild-type littermates 
(DeChiara et al. 1990; DeChiara et al. 1991). Therefore, physiological deficiency in 
IGF2 results in embryonic growth retardation.
The structure o f the Ig/2 gene is largely conserved in humans and mice, with 
transcription initiating from four promoters in each species (termed P1-P4 in humans 
and P0-P3 at the mouse locus, see Figure 1) although there are some contrasting 
features. Human P I, from which transcripts are initiated upon both alleles specifically 
in the adult liver, does not have a representative homologue at the mouse locus 
(Ekstrom et al. 1995). Mouse P0, from which a placental-specific transcript is 
produced, is absent from the human sequence (Moore et al. 1997). P2-P4 in humans 
and P1-P3 in the mouse, are functionally equivalent and are expressed in co-ordinate 
fashion during development (Feil 1997).
The Igf2 gene maps to mouse distal chromosome 7 in a cluster of imprinted genes that 
include H I 9, Ins2, Mash2 and P57KIP2 and shows conserved linkage in humans, on 
chromosome llp l5 .5  (Paulsen 1998; Paulsen 2000), a region associated with the rare 
paediatric overgrowth disorder Beckwith Weidemann Syndrome (BWS) that affects 1 
in 11700 live births on average. Individuals with the disease present a complex array 
of clinical features, including somatic overgrowth, placentomegaly, visceromegaly, 
macroglossia, cleft palate, omphalocele, polydactyly and a predisposition to childhood 
tumours (Weksberg 1996) (and references therein).
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Figure 1. The Igf2IH19 locus in the mouse. Map of the lOOkb region 
showing the genomic arrangement of the Igf2 and H I 9 genes and 
surrounding c/s-elements. Open boxes represent exons of the genes. The 
Igf2 gene is comprised by eight exons in total, including placental specific 
exons 1 and 2 (ul and u2) and six other exons. The H I9 gene is comprised 
of five short exons interspersed by 4 very short introns. Differentially 
methylated regions (DMRs) are represented as arrows; at Igf2, 
differentially methylated regions 0, 1 and 2 (DMRO, DMR1, DMR2); at 
HI 9, differentially methylated domain (DMD) and H I 9 promoter proximal 
region. Regions that confer enhancer activity at this locus are represented 
as ovals; Igf2!H19 centrally conserved domain (CCD); H19 endoderm- 
specific enhancers (EE); skeletal muscle-specific enhancers (SME).
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Dosage of imprinted gene products is critical for normal development and the 
available evidence suggests that loss of imprinting (LOI) mutations leading to biallelic 
expression of IGF2, a frequent observation in BWS patients, have a causal role in the 
disease by generating abnormally high levels of IGF2 (Weksberg 1993). The majority 
of BWS cases arise sporadically, though about 15% of cases show an autosomal- 
dominant pattern o f inheritance. In addition, most patients present no obvious 
cytogenetic abnormalities, but in a small number of cases paternal UPD of 1 lp l 5.5 is 
correlated with biallelic IGF2 expression (Weksberg 1996) (and references therein). 
BWS is genetically heterogeneous and multiple imprinted genes located within the 
1 l p l 5.5 critical region are probably involved in the pathogenesis o f the disease. In 
particular, biallelic expression of the KVLQT1 antisense transcript, LIT1, which 
normally displays paternal-specific expression, is the most common molecular defect 
in found in BWS (Lee et al. 1999). In addition, mutations affecting the maternally
K I P ' )expressed P57 gene, which encodes a cyclin-dependent kinase inhibitor, are also 
found, but occur at a much lower frequency (Engel et al. 2000; Gaston 2000; Li 
2001b). Almost all o f the clinical features of BWS can be recapitulated in a mouse 
model in which loss of p57KIP2 function is lost and Igf2 is overexpressed, therefore 
supporting a causal role for P57K1P2 in this disease (Zhang 1997; Caspary et al. 1999). 
In addition, recent work has revealed the presence of an inherited microdeletion in 
familial BWS, which disrupts expression of the LIT1 transcript and leads to
• • K I P )concomitant silencing o f P57 providing direct evidence o f a mechanistic route to 
the disease (Niemitz 2004).
Aside from an association with overgrowth in BWS, biallelic IGF2 expression is 
found in greater than 70% of all tumours examined and is frequently observed in 
Wilms’ tumour, a familial and sporadic paediatric tumour o f the kidney, a neoplasm 
often manifested in BWS (reviewed in (Reeve 1996)). In addition, biallelic IGF2 
expression has also been shown to occur frequently in colorectal cancer (Takano 
2000).
Although not formally substantiated in humans, a causal role for IGF2 in the 
overgrowth features of BWS and in many instances of cancer is supported indirectly 
by evidence from mouse models. Transgenic overexpression o f Igf2 in mice under the 
control o f a bovine keratin promoter, which directs transgene expression to the skin,
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gut and uterus, resulted in disproportionate overgrowth of those tissues (Ward et al.
1994). Similarly, mice carrying a deletion of the H I9 gene and its 5’ flanking 
sequence, which leads to biallelic Ig/2 expression, were found to be 27% heavier than 
wild-type littermates at birth, consistent with an excess of IGF2 (Leighton 1995). In 
further transgenic work, overexpression of Igf2 manifested key aspects o f the BWS 
phenotype, including somatic overgrowth, tongue overgrowth and skeletal 
abnormalities (Sun et al. 1997). These experiments provide clear evidence that 
abnormal excess o f IGF2 can lead to both local and systemic overgrowth, thus 
establishing the Ig/2 gene as an important determinant o f BWS and tumour 
progression.
IGF2 exerts its growth effects primarily by signalling through the type 1 insulin-like 
growth factor receptor (Igf 1 r) and to a lesser extent via the structurally related insulin 
receptor (Insr) (Liu 1993; Louvi 1997; Efstratiadis 1998). Its cognate receptor, the 
type 2 insulin-like growth factor receptor (Igf2r) that also functions as the cation- 
independent mannose-6-phosphate receptor, is not thought to have a signalling role, 
but rather removes excess IGF2 by receptor-mediated endocytosis (Wang et al. 1994). 
Intriguingly, Igf2r is encoded by the imprinted and maternally expressed Igf2r gene 
(Barlow et al. 1991), and consistent with a role that is antagonistic to Igf2 function, 
mice inheriting a maternal deletion in the Igf2r gene displayed embryonic overgrowth, 
weighing 130% of wild-type littermates at birth (Lau 1994; Wang et al. 1994). Double 
mutant embryos carrying a maternal deletion of H I 9 and proximal flanking 
sequences, such that Igf2 was biallelically expressed and in addition carry a maternal 
deletion in Igf2r, such that IGF2 turnover is compromised, accumulated IGF2 protein 
to extremely high levels. This excess of IGF2 caused somatic overgrowth, 
visceromegaly, placentomegaly, omphalocele, and cardiac and adrenal defects, all of 
which are consistent with the BWS phenotype (Eggenschwiler et al. 1997).
H19
The H I9 gene is thought to produce one of the most abundant transcripts known 
(Brannan 1990). H19 RNA behaves as a classical mRNA, in that it is transcribed by 
RNA polymerase II, 5’ capped, polyadenylated, spliced and exported to the cytoplasm 
(Brannan 1990). The structure o f the H I9 gene is highly similar in humans and mice 
(Figure 1) consisting of 5 exons separated by four small introns, with transcription
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initiated from a single promoter in both cases (Pachnis et al. 1988). The H I9 gene is 
tightly linked to Ig/2 in humans and mice, with the two genes separated by 
approximately 90kb o f intervening sequence in the mouse (Zemel et al. 1992). H I9 is 
oppositely imprinted to Igf2 in both species, showing predominant expression from 
the maternal allele in most tissues (Bartolomei et al. 1991; Zhang 1992).
Overall, the human and mouse H I 9 homologues share 77% identity at the DNA 
sequence level, with several open reading frames (ORFs) identified in both species, of 
which the largest example in the mouse is sufficient to encode a protein o f 14kDa, yet 
strikingly, no ORF conserved along its entire length exists between the two species 
(Pachnis et al.; Brannan 1990). To date, no description of a protein coding function 
for H I9 has emerged and the gene is widely held to function as an RNA.
Several targeted deletions of H I9 have been described in mice, though none reveal 
clear evidence o f a functional role for this gene (Leighton 1995; Ripoche et al. 1997; 
Schmidt et al. 1999), however evidence from an in vitro study implicates tumour 
supressor activity for H I9 RNA, possibly consistent with a role in negatively 
regulating growth (Hao 1993). The tight linkage, reciprocal imprinting and 
overlapping spatio-temporal expression of H I 9 with Ig/2 has led to speculation that 
the two genes might be functionally coupled. H19 RNA has been observed to co- 
localise with Ig/2 mRNA on polysomes and other in vitro work has shown that a 
region encoded by exons 4 and 5 o f the mature transcript was required both for 
interaction with the Ig/2 mRNA binding protein (IMP) and for its own targeting to 
cytoplasmic sites where IMP is localised (Li et al. 1998; Runge et al. 2000). These 
studies point to an attractive hypothesis where H I 9 RNA co-localises with Igf2 
mRNA in the cytoplasm, potentially regulating Ig/2 expression in trans by a 
posttranscriptional mechanism. In the absence of firm in vivo evidence supporting this 
proposal, the function o f the H I9 gene remains obscure, though the high levels to 
which H I 9 RNA accumulates and its conservation across several species suggest that 




The Ig/2 and H I 9 genes are widely expressed in both the mouse embryo and 
extraembryonic tissues during development and strikingly, display almost identical 
spatio-temporal expression patterns (Figure 2). It is generally accepted that both 
genes are highly expressed in derivatives of endoderm, mesoderm and neural crest 
from early stages o f development and in each case transcripts become highly 
abundant in most major organ systems during their formation (Beck 1987; 
Stylianopoulou et al. 1988a; DeChiara et al. 1991; Poirier 1991). Igf2 and H19 
expression is confined to embryonic stages of development and declines sharply in 
most tissues shortly after birth, though H I9 expression in mice has been reported to 
persist at low levels in skeletal muscle postnatally (Poirier 1991). Whilst the spatio- 
temporal characteristics o f IGF2 and H I9 expression in humans are similar to that of 
the mouse (Lustig 1994; Ohlsson et al. 1994), there are some exceptions. Most 
notably, in humans IGF2 expression persists at high levels in the liver o f adults where 
it occurs from both alleles (Ekstrom et al. 1995), whilst in mice, Igf2 expression is 
lost from the liver during early postnatal stages and does not occur in the adult.
Brain
Early investigations that utilised an in situ hybridisation approach revealed a stark 
contrast in Igf2/H19 gene expression levels between peripheral mesoderm and 
endoderm derivatives, in which both genes found to be broadly and abundantly 
expressed and the central nervous system (CNS), where expression appeared to be 
almost completely absent (Beck 1987; Stylianopoulou et al. 1988a; Stylianopoulou et 
al. 1988b; DeChiara et al. 1991; Poirier 1991)(and see Figure 2). Though Ig/2 
expression was not generally apparent, intense hybridisation signals were noted at 
highly discrete sites, which corresponded to the choroid plexi, projecting into each of 
the four cerebral ventricles (Stylianopoulou et al. 1988b). Igf2 expression localised 
both to the choroid plexus epithelium, a neuroectodermal derivative and the stromal 
core o f this organ, which arises principally from mesoderm (Stylianopoulou et al. 
1988b; DeChiara et al. 1991; Catala 1998). The structure and development o f the 
choroid plexus is discussed more fully in a later section of this chapter. Igf2 
expression was also found in the two innermost membranes surrounding the brain and 
spinal cord, the pia mater and arachnoid mater, known collectively as the
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Figure 2. Igf2 and H19 mRNA expression during embryogenesis.
In situ hybridisation in embryos at e l4.5 of gestation shows 
expression of the Igf2 and H19 genes (dark purple staining) in a 
closely overlapping distribution, that principally involves the 
mesodermal and endodermal lineages. Magnifications xl2.
leptomeninges and in addition, was detected in the trabeculae, the cytoplasmic 
processes that interconnect these membranes (Stylianopoulou et al. 1988b; DeChiara 
et al. 1991). Ig/2 is not imprinted and is biallelically expressed at these sites, with 
expression from both alleles continuing at adult stages, contrary to all other sites 
where its expression is imprinted and downregulated shortly after birth (DeChiara et 
al. 1991; Svensson 1995). That is, Ig/2 escapes imprinted regulation in the choroid 
plexus and leptomeninges.
More recent work has established that biallelic Igf2 expression occurs in further 
derivatives of neuroectodermal origin, in mid to late gestation embryos, including the 
neuroepithelium in the vicinity of the optic recesses and in bilateral stripes running 
through the neuroepithelium parallel to the ventral medial region of the hindbrain 
(Hemberger 1998). Igf2 expression has also been observed in the granule cell layer of 
the cerebellum at postnatal stages, though in contrast to other sites o f brain 
expression, this was reported to occur predominantly from the paternal allele (Hetts 
1997). As might be expected on the premise of its co-expression with Igf2 in most 
other tissues, H I9 expression has also been reported in the choroid plexus and 
leptomeninges o f the developing brain, but in contrast to Ig/2, maintains imprinting 
with maternal-specific expression at these sites (Svensson 1995).
Biallelic IGF2 expression has been described in the choroid plexus and leptomeninges 
of the developing human fetus (Ohlsson et al. 1994; Pham 1998) and at several other 
sites including the pons, Raphe nucleus and hypothalamus (Pham 1998) though in 
contrast to the mouse, H I 9 expression, where examined, has not been detected at 
these sites (Ohlsson et al. 1994). However, biallelic H19 expression has been 
observed in whole human fetal brain analyses (Pham 1998). The reasons for this 
discrepancy are unclear but could be explained by the slightly different developmental 
stages that were analysed by the two groups.
C/s-elements required for lgf2IH19 expression
The overlapping expression patterns, reciprocal imprinting and tight linkage of Ig/2 
and H19 has led to the suggestion that the two genes are co-ordinately regulated. 
Numerous molecular studies have identified and characterised several c/s-acting 
regulatory elements surrounding the Igf2/H19 locus that are required for the correct
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tissue-specific expression of both genes (for review see (Amey 2003)). Elements that 
confer gene expression in derivatives o f each of the three principal embryonic layers, 
endoderm, mesoderm and ectoderm (brain) will be briefly discussed.
Endoderm-specific elements
Co-expression of Igf2 and H I9 in endoderm tissues is attributed to a pair of shared 
enhancers, termed here as the H I 9 enhancers, situated in a region +9 to +11 kb relative 
to the H I9 transcription start site (Yoo-Warren et al. 1988)(and see Figure 1). The 
tissue-specific function of this region was originally identified with an in vitro 
approach, which revealed enhancer activity in liver derived cell lines but not HeLa 
cells (Yoo-Warren et al. 1988). Analysis o f this region within the context of a 
germline deletion corroborated the tissue-specific enhancer activity of these elements 
observed in the earlier in vitro analysis. Upon paternal transmission o f the deletion, 
Ig/2 expression, but not H I9 expression, was substantially downregulated in tissues 
having a significant endoderm component, in particular the liver and gut, yet there 
was little or no change in the level o f expression in skeletal muscle or brain. Upon 
maternal transmission, a reciprocal phenotype was observed with H I 9 expression 
reduced in an identical range of tissues and Ig/2 expression unaffected (Leighton et al.
1995). Therefore, the endoderm-specific expression of both Ig/2 and H I9 is dependent 
upon a shared enhancer region.
Mouse transgenic studies indicate that, in addition to functioning in endoderm, 
regional activity o f the H I9 enhancer pair may also encompass non-endodermal 
tissues. Consistent with the transient and knockout experiments, these elements 
reproducibly conferred upon H I 9 promoter-lacZ reporter transgenes, expression in 
liver and gut endoderm, but were also able to drive reporter gene expression in the 
sclerotome compartment of the somites, a mesoderm derivative that later generates 
the spinal vertebrae (Brenton et al. 1999). More recent analysis of each of the two 
elements separately upon distinct transgenes, indicates that the property o f endoderm 
specific activity resides entirely in the 3’ most element, with enhancer activity in 
sclerotome conferred by the 5’ most element of the pair (Ishihara and Jinno 2000). 
Therefore, the H I9 enhancer region principally upregulates Igf2 and H I9 expression 




As discussed, whilst a subset of Igf2/H19 mesoderm-specific expression may be 
attributed to activity within the H I 9 enhancer region, this is clearly not sufficient to 
account for the complete range o f mesodermal expression exhibited by the two genes, 
thus arguing for the existence of additional enhancer elements at this locus. The co­
expression of Ig/2 and H I 9 in mesoderm argues that the two genes might share 
elements conferring expression in this lineage, as is the case for the endoderm 
enhancers. In pioneering work, a 130kb yeast artificial chromosome (YAC) transgene 
that contained sequences inclusive of Igf2 exon 1 to a position +36kb relative to the 
H I 9 transcription start site (represented in Figure 1), was shown when present at low 
copy number, to confer appropriate expression of a lacZ reporter gene in a range of 
mesodermal tissues including skeletal muscle, consistent with the known expression 
profile of the endogenous Ig/2 gene, though expression in cardiac muscle was not 
conferred by the YAC (Ainscough et al. 1997). The authors concluded that elements 
conferring gene expression in mesodermal tissues and skeletal muscle, but not cardiac 
muscle must be located within the boundaries of the 130kb domain defined by the 
YAC. A subsequent study that utilised the same large YAC, provided evidence that at 
least three distinct enhancer regions are required for correct H I9 expression and that 
expression o f the gene in skeletal muscle is conferred by an activity that is separable 
from that driving expression in the remaining mesoderm tissues (Ainscough et al. 
2000a). These early experiments provided the first indication that mesodermal 
expression o f Igf2/H19 is unlikely to be under the control o f a single region, therefore 
implicating the involvement of multiple elements for correct expression in this 
lineage.
A subsequent study identified three putative enhancer elements situated in the +22kb 
to +28kb interval with respect to the H I9 gene, which were subsequently shown to 
confer upon Igf2 promoter -lacZ reporter transgenes, expression in several mesodermal 
derivatives, consistent with the findings of the large YAC transgene (Ishihara and 
Jinno 2000). In an independent study, elements from within this region demonstrated 
enhancer activity in muscle-derived cell lines, thus supporting the transgenic data 
(Kaffer 2000). The requirement for these elements in directing Igf2 and H19 
expression in skeletal muscle and other mesodermal tissues was formally addressed 
by creation o f 24kb deletion that removed a region spanning +10kb to +34kb relative
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to H I 9, including the putative enhancers. Maternal transmission of the deletion led to 
a dramatic reduction o f H I 9 expression in skeletal muscle and tongue, but not in other 
mesodermal tissues such as heart, lung, kidney or placenta. Paternal inheritance of the 
deletion led to a qualitatively identical reduction in Igf2 expression, though the 
quantitative effects of the deletion were not as significant as those observed for H I 9 
(Kaffer et a l  2001). This study nonetheless confirmed the expectation that Ig/2 and 
HI 9 utilise shared skeletal muscle enhancers located downstream of H I 9 (see Figure 
1), consistent with the expression pattern of the large YAC transgene (Ainscough et 
a l 1997). This work also indicated that elements governing expression in other 
mesodermal tissues (heart, lung, kidney, placenta) must lie outside of the region 
deleted.
Recent work in the context of the mouse mutant, minute (mnt), which carries a small 
chromosomal inversion, has clarified the issue o f these elusive elements. Genomic 
analysis mapped the first breakpoint o f the mnt inversion to a region approximately 
25kb downstream of H I 9, where the skeletal muscle enhancers are located. It was 
perhaps then unsurprising that paternal inheritance of mnt led to severely reduced Igf2 
expression in skeletal muscle and tongue, however, almost all other tissues with a 
mesodermal component including heart, kidney, lung and placenta were similarly 
affected (Davies et a l  2002). The authors concluded, when considered with prior 
transgenic and knockout experiments, evidence from the mnt study indicates that the 
additional mesodermal elements lie further 3’ of the skeletal muscle enhancers. 
Collectively, the evidence from studies of YAC transgenes, germline deletions and the 
mnt mutant indicate that the majority o f elements conferring Igf2 and H I9 expression 
in tissues of mesoderm and endoderm origin, where both genes are imprinted, are 
located 3’ of H I 9. There are, however, important exceptions to this rule as recent 
transgenic studies provide evidence that additional enhancers with some activity in 
mesoderm derivatives, possibly specific to Ig/2, reside within two distinct regions 
situated 5’ o f H I 9 in the Igf2/H19 intergenic region (Drewell et a l  2002a; 
Charalambous et a l  2004).
Brain-specific elements
Igf2 is biallelically expressed in the exchange tissues o f the brain, the choroid plexus 
and leptomeninges o f the brain (DeChiara et al. 1991) though mechanisms regulating
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its expression at these sites are not fully understood. Whilst several tissue-specific 
enhancer regions exist 3’ of the H I9 gene, it seems unlikely that these elements are 
sufficient for regional enhancement of Igf2 expression in the brain, although that the 
choroid plexus stroma and leptomeninges are comprised of a significant mesoderm 
component, a lineage in which the 3’ enhancers are active, argues that these elements 
might play a minor role (Catala 1998).
The CCD
The centrally conserved domain (CCD) was originally identified by Koide et al. 
(Koide et al. 1994) in a study of a 130kb genomic region that included both Ig/2 and 
H I9 genes. The CCD, a 2kb region of GC-rich sequence, is located approximately 
32kb 5’ of the H I9 gene in the mouse (see Figure 1) and is conserved in mammals. In 
all tissues examined, the CCD has been found to be unmethylated and in addition, the 
region exists in open chromatin conformation, as evidenced by the presence of three 
sites of strong hypersensitivity to the nuclease, DNAsel, a feature that is highly 
suggestive o f a functional role (Koide 1994).
A more recent study refined the earlier analysis of this region, identifying two blocks 
of sequence, region 1 and region 2 that are highly conserved between humans and 
mice. Region 1 exhibits 86% similarity between the two species over lOObp and 
coincides with the three sites of DNasel hypersensitivity observed previously (Koide 
1994). Deletion o f the 5’ most lkb of the CCD within the context o f a large YAC 
transgene, which removed region 1 and the hypersensitive sites resulted in 
reactivation of the maternal Igf2 allele in a subset of tissues with a significant skeletal 
muscle component, including the tongue, after e l7.5 o f development, continuing at 
postnatal stages (Ainscough et al. 2000b). That is, region 1 contains a muscle-specific 
silencer element that functions in late embryogenesis and in postnatal development.
Region 2 displays 87% similarity between humans and mice over approximately 
200bp, and intriguingly, contains an ORF that is conserved along its entire length in 
mouse, rat and human sequence, though three independent studies have failed to 
detect transcripts from this region (Koide et al. 1994; Ainscough et al. 2000b; 
Charalambous 2000).
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Several lines of evidence demonstrate that enhancer elements conferring Igf2 
expression in the choroid plexus and leptomeninges reside within the CCD. Ward et 
al. (Ward et al. 1997) observed that the CCD, when present upon an Igf2 promoter 
(P3)-Luciferase reporter transgene, increased reporter gene activity in whole brain 
lysates by greater than 40-fold compared against that o f a control transgene containing 
P3-Luciferase alone. More detailed analysis of V3-Luciferase~CCD lines revealed that 
reporter gene expression levels were more than 20-fold enriched in pooled lysates of 
dissected choroid plexus and leptomeninges, compared with lysates prepared from 
whole brain tissue depleted of these tissues, thus indicating that the CCD specifically 
upregulates Igf2 promoter activity at these sites (Ward et al. 1997). A recent study 
demonstrated that the CCD, when placed in cis to a P3-lacZ reporter transgene, 
reproducibly conferred reporter gene expression in the choroid plexus and 
leptomeninges, thus corroborating the findings o f the earlier transgenic analysis. In 
the same study, the CCD was reported to confer reporter gene expression in additional 
tissues, where Ig/2 is imprinted, including the dorso-lateral compartment of the 
somites, the intrinsic muscles of the tongue and a range of neural crest derivatives 
(Charalambous et al. 2004).
The function o f the CCD has also been tested within the context o f a 12kb germline 
deletion, in which a substantial decrease in the level of Igf2 expression was observed 
specifically in the choroid plexus and leptomeninges, whether the deletion was 
inherited from either parent. Therefore, the CCD acts as an enhancer of Ig/2 
expression upon both parental alleles in the exchange tissues of the brain. 
Interestingly, the deletion did not completely eliminate Ig/2 expression from these 
sites, suggesting that additional elements, presumably located outside o f the 12kb 
deletion, are required for quantitatively normal expression in these tissues. By 
contrast, no change in the level o f H I9 RNA was reported, either in the brain or at any 
other site, suggesting that the CCD, when present at its normal endogenous position, 
does not mediate expression of H I9 (Jones et al. 2001). In addition to the effects upon 
Igf2 in the brain, a slight relaxation of Igf2 imprinting was observed in skeletal muscle 
and tongue upon maternal inheritance of the deletion (Jones et al. 2001), an 
observation consistent with the presence of a maternal allele-specific muscle silencer 
described at the CCD in an earlier report (Ainscough et al. 2000b).
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Current evidence therefore supports a multifunctional role for the CCD, principally as 
a regional enhancer o f Ig/2 expression in the choroid plexus and leptomeninges (Ward 
et al. 1997; Jones et al. 2001; Charalambous et al. 2004), where the gene is 
biallelically expressed, but also as an allele-specific silencer with activity in muscle, 
where Igf2 is imprinted (Ainscough et al. 2000b; Jones et al. 2001). Deletion 
experiments assign the silencer function of the CCD to the first o f two blocks of 
conserved sequence, region 1. Since no change in the level o f Igf2 expression was 
reported in the choroid plexus and leptomeninges following the deletion o f region 1, 
the most likely location for the exchange tissue enhancers is region 2, the function of 
which remains to be verified (Ainscough et al. 2000b).
Differentially methylated regions at lgf2IH19
Correct genome methylation was shown to be essential for imprinting of the Igf2 and 
H I9 genes, by analysis o f embryos homozygous for a mutation in the Dnmtl gene, 
where H I9 was biallelically expressed and Igf2 silenced upon both alleles (Li 1993). 
That is, methylation regulates both genes, but in a directly opposing manner. As 
already discussed, regions o f differential methylation (DMRs) have been shown to 
overlap CpG-rich sequences located in the vicinity o f imprinted genes, but not non­
imprinted loci, and it is generally accepted that this modification constitutes at least 
part of the marking process that distinguishes the parental origin o f the alleles (Reik 
2001b)(and references therein).
For differential methylation to meet the criteria of a primary imprinting mark that 
distinguishes the parental alleles, this modification must be established in the gametes, 
whilst the parental genomes are separated, then be maintained postzygotically such 
that the methylated allele withstands demethylation at preimplantation stages and the 
unmethylated allele is protected against de novo methylation during early post 
implantation development, with the marks sustained in somatic tissues thereafter. 
Several DMRs have been identified in sequences surrounding the Igf2 and H I 9 genes 
and as will become evident from the following text, these regions contain regulatory 
elements that either promote or repress gene expression dependent upon their 
methylation status.
44
Differential methylation at H19
The HI 9 gene is hypermethylated upon the inactive paternal allele in a region that 
encompasses the gene body and 4kb of immediate 5’ flanking sequence, in sperm and 
in somatic tissues (Bartolomei et al. 1993; Brandeis et al. 1993; Ferguson-Smith 
1993). However, the maintenance of differential methylation throughout the entire 
course of pre- and postimplantation development, is restricted to a 2kb region 
positioned -2  to —4 kb relative to the H I 9 transcription start site, consistent with the 
qualities of an imprinting mark (Tremblay et al. 1995; Tremblay et al. 1997). By 
contrast, the immediate promoter-proximal region and the structural gene are 
demethylated in the blastocyst and reacquire differential methylation during 
subsequent post implantation development (Brandeis et al. 1993; Tremblay et al. 
1995; Tremblay et al. 1997), indicating that these regions do not act to distinguish the 
alleles.
The DMD
As described above, the differentially methylated domain (DMD) positioned -2kb to 
-4kb upstream relative to H19 (see Figure 1), bears epigenetic features consistent 
with functioning as a primary imprinting signal, in that its paternal-specific 
methylation is established in the gametes and is not altered by waves o f demethylation 
and de novo methylation that successively sweep through the genome during pre­
implantation development (Tremblay et al. 1995; Tremblay et al. 1997). In addition to 
these modifications, the DMD is also marked by parental origin-specific differences 
in chromatin structure between the alleles. Sites of hypersensitivity to nucleases, map 
within two blocks o f sequence, HS1 and HS2, located approximately -3.8kb and -  
2.5kb relative to the H I9 transcriptional start site and are specific to the unmethylated 
maternal allele (Hark and Tilghman 1998). Subsequent analyses o f this region 
observed that the maternal allele bears an unusual chromatin conformation, consistent 
with local displacement of the nucleosomal array by non-histone protein-DNA 
interactions (Khosla et al. 1999; Kanduri 2000a). Therefore the DMD exists in 
alternate epigenetic states, dependent upon its parental origin. Subsequent studies 
have established that it constitutes an imprinting control region (ICR) with the 
paternal epigenotype (methylation) and the maternal epigenotype (chromatin 
insulator) respectively required for the monoallelic expression o f the H I 9 and Igf2
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genes. The work that has elucidated these functions of the DMD is discussed in the 
text below.
Early transgenic experiments provided evidence that the DMD contained sequences 
sufficient to direct imprinting at the H I9 locus. A 14kb transgene, which included 4kb 
of the H I9 5’ flanking sequence, an internally deleted H I 9 gene and an 8kb portion of 
the 3’ region including the endodermal enhancers, displayed imprinted expression and 
parental origin-specific methylation in a manner consistent with that o f the 
endogenous H I9 locus (Bartolomei et al. 1993). That is, the transgene was expressed 
and hypomethylated upon maternal transmission, but silenced and hypermethylated 
upon paternal transmission. When a 2kb region (containing the DMD) was deleted 
from the 5’flanking region, the transgene was expressed and hypomethylated, 
irrespective o f the sex of the transmitting parent (Elson and Bartolomei 1997). 
Therefore, the DMD contains sequences sufficient to confer imprinting, at the levels 
o f both parental allele specific expression and methylation, at ectopic loci.
As discussed earlier, the almost identical spatio-temporal expression patterns and 
reciprocal imprinting o f the Igf2 and H I 9 genes is suggestive of a functional link 
between the two genes. Deletion o f distinct enhancer regions located 3’ of H I9 has 
established that the expression of both genes is, in endodermal and some mesodermal 
tissues, dependent upon shared elements (Leighton et al. 1995; Kaffer et al. 2001). 
Deletions encompassing the H I 9 gene region provided the first indications that the 
imprinting o f the two genes might also be functionally coupled. When the H I9 gene 
was deleted along with its 5’ flank (which contains the DMD) from the maternal 
chromosome, reactivation of Ig/2 was observed in cis (Leighton 1995). Analysis of a 
smaller deletion that removed the H I 9 structural gene, but not the 5’ flank, showed 
that whilst Igf2 was again reactivated, the effect was minor in comparison with that 
observed in the large deletion (Ripoche et al. 1997), thus arguing that the 5’ flank of 
H I9 (and hence the DMD) plays a functional role in silencing at the Igf2 locus.
The necessity o f the DMD at its endogenous location for both Ig/2 and H I 9 
imprinting was formally demonstrated by deletion of a 1.6kb region between -3.7kb 
and -2.1 kb upstream of H I 9, which removed most of the differentially methylated 
sequences and the hypersensitive sites. Paternal transmission of this deletion led to
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reactivation o f H I 9 expression in a subset of tissues, including liver and gut endoderm 
and skeletal muscle, with a concomitant loss of methylation in the adjacent promoter- 
proximal region and structural gene. Upon maternal transmission, the reciprocal 
situation was seen, with reactivation o f the normally silent Igf2 allele (Thorvaldsen et 
al. 1998). The DMD is therefore required for the imprinted expression of both genes.
Whilst the work o f Thorvaldsen et al. demonstrated the requirement of the DMD for 
imprinting at Igf2/H19, it failed to differentiate between a role in establishment or 
maintenance o f imprinting. To discern the exact role of the DMD, a subsequent study 
utilised the approach of cre-loxP mediated conditional mutagenesis to delete this 
region at three different developmental stages, in the germline, in the zygote and in 
differentiated tissue. Paternal deletions of the DMD in the germline and zygote, led to 
reactivation o f H I9 expression in cis and loss of methylation in the adjacent promoter- 
proximal region, therefore demonstrating a requirement of this region for 
establishment of imprints in the germline and for maintenance during post-zygotic 
development. However, following deletion of the DMD in differentiated tissues, 
paternal-specific silencing and methylation o f H I9 was maintained. Deletion o f the 
DMD on the maternal chromosome resulted in reactivation of Igf2 in cis, irrespective 
of whether the deletion was imposed in the germline, the zygote or in differentiated 
tissue (Srivastava 2000). The DMD was therefore proposed to contain two distinct 
functions. The first is required to establish silencing o f the paternal H I9 allele during 
early development by directing methylation of its promoter region (and possibly 
induction of heterochromatin), but is dispensable for maintenance o f H I 9 silencing in 
differentiated tissues. By contrast, the presence of a second silencing function is 
required at all stages o f development to repress the maternal Igf2 allele. Both 
functions are discussed below.
Silencer function o f  the DMD
The conclusion o f Srivastava et al. that silencing of Ig/2 and H I 9 is conferred by 
separate mechanisms is supported by analysis of a smaller 1.2kb deletion within the 
DMD, that removed sequences between -2.9kb to -1.7kb, including the hypersensitive 
site, HS2. Paternal transmission of this deletion led to reactivation of H I 9 in cis, in a 
subset of endodermal tissues, though there was no effect upon Igf2 following maternal 
transmission o f the deletion, indicating that the sequences necessary for its imprinting
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were intact. Surprisingly, the deletion did not affect the differential methylation o f the 
remaining DMD sequences or the adjacent H I9 promoter-proximal region (Drewell et 
al. 2000). The authors concluded that the 1.2kb element acts specifically to silence the 
paternal H I 9 allele in a subset of tissues by a mechanism that appeared to be 
independent o f DNA methylation. This conclusion is consistent with an earlier study 
in which the same 1.2kb mouse element conferred silencing upon reporter genes in 
transgenic Drosophila, a species that lacks genome methylation (Lyko et al. 1997). 
However at its endogenous location, the silencer is methylated exclusively upon the 
paternal allele, therefore this modification could play some role in the allele-specific 
activity o f this element. A subsequent study has demonstrated that the methyl-binding 
domain (MBD) containing repressor, MeCP2, is recruited to the silencer in vivo, with 
this protein and HDAC activity required for DMD-mediated silencing of a reporter 
gene in vitro (Drewell et al. 2002b).
The silencing o f the paternal H I9 allele is therefore likely to be mediated by paternal- 
specific methylation o f the DMD, which spreads into the H I 9 promoter region during 
postimplantation development and initiates a stable heterochromatic state. This 
appears to be directed by the protein MeCP2, but possibly involves a methylation- 
independent silencing mechanism.
Insulator function o f  the DMD
Chromatin insulators are thought to define distinct transcriptional domains in the 
genome, preventing inappropriate gene silencing or activation by restricting the 
expansion of heterochromatin and blocking promoter-enhancer interactions (reviewed 
in (Bell 1999a)). To be functional, an insulator must be positioned between a 
promoter and an enhancer to prevent the enhancer activating transcription. Insulator 
elements therefore block promoter-enhancer communication in a position dependent 
manner.
Two lines of evidence suggested that insulator activity might be present within the 
DMD, possibly involved in silencing Ig/2 by blocking access to shared enhancers 
located 3’ of H I 9. Relocation of the H I9 endoderm enhancers from their endogenous 
location to a position 5’ of H I9 in the intergenic region resulted in reactivation of the 
maternal Igf2 allele in tissues where these enhancers are normally active (Webber et
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al. 1998). In further work, the DMD was relocated to a position between the 
endodermal and skeletal muscle enhancers, where upon maternal inheritance o f this 
mutation, H I 9 expression was drastically reduced in muscle but unaffected in 
endodermal tissues (Kaffer 2000). Location of enhancers relative to the DMD is 
therefore a critical determinant o f imprinting mechanisms at the Igf2IH19 locus. The 
dependence of Igf2 and H19 expression on the position of enhancers relative to the 
DMD could be explained by a model proposing the existence of an insulator within 
this region.
In vitro studies have examined the insulator function of the DMD, when in isolation 
from its genomic context. As such the full length DMD was shown to confer position 
dependent silencing upon reporter gene constructs consistent with having insulator 
function. (Bell 2000; Hark et al. 2000; Kanduri 2000a; Holmgren 2001). Analysis of 
smaller fragments o f the DMD mapped this activity to the hypersensitive sites, H S1 
and HS2, identified within this region by an earlier study (Hark and Tilghman 1998).
Binding sites for the protein, CTCF, a critical regulator o f the chicken p-globin 
insulator (Bell 1999b), were identified within these hypersensitive sites (Bell 2000; 
Hark et al. 2000). Experiments performed in vitro established that insulator activity is 
dependent upon CTCF binding at these sites, and that this binding occurs in a 
methylation-dependent manner. Methylation of CpGs within the CTCF-binding sites 
eliminated binding of CTCF in vitro, and deletion of these sites from the context of 
the DMD resulted in loss o f enhancer-blocking activity in tissue culture cells, thereby 
permitting expression of a reporter gene (Bell 2000; Hark et al. 2000). Therefore, 
activity of the insulator is mediated by the protein, CTCF, and is restricted to the 
unmethylated maternal allele of the DMD.
In more recent work, targeted mutagenesis was employed to introduce point mutations 
into each of the four CTCF binding sites within the DMD, thus testing the 
requirement for CTCF in Igf2 imprinting in vivo. Maternal transmission o f this 
mutation led to reactivation of Igf2 expression, consistent with disrupted CTCF 
binding and loss of insulator function on the maternal allele. Methylation analysis of 
the mutated DMD revealed that whilst the correct unmethylated state was essentially
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maintained in oocytes and blastocysts, abnormal methylation of this region was 
observed in differentiated tissues. Therefore, in addition to its role in activating the 
insulator, CTCF binding also is required to maintain the maternally unmethylated 
state of the DMD during postimplantation development (Schoenherr et al. 2003). A 
recent report describing disruption of CTCF function in oocytes by an RNAi-mediated 
approach, provided evidence in support of a role for CTCF in maintaining the 
unmethylated state of the DMD in this tissue (Fedoriw et al. 2004), contrary to the 
findings of Schoenherr et al. Despite this inconsistency, both studies point to an 
additional role for CTCF in conferring protection against aberrant de novo 
methylation during development.
In summary, imprinted expression of Igf2 is mediated, principally, by a methylation- 
dependent insulator function of the DMD. In the unmethylated state, the insulator 
blocks interaction of Igf2 promoters with tissue specific enhancers located 3’ of HI 9, 
thus explaining the silence of the maternal Igf2 allele. Paternal-specific methylation of 
the DMD abolishes insulator activity, allowing enhancers to engage the Igf2 
promoters, leading to transcription o f the paternal Igf2 allele. Bound CTCF protein 
appears to be required to maintain the unmethylated state o f the DMD that is crucial 
for this insulator function. An anticipated consequence of this insulator activity is that 
enhancers driving Igf2 expression in imprinted tissues will be located 3’ of the DMD 
and their activity thus blocked on the maternal allele. As discussed in an earlier 
section o f this chapter, the majority of enhancers conferring expression in imprinted 
endodermal and mesodermal tissues are located 3’ of the H I 9 gene (Leighton et al. 
1995; Kaffer et al. 2001), thus supporting this assertion. By the same argument, this 
model of imprinting predicts that enhancers driving non-imprinted, or biallelic 
expression will be located 5’ o f the DMD, thereby avoiding the influence of the 
insulator. The identification o f an enhancer, the CCD, which is located 5’ of the DMD 
in the intergenic region and drives biallelic Igf2 expression in the choroid plexus and 
leptomeninges, fulfils this prediction (Jones et al. 2001; Charalambous et al. 2004).
Differential methylation at lgf2
Three regions o f differential methylation mark the Igf2 gene (see Figure 1). DMR0, 
which overlaps Ig/2 promoter 0 (P0), the site of initiation o f a placental-specific
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transcript, displays maternal allele specific methylation exclusively in the placenta but 
is biallelically methylated in embryonic tissues (Moore et al. 1997).
DMR 1 overlaps a 600bp region located approximately 3kb 5’ of Igf2 promoter 1. A 
further region, DMR2, is located within the Igf2 structural gene and covers a 2.4kb 
region spanning exons 4-6. Both DMRs display predominant methylation of the 
paternal chromosome in the majority o f tissues. However, these modifications though 
present in sperm, are lost during pre-implantation development and re-established at 
later stages and therefore are not thought to represent primary imprinting marks 
(Sasaki et al. 1992; Brandeis et a l  1993; Feil et al. 1994; Moore et al. 1997). 
Intriguingly, both regions are highly methylated upon both parental alleles in the adult 
choroid plexus, a tissue where Ig/2 is biallelically expressed, providing evidence of an 
epigenetic basis to this non-imprinted mode of expression (Feil et al. 1994). A 
detailed study o f these regions during embryogenesis revealed that their differential 
methylation is most pronounced in tissues with a significant mesodermal component, 
with the exception of skeletal muscle, in which both regions are methylated 
equivalently until birth (Weber 2001). Additionally, the correlation between paternal- 
specific methylation o f these DMRs and the exclusive paternal-specific expression of 
Igf2 in many tissues has led to the hypothesis that these regions harbour silencer 
elements that are inactivated by methylation.
The requirement o f DMR 1 for Igf2 imprinting was tested within the context o f a 5kb 
germline deletion. Upon maternal transmission of the deletion, Igf2 expression was 
reactivated in most mesodermal tissues, but not skeletal muscle. Paternal or maternal 
transmission of the deletion led to continued expression of Ig/2 postnatally, in contrast 
to the wild type gene, which is silenced shortly after birth in most tissues. In addition 
the deletion had no effect upon the expression or imprinting of H I 9 (Constancia et al. 
2000). Therefore, DMR1 contains a methylation-dependent silencer element that is, 
required for imprinting of Igf2 in mesodermal tissues, with the exception of skeletal 
muscle. In further work, an additional silencer element was identified within this 
sequence, with its silencing function mediated by methylation-dependent binding of 
the repressor protein, GCF2, though this activity was not shown to be tissue specific 
(Eden et al. 2001).
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The necessity of DMR2 for imprinting at Igf2 was addressed by insertion of a lacZ 
reporter gene cassette, replacing a 4.65kb region between exons 4-6 that included 
DMR2. However, deletion of this region did not lead to reactivation of the maternal 
Igf2 allele, as assayed by examination of reporter gene expression following maternal 
transmission of the mutation. Therefore, in contrast to the role demonstrated for 
DMR1, DMR2 is not required to silence the maternal Ig/2 allele. However, in the 
same study, deletion o f an intensely methylated 54bp core element located within 
DMR2 led in decreased Igf2 expression, consistent with a function in activating 
transcription. Analysis o f this region in vitro revealed that the activating function of 
this element was regulated by its methylation (Murrell et al. 2001). Therefore, a core 
element within the DMR2 region activates Igf2 expression in a methylation-dependent 
manner.
The role of DMR 1 and DMR2 in mediating ///9-independent silencing and activation 
respectively, argues for the existence of imprinting controls distinct from that 
provided by the DMD. Interestingly, recent work indicates that correct parental 
origin-specific methylation within both Ig/2 proximal DMRs is directed by 
modifications at the DMD acting in cis. Whilst paternal-specific methylation in these 
DMRs is normally established after implantation, both DMR1 and DMR2 were 
incorrectly de novo methylated upon the maternal chromosome following deletion of 
the DMD in cis. In addition, DMR2, but not the DMD, became methylated upon the 
maternal chromosome following deletion of DMR1 (Lopes et al. 2003). Therefore, 
the DMD is required on the maternal allele to protect DMR1 and 2 from methylation, 
and DMR1 is required to protect DMR2, but not the DMD, from methylation 
suggesting that the establishment of epigenetic modifications within these DMRs is 
coordinated in a hierarchical fashion.
The Choroid Plexus
There are four choroid plexuses in the brain, the two largest being found in the lateral 
ventricles, a smaller structure in the third ventricle and a morphologically distinct 
structure occurring in the fourth ventricle. The choroid plexuses are the major sites of 
cerebrospinal fluid (CSF) production that circulates through the ventricles and out into 
the subarachnoid space, providing both buoyant protection and nourishment to the 
brain and spinal cord (reviewed in (Speake 2001)). The choroid plexuses, together
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with the leptomeninges, comprise the major blood-CSF interface, mediating the 
exchange of biologically important molecules such as hormones and growth factors 
between peripheral circulation and the central nervous system (CNS) (reviewed in 
(Segal 2001)).
The choroid plexus is formed by the apposition of two principal components, an outer 
secretory epithelium and a capillary-rich stromal core (see Figure 3). The epithelium 
consists of modified ependyma, a morphologically uniform cuboidal cell layer that 
lines the cerebral ventricles with which it is continuous and sits upon a basement 
membrane that contacts its basal surface. The epithelial cells are connected at their 
lateral surfaces by an occluding band of tight junctions that prevent passive exchange 
between the blood and the CSF by the pathway between the cells (Brightman and 
Reese 1969). In addition, choroid plexus epithelial cells display abundant 
mitochondria, rough endoplasmic reticulum and secretory vesicles, thus suggesting a 
significant involvement in secretion (Sturrock 1979).
Transmission electron microscopy (TEM) imaging of the choroid plexus epithelium 
reveals that the cells are distinctly polarised, with numerous apical microvilli and 
basally located nuclei, features again consistent with a role in secretion. The surface 
of these cells is covered with cilia, the beating of which is thought to facilitate mixing 
and movement o f CSF through the ventricular system. Interestingly, electron lucent 
and dense (light and dark) cells have been observed in the choroid plexus epithelium 
of several mammalian species (Dohrmann 1970; Sturrock 1979). Sturrock, in a study 
of the developing mouse choroid plexus showed that these cells first become apparent 
at e l4.5 o f development and provided quantitative evidence that the light cells 
predominate with the number of dark cells comprising approximately 11% of total 
epithelial cell number at all stages examined thereafter. It was proposed that dark cells 
contain a greater number of subcellular organelles such as mitochondria and 
ribosomes and it was suggested that these cells are engaged in distinct metabolic 
activities. To date, it remains unclear whether this morphological dichotomy translates 
into functional differences, for example in protein synthesis or secretion, or represents 
a mechanism of cell-turnover (Sturrock 1979). That differentiated choroid plexus 
epithelial cells lack the ability to proliferate would seem to exclude a mechanism of 







Figure 3. The choroid plexus. The structure of the choroid plexus is 
represented schematically. The simple columnar epithelium (green nuclei) 
of the choroid plexus is highly folded and is continuous with the 
ependymal cell layer (white nuclei) which lines the ventricles. The 
epithelial cells are polarised and display numerous microvillae upon their 
apical surface which faces the ventricle lumen. The epithelium surrounds 
the capillary rich stromal component of this organ, with which it is 
intimately associated. The principal function of the choroid plexus is the 
synthesis and secretion of CSF and this organ constitutes a major blood- 
CSF interface. The directional movement of CSF across the epithelium is 
indicated by large vertical arrows.
studies implicate a function in fluid homeostasis, as dark cell frequency is increased in 
mice homozygous for the hydrocephalus and polydactyl (hpy/hpy) mutation and also 
in water deprived wild-type mice (Shuman 1991).
The stromal mesenchyme o f this organ is completely enveloped by the epithelial 
component and is principally comprised by the leptomeningeal cells of the pia mater, 
but also contains many other cell-types including fibroblasts, macrophages, neuronal 
termini and importantly, an extensive network of capillary endothelium. Capillaries in 
the choroid plexus stroma are unusual in that they have numerous fenestrations that 
permit access of blood-plasma components to the basal side o f the epithelium, 
contrary to the majority of cerebral capillaries, which have a tight structure and 
constitute the blood brain barrier (Brightman and Reese 1969).
Development of the choroid plexus
The development of the choroid plexus has been studies in a number of species 
(reviewed in (Catala 1998)). Cell lineage studies performed in the chick-quail 
chimaera system reveal that this organ has a dual embryonic origin. The epithelial 
component arises entirely from the embryonic neuroepithelium that lines the lumen of 
the neural tube, whilst the mesenchymal and vascular components o f the stroma are 
derived from cephalic paraxial mesoderm (Wilting 1989).
Morphogenesis o f the choroid plexus in the mouse commences shortly after neural 
tube closure at elO, where a thinning becomes evident in regions of the 
neuroepithelium destined to form the choroid plexus epithelium. During the next two 
days, these regions extend outwards into the ventricle lumen, the motive force for 
which is thought to involve the rapid invasion of stromal mesenchyme from beneath. 
As the evagination of the choroid plexus continues it becomes rigorously folded and 
by el 4.5 o f development has assumed its characteristic lobulate morphology (Sturrock 
1979). The choroid plexus appears first in the fourth ventricle, shortly followed by 
those occupying the lateral and third ventricles, with this order a consistent feature of 
all species examined so far (Dziegielewska 2001) (and references therein). As the 
epithelium cells mature, they undergo transition from a psuedostratified to a tall 
columnar morphology and this morphological differentiation is accompanied by the 
expression of a number o f diagnostic biochemical markers including the thyroid
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hormone transport protein, transthyretin (TTR) and numerous enzymes, consistent 
with a central metabolic role for these cells in the CNS (Murakami 1987; Catala 1998) 
(and references therein).
Genes regulating choroid plexus development
The molecular and genetic basis of choroid plexus morphogenesis is poorly 
understood and in addition, most o f what is known has emerged serendipitously in 
studies of neural fate specification. In rat embryos, expression of the actin-regulatory 
protein, tropomyosin, in the neuroepithelium layer defines future sites o f choroid 
plexus formation before the characteristic folded morphology o f this organ can be 
detected (Nicholson-Flynn et al. 1996). It was proposed that the early appearance of 
tropomyosin expression, which reportedly preceded even that of TTR, reflects the 
active rearrangement o f cytoskeletal elements in preparation for the morphogenetic 
movements that later generate this organ (Murakami 1987; Nicholson-Flynn et al.
1996). These observations suggest that the choroid plexus phenotype is specified at an 
early stage of neuroectodermal differentiation.
The intrinsic capacity of early neuroectoderm to differentiate into choroid plexus 
epithelial cells has been examined using an in vitro approach to culture explanted 
mouse neuroectoderm tissue. Using TTR expression as a differentiation marker, it was 
found that the potential o f the explants to differentiate into choroid plexus epithelial 
cells was widespread in rostral regions prior to neurulation at e8.5, but demonstrated 
progressive spatial restriction to domains that eventually give rise to the choroid 
plexus, in embryos at e9.5 and e l0.5 (Thomas 1993). Therefore, the specification of 
the choroid plexus epithelium fate represents an early step in the regionalisation o f the 
neural tube and is likely to be dependent upon dynamic positional cues.
Recent work provides evidence that bone morphogenetic proteins (BMPs), a family of 
secreted factors encoded by Bmp genes, are involved in this process. Co-expression of 
Bmp2 and Bmp4 marks the dorso-medial neuroepithelium of the telencephalon, a 
region from which the choroid plexus epithelium later arises, thus implicating a role 
for these genes in the specification o f this tissue (Furuta 1997). The widespread 
expression of BMP receptor genes in the dorsal neural tube, encompassing regions 
destined to form the choroid plexus is consistent with this hypothesis (Dewulf 1995).
56
The necessity of BMP signalling for the specification of dorsal telencephalic fates was 
tested in a recent study using cre-ZoxP-mediated conditional mutagenesis to create a 
telencephalon-specific deletion of the Bmprla  gene, which encodes the BMPR1A 
receptor. Embryos homozygous for this mutation failed to generate the choroid plexus 
structure in the lateral ventricles of the brain. Instead choroid plexus epithelial 
precursors remained in a proliferative state throughout development, lacked 
expression o f tissue-specific marker, TTR, and showed reduced expression of M sxl, a 
BMP-responsive dorsal midline marker (Hebert 2002). BMP signalling is therefore 
required to correctly specify and differentiate the choroid plexus. In subsequent work, 
disruption of the Bmp4 gene in the telencephalon did not, however, reveal any 
patterning defects and the choroid plexus developed normally (Hebert 2003). The 
absence of an effect following loss o f Bmp4, together with the role of the BMPR1A 
receptor with which BMP4 is thought to interact, argues that loss o f Bmp4 function 
was compensated for by other Bmp genes acting in a redundant manner. At least one 
other BMP ligand, possibly acting in concert with BMP4, therefore appears to be 
required for normal development of the choroid plexus.
Studies o f the mouse mutant, extra-toes (Xt/Xt), have provided a further insight into 
the nature of signals potentially regulating choroid plexus development. The X t allele 
carries a deletion in Gli3, a vertebrate homologue of the Drosophila gene, cubitus 
interruptus (ci), a transcription factor that regulates wingless, the canonical member of 
the Wnt family of secreted morphogens (Franz 1994; Von Ohlen 1997). The choroid 
plexus of the lateral ventricles fails to form in Xt/Xt embryos (Franz 1994). However, 
this failure was thought not to be a direct consequence of Xt, as Gli3 expression, 
whilst widespread in the dorsal telencephalon, does not occur in the choroid plexus. 
Instead this was attributed to loss of a G7/3-dependent Wnt-rich signalling centre, the 
cortical hem, a tissue thought to provide dorsalising cues necessary to pattern the 
adjacent choroid plexus (Grove 1998). More detailed examination o f these embryos 
revealed that, whilst some thinning of the neuroepithelium was detected, consistent 
with progress to the earliest stages of choroid plexus morphogenesis, these precursor 
cells remained in a proliferative state and did not express the marker TTR, bearing a 
striking similarity to observations made in Bm prla  mutants (Grove 1998; Hebert 
2002). A further study demonstrated loss o f expression of multiple Bmp genes, 
including Bmp4, from the cortical hem in Xt/Xt embryos suggesting that BMP
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signalling, acting downstream of GU3, is also involved in the choroid plexus 
phenotype of this mutant (Tole 2000).
These studies indicate that in the absence o f BMP, and possibly Wnt signalling, 
choroid plexus development is blocked at an early stage, prior to the establishment of 
the characteristic columnar, 777?-expressing epithelium. That this effect is limited to 
the choroid plexus of the lateral ventricle (choroid plexi at other sites develop 
normally in Bm prla-deficient and Xt/Xt mice) suggests that distinct, and as yet 
unidentified positional signals are required to pattern the third and fourth ventricle 
choroid plexi of the brain.
In vitro culture systems
Scientific investigation of the choroid plexus is often limited because of the small size 
and inaccessibility o f this organ. In vitro approaches involving primary culture 
systems have been essential in order to overcome these limitations. For the purposes 
of primary culture, choroid plexus epithelial cells are preferred because they perform 
most o f the biological secretory and exchange functions o f the choroid plexus that 
researchers wish to investigate. Moreover, the epithelium is the more homogeneous 
tissue, hence better suited to studies where variability might detrimentally affect 
quantitative analysis. Cultured choroid plexus epithelial cells faithfully reproduce 
morphological and biochemical features that are characteristic o f the choroid plexus 
epithelium in vivo (Villalobos et al. 1997). As such, choroid plexus cell cultures have 
allowed biological questions to be rapidly and reliably tested, particularly those 
investigations that use the cells to recapitulate in vitro the barrier functions o f the 
choroid plexus epithelium in vivo, for example the study of transport of novel drugs, 
organic substrates and proteins across the blood-CSF barrier (reviewed in (Ghersi- 
Egea 2001)).
Summary
The Igf2 and H I 9 genes are widely expressed in the mesodermal and endodermal 
lineages during development. Igf2 is, with the exception of the choroid plexus and 
leptomeninges, predominantly expressed from the paternally inherited allele 
(DeChiara et al. 1991), whilst for H I 9, it is transcription o f the maternal allele that 
predominates in the majority o f tissues (Bartolomei et al. 1991). The correct
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monoallelic expression of Igf2 is frequently disrupted in the paediatric overgrowth 
disorder, BWS, with biallelic expression of the gene observed in many cases.
Current evidence favours an insulator model to explain imprinting at the Igf2IH19 
locus. This involves complex interactions between an imprinting control region (ICR), 
situated within a differentially methylated domain (DMD) 2-4kb 5’ of HI 9 and an 
array of c/s-acting enhancer elements, principally located in sequences 3’ of the H I9 
gene, which confer expression in a tissue-specific manner. The DMD exists in two 
epigenetic states, dependent upon its parental origin. Following transmission through 
the paternal germline, it is hypermethylated, and is required to initiate, but not 
maintain, silencing o f the H I9 gene by establishment of secondary methylation 
imprints and a closed chromatin conformation over the promoter region. After 
maternal transmission, it is devoid of methylation, exists in an open chromatin 
conformation and is required to initiate and also maintain silencing of Igf2 in cis 
(Tremblay et a l  1997; Srivastava 2000). The DMD contains a chromatin boundary or 
insulator element that acts to block the interaction o f Igf2 promoters with mesoderm- 
and endoderm-specific enhancer regions that lie 3’ of H I 9, providing an epigenetic 
basis to imprinted gene expression in tissues where these enhancers are active (Bell 
2000; Hark et al. 2000; Szabo 2000).
Igf2 escapes imprinted regulation and is biallelically expressed in the choroid plexus 
and leptomeninges, thus reflecting the situation often seen in BWS, though H19 
maintains maternal-specific expression at these sites. Imprinting of the two genes 
therefore appears to be dissociated, suggesting that distinct mechanisms may govern 
expression from each locus in this tissue. Whilst the c/s-elements responsible for 
correct imprinting and expression of Igf2/H19 in endodermal and mesodermal tissues 
have been identified, those required to initiate and maintain biallelic Ig/2 expression 
in the choroid plexus have not been fully characterised. One such element, an 
enhancer driving Igf2 expression in the choroid plexus, is located at the CCD, situated 
5’ of the DMD, a position presumably unaffected by insulator activity and provides 
one mechanism for biallelic expression in this tissue.
Regions o f paternal specific hypermethylation, DMR1 and DMR2, situated proximal 
to Igf2, that respectively confer methylation dependent silencing and activation are
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uncharacteristically hypermethylated on both alleles in the choroid plexus, suggesting 
a possible epigenetic route to biallelic Igf2 expression in this tissue. To date, no 
attempt has been made to examine the methylation status o f the DMD in the choroid 
plexus, though the central role played by this region in the initiation and maintenance 
o f imprinting and its hierarchical influence upon Igf2 proximal DMRs is suggestive of 
its participation at non-imprinted sites of Igf2 expression.
Aims
The purpose o f this study is to elucidate c/s-elements and mechanisms that confer 
biallelic Igf2 expression in the choroid plexus. Current evidence is not informative of 
whether Igf2 expression is initially imprinted in the primitive choroid plexus, 
becoming biallelic as development proceeds, or alternatively whether both alleles are 
active from the onset o f expression. Resolving these questions by allele-specific 
analysis at the whole organ level would not be straightforward, as the choroid plexus 
is small and inaccessible at all stages o f its development, thus requiring repeated 
microdissection from many animals. In addition, a whole organ approach makes over 
simplistic assumptions about the composition o f the choroid plexus, which is 
comprised by a variety o f distinct cell types arising from both neuroectodermal and 
mesodermal lineages, thus further complicating the analysis. Therefore allele-specific 
analysis to examine the imprinting status of Igf2 expression during choroid plexus 
development will be performed in situ, using a combined approach of in situ 
hybridisation analysis and lacZ reporter gene expression assays. It is hoped that this 
dual methodology will provide detailed information upon the developmental timing of 
Ig/2 expression in the choroid plexus, its imprinting status and resolve the precise cell 
types, for example the epithelium or stroma, in which the gene becomes expressed 
during development.
Is the CCD the sole element driving biallelic expression in the choroid plexus, or as 
implicated by previous work (Jones et al. 2001), are other elements also required? If 
the insulator model of imprinting is correct, novel enhancer elements would be 
expected to be situated 5’ of the DMD, an arrangement thought permissive for 
promoter-enhancer communication upon both alleles. A mouse transgenic system 
provides one of the most robust approaches to the identification and characterisation 
of c/s-elements required for tissue and developmental stage specific gene expression
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in vivo. However, the establishment of transgenic lines is labour intensive, time 
consuming and subject to ethical considerations. In this study, primary cultures 
derived from the choroid plexus epithelium will be used as a preliminary means to test 
the function of putative regulatory elements isolated from the Igf2!H19 locus, by their 
use in transient reporter gene expression assays. Although not a replacement for the in 
vivo approach, in vitro studies permit a reduction in the number of animals used and, 
it is hoped, will allow rapid evaluation of c/s-elements potentially involved in biallelic 
Igf2 expression in the choroid plexus. Any regions identified as showing tissue- 
specific enhancer activity in the primary cultures would provide good candidates for 
subsequent analysis in a transgenic system.
Are epigenetic factors involved in the mechanism of biallelic Igf2 expression in 
choroid plexus tissue? As already discussed, DMR1 and DMR2 are 
uncharacteristically methylated upon both alleles in the choroid plexus. Whether this 
is a determinant factor or a consequence of biallelic Ig/2 expression in this tissue will 
be addressed with an in vitro approach, by treatment of cultured choroid plexus cells 
with the DNA methyltransferase inhibitor, 5-aza-2’-deoxycytidine. Primary choroid 
plexus cultures discussed above could be used for such imprinting manipulation 
studies, although an immortal mouse choroid plexus epithelial cell line would be far 
better suited to this purpose. As no cell line of this description exists, derivation of 
immortal cell lines from the choroid plexus epithelium will form a primary aim o f this 
study. A line of transgenic mice that overexpress SV40 large T-antigen protein in the 
choroid plexus epithelium have been obtained (described in Chapter 5) and will 
provide a resource from which, it is hoped, an immortal choroid plexus epithelial cell 
line can be created. The cell line will also carry suitable DNA polymorphisms such 
that the identity of the parental alleles can be distinguished for the purposes of gene 
expression and methylation analysis.
What is the role o f the DMD? Methylation analysis of this region will be carried out 
to ascertain whether it bears characteristic paternal-specific hypermethylation marks 
in choroid plexus tissue or, as shown for DMR1 and DMR2, if  it is highly methylated 
on both alleles. This will be conducted at the whole organ level, as was done 
previously by others for DMR1 and DMR2, but could also be performed in one, or 
both o f the in vitro culture systems discussed above, which it is presumed, would bear
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epigenetic marks appropriate to the choroid plexus. The methylation status o f the 
DMD in the choroid plexus could be informative of a potential role in biallelic Igf2 
expression in this tissue.
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CHAPTER 2: MATERIALS AND METHODS 
Molecular Cloning Techniques
Digestion of plasmid DNA with restriction enzymes
Plasmid DNA up to lpg  amounts was digested according to the supplier’s instructions 
(Promega) and as described in the Protocols and Applications Guide. Typically 
digests were carried out in 20pl reactions that contained the DNA, 2pi o f lOx buffer 
and 10 units of enzyme made to volume with water. Larger quantities of plasmid 
DNA were digested in reaction volumes scaled up as appropriate. Digests were 
incubated at 37°C for at least 1 hour. The efficiency of the digests was checked by 
electrophoresis of small aliquots through agarose gels as described (Sambrook 1989).
Purification of DNA from solutions and agarose gels
DNA fragments were purified from agarose gels or from enzymatic reactions prior to 
cloning with the Qiaquick gel purification or nucleotide removal kits respectively 
(Qiagen). The kits were used according to the manufacturers instructions.
Conversion of 5 ' and 3’ recessed ends to blunt ends
If required prior to ligation, 5’and 3’ recessed plasmid vector and insert DNA ends 
were filled-in or removed by treatment with T4 DNA polymerase as described in the 
Protocols and Applications Guide (Promega). In brief, reactions were carried out in 
volumes o f 50-1 OOpl containing an appropriate volume of 10x reaction buffer, 
lOOpM of each dNTP and 5 units of T4 DNA polymerase for each lp g  of template 
DNA. Reactions were incubated at 37°C for 10 mins and the enzyme inactivated by 
incubating at 75°C for 10 mins.
Dephosphorylation of plasmid ends
To prevent self-ligation of linear plasmid DNA during ligation reactions, shrimp 
alkaline phosphatase (SAP) was used according to the manufacturers instructions 
(UpState Biotechnologies, USA). In brief, restriction digests o f plasmid DNA were 
made to twice the original volume with water also incorporating an appropriate 
amount o f lOx SAP reaction buffer and 0.5-1 units of SAP enzyme. Reactions were 
then incubated for 1 hour at 37°C after which the SAP enzyme was inactivated by 
incubating at 65°C for 15 mins.
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DNA precipitation
DNA solutions were precipitated by addition of 0.1 volume of 3M sodium acetate 
pH5.2 and 0.7 volumes of isopropanol, then incubated at RT for 10 mins. DNA was 
pelleted by centrifugation for 15 mins at RT, then washed with 70% Ethanol. DNA 
was centrifuged for a further 2 mins, the wash discarded and the pellet air-dried at RT 
and resuspended in an appropriate volume of water or TE Buffer (lOmM Tris-HCl 
pH8, ImM EDTA).
DNA and RNA quantification
For those samples expected to contain limited amounts o f DNA, for instance 
fragments obtained following purification from agarose gels were quantified by 
agarose gel electrophoresis. This was done by comparison o f band intensities of 
unknown samples with bands of known concentration in either lkb or lOObp 
quantitative DNA ladders (New England Biolabs) electrophoresed in adjacent lanes. 
Gels were stained with ethidium bromide (Sigma) and visualised with an ultraviolet 
transilluminator (UVP). Large-scale plasmid DNA, genomic DNA and total RNA 
preparations were analysed using a Beckman DU®530 Life Science UV-visible 
spectrophotometer with pre-programmed DNA/ RNA quantitation (Beckman- 
Coulter). Prior to analysis, DNA samples were diluted 1:100 fold in TE buffer. 
Aliquots of IOOjlxI were taken from the diluted samples and readings taken in a lOOpl 
quartz cell at 260nm wavelength, using TE buffer to calibrate the zero point.
Ligation of plasmid vector with insert DNA fragments
Ligations were performed using reagents and protocols from Promega. Reactions 
were set up in lOjul volumes that contained 50-100ng purified plasmid vector DNA 
mixed with a 2-3 fold molar excess o f insert DNA and incubated overnight at 4°C. 
Molar ratios of plasmid vector:insert DNA were calculated as follows:-
ng vector DNA x kb size insert DNA x molar ratio of insert
kb size o f vector vector
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Oligonucleotide linker synthesis
Approximately 500pM of complementary oligonucleotides were made to 50pl 
volumes in annealing buffer (lOmM Tris; lOmM MgCh), denatured by incubating at 
80 °C for 10 mins, then annealed by slowly cooling to room temperature. Prior to 
ligation into plasmid vectors, annealed fragments were 5’-phosphorylated using 
polynucleotide kinase (Promega) in the presence of dATP according to the 
manufacturers instructions.
Preparation of competent E. coli cells
Competent cells for molecular cloning were made using a rapid protocol (Nishimura 
1990). A culture was set up by inoculating 0.5ml of an E.coli D H 5a starter culture 
into 50mls LB broth (supplemented with lOmM magnesium sulphate and 0.2% 
glucose) and then grown with aeration to mid log phase. The culture was incubated on 
ice for 10 min and centrifuged at 1500g for 10 min at 4°C and the supernatant 
discarded. The cell pellet was gently resuspended in 0.5 ml of ice-cold LB broth and 
then 2.5 ml storage solution was added (36% glycerol; 12% PEG 7500; 12mM 
magnesium sulphate in LB broth sterilised by filtration). The cell suspension was 
gently mixed by pipetting, divided into lOOpl aliquots and stored at -80°C.
Transformation of competent E.coli with recombinant plasmids 
Frozen aliquots o f competent E.coli D H 5a cells were thawed on ice and mixed with 
l-5pl of plasmid DNA or a ligation reaction and incubated on ice for 15 to 30 mins. 
The cells were heatshocked at 42°C for 60 secs then immediately returned to ice for 1 - 
2 mins, diluted 10-fold in SOC medium (Sambrook 1989) (pre-warmed at 37°C) and 
incubated at 37°C for 1 hour with rapid shaking (200 rpm) to allow expression of 
antibiotic resistance. Aliquots of 50-1 OOjul were taken from each transformation, 
spread out on LB agar plates (Sambrook 1989) containing 50pg m l'1 of carbenicillin 
(Sigma) and incubated overnight at 37°C. For blue/white selection of non­
recombinant versus recombinant clones, lOOpl of 200mg ml"1 isopropyl-p-D- 
thiogalactopyranoside (IPTG; Melford Laboratories, UK) and 500pl of a 40mg m l'1 
solution of 5-bromo-4-chloro-3-indolyl-P-D-galactoside (X-gal; Melford Laboratories, 
UK) in di-methyl formamide (Sigma) were incorporated into 500 ml molten LB agar.
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Isolation of plasmid DNA
Small-scale plasmid DNA preparations (minipreps) as required for screening 
recombinant clones were performed with the Wizard MiniPreps Kit (Promega) 
according to the manufacturers instructions. Large-scale preparation o f high-quality 
plasmid DNA as required for transfection of mammalian cells or for in vitro 
transcription o f RNA probes, was done with the CONCERT Maxiprep system 
(Invitrogen) according to the manufacturers instructions.
Isolation of high-purity genomic DNA from mouse tissues 
The DNeasy genomic DNA purification kit (Qiagen) was used according to the 
manufacturers instructions to isolate high-purity DNA from mouse tissues or cultured 
cells suitable for PCR amplification o f long or GC-rich DNA templates.
DNA sequencing
All samples for DNA sequencing were analysed by automated fluorescent sequencing 
by Paul Jones at the Core Sequencing Facility in the Dept. Biology and Biochemistry 
at the University o f Bath. In brief, between 150-250ng plasmid DNA was mixed with 
lOpM of sequencing primer and made to a total volume of 6pi with water. Sequencing 
reactions were then done with ABI Big-Dye termination reagents using various 
primers (shown below) and the reactions analysed with ABI 377 DNA sequencer 
(Applied Biosystems).
T7 (Invitrogen) 5 ’ C GGG AT AT C ACTC AGC AT A AT G-3 ’
T3 (Invitrogen) 5’ AATTAACCCTCACTAAAGGG-3 ’
SP6 (Invitrogen) 5 ’ ATTTAGGT G AC ACT AT AGA AT AC-3 ’
M l3 -20 (Stratagene) 5’ GTAAAACGACGGCCAGT-3’
M13 R (Stratagene) 5 ’ GGAACAGCTATGACCATG-3 ’
Polymerase chain reaction (PCR)
Standard PCR reactions were done in 20pl reactions in an MJ research thermal cycler 
using l . lx  Reddy Mix PCR buffer with 1.5mM MgCL according to the manufacturers 
instructions (AB-Gene) with primers at 0.2pM. In some instances where genomic or 
cDNA fragments in excess o f lkb were amplified, more specific reaction conditions
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were required. These reactions were done with variable (l-2.5mM) 
Mg concentration, 2mM dNTPs and 1 unit Thermoprime Taq polymerase in lx  
Thermoprime reaction buffer (AB-Gene). Unless stated otherwise in the relevant 
Results chapters cycling conditions were 94°C for 5 mins; then 94°C for 1 min, 60°C 
for 1 min, 72°C for 1 min for 35 cycles; with a final cycle o f 72°C for 5 min. For 
amplification o f long DNA templates (>5kb) the Expand high-fidelity polymerase kit
(Roche) was used according to the manufacturers instructions. An optimisation
2+
protocol was used to determine specific reaction conditions (concentration of Mg , 
dNTPs and primers) for standard and long template PCR (shown in Figure 4) 
Completed PCR reactions were analysed by agarose gel electrophoresis.
Mice
Inbred laboratory strains
Unless stated otherwise, Fi mice derived from C57BL/6J x CBA crosses and embryos 
derived from Fi crosses were used in all protocols. Mice were maintained on a 12- 
hour light/dark cycle in all cases.
Transgenic mice
The lacZDM RT  mice, which carry a /acZ-neomycin cassette insertion at the Igf2 
locus were created in previous work and were maintained on an Fi background 
(Murrell et al. 2001).
The T 121 mice, which carry a transgene for overexpression of a truncated SV40 large 
T-antigen protein in the choroid plexus epithelium were created in previous work 
(Saenz Robles et al. 1994) and were maintained as homozygotes on an Fj (C57BL/6J 
x DBA) background.
The p53 knockout mice, which carry a targeted deletion at the p53  locus were created 
in previous work (Clarke 1993) and were maintained on an Fi background.
Genotyping transgenic mice by PCR
For rapid genotyping o f transgenic lines a PCR based assay was used. Crude tissue 
lysates were made by incubating yolk sacs, ear punches or tail tip biopsies at 100°C 
for 10 mins in 600pl 50mM NaOH. Lysates were made pH neutral by adding 50pl o f
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Figure 4. PCR optimisation protocol
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16pl 1 6 p J
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each primer each primer
25.5pl water 
3pl 10x buffer 
1.5pl Taq
1M Tris-HCl (pH8) after which 1 )nl aliquots was taken from each and PCR-amplified 
in 20pl reactions (see section describing PCR) using primers appropriate to the strain.
For the lacZDMKT  mice, two pairs of primers were used to distinguish animals that 
were either WT, heterozygous or homozygous for the mutation. Primers internal to 
the lacZ reporter gene were used to amplify a 206bp product from the disrupted Igf2 
allele:- forward 5’-CTG TGA GAA CCT TCC AGC CTT TTC-3’; reverse 5’-CAA 
GGC GAT TAA GTT GGG TAA CGC C -3 \ The second pair of primers which span 
the 3’ end of intron 3 to the 5’ end of exon 4 of the mouse Igf2 gene were used to 
amplify a 190bp product from the WT Igf2 allele:- forward 5’AG A GGA GTG TTG 
TTT CCG TAG C-3’; reverse 5’GTC CCA TTA CAG GTA GAG GTG C -3 \ These 
primer pairs were run in separate reactions. For the T 121 mice, primers internal to the 
LPV-SV40 transgene were used to amplify a 170bp product in individuals positive for 
the transgene:- forward 5’CTA GTG ATG ATG AGG CTA CTG-3’ reverse 5’TTC 
TTG TAT AGC AGT GCA GC-3’. For the p53  knockout mice, primers used to 
distinguish animals that were either WT, heterozygous or homozygous are described 
(Malcolmson 1997). In all cases, the cycling profile was 94°C for 5 mins; then 94°C 
for 1 min, 60°C for 1 min, 72°C for 1 min for 34 cycles; with a final cycle o f 72°C for 
5 mins.
Southern Analysis
Southern (DNA blotting) analysis was performed according to standard protocols 
(Sambrook 1989) with modifications described below.
Genomic DNA extraction from tissue
Tissue biopsies were placed in tubes and digested by incubating with 525pl tail buffer 
(50mM Tris-HCl pH8, lOOmM EDTA lOOmM Sodium chloride, 1% SDS in water) 
and 3 5 pi o f a lOmg m l'1 Proteinase K solution at 55°C overnight. To remove total 
RNA, the digests were incubated with 2pl 0.2mg ml"1 RNase A at 37°C for 1 hour. 
Proteins were removed by addition of 200pl 5M Sodium chloride and 700pl 
chloroform: isoamyl alcohol followed by gentle mixing for 2 hours on a rocking 
platform, then centrifugation at 10000 rpm for 10 mins to separate the aqueous and 
organic phases. The aqueous layer was transferred to a clean tube, the genomic DNA
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precipitated by addition of 700pi of isopropanol and then pelleted by centrifugation at 
10000 rpm for 10 mins. DNA pellets were washed with 300pl 70% (v/v) ethanol at 4° 
C for lh, spun briefly, the ethanol removed and the pellets air-dried. DNA was 
resuspended in 200pl TE buffer (lOmM Tris-HCl, ImM EDTA) then incubated with 
gentle agitation overnight to dissolve.
Synthesis of a-32P(dCTP)-labelled DNA probes.
Probes were synthesised using the Hi-Prime random priming kit (Roche) according to 
the manufacturers instructions. In brief, 20ng of a gel purified probe DNA fragment 
was made to 13.5pi with water then heat denatured at 100°C for 5 mins, chilled on ice 
for 5 mins, then incubated with 4pl of Hi-prime polymerase mix and 2.5pi a- 
32P(dCTP) nucleotide (Amersham) in a total volume of 20pl for 1 hour at 37°C. 
Labelled probes were purified from the unincorporated nucleotide by centrifugation 
through sephadex G-50 columns in 200pl of TE buffer. Probes were heat denatured a 
second time, and chilled on ice until required.
Blotting and hybridisation
Approximately lOpg amounts of genomic DNA samples were digested with various 
restriction enzymes, size fractionated by electrophoresis through a 1% agarose gel, 
blotted onto N+ nylon membranes (Osmonics, USA) and crosslinked with a CL-1000 
ultraviolet crosslinker (UVP). For the hybridisation, a modification o f the protocol 
described by Church and Gilbert was used (Church 1984). The buffer used for pre­
hybridisation and hybridisation was identical (0.5M sodium di-hydrogen 
orthophosphate, ImM EDTA, 7% sodium dodecyl sulphate (SDS), 1% bovine serum 
albumin (BSA)). In each case immediately before use, lOOpg ml"1 sonicated and heat- 
denatured salmon sperm was added. Membranes were placed in glass hybridisation 
tubes containing 15ml of pre-heated hybridisation buffer then pre-hybridised for 4 
hours at 65°C. For the hybridisation, a -32P(dCTP) labelled probes were synthesised as 
described and added to the hybridisation tubes containing 15mls fresh pre-heated 
church buffer and hybridised to the membranes overnight at 65°C. Post hybridisation 
washes were carried out in 150ml volumes with the following solutions. Washl 
(40mM sodium di-hydrogen orthophosphate, ImM EDTA 5% SDS, 0.5% BSA). 
Wash 2 (40mM sodium di-hydrogen orthophosphate, ImM EDTA 1% SDS). Both
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washes were done twice each for 30 mins at 65°C. Membranes were covered in saran 
wrap and autoradiographed at -80°C with intensifying screens using BIOMAX MS-1 




All reagents for RNA analysis (excluding Tris-based buffers) were made RNAse-free 
by incubating overnight with 0.05% di-ethyl pyrocarbonate (DEPC; Sigma) at RT. 
Excess DEPC was removed from the reagents by autoclaving.
Isolation of Total RNA
Tissue for RNA extraction was homogenised in TRI reagent (Sigma) using an Ultra- 
Turrax homogeniser. Homogenates were then either stored at -70°C or processed 
immediately. The homogenates were centrifuged at 13000 rpm for 10 mins at 4°C, the 
supernatant transferred in 1 ml aliquots to clean 1.5 ml eppendorf tubes then extracted 
with 200fal chloroform and centrifuged at 13000 rpm for 15 mins at 4°C. The aqueous 
phase was transferred to a clean tube, mixed with 1/10 volume of isopropanol, 
centrifuged at 13000 rpm for 10 mins at 4°C. The supernatant was transferred to a 
clean tube, the RNA precipitated by addition of an equal volume of isopropanol and 
pelleted by centrifuging at 13000 rpm for 10 mins at 4°C. RNA pellets were washed 
with 75% ethanol, air dried and dissolved in DEPC-treated water and stored at -70°C.
Northern (RNA) blotting and hybridisation
A standard protocol was used with some modifications (Sambrook 1989) All reagents 
were made RNAse-free. Total RNA was prepared as described. Between 6-20pg of 
total RNA samples were denatured by mixing with 5 pi 10x MOPS buffer (0.2M 3-[N 
morpholino]propanesulphonic acid, 0.05M sodium acetate, 0.01M EDTA, made in 
DEPC-treated water and adjusted to pH7) 8.75pl 37% formaldehyde, 25jnl formamide 
and made up to 50pl DEPC-treated water and incubated at 55°C for 15 mins. 
Denatured total RNA samples were separated by electrophoresis through a 1.2% 
agarose-MOPS-formaldehyde gel ( lx  MOPS, 1.1% formaldehyde) then blotted and 
crosslinked as described for Southern analysis.
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The buffer for the pre-hybridisation and hybridisation was identical (6xSSC, 5x 
Denhardts reagent, 0.5% SDS). The hybridisation buffers were prepared fresh by 
dilution of a 20x SSC stock (3M sodium chloride, 0.3M sodium citrate) and lOOx 
Denhardts reagent stock (2g each of Ficoll 400, polyvinylpyrrolidone and BSA; 
Sigma) in DEPC-treated water. Immediately before use lOOpg m l'1 sonicated and heat 
denatured salmon sperm DNA was added. Membranes were placed in hybridisation 
tubes containing 15ml hybridisation buffer then pre-hybridised for 4 hours at 65°C. 
For the hybridisation, a -32P(dCTP) labelled probes were generated as described then 
added to the hybridisation tubes containing 15ml pre-warmed hybridisation buffer and 
hybridised to the membranes overnight at 65°C. The post-hybridisation washes were 
done in large (150ml) volumes. Wash 1 (2xSSC, 0.5% SDS) and wash 2 (0.5xSSC 
0.5% SDS) were each done twice for 30 mins at 65°C. Autoradiography was done as 
described for Southern analysis.
Probes
DNA probes used for Southern and Northern hybridisation are described in the 
relevant results chapters.
Reverse Transcription and Polymerase Chain Reaction (RT- PCR)
DNAsel treatment of total RNA extracts
For the purposes o f RT-PCR analysis, genomic DNA contamination was removed 
from RNA extracts by treatment with DNAsel. Total RNA in 50pl water was made to 
1 OOjlxI with lOpl DNAse reaction buffer, lOpl lOOmM DTT, 28pl water, 100 units 
rRNasin® ribonuclease inhibitor, 2 units RQ1 RNAse-free DNase (all Promega) and 
incubated at 37°C for 15 mins. The digested RNA was extracted with an equal 
volume of phenol: chloroform: isoamyl alcohol (125:24:1, pH4.7; Sigma) and 
centrifuged at 13000 rpm for 2 mins. The aqueous phase was extracted a second time 
with chloroform then transferred to a clean tube and the RNA precipitated by addition 
of 0.1 volumes 3M sodium acetate and 2.5 volumes of absolute ethanol. The RNA 
was pelleted by centrifuging at 13000 rpm for 10 mins at 4°C and the pellets washed 
with 70% ethanol then air-dried, dissolved in DEPC-treated water and stored at -70°C.
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Complementary DNA (cDNA) synthesis
First strand cDNA was synthesised from various total RNA samples using 
Superscriptll™ reverse transcriptase (Invitrogen) according to the manufacturers 
instructions. In brief, 4pg o f total RNA was annealed with either random hexamer or 
Oligo-dT primers (Promega) then reverse transcribed at 42°C for 50 mins. ‘Mock’ 
reverse-transcribed reactions were done in parallel for each cDNA sample in which 
the reverse transcriptase was omitted. PCR reactions were done as described (see 
section describing polymerase chain reaction) using 0.3pi cDNA template. In all cases 
the efficacy of the cDNA synthesis and relative abundance of expressed sequences 
were judged by PCR-amplification of cDNA samples using primers designed to the 
mouse p-actin sequence: forward 5’ GAC CCA GAT CAT GTT TGA GAC C-3’ and 




Established cell lines were obtained from the European Collection of Cell Cultures 
(ECACC). The human hepatocellular carcinoma-derived Hep G2 cell line (Aden 
1979) was maintained in DMEM (Sigma) supplemented with 10% foetal bovine 
serum (FBS), 2mM glutamine, 1% non-essential amino acids, 50U ml’1 penicillin, 50 
pg m l'1 streptomycin, 2.5pg ml amphotericin-B (all Gibco-BRL) at 37°C with 5% 
CO2 . The mouse fibroblast NIH:3T3 cell line (Uchida 1969) was maintained in 
DMEM nutrient mix-F12/ glutamax II supplemented with 10% FBS, 50U ml’1 
penicillin, 50 pg ml"1 streptomycin, 2.5pg ml amphotericin-B (Gibco-BRL) at 37°C 
with 5% CO2 . The origin of primary choroid plexus epithelial cells is described 
below.
Isolation and culture of primary choroid plexus epithelial cells 
A  modification o f the protocol described in Hoffmann et al. was used (Hoffmann 
1996). Whole brains were removed intact from litters of neonatal mice aged between 
postnatal days 1-6 and transferred, under aseptic conditions to pre-warmed complete 
growth medium DMEM nutrient mix-F12 supplemented with 10% FBS (foetal bovine 
serum) 50U ml’1 penicillin, 50 pg ml’1 streptomycin, 2.5pg ml’1 amphotericin (all
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Gibco-BRL). Lateral and fourth ventricle plexuses were then dissected from the 
brains, washed by immersion in pre-warmed Hanks buffered salt solution (HBSS; 
Sigma) and collected by centrifugation. The plexi were enzymatically disaggregated 
by digestion with pronase enzyme as described previously (Crook 1981). Pronase 
enzyme (Calbiochem) was made at 2mg ml’1 in HBSS and incubated at 37°C for 5 
mins after which digestion was terminated by addition o f growth medium. The 
digested tissue fragments were collected by centrifugation at 1000 rpm for 4 mins 
then re-suspended by gentle repeated pipetting in 1ml complete growth medium to 
generate a suspension o f single cells and small cell aggregates. Cells were further 
diluted with an appropriate volume of complete growth medium and plated in 35mm 
cell culture plates or 6-well plates and incubated undisturbed at 37°C with 5% CO2 for
24 hours to allow for cell attachment. The medium containing unattached cells and 
debris was removed and after a single wash with PBS and replaced with fresh medium 
supplemented with the drug cytosine p-D-arabinofuranoside (CAF; Sigma) to inhibit 
fibroblast proliferation. Positive selection for slower growing choroid plexus 
epithelial cells was established by alternating the cultures between CAF and CAF-free 
medium every 48h thereafter.
Transfection of plasmid DNA into continuous cell lines.
High quality plasmid DNA was prepared as described (see section describing isolation 
of plasmid DNA). HepG2 and NIH:3T3 cells were transfected with plasmid DNA 
using the FuGENE 6 reagent (Roche) according to the manufacturers instructions for 
transient transfection of adherent cells. These cell lines were seeded in 6-well plates 
and each well transfected with lpg  of various test plasmid DNA constructs. In the 
instance o f Luciferase reporter constructs, lp g  of pSV40-Pgal vector (Promega) was 
co-transfected as an internal control for variable transfection efficiency. The 
pBluescriptll KS+ vector (Stratagene) was transfected as a negative control for 
Luciferase expression.
Transfection of plasmid DNA into primary choroid plexus epithelial cells 
Primary choroid plexus epithelial cells were prepared as described. To derive 
sufficient numbers of cells for transfection choroid plexuses were removed from 20-
25 neonatal mice. Cells were plated in 6-well plates at approximately lx lO 6 cells per
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well then each well immediately transfected with lpg  supercoiled test plasmid 
constructs using the Effectene transfection kit (Qiagen), essentially according to the 
manufacturers instructions. Transfection efficiency estimation and negative controls 
were done as for continuous cell lines. In an optimised protocol, both the test and 
control constructs DNA were mixed in the bottom of 1.5ml eppendorf tubes, and 
diluted with EC buffer to a total volume of 75pl. Enhancer reagent was added at 8pi 
per pg DNA added and the tubes incubated at RT for 5 mins, 12pl Effectene reagent 
was added, mixed with the DNA by gentle flicking and incubated at RT for a further 
10 mins to allow transfection complexes to form. The entire contents o f each tube was 
added drop wise to individual wells and mixed with the culture medium by gently 
rocking the plates. Plates were incubated overnight at 37°C, 5% CO2 . Medium 
containing the transfection complexes was aspirated, the cells washed once with PBS 
then fresh growth medium added and the cells incubated for a further 48 hours to 
allow for reporter gene expression.
Assay for Luciferase-specific activity of transfected ceils
To harvest cells for analysis o f Luciferase-spQcific activity, growth medium was 
aspirated, the cells washed twice with PBS, then lysed by the addition o f 200pl cell 
culture lysis reagent (Promega) to each well. Lysates were collected by scraping, 
transferred to clean tubes, then vortexed for 10 secs and centrifuged at 13,000 rpm for 
2 mins to remove cell debris. Supernatants were transferred to clean tubes and either 
assayed for Luciferase immediately or stored at -80°C until required. Lysates were 
loaded into a 96-well microtitre plate in 5 pi quadruplicate samples and Luciferase- 
specific activity measured with the addition of 25 pi of Lucifer ase-d&s&y reagent 
(Promega) per well in an automated Berthold LB96V microplate luminometer. Light 
outputs were measured with a 10 second delay after reagent dispense. Total 
Luciferase levels were determined by expressing the raw luminescence values of 
unknowns against that o f a Luciferase standard series made by serial 10-fold dilutions 
o f a 2ng pi"1 Luciferase standard stock (Sigma).
Soluble protein and p-gaiactosidase assays
Total Luciferase measurements per well were normalised against soluble protein 
levels to correct for cell mass. A 5pi aliquot taken from each cell lysate was diluted
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10-fold in water. 1 OjlxI aliquots were taken from these dilutions in duplicate, loaded 
into 96-well microtitre plates, mixed with 200pl BioRad protein reagent then 
incubated at RT for 30 mins. Protein measurements were made against a series of 
BSA standards (Bradford 1976) by reading absorbances at 590nm in a colorimetric 
assay. Luciferase values were also normalised for transfection efficiency against 
relative P-galactosidase activity levels. Activities were determined by the conversion 
of ONPG substrate with absorbances read at 405nm in a colorimetric assay as 
described (Norton 1985).
Generation of immortal choroid plexus epithelial cell lines
Isolation and culture of choroid plexus tumour tissue
Choroid plexus papillomas were induced genetically by crossing mice of the T 121 line 
with the p53 knockout line. Animals were monitored daily and those showing 
evidence of choroid plexus tumour formation (as judged by a bulging cranium) were 
sacrificed, the brain dissected and held in prewarmed growth medium. Choroid plexus 
tumours were removed, washed twice in HBSS, chopped into small pieces (approx 
2mm3) with sterile scissors then given several further washes by repeated re­
suspension and centrifugation in prewarmed HBSS. The tissue was disaggregated by 
digestion with 2mg m l'1 Pronase (Calbiochem) in HBSS at 37°C for 10 mins, then 
diluted in growth medium and centrifuged to collect the cells. Supernatant was 
removed and the cells resuspended in growth medium and plated as described for 
primary culture. The cells were washed in PBS and medium replaced daily for the 
initial 5 days to remove dead cells and debris.
Cloning cell lines by limiting dilution
A modification o f a previously described protocol was used (Freshney 1987). Two 
rounds of colony formation in 96-well plates was required to isolate cell clones. 
Epithelial cell colonies from the primary tumour cultures described previously were 
isolated from other cell types by trypsinising from within 5mm steel cloning rings. 
Isolated colonies were taken up in growth medium, disaggregated with gentle 
pipetting and the resulting cell suspensions then split between 8-10 wells o f a 96-well 
plate with a final volume of 200pl of growth medium used per well. Plates containing 
the cells were then incubated for two weeks until cultures enriched for epithelial cell
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colonies had established. Those colonies exhibiting rapid growth and good epithelial 
morphology were selected for further purification by the limiting dilution method. 
Colonies were trypsinised, re-suspended in 0.5 ml complete growth medium and 
disaggregated by repeated pipetting to form a suspension consisting of single cells and 
small cell aggregates. Estimates o f cell numbers in the suspension was performed by 
removing 10pl aliquots and counting on a slide haemocytometer. The suspension was 
then appropriately diluted in cloning medium (identical to primary culture medium 
but supplemented with 20% FBS and lOng m l'1 epidermal growth factor) to give a 
30ml suspension containing 5-10 cells/ aggregates ml’1. The suspension was seeded in 
96-well plates at 200pl per well, then each well was inspected to confirm that only 
one cell or cell aggregate was present in each well. The plates were incubated 
undisturbed under standard conditions for at least 5 days, after which they were 
inspected again to identify wells containing established colonies. Single colonies that 
had formed in isolation in a well were disaggregated by mild digestion in trypsin- 
EDTA and allowed to re-attach as smaller fragments to accelerate their outgrowth. 
After a further seven to ten days morphologically homogeneous clones were re­
adapted to standard growth medium containing 10% FBS with no EGF 
supplementation, then expanded by culturing successively through, 96-well, 24-well, 
and 6-well plates over a period o f approximately 6 weeks. Those clones maintaining 
epithelial morphology and rapid growth after expansion were selected as cell lines and 
expanded further. Cell lines were maintained in 75cm2 flasks as described for primary 
choroid plexus epithelial cells.
Growth curves
The growth rates o f choroid plexus epithelial cells in primary and immortal cultures 
were measured by performing cell number counts with a haemocytometer at selected 
time points from cell plating. A Cell suspension was counted then seeded in a 24-well 
plate at 1ml per well and allowed to attach overnight under standard culture 
conditions. Plating efficiency was estimated as the number o f cells attached 24 hours 
after plating divided by the number seeded. Counts were performed at 48 hour 
intervals thereafter. The cell number at each time point was estimated from the mean 
count of quadruplicate wells with each well counted twice.
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In situ expression analysis in cultured mammalian cells
Staining for p-galactosidase activity in situ in cultured cells 
Mammalian cells or cell lines were grown in 35mm plates with glass coverslips. Cells 
were washed twice in PBS and fixed with 0.8% glutaraldehyde in PBS for 10 min at 
4°C. Cells were washed three times for 5 mins in PBS, then permeabilised by 
incubating in 0.1% triton X-100, 2mM MgCb in PBS for 15 min at RT. Cells were 
washed three times for 5 mins in PBS then stained for P-gal activity by incubating in 
X-gal staining reagent (2mM MgCb, 5mM potassium ferricyanide, 5mM potassium 
ferrocyanide, 0.01% sodium deoxycholate, lm g ml"1 X-gal in PBS) overnight at 37°C. 
After staining, cells were rinsed in PBS and post-fixed in 0.8% glutaraldehyde in PBS 
for 1 hour at 4°C then washed briefly in PBS, then the coverslips removed and 
mounted on slides in Aquatex mounting medium (Merck) and analysed by light 
microscopy.
mRNA in situ hybridisation in cultured cells
Mammalian cells or cell lines were grown in 2-well (2ml) tissue culture chamber 
slides (Nunc). Cells were washed once in PBS and fixed in 4% paraformaldehyde, 
0.25% glutaraldehyde in PBS for 1 hour at 4°C. Slides were washed three times in 
PBS then stored under 70% ethanol at 4°C until required. The culture chambers were 
removed and the slides were taken into absolute ethanol for 5 mins then rehydrated 
through graded ethanols and the remainder of the protocol done as for slide mRNA in 
situ but with the Proteinase-K digestion omitted. Following the colour reaction the 
slides were washed in PBS and mounted with glass coverslips using Aquatex 
mounting medium (Merck).
Immuno-fluorescence cytochemistry
Mammalian cells or cell lines were grown in 35mm plates on glass coverslips under 
standard culture conditions as described previously. Cells were washed briefly in 
PBS, then fixed in either 4% paraformaldehyde in PBS for 15 mins at 4°C, or if  cells 
were to be stained for cytoskeleton proteins, fixation was done in a 1:1 mixture of 
acetone and methanol for 5 mins at -20°C. Cells were washed three times for 5 mins 
in PBS then permeabilised by incubating in 0.1% Triton-X-100 in PBS for 30 mins at 
RT. Cells were washed three times for 5 mins in PBS then pre-blocked in 2%
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blocking buffer (Roche) in PBS for 1 hour at RT. When staining for cytoskeleton 
proteins an antigen retrieval step was included prior to blocking by incubating cells in 
lOmM citric acid (Sigma) for 1 hour at 60°C. Primary antibodies diluted in blocking 
reagent (various dilutions between 1:100-300), were added to the cells and incubated 
overnight at 4°C. Primary antibodies used and their sources are listed in the relevant 
Results chapters. Coverslips were removed from the dishes and washed three times 
for 15 mins in a large volume of PBS then incubated with fluorescein-labelled a- 
rabbit or a-mouse IgG secondary antibodies (Vector Laboratories), diluted 1:100 in 
blocking buffer and incubated for 3 hours in the dark at RT. Secondary antibodies 
were removed by washing three times for 15 mins in PBS. Coverslips were mounted 
onto glass slides with gelvatol and slides kept in the dark until required. Bright field 
and FITC images were obtained with assistance from Dr. David Tosh using a 
Zeiss510 Confocal Laser Scanning Microscope.
In situ expression analysis in whole mount preparations 
Whole mount mRNA in situ hybridisation
Embryo collection
Embryos were taken from pregnant female mice with gestational age estimated by 
daily inspection for copulation plugs (with appearance o f plugs designated embryonic 
day e0.5). Embryos were fixed in 4% paraformaldehyde in PBS overnight at 4°C. 
Unless stated otherwise, all subsequent steps were performed in 2ml round bottomed 
tubes (Treff). All reagents for prehybridisation/ hybridisation steps were made 
RNAse-free by treatment with DEPC as described. Embryos were washed in PBT 
(PBS, 0.1% Tween 20; Sigma) and dehydrated through a methanol series (10 mins 
each in 25%, 50% 75% and absolute methanol in PBT) then stored in absolute 
methanol at -20°C until required.
Synthesis of DIG-labelled RNA probes
Approximately 20pg o f plasmid probe template DNA was linearised by digestion 
with appropriate restriction enzymes then purified using the Qiaquick nucleotide 
removal kit (Qiagen) according to the manufacturers instructions. Digoxigenin (DIG)- 
UTP labelled antisense RNA probes were transcribed from the purified DNA 
templates using the DIG RNA labelling kit (Roche) according to the manufacturers
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instructions. A complementary sense control probe was synthesised in each case. The 
efficacies of the transcription reactions were assayed by analysing a 2pl aliquot of 
each by agarose gel electrophoresis.
Prehybridisation
Embryos were rehydrated through the same methanol series in reverse and washed x2 
in PBT at RT. Embryos were bleached in 6% hydrogen peroxide (Sigma) in PBT for 
40 mins at RT, washed three times in PBT and mildly digested with lOpg m l'1 
Proteinase K in PBT for 15 mins at RT. Digestion was stopped with a wash in 2mg 
ml"1 glycine in PBT for 5 mins at RT. Embryos were washed twice in PBT then post­
fixed in 0.2% glutaraldehyde/ 4% paraformaldehyde in PBT for 20 mins at RT. 
Embryos were washed twice in PBT then prehybridised at 65°C for at least an hour in 
buffer containing 5xSSC pH4.5, 50% formamide, 0.1% Tween 20, 50pg ml"1 Heparin 
(all from Sigma).
Hybridisation and washes
The hybridisation buffer was identical to that used for the prehybridisation step but 
also included 100pg ml"1 each of yeast transfer RNA and herring sperm DNA 
(Sigma). RNA probes were synthesised as described in the section above.. Probes 
used are listed in the relevant Chapters. Probes were denatured at 70°C for 10 mins, 
chilled on ice, then added at to the hybridisation buffer at 4pl m l'1. Embryos were 
hybridised with the probes at 65°C overnight. To remove non-specifically bound 
probe, embryos were subjected to a series of washes and treatment with RNAse A as 
follows. Washes at low stringency were done twice for 30 mins in solution I (5xSSC 
pH4.5, 50% formamide, 1% SDS) at 65°C, once for 10 mins in a 1:1 mixture of 
solution I and solution II (0.5M sodium chloride, lOmM Tris pH 7.5, 0.1% Tween 20) 
at 65°C, then three times for 5 mins in solution II. RNAse A treatment was performed 
by incubating twice for 30 mins in lOOpg ml"1 RNAse A (Sigma) in solution II at 37° 
C. Embryos were washed once for 5 mins in solution II, then washed at high 
stringency once for 5 mins in solution III (2xSSC pH4.5, 50% formamide), followed 
by washing twice for 30 mins in solution III at 60°C.
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Preparation of mouse embryo powder
Embryos between stages e l2.5 -  14.5 dpc were dissected and washed in ice-cold PBS. 
The embryos were homogenised with a minimum volume of PBS, 4 volumes of ice- 
cold acetone were added and the resulting slurry incubated on ice for 30 mins. The 
slurry was pelleted by centrifuging at lOOOOxg for 10 mins at 4°C, the supernatant 
discarded, the pellet washed with ice-cold acetone and pelleted as before. The pellet 
was transferred to filter paper to dry then ground to a fine powder with a pestle and 
mortar and stored at RT.
Pre-absorption of anti-digoxigenin conjugate
A small amount o f mouse embryo powder (~20pl) was placed in an eppendorf tube, a 
suspension made in 1ml TBT and heat inactivated at 70°C for 30 mins. Powder was 
collected by brief centrifugation, the supernatant was discarded and the pellet cooled 
on ice. The powder was resuspended in 1ml of an appropriate blocking buffer and the 
antibody added at an appropriate dilution (for whole mount in situ 1ml of 1% lamb 
serum in TBT was used and the sheep a-digoxigenin alkaline phosphatase conjugate 
added at a 1:2000 dilution). The antibody in blocking buffer/ embryo powder was 
then incubated on a rotator for at least 1 hour at 4°C. The powder was removed from 
the antibody solution by centrifuging at 10000 rpm for 5 mins at 4°C and the 
supernatant containing the antibody/blocking buffer transferred to a clean tube and 
kept at 4°C until ready for use.
Immuno-detection of the probe and colour reaction.
Embryos were washed three times for 5 mins in Tris-Buffered Saline (TBST; 136mM 
sodium chloride, 3mM potassium chloride, 25mM Tris-pH 7.5, 0.1% Tween 20). 
Embryos were pre-blocked prior to addition of the antibody by incubating in 10% 
lamb serum (Gibco) in TBST for at least 2.5 hours at RT. Embryos were then 
immunostained for the specifically bound probe by incubating with a sheep polyclonal 
a-digoxigenin alkaline phosphatase conjugate (Roche) pre-absorbed as described and 
diluted at 1:1000 in 1% lamb serum in TBST overnight at 4°C. Non-specifically 
bound antibody was removed by washing three times for 5 mins then five times for 1 
hour at RT. A final TBST wash was performed overnight at 4°C. Embryos were 
stained using an alkaline phosphatase colour reaction as follows. Embryos were
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washed three times for 10 mins in NTMT buffer (lOOmM Tris pH9.5, lOOmM 
Sodium chloride, 50mM Magnesium chloride, 0.1% Tween 20) then stained by 
incubating at RT in colour substrate solution prepared by dissolving nitroblue 
tetrazolium chloride (NBT) / 5-Bromo-4-chloro-3-indolyl phosphate, toluidine salt 
(BCIP) tablets in water (Roche) as described in the manufacturers instructions. After 
the colour reaction was complete, embryos were washed twice for 10 mins in NTMT 
buffer. The contrast of the stained versus non-stained tissues was enhanced by 
washing overnight in a large volume of PBT. Embryos were post-fixed in 4% 
paraformaldehyde in PBS for 2 hours at 4°C, rinsed in PBT then taken through a 
glycerol in PBS series (50%, 80%, 100%) and photographed.
Whole mount staining for p-galactosidase in situ
p-galactosidase expression in situ was analysed as previously described (Ainscough et 
al. 1997). Embryos with gestational ages between e8.5 and e l4.5 dissected from 
pregnant female mice, and adult brains, were washed twice in ice-cold PBS, then 
fixed in a solution of ice-cold 5% formaldehyde, 0.8% glutaraldehyde, 2mM MgCh, 
0.01% (w/v) sodium deoxycholate, 0.02% (v/v) Igepal (all Sigma) in PBS for 1-2 
hours depending on embryo size. Fixed embryos were washed twice in PBS at RT for 
15 mins each to remove traces of fixative, then stained in freshly prepared X-gal 
reagent containing lm g ml"1 X-gal, 2mM MgCE,, 5mM potassium ferricyanide, 5mM 
potassium ferrocyanide, 0.01% sodium deoxycholate in PBS for 48 hours at 30°C. To 
enhance reagent penetration and examine internal P-gal expression, embryos larger 
than e l4.5 were fixed for 30 mins, frozen briefly on dry ice and sagittally bisected 
using a scalpel blade then re-fixed, washed and stained in X-gal reagent as above. 
After staining, embryos were washed in PBS for 30 mins at RT, post-fixed overnight 
at 4°C and stored in 70% ethanol. For histological analysis o f X-gal staining, tissues 
were processed into wax blocks as described. Sections were cut at 7pm thickness, de­
waxed by soaking in Histoclear then re-hydrated by passage through a graded ethanol 
series, counterstained with nuclear-fast red (Vector Laboratories) for 1 min, washed 
for 2 mins in tap water, then dehydrated as before and mounted under glass coverslips 
in DPX (BDH).
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In situ expression analysis in histological preparations
Paraffin embedding and sectioning
Embryos and tissues for slide mRNA in situ hybridisation were fixed in 4% 
paraformaldehyde in PBS overnight at 4°C. For protein immunohistochemistry 
fixation was done with Zambonis’ buffer (0.85% paraformaldehyde, 0.15% saturated 
picric acid (Sigma) in PBS) overnight at 4°C. Samples were rinsed in PBS then 
transferred into 70% ethanol and either processed immediately or stored for not longer 
than 1 week at 4°C. Samples were processed for paraffin histology using an 
automated tissue processor (Leica). In brief tissue samples were dehydrated through 
an ethanol series (2 hours each in 70%, 70%, 90%, 90%, 95%, 100%, 100%), cleared 
in Histoclear (National Diagnostics, UK) then soaked for 2 hours in molten paraffin 
wax before embedding in wax blocks. Blocks were cut into serial sections o f varying 
thickness between 7-10pm. Sections were floated and collected on APTES-treated 
glass slides. Slides were kept dust-free at 4°C until required.
Slide mRNA in situ hybridisation
Prehybridisation
All reagents and solutions were made RNAse free by treatment with DEPC as 
described. Slides containing 8pM paraffin sections were de-waxed by soaking twice 
for 10 mins in Histoclear (National Diagnostics, UK) and were re-hydrated by passage 
through an ethanol in water series (100, 100%, 95%, 80%, 70%, 50%, 30%) then 
washed in PBS for 5 mins. Slides were fixed in 4% paraformaldehyde in PBS for 30 
mins, washed twice for 5 mins in PBS then digested by incubating in 25p,g m l'1 
Proteinase K in PBS for 10 mins. Slides were washed twice for 5 mins in PBS, twice 
for 5 mins in 2xSSC buffer then incubated in Tris-glycine buffer (0.5M Tris, 0.5M 
Glycine) for 30 mins, immersed briefly in PBS, then dehydrated by passing through 
the same ethanol series in reverse and air dried at RT for at least 30 mins.
Hybridisation and washes
RNA probes were synthesised as described (see section describing RNA probe 
synthesis). Probes used are listed in the relevant results chapters. Probes were added 
to the hybridisation buffer (5xSSC, 40% formamide, lx  Denhardts reagent (see 
section describing Northern hybridisation and blotting), lOOpg m l'1 each o f Yeast
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transfer RNA and Herring sperm DNA; Sigma) at 4pl ml’1 and then denatured at 95°C 
for 5 mins, chilled on ice for 5 mins then pipetted onto the slides at 80pl hybridisation 
buffer per slide. Slides were covered with strips of parafilm to prevent evaporation of 
the buffer, placed in a sealed humidified chamber and hybridised overnight at various 
temperatures between 55-65°C depending on the probe used. To remove non- 
specifically hybridised probe, slides were washed three times for 15 mins in 5xSSC, 
then washed once for 40 mins in post-hybridisation buffer (20% formamide, 0.5x 
SSC) at hybridisation temperature, once for 15 mins in 2xSSC, then incubated in 
lOpg m l'1 RNAse A in 2xSSC for 30 mins at 37°C. Slides were washed once for 15 
mins in 2xSSC, once for 20 mins in post-hybridisation buffer at 5°C below 
hybridisation temperature, then once for 15 mins in 2xSSC.
Immuno-detection of the probe and colour reaction
Slides were incubated overnight with a sheep polyclonal a-digoxigenin alkaline 
phosphatase conjugate, 1:500 in 1% blocking buffer (Roche) in PBS overnight at 4°C. 
Non-specifically bound antibody was removed by washing three times for 10 mins, 
three times for 30 mins ad twice for lhour in PBS. Slides were washed three times for 
10 mins in NTMT buffer (lOOmM Tris pH9.5, lOOmM Sodium chloride, 50mM 
Magnesium chloride, 0.1% Triton X-100; Sigma) then stained by immersing in an 
alkaline phosphatase colour substrate solution prepared by dissolving nitroblue 
tetrazolium chloride (NBT)/ 5-Bromo-4-chloro-3-indolyl phosphate, toluidine salt 
(BCIP) tablets in water (Roche) as described in the manufacturers instructions. 
Staining was performed overnight at RT. After the colour reaction was judged to be 
complete, slides were washed briefly in PBS, post-fixed in 4% paraformaldehyde in 
PBS for 1 hour at 4°C, rinsed again in PBS and mounted with glass coverslips using 
Aquatex mounting medium (Merck).
Immunohistochemistry
Slides were de-waxed by soaking twice for 5 mins in Histoclear (National 
Diagnostics, UK), then rehydrated by passage through an ethanol series (1 min each in 
100%, 100%, 95%, 70%) and held in PBT at RT. An antigen retrieval step was 
performed by boiling the slides in lOmM citric acid (three times for 5 mins in a 650W 
microwave oven on full power). Slides were then incubated in 0.3% hydrogen
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peroxide (Sigma) for 30 mins at RT to inactivate any endogenous peroxidase activity 
in the tissue. Slides were washed three times for 5 mins with PBT then pre-blocked in 
10% bovine serum albumin in PBT for 1 hour at RT. Primary antibodies, their sources 
and concentrations at which they were used are listed in the relevant results chapters. 
Antibodies were applied to the slides in 200pl blocking solution and incubated 
overnight at 4°C. Slides were washed three times for 5 mins in PBT then incubated 
with either biotinylated a-goat or a-rabbit IgG secondary antibodies. Secondary 
antibodies were diluted 1:500 in blocking solution, applied to the slides and incubated 
for 1 hour at RT. Slides were washed three times for 5 mins in PBT, then covered 
with Vectastain ready-to-use Vector Elite ABC reagent (Vector Laboratories) and 
incubated at RT for 45 mins. Slides were washed three times for 5 mins in PBT and 
stained using the Vectastain DAB kit (Vector Laboratories) according to the 
manufacturers instructions. When staining was judged to be complete slides were 
rinsed briefly in PBS then counterstained in Mayers haematoxylin (Vector 
Laboratories) dehydrated through graded ethanols and mounted in DPX (BDH).
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CHAPTER 3: DEVELOPMENTAL GENE EXPRESSION ANALYSIS
Introduction
The Igf2 and H19 genes are broadly expressed in mesodermal and endodermal tissues, 
where both genes are imprinted. A differentially methylated domain (DMD) located 
in the 5’flank of the H I9 gene regulates the imprinting o f both genes by functioning, 
in part, as a chromatin insulator that prevents access to shared enhancers situated 
further 3’ of H I9 (Thorvaldsen et al. 1998; Bell 2000; Hark et al. 2000). Igf2 escapes 
imprinted regulation and is biallelically expressed in the exchange tissues of the brain, 
the choroid plexus and leptomeninges, whereas HI 9 reportedly maintains imprinted 
expression at these sites (DeChiara et a l 1991; Ohlsson et al. 1994; Svensson 1995). 
Elements that confer Igf2 expression in these tissues are anticipated to lie 5’ o f the 
DMD and therefore not be affected by insulator activity. In agreement with this 
proposal, a tissue specific enhancer region for expression in the choroid plexus and 
leptomeninges is located at the CCD, situated 5’ of the DMD in the intergenic region 
(Ward et a l  1997; Jones et a l  2001; Charalambous et a l  2004). Differentially 
methylated regions (DMR1 and DMR2) situated proximal to Igf2, that respectively 
confer methylation dependent silencing and activation (Constancia et a l  2000; Eden 
et a l  2001; Murrell et a l  2001), are hypermethylated on both alleles in the choroid 
plexus, suggesting that epigenetic mechanisms are also required for biallelic 
expression in this tissue (Feil et a l  1994).
How these elements might initiate and/or maintain expression, in the choroid plexus, 
of the otherwise normally silent maternal Ig/2 allele is unknown. No previous attempt 
has been made to characterise the timing of Igf2 expression, its imprinting status, and 
the precise cell types (i.e. epithelium or stroma) in which the gene becomes expressed, 
during choroid plexus development. Are both alleles active from the onset of 
expression, or as implicated by studies in the rat, is expression initially imprinted, 
becoming biallelic as development proceeds (Overall 1997). Clarification o f these 
issues could be informative of when regulatory elements critical to biallelic 
expression are likely to act. The aim of work in this chapter was to address these 
questions by detailed description o f allele-specific Igf2/H19 expression patterns in the 
context of the developing brain, with emphasis upon the choroid plexus.
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The choroid plexi are both small and inaccessible at all stages o f development, thus an 
appropriate methodology for gene expression analysis in this organ is one which can 
be performed in situ and at single-cell resolution. Techniques that have a histological 
basis such as mRNA in situ hybridisation generally satisfy these criteria, indeed 
studies that initially defined the choroid plexus and leptomeninges as sites of Igf2 
expression utilised an in situ hybridisation approach (Stylianopoulou et al. 1988a; 
Stylianopoulou et al. 1988b; DeChiara et al. 1991). However these studies used 
radioactive labelling of RNA probes, which were detected by the precipitation of 
elemental silver over the tissue sections in a layer of photographic emulsion. Although 
sensitive, this method lacks resolution at the cellular level, thus for the purposes of 
this study, a modified non-radioactive mRNA in situ technique was employed. This 
involves the chemical labelling of RNA probes, which are detected by means of an 
enzyme-linked antibody conjugate, followed by a colour substrate reaction within 
tissue sections. This approach achieves a superior single cell resolution of mRNA than 
the older protocol and has also permitted the technique to be extended to analysis in 
whole mount preparations (Wilkinson 1992).
A second strategy for gene expression analysis involved the use of the E.coli-derived 
lacZ gene as a reporter gene. Previous studies have used this approach to describe the 
expression conferred by regulatory elements at the Igf2/H19 locus, both in the context 
of ectopic transgenes and germline deletions (Ainscough et al. 1997; Brenton et al. 
1999; Ainscough et al. 2000b; Murrell et al. 2001). The lacZ gene encodes p- 
galactosidase, an enzyme involved in lactose metabolism whose activity can be 
detected in cells by means of a sensitive histochemical reaction. This involves the 
conversion of the synthetic substrate, 5-bromo-4-chloro-3-indolyl-P-D-galactoside (x- 
gal) to an insoluble intensely blue product, which produces beautifully resolved 
expression patterns, p-galactosidase is extremely stable and its activity is not 
adversely affected by exposure to most histological fixatives. Moreover processed 
tissue retains x-gal staining well enough that it may be visualised in sections and 
additionally this approach is not subject to the degree of tissue destruction produced 
by in situ hybridisation. Whole mount p-galactosidase expression assays can be 
problematic under certain conditions. Poor stain penetration may leave the interior 
structures of larger tissues unstained even after lengthy incubations in staining buffer,
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although it has been found that bisection of tissues prior to staining considerably 
enhances stain penetration (Ainscough et al. 1997). Another potential disadvantage is 
that some mammalian cells contain an endogenous lysosomal P-galactosidase-like 
activity. This activity is only present at a low pH and may be blocked by performing 
the staining at a pH greater than 7.4 (Alam and Cook 1990). When performed under 
the correct conditions p-galactosidase expression assays offer the advantage of a 
superb single-cell resolution of gene expression that can be superior to that given by 
in situ hybridisation, as exemplified by analysis of a lacZ reporter gene knock-in 
mutation at the mouse Delta 1 {D ill) locus (Beckers 1999).
In the present study, to examine the developmental profile o f Igf2 expression in situ, 
an Igf2-lacZ reporter gene knock-in mutant was analysed in p-galactosidase whole 
mount expression assays. The mutant line named lacZDMKT was described 
previously, to make a deletion o f the differentially methylated region 2 (DMR2), a 
putative imprinting element, within the Igf2 structural gene (Murrell et al. 2001). To 
create this deletion, a 4.65kb region spanning exons 4-6, also containing the DMR2 
region was replaced with a promoter-less IRES-facZ-neomycin resistance cassette 
(Figure 5). Upon paternal transmission of lacZDMR2\ reporter gene expression was 
widespread in mesodermal and endodermal tissues, but was absent from the brain 
with the exception of the exchange tissues, whereas upon maternal transmission, 
reporter gene expression was confined to the exchange tissues, consistent with the 
expression profile o f Igf2 (DeChiara et al. 1991; Murrell et al. 2001). Therefore, 
deletion of DMR2 does not appear to perturb either the regional expression pattern or 
imprinting status o f Ig/2. In this mutant it is reasonable to assume that reporter gene 
expression reflects that o f the endogenous Igf2 gene.
An important finding o f work presented in this chapter was that o f variegated Igf2 
expression in the choroid plexus epithelium. This manifested finely scattered 
expression in isolated cells or small cell clusters and was evident from the earliest 
point at which Ig/2 expression could be detected in this tissue. This ‘salt and pepper’ 
arrangement appeared highly reminiscent of lateral inhibition (discussed below), a 
mechanism central to the canonical Notch signalling pathway (for review see (Lewis 
1998)), known to generate asymmetric cell fates in a number of metazoan organisms.
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Figure 5. The lacZD M Kl' genomic region. A 4.65kb region at the Igf2 
locus defined by two BamWX sites, containing the Igf2 coding exons (4-6) 
and the overlapping DMR2 region was replaced with an IRES\lacZ- 
neomycin resistance cassette (Murrell et a l 2002). The deleted region is 
shown by broken lines. DMR1 and DMR2 are represented as solid arrows; 
Igf2 exons are shown as open boxes; Igf2 promoters (initiating in the leader 
exons 1,2 and 3) are indicated by short arrows.
Notch genes encode a family of conserved transmembrane receptors that interact with 
the membrane bound ligands encoded by the Delta, Serrate, Lag (DSL) family genes 
(with mammalian Serrate genes renamed as Jagged) all o f which were originally 
identified in Drosophila. Signalling through Notch receptors is thought to occur via 
direct interactions with Delta and Serrate/Jagged ligands positioned upon adjacent 
cells. This results in the proteolytic cleavage of the Notch intracellular domain 
(NICD) which translocates to the nucleus and functions as a transcriptional co­
activator in concert with the transcription factor RBP-Jk/CBF1, a mammalian 
homologue o f the Drosophila gene, Suppressor o f Hairless (SuH). It is thought that 
unbound RBP-Jk/CBF1 mediates transcriptional repression in combination with the 
histone-deacetylase complex SMRT/sin3/HDAC. NICD binding to RBP-Jk/CBF1 
displaces the co-repressors and subverts RBP-Jk/CBF1 function to activate 
transcription, by recruitment of histone-acetyl transferases (Kao 1998; Kurooka 
2000). Activated RBP-Jk/CBF1 promotes expression o f basic helix-loop-helix 
(bHLH) transcriptional repressor proteins encoded by Hes genes, the mammalian 
homologues o f Enhancer o f Split genes in Drosophila. These molecules are thought to 
function as key regulators of downstream target genes, which directly mediate cell 
fate decisions (Jarriault 1998; Kao 1998).
These events, it is proposed, act according to the lateral inhibition model (reviewed in 
(Lewis 1998)). Lateral inhibition is a mechanism by which an aptly named ‘salt and 
pepper’ arrangement o f different cell fates arises from a population of identical 
progenitor cells. This commences in a field of undifferentiated cells that uniformly 
express Notch receptors. Ligands encoded by Delta (and Jagged) genes present upon 
a small number o f these cells activate Notch receptors and via intracellular signalling 
events involving NICD, repress the expression of Delta ligands in adjacent cells. The 
system is thought to be self-reinforcing, such that small differences in the number of 
Delta ligands present upon adjacent cells become accentuated. That is, cells with a 
slightly greater concentration of ligands will prevail whilst any adjacent cells with 
relatively less ligand will lose ligand expression altogether. Delta expressing cells are 
permitted to differentiate whilst those lacking Delta remain undifferentiated. 
Therefore, Notch signalling imposes specific fates upon isolated cells, in a Delta
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dependent manner, whilst simultaneously preventing adjacent cells from following the 
same fate.
In mammals, four Notch genes (Notchl-4), and at least six DSL gene homologues 
{Dill, D lkl, DIB, DU4, Jagged 1-2) have been identified, many of which perform 
essential functions during embryogenesis. Disruption of Notchl, Notch2 or D ill in 
mice results in early embryonic lethality with severe defects in somite patterning and 
neurogenesis (Swiatek et a l  1994; Hrabe de Angelis et al. 1997; Hamada et al. 1999). 
Recent studies also demonstrate a role for Notch signalling in patterning the vascular 
system. Jaggedl null or Notchl/Notch4 compound mutant mice die in utero due to 
severe vascular disorganisation (Loomes 1999; Krebs et al. 2000). In contrast, mice 
carrying deletions in the Notch3 gene were reported to be viable and phenotypically 
normal (Krebs et al. 2003).
Work presented in this chapter shows that Igf2 expression is confined to a scattered 
subpopulation of differentiating choroid plexus epithelial precursor cells, commencing 
at e l0.5 of development (Figures 6 and 9). A Notch-dependent mechanism involved 
in the specification o f Igf2 positive and negative subpopulations, it is proposed, would 
be expected to be active in this tissue at, or immediately preceding, this stage and the 
expression of Notch and Delta genes in the choroid plexus epithelium, or adjacent 
tissue (stroma) at this time would be consistent with this expectation. Notch, Delta 
and Jagged gene expression during mouse embryogenesis is widely documented, 
although in only a small number of published works, describing Notchl, Notch2 and 
D ill, do the authors refer to gene expression in the choroid plexus (Higuchi 1995; 
Hrabe de Angelis et al. 1997; Hamada et a l  1999). However, these studies neither 
discriminate gene expression in the epithelial and stromal components o f this tissue 
nor do they describe the earliest stages o f choroid plexus development where 
variegated Ig/2 expression commences. Therefore, a second aim of the present study 
was to establish expression patterns for Notch, Delta and Jagged genes in the 
developing choroid plexus as a means to address a potential involvement of Notch 
signalling in the specification of distinct Ig/2 phenotypes amongst choroid plexus 
epithelial cells. This initially involved RT-PCR analysis to ask which of the Notch, 
Delta and Jagged genes are generally represented in whole choroid plexus mRNA and
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was followed by in situ hybridisation analysis to examine expression in the epithelial 
and stromal components of this tissue.
Materials and Methods
Probes
The Ig/2 probe was a 1.5kb cDNA fragment spanning exon 6 of the mouse Igf2 gene 
cloned into the Bluescript II KS+ vector (described in (Charalambous et al. 2004)). 
The H19 probe was a 346bp cDNA fragment spanning exons 3-4 o f the mouse H19 
gene, PCR-amplified from neonate liver cDNA using the primers:- 5’AAT GAG TTT 
CTA GGG AGG GAG G-3’ and 5’GGA AAA GTG AAA GAA CAG ACG G-3’ 
then ligated into the pGEM-T easy vector. The FoxJl probe was a 1.7kb cDNA 
fragment spanning exons 1-2 of the mouse FoxJl gene, PCR-amplified from choroid 
plexus cDNA using the primers:- 5’GCC CCT GAC CCA ACC ACC CCA CAC-3’ 
and 5’CCG CCC CCT GAC GAC GTG GAC TAT-3’ and cloned as for the H19 
probe. The CTCF probe was a 2kb cDNA fragment, cloned into the Bluescript II SK+ 
vector (Prof. Hiroyuki Sasaki, unpublished). The origin of Notch, Delta and Jagged 
probes is described in the results section of this chapter. For in situ hybridisation, 
plasmids containing probes were linearised by digestion with restriction enzymes and 
linearised fragments used in transcription reactions to synthesise RNA probes (see 
Chapter 2 sections describing digestion of plasmid DNA with restriction enzymes and 
synthesis of DIG-labelled RNA probes). Details for all probes are listed in Table 1.
Antibodies
Commercially available primary antibodies were obtained for transthyretin (TTR) 
transferrin (TFN), albumin (Alb), typel insulin-like growth factor receptor (Igflr), 
fibroblast growth factor receptor 3 (Fgfr3) and insulin for the purposes of 
immunohistochemistry (Table 2).
PCR Primers
Primers corresponding to all known mouse Notch, Delta and Jagged homologues 
were designed from full-length cDNA sequences obtained from the ENSEMBL and 
GENBANK databases. The Genetool program (Biotools, UK) was used to select 
primers from these sequences (listed in Table 3).
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Probe Digest Orientation Polymerase
Igf2 Hindlll Antisense T7
Xbal Sense T3
H19 Sacl I Antisense SP6
Spe I Sense T7
Foxjl * Spe I Antisense T7
Spe I Sense T7
CTCF EcoBl Antisense T7
Notl Sense T3
Notchl Sail Antisense T7
Xbal Sense SP6
Notch2 Sail Antisense T7
Xbal Sense T3
Notch3 EcoBl Antisense T3
Notl Sense T7
Notch4 EcoBl Antisense T7
BamRl Sense T3
Dill EcoBl Antisense T3
Notl Sense T7
Dlkl EcoBl Antisense T7
BamRl Sense T3
DU3 EcoBl Antisense T7
BamRl Sense T3
DU4 Sah Antisense T7
Notl Sense SP6
Jagl San Antisense T7
Notl Sense SP6
Jag2 EcoBl Antisense T3
Notl Sense T7
Table 1. RNA probes used for in situ hybridisation analysis. Probes were 
generated by in vitro transcription of plasmid DNA templates. The restriction 
enzymes used to linearise plasmid templates, the RNA polymerases (T7, T3 or SP6) 
used and the orientation o f the synthesised probes are shown. * Plasmid templates with 
probe DNA ligated in both sense and antisense orientations were obtained for Foxjl.
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Table 2. Primary antibodies used for immunohistochemistry. The primary 
antibodies and the antigens to which they are raised are shown in the far left column. 
The source species in which the antibodies were raised, the manufacturer and the 





5’CGC AAT GGG GGC ACC TGT GAC CT-3’ 
5’TGG CAC GGC AGG CAC AGC GAT AG-3’
Notch2 forward
reverse
5’CCG CAG GGC ATG TTG GGG AAA G-3’
5’GGG CAG TCG TCG ATA TTC CGC TCA-3’
Notch3 forward
reverse
5’CAC GGG GAA GGG GCA CAG GGC ACT-3’ 
5’CCG CCG CCG TCG TCG CCT GAT-3’
Notch4 forward
reverse
5’CCC ACA CCC CCA AGC TCC CGT AGT-3’ 
5’AGC GGC ACT GGA TCT GGG GGT ATG-3’
D ill forward
reverse
5’CGG GCC AGG GGA GCT ACA CAT G-3’ 
5’GGC GCT CAG CTC ACA GAC CTT GC-3’
Dlkl forward
reverse
5’GCC CGA GCA ACA CAT CCT GAA GGT-3’ 
5’GGG GTG GGG AAC GCT GCT TAG ATC-3’
DU3 forward
reverse
5’GCG GCT TGT GTG TTG GCG GTG AA-3’ 
5’GCC GGC GCA GTC GTC CAG GTC-3’
DU4 forward
reverse
5’CTG CGA ATG CCC CCC CAA CTT TAC-3’
5’GGG CAC AGG GAC TTC GGG CAC AAT-3’
Jaggedl forward
reverse
5’CCC CGA GGA CAA CAC CAC CAA CAA-3’ 
5’CCG CTG GGG GCC TTC TCC TCT C-3’
Jagged2 forward
reverse
5’GCG GGT TCG AGG CAG GGT CCA G-3’
5’GGG GAG GCA GTC GTT GGG ATT GA-3’




Allele-specific lacZDMR2' reporter gene assays
To separately examine expression from the paternal and maternal Igf2 alleles at 
embryonic stages, timed matings were set up between male or female lacZDMR2' 
heterozygous animals and respective Fi partners. The gestational stage following a 
successful mating was taken as e0.5 days post coitum (dpc) as judged by detection of 
a copulation plug, assuming a mid-dark cycle mating had occurred. Embryos were 
dissected at various time points between e9.5 and el4.5 o f gestation, then fixed and 
stained for p-galactosidase activity in situ (see Chapter 2 section that describes whole 
mount p-galactosidase staining in situ) and genotyped for the presence of the 
lacZDMR2~ allele from yolk-sac tissue (see Chapter 2 section that describes 
genotyping mice by PCR). Whole brains were dissected from paternal and maternal 
transmission lacZDM RT  adult mice at 3 months of age and treated as described for 
embryos. Where analysis in greater detail was required, stained embryos were wax 
embedded and sectioned as described (see Chapter 2 section that describes paraffin 
embedding). Positive staining was not observed in tissues derived from non- 
transgenic littermates at any of the embryonic or adult stages examined in this 
analysis (not shown).
Expression at e9.5 
Paternal transmission
At e9.5 reporter gene expression was widespread in mesodermal and endodermal 
derivatives as expected for the paternal allele of Ig/2 (Figure 6a). Strong staining was 
seen in the presomitic mesoderm, myotome and sclerotome compartments o f formed 
somites, fore limb buds, condensing mesenchyme o f the hind limb buds, developing 
heart, and visceral organs. In the brain, reporter gene expression appeared to be absent 
from the regions o f neuroepithelium that later generate the choroid plexi. Analysis of 
sections made in the sagittal plane did not reveal any hidden staining in these regions 
of the neuroepithelium (not shown). Expression of the reporter was strong in blood 
vessels with intense staining in the carotid arteries extending upwards from the dorsal 
aorta, primary head veins and in the network of cerebral capillaries supplying the 
prosencephalon and mesencephalon (not shown). Staining was also seen in the
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streams of trigeminal and facial neural crest cells migrating into the first and second 
branchial arches.
Maternal transmission
Reporter gene expression was not detected in e9.5 embryos (Figure 6b).
Expression at e10.5 
Paternal transmission
At el 0.5 expression o f the reporter at peripheral sites was similar in distribution to the 
previous stage (Figure 6c). In the brain staining persisted in the carotid arteries and 
primary head veins and had become more widespread in the cerebral capillary 
network (not shown). Regional expression had commenced in the neuroepithelium of 
the metencephalon (the presumptive choroid plexus epithelium), although in many 
embryos, intense staining in the overlying surface ectoderm and mesenchymal layers 
made its direct observation in whole mount difficult. Analysis of these embryos in 
sagittal sections revealed strong staining in a scattered population of cells in this 
region of the neuroepithelium, with uniform staining seen in the overlying 
mesenchyme that later invades to form the choroid plexus stroma (Figure 9). Staining 
was also strong in Rathke’s pouch, the precursor of the anterior pituitary, but was 
notably absent from the adjacent infundibulum, the region from which the posterior 
neural pituitary is formed (not shown). Stained cells were seen in the ventral aspect of 
the neuroepithelium lining the optic recesses and in a small area of mesenchyme 
overlying the antero-medial wall of the telencephalic vesicles (not shown). Staining 
was now evident in the trigeminal ganglion and had intensified in the streams of 
trigeminal and facial neural crest invading the branchial arches.
Maternal transmission
At e l 0.5, the first evidence of reporter expression was seen at several sites in the 
developing brain (Figure 6d-j; Figure 9). The neuroepithelium in the roof plate of 
the metencephalon was clearly stained. As upon paternal transmission this staining 
was restricted to a scattered population of cells and in most embryos occupied a 
narrow band dorsomedially, extending to wider domains more laterally. This domain 
of expression appeared to coincide with the choroid plaque from which the fourth 
ventricle choroid plexus epithelium later expands. Analysis of sections made in the
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sagittal plane revealed that the staining was present exclusively in the neuroepithelium 
and that in contrast to paternal transmission embryos was altogether absent from the 
overlying mesenchyme that later forms the choroid plexus stroma. In other areas of 
the brain and as upon paternal transmission, a small area of mesenchyme overlying 
the anterior-most aspect of the medial wall separating the telencephalic vesicles was 
stained. Unlike paternal transmission embryos, expression of the reporter was seen in 
a thin dorso-medial stripe o f cells running in an antero-posterior direction through the 
neuroepithelium of the mesencephalon. Expression of the reporter was not detected in 
cerebral blood vessels or in cranial neural crest derivatives at this stage.
Expression ate 12.5 
Paternal transmission
At e l2.5 (Figure 7a) expression of the reporter was again strong and widespread in 
peripheral tissues. In the evaginating fourth ventricle choroid plexus, expression of the 
reporter was clearly restricted to a small number of cells in the epithelium. By contrast 
staining was stronger and uniform in the invading stromal mesenchyme. This was 
particularly evident in sagittal sections (Figure 9). Expression had now commenced 
in the condensing mesenchyme of the leptomeninges surrounding the brain and the 
spinal cord and continued at high levels in cerebral blood vessels(not shown). Staining 
remained in Rathkes pouch and in the ventral neuroepithelium of the optic recesses 
(not shown).
Maternal transmission
At e l2.5 (Figure 7b; Figure 9) clear staining was seen in the evaginating choroid 
plexus epithelium and maintained a scattered distribution. Staining was still evident in 
the dorso-medial neuroepithelium of the mesencephalon but had declined from 
previous levels in the majority of embryos examined. Clear staining was seen for the 
first time in leptomeninges although in most embryos this was restricted to isolated 
areas underneath the ventral mid- and hind-brain regions and appeared weaker than 
that seen upon paternal transmission. Expression of the reporter remained absent from 
cerebral blood vessels and cranial neural crest derivatives (not shown).
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Figure 6. Allele-specific lacZDM RT  reporter gene expression assays, 
e9.5 and el0.5 embryos. Embryos were fixed and stained for the 
presence of P-galactosidase activity (blue staining), then examined by 
light microscopy. A,B expression at e9.5 (x20) ; A paternal transmission 
showed widespread expression in mesoderm and endoderm; B maternal 
transmission showed that expression was completely absent in embryos 
of this stage. C,D expression at e l 0.5 (xl6); C paternal transmission at 
e l0.5 with expression generally distributed as for the previous stage; D 
expression was generally absent following maternal transmission except 
in those sites described below. E,F,G sites of expression in maternal 
transmission embryos at e l0.5; E dorsal view of staining (arrows) in the 
roof o f the metencephalon (x50); F dorsal view of staining (arrow) along 
the dorsal midline o f the mesencephalon (x80); G dissected telencephalic 
vesicles showing staining (arrow) in the mesenchyme at their interfaces 
(x50). H ,I,J Detailed analysis o f sites of expression described above in 
maternal transmission e l 0.5 embryos; H in sagittal section, sites of 
staining (arrows) localised in the innermost neuroepithelium layer lining 
the roof of the metencephalon (x400); I in frontal section, stained cells at 
the dorsal midline of the mesencephalon also localised in the 
neuroepithelium (x 100); J  in frontal section, staining (arrow) localised to 
mesenchyme in the medial wall separating the telencephalic vesicles 
(x 100). Detailed analysis of paternal specific lacZDMR.2' expression is 
not shown. Sections were counterstained with nuclear fast red. 
Abbreviations; ba, branchial arches; cp, choroid plexus; lb, limb bud; 




Expression at e14.5 
Paternal transmission
At e l4 .5  (Figure 7c) reporter gene expression was similar peripherally to that of 
e l 2.5 embryos. In the brain, the reporter remained strongly expressed in the now fully 
differentiated choroid plexus with staining present in both the epithelium and stroma 
(Figure 9). As before, staining was restricted to a small subpopulation of epithelial 
cells, bu t was uniform in the stromal mesenchyme and pericytes of stromal capillaries. 
Expression had intensified in the leptomeninges with strong staining present in the pia 
and arachnoid mater and was also evident within interconnecting trabecular processes 
(not shown). Staining was also evident in small blood vessels closely associated and 
continuous with the pia mater. Expression in cerebral capillaries (Figure 11) 
elsewhere in the CNS although strongly evident, appeared to be declining with fewer 
pericytes stained in comparison with earlier stages examined. Expression continued at 
high levels throughout the differentiating anterior pituitary and had now appeared in 
the mesenchyme invading the cerebellar primordium (not shown).
Maternal transmission
At e l4.5 (Figure 7d) reporter gene expression continued in the differentiated choroid 
plexus with staining in many epithelial cells. Staining remained mostly absent from 
the stroma, although staining in capillary pericytes was occasionally seen. As 
observed upon paternal transmission, expression was now present throughout the 
leptomeninges including regions surrounding the spinal cord. Staining had become 
apparent in blood vessels throughout the brain parenchyma and was particularly 
evident in capillaries intimately associated with the pia mater (Figure 11). Reporter 
gene expression seen in the dorso-medial mesencephalon at earlier stages had 
disappeared. Outside of the brain staining was seen in a cell subset of the tongue and 
in cartilage primordia of the clavicles, vertebrae (Figure 7d-g) and limbs (not shown).
Expression in the adult brain 
Paternal transmission
In 3 month-old whole brain analysis (Figure 8), staining was present in a 
subpopulation of choroid plexus epithelial cells, but with the exception of capillaries, 
was generally not seen in the stroma. Staining was evident in the pia mater (the 
overlying arachnoid mater was missing in most cases and was presumed to have
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Figure 7. Allele-specific lacZD M K l ' reporter gene expression assays, 
el2.5 and el4.5 embryos. Embryos were bisected, fixed and stained for 
the presence of P-galactosidase activity (blue staining), then examined by 
light microscopy. A,B expression at e l2.5 (xl2); A paternal transmission 
showing widespread expression in mesoderm and endoderm; B maternal 
transmission with expression restricted to the developing choroid plexus. 
C,D Expression at el4.5 (xlO); C paternal transmission with expression 
generally distributed as for the previous stage; D maternal transmission 
with expression evident at several sites within and outside the brain. E,F,G 
Detailed analysis of sites o f expression in peripheral tissues following 
maternal transmission embryos at e l4.5, in sagittal section, E staining in a 
subset of cells in the tongue (x200); F staining (arrows) in condensing 
vertebrae (x200); G staining in epithelium (arrows) lining the aortic 
outflow tract o f the heart (x400). Detailed analysis of paternal expression 
is not shown. Sections were counterstained with nuclear fast red. 
Abbreviations’, ao, aortic outflow tract of the heart; cl, clavicle; cp, choroid 
plexus; en, capillary endothelium; to, tongue. Magnifications are indicated.
Paternal Maternal
e14.5
^  • •' ^
remained attached to the skull following dissection) and in capillaries associated with 
the pia mater and also distributed throughout the brain parenchyma (not shown). 
Expression was also seen at other sites, with staining evident in neurons surrounding 
the ventral and paraventricular regions of the hypothalamus. Neuronal staining was 
also seen in the giant purkinje cells o f the cerebellum, but was absent from the 
adjacent granular cell and molecular layers (not shown, see maternal transmission).
Maternal transmission
Reporter gene expression (Figure 8) was as described for paternal transmission, 
however staining appeared to be more intense and was noticeably more widespread in 
capillaries. As upon paternal transmission, some neuronal expression was present with 
staining seen in the giant purkinje cells of the cerebellum and in hypothalamic 
neurons. In contrast to paternal transmission, staining was seen in other neurons 
occupying the subventricular regions surrounding the lateral ventricles (not shown).
TTR expression in the developing choroid plexus
Choroid plexus epithelial cells express high levels o f Transthyretin (TTR) upon 
differentiation from the embryonic neuroepithelium and this gene is thus a sensitive 
marker for this cell type (Murakami 1987). In the /acZDMR2' reporter gene assays, 
expression was observed at e l0.5, in a sheet o f neuroepithelial cells lining the roof of 
the metencephalon, upon paternal and maternal transmission. To confirm that this 
reporter gene activity was associated with the presumptive choroid plexus epithelium, 
particularly at this early stage (e l0.5) where the organ is not morphologically evident, 
immunohistochemistry was performed (see Chapter 2 section describing 
immunohistochemistry) using a primary antibody to TTR in sections o f WT embryos, 
that contained the choroid plexus or regions destined to form the choroid plexus 
(Figure 9). At e l 0.5, TTR staining was seen in a domain o f metencephalic 
neuroepithelium, apparently overlapping with the reporter gene expression described 
above. At e l2.5 and el4.5, TTR staining was seen exclusively in the definitive 
choroid plexus epithelium. Notably, TTR expression was uniform in the epithelium at 
all stages examined, in contrast with the variegated lacZD M Rl' reporter gene 
expression observed in this tissue. The region of metencephalic neuroepithelium 
marked by lacZDM Kl- reporter gene expression at e l0.5 was therefore populated by 
differentiating choroid plexus epithelial cells.
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Figure 8. Allele-specific lacZDM Rl' reporter gene expression assays, 
adult brain. Brains were bisected, fixed and stained for the presence of 
P-galactosidase activity (blue staining), then examined by light 
microscopy. A-D Staining in bisected brains (xlO); A,B paternal 
transmission of lacZDMR2’ showing the internal and external views 
respectively xlO. C,D Maternal transmission with similar views shown. 
E,F Staining in meninges of maternal transmission brains; E surface 
view showing staining (arrows) in meningeal blood vessels; F in sagittal 
section, staining (arrow) was localised in leptomeninges and capillary 
endothelium (x200). G staining in the choroid plexus was confined to 
the epithelium, but was mostly absent from the stroma (x400). H 
Staining (arrows) was also seen in the giant purkinje cells of the 
cerebellum but was absent from adjacent granule cell and molecular 
layers (x400). Sections were counterstained with nuclear fast red. 
Abbreviations', cp, choroid plexus; ep, choroid plexus epithelium; s, 
stroma; en, capillary endothelium; lm, leptomeninges; hy, hypothalamic 
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Figure 9. Allele-specific /acZDMR2' reporter gene expression assays, 
choroid plexus development. Embryos were fixed and stained for the 
presence of P-galactosidase activity (blue staining), sectioned in the 
sagittal plane and examined by light microscopy. Reporter gene 
expression was not detected in the presumptive choroid plexus epithelium 
before e l0.5; A,B at e l 0.5, expression of the reporter was present, with 
staining in both a scattered population of ependymal cells (presumptive 
epithelium) following both paternal and maternal transmission but was 
only seen in overlying mesenchyme (presumptive stroma) following 
paternal transmission; D,E,G,H at el2.5 and el4.5, reporter gene 
expression was again scattered in the expanding epithelium upon both 
paternal and maternal transmission, but was only seen in the stroma 
following paternal transmission of lacZDM Rl'. Sections were 
counterstained with nuclear fast red. C,F,I TTR protein expression in the 
developing choroid plexus. Sections containing the choroid plexus were 
prepared from WT embryos and stained for the presence of TTR and the 
distribution of staining visualised with brightfield microscopy. TTR 
positive staining (brown precipitate) was seen in the presumptive and 
definitive choroid plexus epithelium, but not the stroma at e l0.5 (C); 
e l2.5 (F); e l4.5 (I). Sections were counterstained with Mayers 












Table 4. Summary of allele-specific /acZDMR2" reporter gene expression assays.
Parental transmission o f lacZDM RT  and the developmental stages examined are 
given in the first and second columns respectively. Sites of expression that were found 
to be unique to a parental allele are shown in normal type whereas those common to 
both alleles (biallelic expression) are shown in either bold type (brain) bold italic type 
(peripheral tissues). Abbreviations; CP, choroid plexus, NC, neural crest.
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Transmission Stage Sites o f  lacZ expression
Paternal e9.5 Head mesenchyme, carotid arteries, primary head veins and 
pericytes of cerebral capillaries, migrating NC of first and second 
branchial arches.
el0.5 Neuroepithelium of metencephalon (CP epithelium), head 
mesenchyme including that overlying choroidal plaque, carotid 
arteries, primary head veins and pericytes of cerebral capillaries, 
migrating NC of 1st and 2nd branchial arches, trigeminal ganglion, 
Rathke’s pouch, ventral neuroepithelium of optic recess, 
mesenchyme overlying medial wall of telencephalic vesicles.
el2.5 CP epithelium and stroma (fourth and lateral ventricles) 
leptomeninges, carotid arteries, pericytes of blood vessels in CP 
stroma and brain parenchyma, Rathke’s pouch, ventral 
neuroepithelium of optic recess, trigeminal ganglion.
el4.5 CP epithelium and stroma (fourth and lateral ventricles), 
leptomeninges, pericytes of blood vessels, ventral 
neuroepithelium of optic recess, anterior pituitary, hypothalamic 
neurons, aortic outflow tract o f the heart, tongue, cartilage 
primordia o f clavicles and vertebrae.
Adult
brain
CP epithelium (fourth and lateral ventricles), pia mater, 
pericytes of blood vessels, hypothalamic neurons, purkinje 
cells of the cerebellum.
Maternal e9.5 None detected
el0.5 Neuroepithelium of metencephalon (CP epithelium), 
mesenchyme overlying medial wall of telencephalic vesicles,
dorso-medial neuroepithelium of mesencephalon.
el2.5 CP epithelium, dorso-medial neuroepithelium of mesencephalon.
el4.5 CP epithelium and stroma (fourth and lateral ventricles), 
leptomeninges, pericytes of blood vessels, hypothalamic 
neurons, aortic outflow tract o f the heart, tongue, cartilage 
primordium o f clavicles and vertebrae.
Adult
brain
CP epithelium (fourth and lateral ventricles), pia mater, 
pericytes of blood vessels, hypothalamic neurons, purkinje 
cells of the cerebellum, subventricular neurons.
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Comparison of /acZDMR2' and endogenous Igf2 expression
The detailed allele-specific lacZ expression data presented in the previous section 
revealed a number of additional sites o f expression not previously reported for Igf2 
including some subtle features that may have been overlooked in other studies. In 
particular, this included the allele-specific choroid plexus expression analysis and the 
novel finding of expression in the brain capillary endothelium. Hypothetically the 
deletion of the DMR2 region in this mutant may have removed or otherwise perturbed 
ds-elements critical for imprinting and expression, thus leading to reporter gene 
expression at ectopic sites. It was therefore necessary to ask if  these features of 
lacZDM Kl' expression accurately reflected the expression and imprinting of the 
endogenous Ig/2 gene, by performing Igf2 in situ hybridisation.
The lacZDMKT  insertion removes the coding exons (4-6) and thus creates a loss-of- 
function mutation at the Igf2 locus. This allele therefore cannot produce any of the 
natural Igf2 transcripts that include these exons. Using an Ig/2 exon 6 probe, in 
embryos heterozygous for lacZDMKT, any Igf2 mRNA detected would have been 
produced by the reciprocal endogenous Igf2 allele. Expression from the endogenous 
paternal and maternal alleles can therefore be examined separately by looking for Igf2 
mRNA in maternal and paternal transmission lacZDMKT  heterozygous embryos 
respectively. A single developmental stage, e l4.5, was taken as representative for this 
analysis. In situ hybridisation was performed using a DIG-labelled antisense Ig/2 exon 
6 probe (see Chapter 2 section describing slide mRNA in situ hybridisation), in 
sections made from el4.5 embryos. The comparisons were made in the choroid plexus 
(Figure 10) and in capillary endothelium (Figure 11). Control hybridisations with a 
sense probe did not produce signals.
Endogenous Igf2 expression
As expected, abundant Ig/2 mRNA was found in both the epithelial and stromal 
compartments o f the choroid plexus (Figure 10) and in the leptomeninges 
(Figurella,d). Interestingly, expression was also evident in the pericytes of 
capillaries throughout the brain (Figure lla ,d ,g). However, in contrast to the strong 
staining seen in the pituitary upon paternal transmission of lacZDMKT  at e l4.5, Igf2 
mRNA was not detected at this site, with the exception of some expression in 
capillaries of the median eminence (not shown).
I l l
Paternal-specific expression (lacZDMR2 +/mat heterozygotes)
The distribution of paternal-specific Igf2 expression resembled that of WT embryos, 
with expression in a small number of scattered cells in the choroid plexus epithelium 
and more uniform expression in the choroid plexus stroma (Figure 10). Expression 
was strong in both the pia and arachnoid mater of the leptomeninges and in pericytes 
of cerebral blood vessels (Figure lib ) .
Maternal-specific expression (lacZDMR2 +/pat heterozygotes)
Maternal-specific Igf2 expression (paternal transmission o f lacZDM Kl') was 
restricted exclusively to the choroid plexus epithelium, leptomeninges and brain 
capillary endothelium. In the choroid plexus epithelium, expression was highly 
variegated with clear positive and negative cells evident, with expression either weak 
or absent from the stroma (Figure 10). Expression was evident in capillary 
endothelium throughout many areas of the brain (Figure 11c).
H19 expression in the developing choroid plexus
It was of interest to establish whether H I9 expression is similar in both its distribution 
and imprinting, to that of Igf2 in the choroid plexus and capillary endothelium of the 
brain or whether differences exist between these genes? An H I9 knockout strain, 
H I9A3, was obtained for this purpose and analysed by in situ hybridisation. This 
strain was created in a previous study and carries a 3kb genomic deletion that removes 
the H I9 structural gene (Ripoche et al. 1997). The H I9A3 allele cannot produce H I9 
RNA, therefore in embryos heterozygous for the H I 9A3 deletion, it can be presumed 
that any natural H I 9 transcripts present must originate from the non-deleted 
endogenous allele. Therefore to examine total endogenous and paternal specific H I9 
expression in the choroid plexus, sections of WT or H I9A3+/mat' heterozygous 
embryos respectively were hybridised with an H19 antisense probe (see Chapter 2 
section describing slide mRNA in situ hybridisation). Control hybridisations with a 
sense probe did not produce signals (not shown).
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Figure 10. Allele-specific in situ hybridisation analysis of Igf2 
expression, choroid plexus. Histological sections containing the choroid 
plexus were prepared from WT, paternal and maternal transmission 
lacZDM Kl' e l4.5 embryos and hybridised with antisense and sense 
probes to Igf2 and the distribution of hybridisation signals (purple 
staining) visualised with brightfield microscopy. A WT expression, 
staining was abundant in the epithelium and stroma; C paternal-specific 
expression (maternal transmission of lacZDMR2~), staining was evident 
in a few isolated epithelial cells and was seen throughout the stroma; E 
maternal-specific expression (maternal transmission of lacZDMKl'), 
staining was present in the epithelium, but was mostly absent from the 
stroma. Igf2 expression in the choroid plexus epithelium was clearly 
variegated in each case. B,D,F maternal lacZDM Kl', paternal 
lacZDM Kl' and WT sections hybridised with an Ig/2 sense probe. 
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Figure 11. Allele-specific in situ hybridisation analysis of Igf2 
expression and lacZDMR2' reporter gene expression, brain capillary 
endothelium. A-C, D,G Histological sections were prepared from WT, 
paternal and maternal transmission lacZDM Kl- e l4.5 embryos and 
hybridised with antisense and sense probes to Igf2 and the distribution of 
hybridisation signals (purple staining) visualised with brightfield 
microscopy. A-C Hindbrain views showing widespread Ig/2 mRNA 
expression in capillary endothelium A endogenous Ig/2 expression ; B 
paternal-specific Igf2 expression (maternal /acZDMR2'); C maternal- 
specific Igf2 expression (maternal lacZDMKl'). The in situ showed 
evidence of biallelic Igf2 expression in endothelium, that is Igf2 mRNA 
was present whether the embryo carried a maternal or paternal disruption 
of the endogenous gene; magnifications x50. D,G separate views of Igf2 
mRNA expression in the endothelium of WT sections, magnifications 
x400 and x600. No signals were seen in sections hybridised with a sense 
control probe (not shown).
E,F,H,I Allele-specific lacZDM Kl- expression. Embryos with paternal 
and maternal transmission of lacZDM Kl- were fixed and stained for the 
presence of p-galactosidase activity (blue staining), sectioned in the 
sagittal plane and the staining visualised by light microscopy. Detailed 
views of allele specific lacZDM Kl- expression in capillary endothelium 
are shown following paternal transmission (E,H) and maternal 
transmission (F,I) maternal transmission. This analysis provides further 
evidence of bi-allelic Igf2 expression in capillary endothelium, with 
staining present in this tissue following transmission of lacZDM Kl- from 
either parent. Sections were counterstained with nuclear fast red. 
Magnifications x400 and x600. Arrowheads indicate sites of expression 





As expected in WT embryos H19 expression was widespread throughout mesodermal 
and endodermal tissues (refer to Figure 2). In the brain, H19 expression appeared to 
coincide with that o f Igf2 at several sites with strong staining seen in the choroid 
plexus stroma, but in contrast to /g/2, could not be detected in the choroid plexus 
epithelium (Figure 12a). Elsewhere H19 expression was seen in the pia mater and 
arachnoid mater of the leptomeninges and in the ventral neuroepithelium occupying 
the optic recesses (not shown). H19 expression was generally absent from brain 
capillary endothelium, although positive staining was occasionally seen in capillaries 
o f the choroid plexus stroma (not shown). Although not previously reported, H I9 
RNA was reproducibly detected in a subpopulation of neurons in the subventricular 
zones surrounding the lateral ventricles (Figure 12c).
Paternal-specific expression (H19A3 +/mat~ heterozygotes)
In H19A3 +/mat’ heterozygotes, paternal-specific H19 expression was not detected in 
either component of the choroid plexus, in subventricular neurons or at any other site 
within or indeed outside of the brain (Figure 12b,d). A maternal H19 deletion 
therefore eliminates all detectable H I9 RNA in the brain, suggesting that the gene is 
robustly imprinted in this tissue and developmental stage.
CTCF expression in the developing choroid plexus
Expression data presented in this study provides evidence supporting biallelic Igf2 
expression and biallelic H19 silencing in choroid plexus epithelial cells. Binding of 
the protein CTCF, to sites within the H19 DMD has been shown to be a critical for the 
maintenance of imprinting o f both genes (Bell 2000; Hark et al. 2000; Kanduri 2000b; 
Schoenherr et a l  2003). No attempt has previously been made to examine CTCF 
expression in the choroid plexus epithelium, where potentially, an absence of this 
factor could be consistent with deregulated Igf2/H19 imprinting in this tissue. In situ 
hybridisation was therefore performed in embryos using an RNA probe derived from 
the full-length CTCF cDNA. Only weak signals were seen with this probe and it was 
not possible to determine whether expression was present or absent in the choroid 
plexus epithelium or at any other site (not shown).
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Figure 12. Allele-specific in situ hybridisation analysis of H19 
expression, choroid plexus. Histological sections, containing the 
choroid plexus, prepared from WT and H19A3+/~ mat el4.5 embryos, 
were hybridised with an antisense probe to H I9 and the distribution of 
hybridisation signals (purple staining) visualised with brightfield 
microscopy. A,B H I9 expression in the choroid plexus, A WT, staining 
was seen in the stroma, but not the epithelium; B H19A3+/' mdt, staining 
was absent from both components of the choroid plexus; C,D H19 
expression in subventricular regions of the brain C WT, staining was 
seen in a subpopulation o f neuronal cells (arrows) ; D H19A3+/'ma\  
staining was fully absent from subventricular regions. All 
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Analysis of differentiation markers in the developing choroid plexus
Immunohistochemistry analysis
Does Igf2 expression uniquely define a subpopulation of choroid plexus epithelial 
cells or are other genes similarly regulated in this tissue? Sections of WT e l4.5 
embryos, containing the choroid plexus, were made and stained with primary 
antibodies (see Chapter 2 section describing immunohistochemistry) to proteins 
known to be expressed in this tissue, Transferrin (TFN), Albumin (Alb), type 1 
Insulin-like growth factor receptor (Igflr), fibroblast growth factor receptor 3 (shown 
in Figure 13) (Chodobski 2001) (and references therein). Positive staining with a 
uniform distribution was observed in the choroid plexus epithelium in all cases. 
Uniform TTR staining in this tissue (previously presented in Figure 9) is also shown 
for comparison. Staining for Insulin (expected to be absent from the choroid plexus 
epithelium) provided a negative control. Staining was not observed in sections 
incubated with the secondary antibody only. This analysis, including additional sites 
of expression not described here, is summarised in Table 5.
In situ hybridisation analysis
An additional choroid plexus epithelial marker, F oxjl, was analysed by in situ 
hybridisation. Foxjl encodes a winged helix domain-containing transcription factor, 
which is required for left-right axis specification and ciliogenesis (Brody 2000). Foxjl 
is expressed in the developing choroid plexus epithelium from e l 0.5 o f mouse 
development and continues to mark this tissue thereafter (Lim 1997). In vitro work 
implicates Foxjl as a regulator of Igf2 expression in the choroid plexus epithelium 
(Lim 1997). Moreover, Foxjl expression is highly variegated in the bronchial 
epithelium of the developing lung (Brody 2000). Foxjl was therefore considered a 
good candidate for showing variegated expression in the choroid plexus epithelium. 
Antisense and sense DIG-labelled RNA probes were obtained for Foxjl and 
hybridised with WT e l4.5 embryo sections (see Chapter 2 section describing slide 
mRNA in situ hybridisation). Foxjl expression (Figure 14) was evident in the choroid 
plexus epithelium and was uniformly distributed. Expression was also seen in the 
nasal epithelium and clear evidence of variegated expression was apparent in the 
bronchial epithelium, both sites consistent with previous work (Brody 2000). Control 
hybridisations with a sense probe did not produce signals. This analysis is 
summarised in Table 5.
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Figure 13. Immunohistochemistry analysis of differentiation 
markers in the choroid plexus epithelium. Histological sections 
containing the choroid plexus were prepared and stained for the 
presence of various differentiation markers and the distribution of 
staining (brown precipitate) in the choroid plexus epithelium visualised 
with brightfield microscopy. A Transthyretin (TTR), positive staining 
was seen in a uniform distribution ; B Transferrin (TFN), staining as 
seen for TTR; C Albumin, staining as seen for TTR; D Fgfr3, staining as 
seen for TTR; E Igflr, staining as seen for TTR; F,G negative controls; 
F section (containing the choroid plexus) incubated with a biotin 
labelled a-rabbit IgG secondary antibody; G Insulin, no staining was 
observed in the choroid plexus epithelium; H Insulin, positive staining 
was observed in differentiating pancreatic p-cells. Sections were 
counterstained with Mayers haematoxylin (blue). All magnifications are 
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Figure 14. In situ hybridisation analysis of FoxJl expression in the 
choroid plexus epithelium. Histological sections containing the choroid 
plexus at e l4.5 were prepared and hybridised with antisense and sense 
probes to Foxjl and the distribution of hybridisation signals (purple 
staining) visualised with brightfield microscopy. The in situ 
hybridisation revealed a highly discrete expression pattern consistent 
with that reported for FoxJl. A expression in the choroid plexus 
epithelium, staining was seen in a uniform distribution; C expression in 
the lung, staining was seen in a subpopulation of bronchial epithelial 
cells, but not the squamous lung epithelium; E expression in the nasal 
epithelium, strong uniform staining was seen. B,D,F Control sections 
hybridised with a sense probe. All magnifications are x200.
Foxjl antisense Foxjl sense
Gene/Marker Method Expression in CP 
epithelium
Expression at other sites
TTR IHC Uniform Leptomeninges (pia and arachnoid 
mater including interconnecting 
trabecular processes), parenchyma of 
the brain and spinal cord. Liver, gut 
epithelium, primordia of vertebrae, 
squamous epithelium of the lung.
TFN IHC Uniform Essentially as described for TTR.
Alb IHC Uniform Essentially as described for TTR.
Foxjl ISH Uniform Epithelium of nasal passages and ear 
canal, columnar epithelium of the lung.
Ig flr IHC Uniform Leptomeninges (pia and arachnoid 
mater) and neurons present in marginal 
regions of cerebral hemispheres and 
midbrain. Weaker staining upon 
neurons in the vicinity of the 
hypothalamus, in the pons, cerebellar 
primordium and medulla oblongata.
Fgfr3 IHC Uniform Leptomeninges (Pia and arachnoid 
mater) neurons in marginal regions of 
cerebral hemispheres. Fairly ubiquitous 
in peripheral tissues.
Ins IHC No expression Differentiating P-cells in pancreatic 
islets.
Table 5. Summary of differentiation marker expression analysis. The markers 
analysed, the method employed and distribution of expression in the choroid plexus 
epithelium, is indicated. Other sites of expression are also described. Abbreviations: 
IHC, immunohistochemistry; ISH, in situ hybridisation.
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A potential involvement of Notch signalling in regulating variegated Igf2 
expression
RT-PCR analysis
As discussed in the Introduction to this chapter, the existence of Igf2 positive and 
negative subpopulations in the choroid plexus epithelium suggested the possible 
involvement o f Notch signalling. RT-PCR analysis was carried out to ask whether 
expression of Notch genes, and their ligands encoded by the Delta and Jagged genes, 
are generally represented in whole choroid plexus mRNA. Total RNA was prepared 
from choroid plexi (see Chapter 2 section describing preparation of total RNA) 
dissected from neonatal Fi mice, complementary DNA (cDNA) was prepared and 
PCR-amplified (see Chapter 2 section describing RT-PCR) using primers specific to 
known murine Notch, Delta and Jagged genes (see Table 3 and Figure 15). In the 
Notch assay, expression o f Notch2 and Notch3 was detected, with basal levels seen for 
Notchl and Notch4. In the Delta!Jagged experiment, D lkl, D114, Jagged 1 and 
Jagged2 were clearly expressed, with basal levels seen for D ill. DU3 expression was 
not detected, though PCR-analysis of genomic DNA confirmed that this observation 
was due to absence o f DU3 expression rather than failure o f the PCR (not shown). 
This analysis therefore demonstrated the expression of all known Notch, Delta and 
Jagged genes, except DU3, in the neonate choroid plexus.
In situ hybridisation analysis
The lateral inhibition model (Lewis 1998), predicts that distinct cell fates will arise 
within a field o f identical cells as a consequence of Notch receptor activity, with 
receptor activation mediated by interaction with Delta ligands present on a subset of 
these cells. Therefore, if  Notch signalling is required to specify different Igf2 
phenotypes within the choroid plexus epithelium, uniform Notch expression and 
variegated Delta!Jagged expression might be predicted in this tissue. RT-PCR 
analysis (above) demonstrated the expression of many Notch, Delta and Jagged genes 
in whole choroid plexus tissue. In situ hybridisation was performed next, to ask if the 
expression o f these genes is localised to the choroid plexus epithelium, and if so, is 
the distribution o f expression consistent with a mechanism of active lateral inhibition, 
that potentially regulates Ig/2 expression?
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Figure 15. RT-PCR analysis of Notch, Delta and Jagged gene 
expression in the choroid plexus. Complementary DNA (cDNA) was 
prepared from neonate choroid plexus tissue and analysed by PCR using 
primers specific to the Notch, Delta and Jagged genes (see Table 3). A 
Notch gene expression; B Delta and Jagged gene expression; C P-actin 
expression (lower panel) shows the successful conversion of RNA to 
cDNA. Samples treated with and without reverse transcriptase are 
indicated as + and -  RT. The molecular weight marker (M) is a lOObp 









Probes for the in situ hybridisation, corresponding to mouse Notch, Delta and Jagged 
genes, were generated from IMAGE consortium cDNA clones obtained from the 
HGMP, UK. The Notchl probe was a lkb cDNA clone. The Notch2 probe was a 
1.8kb cDNA clone. The Notch3 probe was a 4kb cDNA clone. The Notch4 probe was 
a 1.3kb cDNA clone. The D lkl probe was a 1.5kb cDNA clone. The D ill probe was a 
lkb cDNA clone. The D113 probe was a 2kb cDNA clone. DH4 was a 700bp cDNA 
clone. The Jagged 1 probe was a 3kb cDNA clone. The Jagged2 probe was a lkb 
cDNA clone. The clones were sequenced in both directions to confirm the identity of 
the cDNA inserts and determine their orientation in relation to the flanking phage 
promoter sites. Several clones were found to contain large tracts of polyadenylation in 
the intervening sequence between the phage promoter sites and the 3’ end of the 
cDNA inserts. An antisense probe generated by transcribing across these regions 
could potentially generate non-specific signals during an in situ hybridisation, thus 
complicating interpretation of the results. The affected clones (those carrying Notch2, 
Notch4, D lkl and Dll3 sequences) were modified to remove polyadenylation 
sequences, as described below.
The Notch2 cDNA was purified away from its parent vector on a 1.8kb Sall-Nsil 
fragment and ligated into the Sail and Pstl (Nsil compatible) sites of Bluescript to 
create the pBS-Notch2 plasmid.
The Notch4 cDNA was purified away from its parent vector on a 0.7kb EcoRl-Fspl 
fragment and ligated into the £coRI and Smal (Fspl compatible) sites of Bluescript to 
create the pBS-Notch4 plasmid.
The D lkl cDNA was purified away from its parent vector on a 1.3kb EcoRl-Nsil 
fragment and ligated into the EcoRl and Pstl sites o f Bluescript to create the pBS- 
D lkl plasmid.
The D113 cDNA was purified away from its parent vector on a 2kb EcoRl-Psil 
fragment and ligated into the £coRI and EcoKV (Psil compatible) sites o f Bluescript 
to create the pBS-D113 plasmid. The identity and orientation of the modified insert 
DNA was verified by sequencing in each case.
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The cDNA clones were linearised by digestion with restriction enzymes and the 
linearised fragments used in transcription reactions to synthesise DIG-labelled 
antisense and sense RNA probes. The restriction enzymes and polymerases used to 
make each probe are listed in Table 1. In situ hybridisation expression data was 
generated for the Notch, Delta and Jagged genes in whole mount embryos at e l0.5 
(not shown) and in sections of e l4.5 embryos (Figure 16). The analysis at both stages 
is summarised in Table 6.
Notch expression at e10.5
Notch3 and Notch4 probes did not produce clear signals. N otchl expression (not 
shown) was distributed as typically described previously (Higuchi 1995) with 
moderate staining generally seen in the somites, though very strong staining was seen 
in the mesoderm of the posteriormost somite pair in the tail. Notchl expression was 
also evident in first and second branchial arches, the telencephalic vesicles and the 
mesencephalon. No evidence of staining was seen in the presumptive choroid plexus 
epithelium. Notch2 expression (not shown) was similar to that of Notchl, with 
particular reference to the somitic expression and was also absent from regions that 
give rise to the choroid plexus epithelium (Higuchi 1995; Hamada et al. 1999).
Delta and Jagged expression at e10.5
DU3, DU4 and both Jagged  probes did not produce clear signals. D ill expression (not 
shown) was highly discrete with intense staining confined to the ventricular regions of 
the brain and the penultimate and posteriormost somite pairs in the tail, consistent 
with previous observations for this gene (Bettenhausen et al. 1995; Beckers 1999) and 
the localisation o f Notch gene expression described above. In contrast, Dlkl 
expression (not shown) was widespread with strong staining seen in the somites, in 
subdomains of the limb buds, branchial arches, liver bud and ventricular regions of 
the brain. Neither D ill, nor D lkl appeared to be expressed in the presumptive choroid 
plexus epithelium.
Notch expression at e 14.5
Notch 1, Notch3 and Notch4 probes did not produce clear signals despite repeated 
attempts to optimise the hybridisation conditions. Notch2 was clearly expressed in the 
choroid plexus epithelium (Figure 16) with uniform staining seen throughout this
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tissue, but was absent from the stroma. Notch2 expression was also detected in 
neurons occupying the subventricular zones surrounding the lateral ventricles and the 
mesencephalon, consistent with earlier work (Higuchi 1995; Hamada et al. 1999).
Delta and Jagged expression at e14.5
D113 and DU4 probes did not produce clear signals. D ill expression (Figure 16) was 
not seen in the choroid plexus, contrary to that described in earlier studies (Beckers 
1999). Staining of moderate intensity was observed in a subset o f neuronal cells that 
occupied the ependymal and subventricular layers of the brain and in the columnar 
epithelium of the comma- and s-shaped bodies of the developing kidney, as seen 
previously (Bettenhausen et al. 1995; Beckers 1999; McCright et al. 2001). D lkl 
expression (Figure 16) was not seen in the choroid plexus epithelium, though some 
staining was evident in the stromal mesenchyme, possibly corresponding to the 
abundant expression o f this gene shown by earlier RT-PCR analysis of whole choroid 
plexus tissue. D lkl was widely expressed in peripheral tissues, with strong signals 
evident in the liver, the pancreatic islets, skeletal muscle including that o f the tongue, 
squamous epithelium of the lung and the pericardium of the heart, but not cardiac 
muscle (not shown). High levels o f expression were seen in glandular cells of the 
anterior pituitary and in a subpopulation of neuronal cells surrounding the 
hypothalamus and the subventricular regions of the lateral ventricles. Expression was 
also evident in what appeared to be smooth muscle cells surrounding cerebral blood 
vessels, though the vessel endothelium itself was not stained (not shown). Jaggedl 
expression (Figure 16) was not observed in the choroid plexus epithelium or stroma, 
and was otherwise restricted to blood vessels throughout peripheral tissues, consistent 
with previous observations (Loomes 1999; Irvin 2004). Expression was evident in a 
subpopulation of neuronal cells that occupied subventricular regions surrounding the 
lateral ventricles, but was not detected in the brain capillary endothelium. Jagged2 
expression was absent from the choroid plexus epithelium and stroma, with 
expression at other sites as described for Jaggedl (not shown).
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Figure 16. In situ hybridisation analysis of Notch, Delta and Jagged 
gene expression in the choroid plexus. Histological sections containing 
the choroid plexus at e l4.5 were prepared and hybridised with antisense 
and sense probes (refer to Table 1) and the distribution o f hybridisation 
signals (purple staining) visualised with brightfield microscopy. A,B 
Notch2 expression; A in brain subventricular regions, staining was seen 
in neurons surrounding the lateral ventricle; B in the choroid plexus 
epithelium, staining was seen in a uniform distribution, but was absent 
from the stroma. C,D,J D ill expression; C in brain subventricular 
regions, staining was seen in a subset of neurons surrounding the lateral 
ventricles (x400); D in the kidney, staining (arrows) was seen in 
condensing epithelium of comma- and s-shaped bodies; J staining was 
absent from the choroid plexus. E,F Jaggedl expression, E in brain 
subventricular regions, staining was similar to that described for D ill 
(x400); F in peripheral blood vessels, those associated with 
mesenchyme o f the developing hind gut are shown (arrows). Staining 
was absent from the choroid plexus (not shown). G,H,I D lkl expression, 
G in brain subventricular regions, staining was similar to that described 
for D ill (x400); H glandular cells of the anterior pituitary; I staining 
was absent from the choroid plexus epithelium, but weak staining was 
seen in the stroma. No signals were seen in sections hybridised with 
sense control probes (not shown). Unless otherwise stated 
magnifications are x200. Abbreviations svr, subventricular region; v, 
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Gene Stage Sites o f  expression
Notchl e l 0 . 5 Neuroepithelium of telencephalon and mesencephalon, mesoderm of 
penultimate somite pair (not shown)
e l 4 . 5 Not detected
Notch2 e l 0 . 5 Neuroepithelium of telencephalon and mesencephalon, mesoderm of 
penultimate somite pair (not shown)
e l 4 . 5 Choroid  plexus epithelium,  subventricular regions surrounding 
lateral ventricles (Figure 16)
Notch3 e l 0 . 5 Not detected
e l 4 . 5 Not detected
Notch4 e l 0 . 5 Not detected
e l 4 . 5 Not detected
D lkl e l 0 . 5 Widespread in embryonic mesoderm and endoderm, limb buds, 
somites, liver bud, branchial arches, nasal recesses, neuroepithelium 
of telencephalon and mesencephalon (not shown)
e l 4 . 5 Subventricular regions of the brain, anterior pituitary (F igu re l6)  
hypothalamus, tongue, liver, smooth muscle surrounding the gut and 
blood vessels, lung epithelium, pancreatic islets, pericardium of the 
heart (not shown)
D ill e l 0 . 5 Neuroepithelium of telencephalon and mesencephalon, mesoderm of 
penultimate and posteriormost somite pairs (not shown)
e l 4 . 5 Subventricular regions surrounding lateral and fourth ventricles of 
the brain, condensing epithelium of the kidney (Figure 16)
DIB e l 0 . 5 Not detected
e l 4 . 5 Not detected
DU4 e l 0 . 5 Not detected
e l 4 . 5 Not detected
Jaggedl e l 0 . 5 Not detected
e l 4 . 5 Endothelium of peripheral blood vessels, subventricular regions 
surrounding lateral ventricles of the brain (Figure 16)
Jagged2 e l 0 . 5 Not detected
e l 4 . 5 Endothelium of peripheral blood vessels (not shown)
Table 6. Summary of Notch, Delta and Jagged in situ hybridisation analysis.
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Conclusions
A principal aim of this chapter was to examine spatio-temporal features of biallelic 
Igf2 expression in the developing brain with emphasis upon the choroid plexus. This 
was addressed by examining the developmental expression profile for Igf2 in the brain 
at several embryonic stages using an Igf2 (lacZD M KI ) reporter gene insertional 
mutant and Igf2 in situ hybridisation.
The lacZDMR2' reporter gene assays revealed the first evidence of biallelic Igf2 
expression at e l 0.5, in a subset of neuroepithelial cells that occupied areas destined to 
form the choroid plexus at later stages. The identity of these cells as precursors for 
choroid plexus epithelium was confirmed by their expression of the diagnostic 
marker, TTR (Murakami 1987) in equivalent regions of WT embryos. Unsurprisingly, 
biallelic expression was also demonstrated at later stages in the differentiated choroid 
plexus epithelium, consistent with previous work (DeChiara et al. 1991). However, in 
the choroid plexus stroma, reporter gene expression was only seen after paternal 
transmission in all stages examined, thus providing evidence that Igf2 is imprinted at 
this site and not biallelically expressed as previously thought (DeChiara et al. 1991; 
Svensson 1995). It is concluded that the expression of Ig/2 in the presumptive choroid 
plexus epithelium is initiated between e9.5 and e l0.5 of development and that this 
expression occurs from both alleles from its onset. Prior to this only paternal-specific 
expression could be detected at any site in the embryo, with both alleles silent in the 
neuroepithelium.
Although not formally described in mice to date, evidence from the lacZDMRT  
reporter assays indicated that Igf2 expression occurs in the capillary endothelium of 
the embryonic brain. This manifested paternal-specific reporter expression at early 
stages, with expression from both parental alleles evident by el4.5. That is, Igf2 
expression in the capillary endothelium is initially imprinted and becomes biallelic 
later in gestation. This expression continued from both alleles in the brain of adult 
mice. Evidence in support of this data comes from studies in the adult rat brain. First, 
Igf2 expression was identified in the capillary endothelium associated with the 
choroid plexus stroma and (Stylianopoulou et al. 1988b) and more widely in the brain 
parenchyma (Logan 1994). More recently, a microarray screen identified an 
enrichment of Igf2 expression in isolated capillary endothelium tissue against a
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comparison with whole brain tissue. Subsequent experiments in the same study 
revealed high levels of Ig/2 expression in capillary endothelium in situ (Li 2001a). 
Given the widespread extent o f the capillary endothelium (which forms an integral 
component of the blood brain barrier) it seems likely that, in addition to the choroid 
plexus and leptomeninges, this is likely to represent a third major source of 
biologically available IGFII peptide in the CNS. Although a definitive function has 
yet to be ascribed to Ig/2 in these tissues, it is perhaps noteworthy that the major sites 
of its brain expression occur in those tissues with exchange or barrier function.
The sites of expression marked by the lacZDMKT allele were largely consistent with 
the Igf2 mRNA in situ data. One exception was found in the anterior lobe of the 
pituitary at e l4.5, where abundant reporter gene expression was seen. Although 
expression of the reporter in Rathkes pouch, the precursor o f the anterior pituitary, 
correlates well with Igf2 mRNA expression at earlier stages, Igf2 mRNA was 
generally not found in the pituitary at el4.5. The el4.5 anterior pituitary is therefore 
considered an ectopic site for lacZDM RT  expression, suggesting that the removal of 
DMR2 in this mutant may have revealed a cryptic silencer element not identified in 
the original analysis of this mutant (Murrell et a l  2001). Elsewhere in the brain, 
maternal-specific lacZDM KZ  expression was seen in the neuroepithelium lining the 
dorsal midline of the mesencephalon. That is, evidence was found for imprinted 
expression of Igf2 that is derived from the opposite allele to that seen at most other 
sites. Whether or not this reflects a genuine feature of Ig/2 expression and imprinting 
awaits allele-specific whole mount Igf2 in situ analysis. Until this data is available, a 
causal effect o f the DMR2 deletion in this expression cannot be excluded. In 
summary, data from the present study indicates that Igf2 expression is much more 
widespread in the developing and mature brain than previously thought. However, this 
expression is not uniformly distributed as has been implied by some studies (Yang 
2003), but rather as illustrated by the data for capillary endothelium, it is concentrated 
in discrete tissues amongst a much greater volume of neuronal tissue, which generally 
lacks expression.
H I9 and Igf2 exhibit overlapping spatio-temporal expression in imprinted peripheral 
tissues, thus it was o f interest to ask whether the co-ordinate expression and 
imprinting o f Igf2/H19 is preserved in the brain. In mice, whilst it has been shown that
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HI 9 maintains imprinted expression in the embryonic choroid plexus the cell-type 
distribution of H I 9 RNA in its epithelial and stromal compartments has not been 
clearly resolved (Svensson 1995). In this study H19 expression, analysed at el4.5, 
was detected in the choroid plexus stroma and leptomeninges of WT embryos, but not 
in embryos carrying a maternal deletion o f the H19 gene. H19 is therefore imprinted 
at these sites. H19 expression was not detected in the choroid plexus epithelium or in 
the capillary endothelium, sites where biallelic expression of Ig/2 was found. 
Conversely, H I 9 expression was found in subventricular neurons, a site not marked 
by lg/2 expression at this stage. This expression was shown to be imprinted as 
evidenced by its absence in the maternal deletion tissue and may correspond to 
neuronal expression seen previously (Svensson 1995). Consistent with previous work 
where paternal-specific expression of H19 could not be found at any site in embryos 
staged between e8-17, evidence arguing for biallelic expression of H I9 was not found 
in any tissue in the present study (Svensson 1998). It is therefore concluded that H I9 
expression is stringently imprinted and does not fully coincide with Ig/2 expression 
(subventricular neurons) in the developing brain, at least at the stage examined.
Therefore, in the choroid plexus epithelium (and brain capillary endothelium) Igf2 is 
biallelically expressed and H19 silenced upon both alleles. In contrast, data for the 
stroma argues that both genes remain imprinted at this site. These findings apparently 
contradict the claim of another study, which argued that in the choroid plexus, the co­
expression of Ig/2 and H I9 occurs from the same chromosome (Svensson 1995). It 
should be noted that this conclusion was drawn from a similar observation that 
imprinted H I9 expression occurs in stromal cells, but was also based upon the 
incorrect assumption that Igf2 is biallelically expressed in the same stromal cells. 
Therefore in both compartments of the choroid plexus, the expression of both genes is 
mutually exclusive in cis, as is the case in peripheral tissues.
Silencing of H I9 and biallelic expression of Ig/2 is particularly striking and suggests 
that the maternal chromosome has assumed paternal characteristics in the choroid 
plexus epithelium. Imprinting of both genes in many tissues is dependent upon 
differential methylation at the DMD (Thorvaldsen et al. 1998; Kaffer 2000; 
Srivastava 2000; Holmgren 2001). Could atypical Igf2IH19 imprinting in the choroid 
plexus epithelium be mediated by epigenetic changes within the DMD itself and/or
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the hierarchy of DMRs that fall under its control? (Lopes et al. 2003; Srivastava 
2003). The developmental timing of these proposed events is unknown, although the 
onset o f biallelic Igf2 expression in choroid plexus epithelial precursors at e l0.5, as 
indicated by /acZDMR2‘ reporter gene expression, suggests that such modifications 
must be initiated prior to, or concomitant with, this stage.
Evidence that methylation is required for maintenance of imprinting is unequivocal, 
as shown by /nms-manipulation studies in mice. In embryos experimentally deficient 
in the maintenance methyltransferase protein, D nm tl, Ig/2 was biallelically silenced 
and H I9 biallelically expressed (Li 1993). Therefore, in the absence of genome 
methylation the mono-allelic expression of both genes was disrupted, and it is 
interesting to note, in the opposite direction to that observed in the choroid plexus 
epithelium. Implicit in this last point, is the question of whether the reciprocal 
situation, that is hypermethylation of both alleles of Igf2 and H I9 can provide a 
mechanistic basis for deregulation of imprinting in a manner consistent with that 
observed in the choroid plexus epithelium?
Two lines of evidence suggest that this may be the case. Overexpression of Dnmtl in 
differentiated ES-cell lines was demonstrated sufficient to bring about biallelic 
expression o f Igf2 and a decrease in expression of H19 (Biniszkiewicz 2002). 
Methylation analysis in the same study revealed that the DMD had become highly 
methylated upon both alleles in these cell lines, although the authors did not report 
methylation data for DMRs proximal to Igf2. Although by no means conclusive, 
genomic hypermethylation by Dnmtl overexpression reveals a possible mechanism by 
which atypical Igf2/H19 imprinting may arise in the choroid plexus epithelium.
As discussed in Chapter 1, in the choroid plexus of adult mice (and in contrast to 
imprinted tissues where differential methylation is seen), the maternal allele of DMRs 
proximal to Igf2 and the structural H I 9 gene adopt a paternal epigenotype, such that 
both alleles are hypermethylated, concordant with biallelic Igf2 expression and H I9 
silencing in this tissue (Feil et al. 1994). Methylation at the DMD was not examined 
in this study, but interestingly a scan of the adjacent H I9 promoter proximal region 
revealed evidence o f differential methylation Consistent with this methylation
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analysis, a recent study has provided evidence that the DMD is differentially 
methylated in whole brain tissue (Yang 2003).
The studies of Feil et al. (Feil et al. 1994) and Yang et al. (Yang 2003) appear to 
describe an asymmetric methylation pattern at the Igf2IH19 locus, such that 
methylation in Ig/2 proximal DMRs is acquired independently of the DMD. However, 
firm conclusions cannot be drawn from either of these studies as comparable tissues 
and developmental stages were not used. A further criticism of these studies concerns 
the use of dissected choroid plexus tissue (that would have included both the epithelial 
and stromal compartments) and whole brain tissue, in which DNA methylation 
analysis is unlikely to be representative as the brain-specific expression and 
imprinting of Igf2 is highly discrete. Clearly Ig/2 expressing tissue would be 
underrepresented in this type of analysis, with genuine methylation profiles 
potentially masked by non-expressing tissue. The present study therefore provides a 
caveat for this type of analysis, suggesting that experiments should instead be 
conducted in a system where sites of expression are enriched, or isolated, from other 
tissues. These points are addressed later in the present study by experiments in 
choroid plexus epithelial cell lines (refer to Chapter 5).
The escape from imprinted expression of Ig/2 together with silencing of H I9, a 
second imprinted gene, could suggest that a more pervasive deregulation of imprinted 
genes occurs in the choroid plexus epithelium and at other sites in the brain. There is 
some, albeit circumstantial, evidence in support of this as other imprinted genes are 
similarly affected. The mouse GrblO gene, although maternally expressed in many 
peripheral tissues, is biallelically expressed in the choroid plexus epithelium 
(Charalambous et al. 2003). Similarly, in the present study, expression of the 
otherwise paternally expressed D lkl gene was not detected in the embryonic choroid 
plexus epithelium, although its expression was evident in adjacent tissues. Therefore, 
at least two further imprinted genes show either biallelic expression or silencing in the 
choroid plexus epithelium.
With the deregulation o f multiple and unlinked imprinted loci, it could be argued that 
a critical trans-imprinting factor is either downregulated or functionally repressed 
upon differentiation of choroid plexus epithelial cells. This hypothesis was tested with
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an in situ hybridisation approach to ask whether the Igf2/H19 regulator, CTCF, is 
expressed in the choroid plexus epithelium? In this instance technical problems with 
the in situ hybridisation prevented a proper evaluation of this issue.
Two other studies suggest that further investigation is warranted. First, disruption of 
CTCF binding by mutation of its consensus sequences within the DMD led to 
uncharacteristic increases in post-zygotic methylation upon the maternal allele of the 
DMD, with concomitant reactivation of maternal Igf2 and decreased expression of 
H I9 in several tissues. Interestingly, the mutated DMD remained devoid of 
methylation in oocytes, suggesting that CTCF is not required to initiate imprinting, 
but rather acts as a post-zygotic maintenance factor (Schoenherr et al. 2003). More 
recent work, that utilised an RNA interference (RNAi)-mediated knockdown of CTCF 
expression in oocytes, demonstrated increased methylation o f the maternal DMD at 
subsequent post-zygotic stages (Fedoriw et al. 2004). These experiments suggest a 
role for CTCF in protecting the DMD (and therefore DMRs proximal to IgfT) from 
the acquisition o f abnormal methylation patterns during post-zygotic development. 
The issue of CTCF expression in the choroid plexus epithelium is addressed later in 
the present study by Northern analysis in immortal cell lines (refer to Chapter 5).
Besides methyltransferases (Li 1993; Biniszkiewicz 2002) and insulator proteins 
(Schoenherr et al. 2003; Fedoriw et al. 2004) other proteins with frw?s-imprinting 
function have been identified (reviewed in (Bird 1999)). Polycomb group (PcG) 
proteins have well-established roles in the stable transcriptional repression of 
developmentally regulated genes via interactions with chromatin and are discussed in 
Chapter 1. Targeted deletion o f the PcG gene, Eed, in mice led to the reactivation of 
normally repressed alleles at several imprinted loci, providing genetic proof of an 
essential role for PcG genes in imprinting (Mager 2003). Igf2/H19 expression was not 
informative at the developmental stages examined by Mager et al. (2003), thus a role 
for Eed in the regulation of Igf2 imprinting has yet to be substantiated. It may be 
relevant that the expression of GrblO, which similar to Igf2 is biallelic in the choroid 
plexus epithelium, was clearly disrupted in Eed knockouts with expression of both 
parental alleles. Interestingly, in another study, a regulatory element from the mouse 
Igf2 locus, the CCD, was shown to confer silencing upon lacZ and miniwhite reporter 
genes in transgenic Drosophila, with silencing mediated by two PcG proteins,
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Enhancer o f  zeste (E[z]) and Posterior sex combs (.Psc) (Erhardt et al. 2003). Given 
the evolutionarily conserved nature of this effect, it might be predicted that 
mammalian PcG homologues mediate the silencing function reported for this element 
in mice (Ainscough et al. 2000b). Future work should attempt to address potential 
roles of PcG proteins as /raw-imprinting factors in the context of the choroid plexus 
epithelium. It might be possible to manipulate mechanisms that initiate biallelic Igf2 
expression upon its differentiation in vivo by overexpression o f PcG genes under early 
choroid plexus or neuroepithelial promoters.
Although not previously reported, the lacZDMR2' assays revealed evidence that only 
a subset of the cells in the choroid plexus epithelium expressed Ig/2. In situ 
hybridisation data corroborated this finding, thereby excluding an involvement of the 
DMR2 deletion in the manifestation of this feature. Additional evidence is provided 
by recent work in transgenic mice where a transgene containing regulatory elements 
from the Igf2/H19 locus, Igf2 promoter 3 (P3) and the CCD, reproducibly conferred 
variegated expression upon a lacZ  reporter gene in the choroid plexus epithelium 
(Charalambous et al. 2004). Interestingly, the CCD alone was shown to confer 
variegated silencing upon the miniwhite reporter gene in transgenic Drosophila, 
providing evidence that this element might be at least partially responsible for the 
effect in the murine choroid plexus (Erhardt et al. 2003). Therefore the CCD (and 
possibly P3) contains the sequences sufficient to impose variegated expression upon 
Igf2. The Drosophila experiments implicate the involvement o f a conserved silencing 
mechanism in this process, possibly mediated by PcG proteins.
The absence of a prior report describing variegated Igf2 expression in the choroid 
plexus suggests that other studies may have overlooked this unusual feature 
(Stylianopoulou et al. 1988b; DeChiara et al. 1991; Svensson 1995; Hemberger 
1998). Since these studies employed radioactive detection methods, a technique of 
relatively lower resolution, variegated expression may not have been apparent, in 
contrast with the higher resolution techniques o f non-radioactive in situ hybridisation 
or lacZ reporter gene assays, as used in the present study.
Variegated expression is evident from the onset of expression in the lineage of 
neuroepithelial cells that give rise to the choroid plexus epithelium and is maintained
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throughout development and into the adult. The lacZDM RT  expression data provided 
evidence that transcription from both parental alleles is subject to variegation, 
although the ratio of positive to negative cells appears to be greater when examining 
expression from the maternal allele, although quantitative cell counting experiments 
were not done to corroborate these observations. Furthermore, whether the expression 
from the respective alleles coincides in the same cell or whether they are expressed in 
distinct non-overlapping cell populations was not addressed in this study. Future 
experiments involving co-localisation of the lacZ gene product with endogenous Igf2 
transcripts or protein in mice heterozygous for the lacZDMKZ  allele is one approach 
that could address these points.
The possibility that the variegation was a consequence of temporal variation in 
initiation of the differentiated choroid plexus phenotype was excluded by evidence 
that expression of TTR, a diagnostic marker, is present in all cells o f the developing 
choroid plexus epithelium. Therefore it is likely that cells both positive and negative 
for Igf2 expression have otherwise correctly assumed the choroid plexus phenotype. 
Conversely, the presence or absence of Igf2 expression could be said to define two 
subtypes of choroid plexus epithelial cell. The biochemical analysis was extended to 
ask whether variable gene expression reflects a more general property of the choroid 
plexus epithelium. Primary antibodies and in situ probes corresponding to several 
other markers were tested for variegated staining in sections of embryonic choroid 
plexus epithelium, although none revealed variegated expression. This analysis, 
although by no means exhaustive, suggests that restriction of gene expression to a 
subset of cells is not likely to be a general feature o f genes expressed in the choroid 
plexus epithelium.
In support o f the data presented in this study, there are precedents for variable 
phenotypes amongst choroid plexus epithelial cells. Most notably, electron lucent and 
dense, or light and dark cells have been described in the choroid plexus epithelium of 
rats, mice and humans (Dohrmann 1970; Sturrock 1979). Sturrock (1979) provided 
quantitative evidence that light cells predominate with the number of dark cells 
comprising approximately 11% of the total cell number and proposed that dark cells 
might contain a greater number of mitochondria and ribosomes, with the implication 
that these cells are engaged in distinct metabolic activities.
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The biological significance o f light and dark cells within the choroid plexus 
epithelium is unclear although evidence from mutant studies suggests that the ratio of 
light to dark cells is linked to CSF secretion and/or homeostasis. Mice homozygous 
for the Hydrocephalus and Polydactyl (Hpy/Hpy) mutation develop hydrocephalus 
early in the postnatal period. The condition develops in the apparent absence of any 
obvious obstruction in the CSF drainage system, suggesting a constitutive, 
inappropriate, secretion of CSF (Bryan 1977). Further work has shown that the 
choroid plexus epithelium of these mice contains an elevated number of dark cells, 
compared with WT animals and it was also shown that a quantitatively equivalent 
induction of dark cells occurs in WT animals deprived of drinking water (Shuman 
1991).
Signalling mediated by arginine vasopressin (AVP), a neuropeptide, has an 
established role in regulating extracellular fluid balance in the CNS of mammals 
(Nilsson 1992). AVP has been shown to curtail CSF secretion from the isolated rat 
choroid plexus in vitro (Liszczak 1986). Therefore AVP negatively regulates CSF 
secretion by the choroid plexus. Consistent with a role for dark cells in water balance, 
this and other studies have shown that AVP mediated decreases in CSF secretion are 
accompanied by an increase in dark cell number (Liszczak 1986; Johanson 1999a). A 
similar effect has been shown to occur following treatment with Fibroblast growth 
factor 2 (FGF2), a protein postulated to act in the same axis as AVP in the central 
regulation o f CSF synthesis (Johanson 1999b; Johanson 2001). This data therefore 
suggests that dark cells are an important feature o f the response to water imbalance in 
the CNS.
Other reported biochemical differences amongst choroid plexus epithelial cells, aside 
from the example given by Ig/2, appear to involve the expression of AVP, 
components of FGF signalling and other molecules previously linked to CSF 
secretion/homeostasis. As such, clusters of cells in the rat choroid plexus epithelium 
demonstrated immunoreactivity to both AVP and FGF receptor antibodies. Therefore 
a subpopulation o f cells in the choroid plexus epithelium is marked by the co­
expression o f AVP and FGF receptors (Szmydynger-Chodobska 2002). Interestingly, 
the cystic fibrosis gene product, the cystic fibrosis transmembrane conductance 
regulator (CFTR), which is known to regulate water flux across many important
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epithelia, by functioning as a cyclic AMP-dependent chloride ion channel, also shows 
variegated expression in the choroid plexus epithelium (Welsh 1992; Hincke 1995). It 
is difficult to reconcile this data with known functions of Ig/2, however an important 
conclusion of this discussion is that, similar to Ig/2, other phenotypic (and possibly 
functional) differences are likely to exist amongst subpopulations o f choroid plexus 
epithelial cells. That these differences appear to be linked to a major function of the 
choroid plexus, that is the secretion of CSF (and fluid homeostasis) underlines the 
importance o f such subpopulations in this tissue, suggesting that a functional role for 
variegated Ig/2 expression in the choroid plexus epithelium may yet be established.
A further aim of this study was to understand how such a cell subpopulation 
expressing Igf2 might be established in the choroid plexus epithelium. The role of 
Notch signalling in the specification of asymmetric cell fates is well documented and 
discussed in the Introduction to this chapter. It was postulated that Notch signalling 
might be involved in the initiation and/or maintenance of variegated expression of 
Ig/2. To this end an investigation of Delta, Jagged and Notch gene expression was 
carried out in the developing choroid plexus in an attempt to identify candidate genes 
for subsequent functional analysis. RT-PCR analysis, although admittedly crude, was 
performed in the isolated choroid plexus of neonate mice as a rapid means to ask 
whether these genes are indeed expressed in this tissue, and revealed the expression of 
all Notch Delta and Jagged genes except DUS. Subsequent in situ hybridisation 
analysis was performed at two further developmental stages spanning the duration of 
choroid plexus morphogenesis, in whole mount preparations at e l 0.5 and in sections 
of e l4.5 embryos, to examine the distribution of expression between the two major 
compartments of the choroid plexus.
The literature suggests that the expression of Notch and Delta genes occurs in a range 
of tissues and spanning several developmental stages, however in situ hybridisation 
analysis in the present study was limited in its ability to uncover many o f these sites 
of expression. Whilst probes for Notch2, DU1, D lkl, Jaggedl and Jagged2 produced 
moderate to strong hybridisation signals in patterns generally consistent with those 
previously reported (Bettenhausen et al. 1995; Higuchi 1995; Hrabe de Angelis et al. 
1997; Beckers 1999; Hamada et al. 1999; McCright et al. 2001; Irvin 2004), with use 
of probes to N otchl, Notch3, Notch4, DH3 and DU4 signals were either diffuse or
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absent. Further attempts to optimise the hybridisation conditions were unsuccessful, 
suggesting that probe dependent problems were the cause of failure in these examples.
It should be noted that, aside from D lk l, even those probes deemed to have worked 
well, did not produce a particularly clear or strong response. An inherent problem of 
in situ hybridisation is that it can be very probe dependent and an explanation for the 
poor performance of in situ probes involves the nucleotide sequence. Notch, Delta and 
Jagged genes contain sequences encoding reiterated conserved motifs, including 
EGF-like repeats and in the case of Notch genes, multiple ankyrin repeats (Lewis 
1998). It is possible that, given their repetitive nature, regions of the probes encoding 
these domains are prone to a degree of secondary structure formation not amenable to 
hybridisation. For the purposes of this study, an involvement o f Notch3, Notch4, DU3 
and D114, cannot be properly evaluated, as expression of these genes could not be 
clearly demonstrated.
Is there sufficient data to support a role for Notch signalling in the specification 
variegated Igf2 expression the choroid plexus epithelium? Notchl and Notch2 
expression was evident at e l 0.5 in subventricular regions o f the brain, and the 
mesoderm of the posteriormost somite pair as previously described (Higuchi 1995). 
However, neither of these genes appeared to be expressed in the vicinity o f the 
presumptive choroid plexus epithelium, although expression of Notch2 has been 
reported in neuroepithelial structures at this stage (Hamada et al. 1999). At el4.5, 
expression o f Notch2, but not of N otchl, was observed in the choroid plexus 
epithelium, consistent with the RT-PCR data and with earlier reports o f its expression 
in this tissue (Higuchi 1995) and appeared to be uniformly distributed. That Notchl 
expression was not found at any site at e l4.5, again implicates probe dependent 
issues, although previous work provides evidence that Notchl is not expressed in the 
choroid plexus at any stage (Higuchi 1995). Therefore, uniform expression of Notch2 
occurs in choroid plexus epithelium at e l4.5, although its expression in choroid 
plexus epithelial precursors at earlier stages remains unresolved.
Of the various Delta and Jagged  ligands analysed, none were found to be expressed in 
either the choroid plexus epithelium or stroma, although expression of D ill , and both 
Jagged genes has been described in the choroid plexus at comparable stages (Hrabe
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de Angelis et al. 1997; Beckers 1999) (Irvin 2004). Further inconsistencies were 
found, in the tissue-specific expression of D ill , suggesting that the probe used did not 
detect expression in all tissues. As expected D ill expression was seen in the 
subventricular neurons of the brain and in the condensing epithelial structures o f the 
kidney at e l4.5, but in contrast to published expression patterns, was not present in 
epithelial structures lining the pancreas and lung, or in muscle lineages (Beckers 
1999; McCright et al. 2001). It is unlikely that these differences are explained by the 
existence of tissue specific transcripts not detected by the probe used here, as only a 
single 3.8kb transcript has been described for this gene (Bettenhausen et al. 1995). It 
is therefore more likely that these inconsistencies result from differences in overall 
expression levels, or probe dependent penetration between tissues. Given the highly 
discrete localisation o f transcripts reported for this and other Notch ligands, it is 
conceivable that these negative factors could decrease hybridisation signals to levels 
below detection thresholds. The use of different probes might improve the detection 
of gene expression, although it is perhaps significant that an initial set of Notch 
probes, not described in this study, also failed to give reproducible hybridisation 
signals. Primary antibodies are commercially available for all mammalian Notch, 
Delta and Jagged proteins, thus an immunohistochemistry approach could provide an 
alternative means by which to further investigate a role for Notch signalling.
In summary, expression of a single Notch gene, Notch2, was demonstrated in the 
mature choroid plexus epithelium. None of the genes encoding its potential ligands, 
Delta or Jagged, were shown to be expressed in an overlapping manner that would be 
consistent with a receptor-ligand interaction in this tissue. On the basis o f this and 
previous expression data, a role for Notch signalling in the specification or 
maintenance of subpopulations in the choroid plexus epithelium, positive and negative 
for lgf2 expression, is neither supported nor excluded. Further work should attempt to 
elucidate the role of Notch2 in a loss-of-function system. This analysis would, 
however, be largely dependent upon availability o f hypomorphic Notch2 mutant 
strains (Notch2 null embryos die prior to the formation of the choroid plexus (Hamada 
et al. 1999)) or tissues and might be better suited to an in vitro approach. Immortal 
choroid plexus epithelial cell lines created in the present study (refer to Chapter 5) 
appear to have retained variegated Igf2 expression and could provide a resource to 
systematically test the function o f Notch2 and other candidates using the RNAi
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technique. However, recent evidence perhaps favours a polycomb-based mechanism 
over Notch-signalling in mediating variegated Igf2 expression in the choroid plexus 
epithelium (Erhardt et al. 2003; Charalambous et al. 2004), therefore future RNAi 
studies of Notch function should be extended to include the PcG genes also implicated 
in this activity.
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CHAPTER 4: IN VITRO INVESTIGATION OF CHOROID PLEXUS CIS 
REGULATORY ELEMENTS
Introduction
The developmental expression analysis identified the choroid plexus epithelium as a 
site of both biallelic and variegated Igf2 expression (Chapter 3). An important step 
toward a complete understanding of mechanisms involved in regulating this pattern of 
expression requires that the necessary c/s-regulatory elements are mapped and 
characterised. Transient expression assays in cultured mammalian cells provide a 
rapid and sensitive means to investigate the role o f regulatory elements isolated from 
endogenous genes. This approach has been employed to define enhancers (Yoo- 
Warren et al. 1988; Kaffer 2000; Drewell et al. 2002a) and dissect boundary or 
silencing functions in imprinting control regions at the Igf2/H19 locus (Bell 2000; 
Hark et al. 2000; Kanduri 2000a; Holmgren 2001; Ginjala 2002). In the present study 
transient expression assays were employed as a means to analyse genomic regions for 
choroid plexus enhancer activity.
Transgenic experiments have shown that at least one enhancer element driving 
expression in the choroid plexus epithelium must reside within the 2kb CCD region 
(discussed in Chapter l)(W ard et al. 1997; Charalambous et al.2004). The function of 
this region has also been tested within the context of a 12kb germline deletion where 
consistent with the loss of an enhancer, decreased Igf2 expression was seen 
specifically in the choroid plexus and leptomeninges (Jones et al. 2001). Importantly, 
this deletion did not result in complete loss of Igf2 expression, suggesting the 
existence o f a second enhancer region situated outside o f the deletion. The precise 
location of the enhancer within the CCD is not known, although it presumably lies 
within one o f the two stretches o f conserved sequence identified within this region 
(Ainscough et al. 2000b). Transgenic experiments have shown the deletion of the first 
of these, CCD region 1, within the context o f a YAC transgene had no apparent 
impact on the expression of a lacZ reporter gene in the brain, suggesting that the 
enhancer lies outside o f this region. The CCD region 2 is therefore a strong candidate 
for the enhancer.
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Where might additional enhancer elements be located? The insulator model has 
established a widely accepted paradigm for Igf2IH19 imprinting and is discussed at 
length in Chapter 1. A major prediction of this model is that enhancers driving 
imprinted expression will be situated 3’ of the chromatin boundary at the DMD, 
whilst those driving biallelic expression will be situated 5’ of this region. Consistent 
with this, known choroid plexus enhancers are located 5’ o f the DMD in the 
intergenic region between Ig fl  and H I9 (Ward et al. 1997; Jones et al. 2001; 
Charalambous et al. 2004). Relocation of the H I 9 endoderm-specific enhancer region 
to the intergenic region resulted in biallelic Ig fl expression in tissues where these 
enhancers are normally active and imprinted expression occurs (Webber et al. 1998). 
Moreover, when the DMD was moved to a position between the endodermal and 
skeletal muscle enhancers, H I9 became biallelically expressed in endodermal tissues 
but was silent in muscle (Kaffer 2000). Enhancer location relative to the DMD is 
therefore a determinant o f imprinted expression at the Ig fl!H I9 locus.
Sequence comparisons o f the Igfl/H19  locus in human and mouse have revealed the 
presence of five conserved non-coding regions, each 120-150bp in length, situated in 
the intergenic region (Onyango et al. 2000). Because o f their location, these regions 
might be predicted to act as choroid plexus-specific enhancers and drive biallelic 
expression in this tissue. The aims of this chapter were to firstly further delineate the 
choroid plexus enhancers within the CCD, by separately testing the function of 
regions 1 and 2 in deletion constructs, and secondly to investigate the function of 
conserved intergenic sequences in an attempt to locate and characterise the additional 
choroid plexus enhancer activity implicated in previous work (Jones et al. 2001).
Continuous cell lines derived from the choroid plexus epithelium were not available at 
the onset although two lines have been established from the rat during the course of 
this work (Kitazawa 2001; Zheng 2002). Primary cultures of choroid plexus 
epithelium have been successfully established from a range o f mammalian species 
(Crook 1981; Thomas 1992; Holm 1994; Ramanathan 1996; Villalobos et al. 1997). 
Although more difficult to manipulate when compared with continuous cell lines, 
primary cultures offer the advantage of closely resembling the parent tissue from 
which they are derived, whereas cell lines have in many cases lost aspects of the 
differentiated phenotype. Therefore to generate a suitable system for use in transient
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The Ig fl  probe is described in the Materials and Methods section at the beginning of 
Chapter 3. The TTR probe was derived from the pTTR7kbexV3 plasmid (Prof R.H. 
Costa unpublished work) and was a lkb Nrul-Stul DNA fragment spanning exons 1-2 
of the mouse TTR gene. For Northern analysis probes were isolated from their parent 
vectors by digestion with restriction enzymes and purification from agarose gels (see 
the relevant Chapter 2 sections). Probes were radioactively labelled prior to use (see 
Chapter 2 section describing synthesis of a -32P(dCTP)-labelled DNA probes).
Antibodies
Primary antibodies to TTR and E-cadherin for immunofluorescence cytochemistry are 
described in the Materials and Methods section at the beginning of Chapter 5.
Plasmids
Igfl-Luciferase constructs, which contained various regulatory regions from the 
Igfl/H19  region were previously described (Ward et al. 1997). The M construct 
contained the Ig fl  Promoter 3 (P3) linked to the Luciferase reporter gene in the 
Bluescript SK+ vector (Stratagene). The constructs A and H were generated by the 
respective insertion o f the H I9 endoderm-specific enhancer region and the CCD into 
M. Two CCD deletion constructs based upon the H construct, pCCD4 and p C C D ll 
contained the CCD with region 1 and region 2 deleted respectively, were obtained 
from Dr. Marika Charalambous.
PCR Primers
The primer sequences used to amplify conserved elements from the IgfllH19  
intergenic region were designed from genomic sequence obtained from the National 
Centre for Biotechnology Information (NCBI) Nucleotide database. Genetool primer 
design software (Biotools, UK) was used to select the primers from these sequences.
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Primer pair Direction Sequence
Conserved 1 forward
reverse
5’CCC CTC ACC CGG CTA CAT CTA CAT-3’ 
5’AGG CCA GAC TTC CCC AGG TAT TGA-3’
Conserved 2 forward
reverse
5’GGC CCT TTC CCT GTT CCC TAG AGA-3’ 
5’GCA AGA GCA AGT GGG AAC CCT GTC-3’
Conserved 3-5 forward
reverse
5’GCT GGC TTG GCT GGG TGG GAT TAG-3’ 
5’GGA CGC TGG CTT GGC ATG GAT TG-3’




Primary culture of choroid plexus epithelial cells
Primary choroid plexus epithelial cells were prepared as described (see Chapter 2 
section describing preparation of primary choroid plexus epithelial cells). This method 
was based upon an existing protocol (Hoffmann 1996) and was subject to further 
modifications which involved plating the recovered cells onto dishes pre-coated with 
fibroblast extracellular matrix (Charalambous 2000). Two additional modifications 
appeared to improve cell viability sufficiently (not quantified) to allow omission of 
the fibroblast ECM, such that isolated cells could be plated directly onto tissue culture 
plastic. First the pronase concentration in HBSS buffer was reduced from 4 to 2mg 
m l'1 and second, dissected brains were held in complete growth medium rather than 
PBS prior to the removal of choroid plexus tissue. These changes appeared to increase 
the number o f small cell aggregates recovered (as opposed to single cells) which are 
likely to plate more efficiently than single cells. To obtain sufficient cell numbers for 
subsequent transfection or gene expression experiments, choroid plexi were dissected 
from the lateral and fourth ventricle of approximately 20 animals (or 2 litters) and 
disaggregated in the presence of pronase as described. Recovered cells were plated 
directly into tissue culture treated plastic dishes and left undisturbed overnight to 
allow for cell attachment, after which unattached cells and debris were removed by 
changing the medium.
Morphology
Cultured cells originating from the choroid plexus epithelium would be expected to 
display a diagnostic epithelial morphology. The cultures were examined by light 
microscopy approximately 48 hours after plating, which revealed that numerous 
colonies of epithelial-like cells had formed with a characteristic closely opposed 
cobblestone morphology (Figure 17a). These cells displayed a granular appearance, 
which is suggestive o f either secretory activity or the presence o f apical microvilli. All 
of these features were consistent with an origin from the choroid plexus epithelium. A 
population of fibroblast-like cells, possibly having originated from the choroid plexus 
stroma, were dispersed between the epithelial colonies. Excessive fibroblastic 
proliferation could be prevented by the inclusion of cytosine P-D-arabinofuranoside 
(CAF), a selective DNA synthesis inhibitor, in the growth medium. Choroid plexus
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epithelial cells have been reported to lack transport mechanisms for arabinose sugars 
and were thus insensitive to the action of this drug (Hoffmann 1996). In this manner, 
confluent cultures enriched for the epithelial colonies were produced a week after 
plating (Figure 17b). However, for the purposes of the transient assays, where 
additional reagents might interfere with transfection or reporter gene expression, the 
CAF treatment was omitted. It was not possible to passage the cultures into finite cell 
lines as the cells were so strongly adherent that their detachment only occurred after 
prolonged incubation with dissociation reagents and any cells that could be persuaded 
to detach exhibited poor plating efficiency upon subsequent passage. Thus 
experimentation with this system was limited to freshly explanted cultures only.
Gene expression
To confirm the origin o f the cultures from choroid plexus epithelium, the expression 
of two genes was examined. As already discussed, the Transthyretin {TTR) gene, is a 
robust marker for choroid plexus epithelial cells (Murakami 1987). Ig fl  expression is 
another marker of choroid plexus epithelium that is expressed from the earliest stages 
of choroid plexus differentiation (see Chapter 3). Additionally, as this study involved 
the dissection of Ig fl  regulatory elements, it was necessary to confirm the expression 
of this gene in the cultures. RNA was isolated from the primary cultures and from 
dissected choroid plexus tissue, which would be expected to abundantly express both 
Ig fl and TTR, thus acting as a positive control for the experiment. RNA was isolated 
from brain tissue depleted of the choroid plexi and meninges, which would not be 
expected to express detectable levels of either gene, and served as a negative control. 
The RNA was analysed by Northern analysis (see Chapter 2 section describing 
Northern analysis). Hybridisations were performed with DNA probes corresponding 
to exon 6 of the Ig fl  gene and exons 1-2 of TTR. The Northern analysis (Figure 18) 
showed that abundant transcripts for Ig fl  and TTR were present in the primary 
cultures and in the positive control tissue. No hybridisation signals were seen in the 
negative controls.
To examine gene expression in situ, the primary choroid plexus cultures were fixed 
and stained with an a-TTR antibody and the antibody visualised with a fluorescein- 
conjugated secondary antibody (see Chapter 2 section describing immunofluorescence
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cytochemistry). High levels of the TTR protein were observed in the majority of 
epithelial cells in a pericytoplasmic distribution (Figure 19). Staining with this 
antibody was absent from the fibroblastic component. E-Cadherin is a sensitive 
marker for all epithelial cells, including those o f the choroid plexus. The cultures were 
also stained with an a-E-Cadherin antibody as described for TTR. E-Cadherin protein 
was exclusively localised to the plasma membranes of the cells in the epithelial 
colonies as would be expected for epithelial cells (Figure 19). Staining was not seen 
within the fibroblast component of the cultures (not shown). The primary cultures 
therefore present morphological and biochemical properties of differentiated choroid 
plexus epithelial cells.
PCR-amplification of Intergenic conserved elements
To address the role o f the intergenic conserved elements (Onyango et al. 2000), a 
strategy was devised to examine their activity in the context of Luciferase reporter 
constructs. For the purposes o f this study these elements were termed C1-C5. Figure 
20a shows their genomic location relative to the Igf2 and H19 genes. A PCR-based 
approach was employed to isolate these elements from genomic DNA. It was apparent 
that the close proximity o f C3, C4 and C5, with all three elements occupying a 4kb 
region in mice, might have some functional significance, as this arrangement is 
conserved in humans (Onyango et a l 2000). It was envisaged that these elements 
should be assayed as a functional unit initially and then the function o f each element 
could be separately tested in deletion constructs. With this in mind, a long template 
PCR strategy was devised to isolate all three elements on a single 5kb genomic 
fragment. Ultimately time constraints prevented the individual analysis of these 
regions. The C l and C2 elements were amplified on shorter genomic fragments with a 
conventional PCR approach. The primers sequences designed to amplify these 
elements together with some flanking DNA, are listed in the Materials and Methods 
section at the beginning o f this chapter. Figure 20b shows the expected sizes of PCR 
products and the approximate position of the conserved elements within these 
products for each primer pair.
PCR-amplifications were performed as described (see Chapter 2 section describing 
PCR). The primer pair for the C2 region amplified the target sequence efficiently
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Figure 17. Primary choroid plexus cultures, morphological analysis
Primary choroid plexus cultures were examined by light microscopy. 
Epithelial-like colonies with a characteristic closely-opposed 
cobblestone morphology were observed at 48 hours (A) after plating. 




Figure 18. Prim ary choroid plexus cultures, Northern analysis of Igf2 
and TTR expression. Total RNA was extracted from the primary choroid 
plexus cultures, from dissected neonate choroid plexus tissue and from 
brain tissue with choroid plexi removed, blotted and hybridised with Igf2 
and TTR probes. The two upper panels show Northern analysis of primary 
choroid plexus RNA for Igf2 and TTR mRNA expression. A band 
corresponding to the 3kb Igf2 transcript was seen in the primary cultures 
and dissected choroid plexus, but not in the brain tissue. TTR expression 
was similarly distributed with a lkb transcript present in the primary 
cultures and dissected choroid plexus tissue, but not in brain. Hybridisation 
with a GAPDH  probe to show equal loading of total RNA in all lanes is 
shown in the lowermost panel.
FITC Merge DIC
Figure 19. Prim ary choroid plexus cultures, immunofluorescence 
analysis of TTR and E-cadherin expression Primary cultures were fixed 
and stained for the presence of TTR and E-cadherin. Images under both 
FITC and DIC conditions were collected by laser scanning confocal 
microscopy (left and right columns respectively). These images were 
overlaid as shown in merge (middle column). A-B show the presence of TTR 
protein in a perinuclear cytoplasmic distribution within a small colony of 
epithelial cells; C DIC image of the same field of cells. D-E show E- 
cadherin staining localised to the plasma membranes surrounding several 
epithelial cells. F DIC image of the same field of cells. Neither protein was 
detected within the fibroblastic component of the cultures. Scale bars show 
either 10 pm (A-C) or 20 pm (D-F)
whereas those for Cl and C3-5 regions did not amplify the expected products and thus 
required optimisation. Conditions that allowed efficient amplification with these 
primer pairs were determined empirically in a series o f 12 optimisation reactions (see 
Chapter 2 section describing PCR optimisation and Figure 21). The amplified 
fragments were purified (see Chapter 2 section describing purification of DNA from 
solutions and agarose gels) and ligated into the pGEM-T-easy vector to create the 
plasmids pGEM-T-Cl, pGEM-T-C2 and pGEM-T-C3-5.
Generation of Igf2-Luciferase reporter constructs
All Luciferase reporter constructs were derived from the M (P3-Luciferase) construct 
and were created as described below. M was linearised at a unique Noil site situated 
immediately 3’ o f the Luciferase sequences and treated with phosphatase (see Chapter 
2 section describing dephosphorylation of plasmid ends) to prevent self-ligation. This 
fragment, designated M -A M  was used to derive all Luciferase constructs by insertion 
of the candidate regulatory regions, isolated by PCR and cloned as described above 
into the Noil sites. To create the C l construct, a 1.2kb Noil fragment containing the 
C l element was purified away from the pGEM-T-Cl plasmid and ligated into M- 
Notl. To create the C2 construct, a 0.75kb Noil fragment containing the C2 element 
was purified away from the pGEM-T-C2 plasmid and ligated into M-TVod. To create 
the C3-5 construct, a 5.1kb Notl fragment containing the C3, C4 and C5 elements was 
purified away from the pGEM-T-Cl plasmid and ligated into M-Afo/I.
A further set o f four constructs was created to investigate potential synergistic 
interactions between the Cl and C2 intergenic elements and the CCD. The P3- 
Luciferase-C l-C C D  construct was created as follows: a 2kb EcoRl fragment 
containing the CCD region was purified from its parent vector and ligated into the 
£coRI site of the pBS II KS+ vector to create the pBS-CCD plasmid. A 1.2kb Notl 
fragment containing the C l element was purified away from the pGEM-T-Cl 
plasmid, the ends filled in by treatment with T4 DNA polymerase (see Chapter 2 
section describing conversion of 5’ and 3’ recessed ends to blunt ends) and ligated 
into the filled-in Hindlll site of the pBS-CCD plasmid to create the pBS-Cl-CCD 
plasmid. An additional Noil site for subsequent manipulations was created within an 
existing Kpnl site at the 5’ end of the multiple cloning site, by insertion of a short 
linker fragment (see Chapter 2 section describing oligonucleotide linker synthesis)..
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Figure 20. Genomic location of Igf2/H19 intergenic conserved regions.
A The Igf2/H19 genomic region (not to scale) is shown with the position of 
conserved regions C l, C2, and C3-5 (shaded boxes) shown relative to the 
Igf2 and H I9 genes. Exons (open boxes) and characterised enhancers 
(ovals) are also shown. B Predicted sizes of the PCR products (open boxes) 
on which the conserved regions (shaded boxes) were isolated are 
described.
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Figure 20. Intergenic conserved regions at the Igf2/H19 locus
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Figure 21. PCR-amplification of Igf2IH19 intergenic conserved 
regions. Optimal PCR conditions were determined empirically by varying 
the concentration o f reaction components (Mg2+, dNTPs and primers) 
across lanes 1-12 (for details of this optimisation see Chapter 2 section 
describing PCR). A. Optimal amplification of the C l region fragment, with 
a 1.2kb band, occurred in reaction 8 (white arrow) with 1.5mM Mg2+, 
4.5mM dNTPs and 2pM  primers. B. Optimal amplification of the C3-5 
region fragment, with a 5.1 kb band, occurred in reaction 1 (white arrow) 
with ImM Mg2+, 0.45mM dNTPs and 0.2pM primers. PCR amplification 
of the C2 region did not require optimisation (not shown). The molecular 
weight marker (M) is a 1 kb DNA ladder with bands of relevant molecular 
weight indicated.





The linker was a homodimer generated by the pairwise-annealing o f the 
oligonucleotide sequence 5 ’ CGCGGCCGCGGTAC-3 ’ where the Notl site is 
underlined. Finally, a 3.2kb Notl fragment containing the fused Cl-CCD regions was 
purified away from the pBS-Cl-CCD plasmid and ligated into M-Ao/I.
The ?3-Luciferase-C2-CCD  construct was created as follows: a 2kb Spel-Nhel 
fragment containing the CCD region was purified from its parent vector and ligated 
into the Spel site of the pGEM-T-C2 plasmid described above to create the pGEM-T- 
C2-CCD plasmid. Finally, a 2.8kb Notl fragment containing the fused C2-CCD 
regions was purified away from the pGEM-T-C2-CCD plasmid and ligated into M- 
Notl.
The Y3-Luciferase-Cl-C2 construct was created as follows: A 1.2kb Notl fragment 
containing the C l element was purified away from the pGEM-T-Cl plasmid, filled-in 
by treatment with T4 DNA polymerase (see Chapter section describing conversion of 
5’ and 3’ ends to blunt ends) ligated into the filled-in Notl site of the pBS II KS+ 
vector to create the pBS-Cl plasmid. The Cl region was purified away from this 
plasmid within a 1.2kb Sacll fragment and ligated into the Sacll site o f the pGEM-T- 
C2 plasmid described above to create the pGEM-T-Cl-C2 plasmid. Finally, a 2kb 
Notl fragment containing the fused C1-C2 regions was purified away from the 
pGEM-T-Cl-C2 plasmid and ligated into M-Aotf.
The ?3-Luciferase-Cl-C2-CCD  construct was created as follows: a 1.2kb Sacll 
fragment containing the C 1 region, the origin o f which is described above and ligated 
into the Sacll site o f the pGEM-T-C2-CCD plasmid also described above, to create 
the pGEM-T-Cl-C2-CCD plasmid. Finally, a 4kb Notl fragment containing the fused 
C1-C2-CCD regions was purified away from the pGEM-T-Cl-C2-CCD plasmid and 
ligated into M-Ao/T All constructs were sequenced across the cloning junctions at 
each stage to confirm the correct identity and orientation o f the inserted fragments.
Transient expression assays
It has been found that greater transfection efficiencies may be achieved in epithelial 
cells by performing transfections whilst the cells are in suspension as opposed to the 
conventional transfection of cells after they have formed an adherent monolayer
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(Sambrook 1989). In the present study, pilot experiments revealed an approximate 2- 
3-fold increase (not quantified) in the number of transfected cells following 
transfection with a constitutive SV40-lacZ plasmid in suspension cells compared with 
an adherent cell transfection (data not shown). Primary choroid plexus cultures were 
transfected immediately following their plating and before attachment had occurred.
Igf2-Luciferase reporter constructs (shown in Figure 22) were transfected into 
primary choroid plexus epithelial cells and HepG2 cells (see Chapter 2 sections 
describing transfection o f plasmid DNA into primary choroid plexus cultures and 
continuous cell lines) for the purposes of three different experiments and Luciferase 
reporter gene measurements were made as described (see Chapter 2 section describing 
transient expression assays). Luciferase measurements were normalised against 
protein levels to control for cell number. In all cases an SV40-/acZ reporter plasmid 
was co-transfected to allow Luciferase measurements to be normalised for 
transfection efficiency. Luciferase expression data was tested for overall significance 
with one-way analysis of variance (ANOVA). Mean expression levels for each 
construct were then tested using Bonferroni’s multiple comparison test. All tests were 
performed at the 5% significance level.
CCD deletion
To further delineate enhancers within the CCD region, Luciferase expression levels 
were determined following the transfection of the H construct and two CCD deletion 
constructs, pCCD4 and p C C D ll, into primary choroid plexus cultures. The A 
construct contains the H I 9 endoderm-specific enhancer region and was transfected as 
a negative control. The results are expressed in Table 8 as ratios of the test constructs 
to the basal expression level provided by the M construct. Mean Luciferase 
expression levels for each construct are summarised in Figure 23. The CCD 
demonstrated silencer activity when in cis to P3 with a 0.243 ± 0.022 level of 
Luciferase reporter gene expression from H compared to basal levels provided by M 
(p=<0.001). Neither o f the deletion constructs showed significant differences in 
Luciferase expression when compared against that of H or with one another.
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Figure 22. Igf2  promoter 3 (P3) Luciferase reporter constructs used 
in transient expression assays. All constructs are derived from the M 
construct (P3-Luciferase). Construct names are shown on the left and 
regulatory regions ligated in cis to P3-Luciferase are shown as open 
boxes on the right. These regulatory regions are contained within the 
following fragments: H I 9 enhancers (2.7kb Spel-Bglll fragment); CCD 
(2kb EcoRl fragment); CCDA r l  (0.9kb Pstl-EcoRl fragment containing 
CCD region 2); CCDA r2 (1.1 kb EcoRl-Pstl fragment containing CCD 
region 1); C l (1.2kb Notl fragment); C2 (0.75kb Notl fragment); C3-5 
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CCD11 CCDA r2
C l P3 Luciferase C1
C2 Luciferase C2
C3-5 P3 Luciferase C3-5
C1-C2 P3 C1 C2
Cl-CCD C1 CCD
C2-CCD P3 Luciferase C2 CCD
C1-C2-CCD P3 C1 C2 CCD
The experiment was repeated in HepG2 cells. The results are expressed in Table 9 as 
ratios of the test constructs to the basal expression level provided by the M construct. 
Mean Luciferase expression levels for each construct are summarised in Figure 24. 
No significant differences were observed in Luciferase reporter gene expression from 
H compared to the basal levels provided by M. in HepG2 cells. Although 
unresponsive in the primary choroid plexus cultures, the A construct containing the 
H19 liver-specific enhancer region mediated a highly significant 11± 0.022 fold 
increase (p=<0.001) in Luciferase reporter gene expression over basal levels, 
confirming that the assay was able to discriminate tissue-specific responses of the 
constructs. In summary, silencing activity from the CCD (H construct) was only 
observed in primary choroid plexus epithelial cells but not HepG2 cells. Enhancer 
activity from the H I 9 endoderm-specific enhancer region was observed in HepG2 
cells consistent with previous work (Yoo-Warren et al. 1988; Leighton et al. 1995; 
Ward et al. 1997) but not in primary choroid plexus cultures.
Intergenic conserved regions
To determine whether any of the conserved intergenic regions could function as 
enhancers when in cis to P3, Luciferase expression levels were measured following 
transfection o f the intergenic region constructs C l, C2 and C3-5 constructs into 
primary choroid plexus epithelial cells. The results are expressed in Table 10 as ratios 
of the test constructs to the basal expression level provided by the M construct. Mean 
Luciferase expression levels for each construct are summarised in Figure 25. None of 
the conserved regions significantly increased Luciferase reporter gene expression over 
basal levels provided by M. The C3-5 construct exhibited a 0.436 ± 0.058 level of 
Luciferase expression compared with basal levels (p=<0.05) suggesting the presence 
of silencer activity.
The experiment was repeated in HepG2 cells. The results are expressed in Table 11 as 
ratios of the test constructs to the basal expression level provided by the M construct. 
Mean Luciferase expression levels for each construct are summarised in Figure 26. 
The C2 construct exhibited a 1.94 ± 0.058 fold increase in Luciferase expression 
compared with basal levels provided by M (p=<0.05) suggesting the presence of 
enhancer activity. As before, the A construct produced a highly significant response.
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Silencer activity from the C3-5 construct observed in choroid plexus cultures was not 
seen in HepG2 cells, in contrast to choroid plexus cultures.
Intergenic conserved region/  CCD synergism
To ask whether the intergenic conserved regions can function as enhancers in 
combination with the CCD when placed together in cis to P3, a series of synergism 
constructs containing various combinations of the C l and C2 elements with the CCD 
were transfected into primary choroid plexus cultures. The results are expressed in 
Table 12 as ratios of the test constructs to the basal expression level provided by the 
M construct. Mean Luciferase expression levels for each construct are summarised in 
Figure 27. None of the constructs exhibited expression levels over basal levels. 
Furthermore no significant differences in expression levels were observed between 
the constructs, indicating that synergistic interactions between the elements tested are 
unlikely. This experiment was not done in HepG2 cells.
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Table 8. Summary of transient expression data for CCD deletion constructs, 
primary choroid plexus cells. The M construct provides the basal expression level 
for this assay, to which the test constructs are compared. Normalised expression levels 
are expressed as construct expression divided by the basal expression level for each 
replicate (n=5). The mean, standard deviation (S.D.) and the standard error of the 
mean (S.E.M.) are presented for each test construct.
Figure 23. Luciferase expression levels following transfection of CCD deletion 
constructs, primary choroid plexus cells. Mean normalised expression levels are 
shown for all test constructs. The mean basal expression level provided by the M 
construct is given as 1. Error bars show the standard error of the mean. There were 
significant differences between M and all test constructs (p= <0.001***)
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Replicate Normalised expression levels: ratio/control
A H CCD4a C C D lla pBS
1 0.6 0.174 0.278 0.261 0.017
2 0.6 0.269 0.346 0.231 0.000
3 0.9 0.309 0.515 0.221 0.000
4 0.6 0.230 0.396 0.395 0.020
5 0.5 0.235 0.395 0.519 0.020
Mean 0.639 0.243 0.386 0.325 0.011
S.D. 0.174 0.050 0.087 0.129 0.010




M A H  CCD4  CCD11 pBS
Figure 23. CCD deletion constructs, prim ary choroid plexus cells.
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Table 9. Summary of transient expression data for CCD deletion constructs, 
HepG2 cells. The M construct provides the basal expression level for this assay, to 
which the test constructs are compared. Normalised expression levels are expressed as 
construct expression divided by the basal expression level for each replicate (n=3). 
The mean, standard deviation (S.D.) and the standard error of the mean (S.E.M.) are 
presented for each test construct.
Figure 24. Luciferase expression levels following transfection of CCD deletion 
constructs, HepG2 cells. Mean normalised expression levels are shown for all test 
constructs. The mean basal expression level provided by the M construct is given as 
1. Error bars show the standard error of the mean. There were significant differences 
between M and A (p= <0.001***).
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Replicate Normalised expression levels: ratio/control
A H CCD4 CCD11 pBS
1 8.8 0.52 0.59 0.59 0.000
2 12.9 0.56 1.000 0.65 0.000
3 11.3 0.52 0.82 0.73 0.000
Mean 11.0 0.533 0.803 0.657 0.000
S.D. 2.061 0.023 0.206 0.070 0.000
S.E.M. 1.190 0.013 0.119 0.041 0.000
* * *12.5”i















M A H CCD4 CCD11 pBS
Figure 24. CCD deletion constructs, HepG2 cells.
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Table 10. Summary of transient expression data for intergenic conserved region 
constructs, primary choroid plexus cells. The M construct provides the basal 
expression level for this assay, to which the test constructs are compared. Normalised 
expression levels are expressed as construct expression divided by the basal 
expression level for each replicate (n=5). The mean, standard deviation (S.D.) and the 
standard error of the mean (S.E.M.) are presented for each test construct.
Figure 25. Luciferase expression levels following transfection of intergenic 
conserved region constructs, primary choroid plexus cells. Mean normalised 
expression levels are shown for all test constructs. The mean basal expression level 
provided by the M construct is given as 1. Error bars show the standard error of the 
mean. There was a significant difference between M and C3 (p= <0.05*).
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Replicate Normalised expression levels: ratio/control
A C l C2 C3 pBS
1 0.880 1.35 1.610 0.450 0.010
2 0.750 1.290 1.440 0.540 0.010
3 0.530 0.680 1.190 0.330 0.010
4 0.920 0.460 1.800 0.580 0.000
5 0.350 0.620 0.960 0.280 0.000
Mean 0.686 0.880 1.400 0.436 0.006
S.D. 0.242 0.410 0.333 0.130 0.005
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Figure 25. Intergenic conserved region constructs, prim ary choroid plexus cells.
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Table 11. Summary of transient expression data for intergenic conserved region 
constructs, HepG2 cells. The M construct provides the basal expression level for this 
assay, to which the test constructs are compared. Normalised expression levels are 
expressed as construct expression divided by the basal expression level for each 
replicate (n=3). The mean, standard deviation (S.D.) and the standard error of the 
mean (S.E.M.) are presented for each test construct.
Figure 26. Luciferase expression levels following transfection of intergenic 
conserved region constructs, HepG2 cells. Mean normalised expression levels are 
shown for all test constructs. The mean basal expression level provided by the M 
construct is given as 1. Error bars show the standard error of the mean. There were 
significant differences between M and A (p= <0.001***) between M and C2 (p= 
<0.05*).
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Replicate Normalised expression levels: ratio/control
A C l C2 C3 pBS
1 5.709 0.86 2.174 0.511 0.000
2 5.336 0.63 1.605 0.303 0.000
3 6.377 0.82 2.045 0.400 0.000
Mean 5.807 0.770 1.941 0.404 0.000
S.D. 0.527 0.122 0.298 0.104 0.000
S.E.M. 0.304 0.070 0.172 0.060 0.000
Figure 26. Luciferase expression levels of intergenic conserved region constructs, 
HepG2 cells.
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Table 12. Summary of transient expression data for enhancer synergism 
constructs, primary choroid plexus cells. The M construct provides the basal 
expression level for this assay, to which the test constructs are compared. Normalised 
expression levels are expressed as construct expression divided by the basal 
expression level for each replicate (n=5). The mean, standard deviation (S.D.) and the 
standard error o f the mean (S.E.M.) are presented for each test construct.
Figure 27. Luciferase expression levels following transfection of enhancer 
synergism constructs, primary choroid plexus cells. Mean normalised expression 
levels are shown for all test constructs. The mean basal expression level provided by 
the M construct is given as 1. Error bars show the standard error of the mean. There 
were no significant differences between any of the test constructs.
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Replicate Normalised expression levels: ratio/control







1 0.6 2.180 2.450 4.630 2.270 3.450 3.540 0.000
2 1.3 1.250 1.750 2.530 1.000 1.430 1.860 0.000
3 1.0 1.040 1.214 1.350 0.860 0.960 0.820 0.000
4 0.3 0.670 1.170 0.950 0.880 0.710 1.330 0.000
5 0.4 0.690 2.440 2.310 0.500 0.940 1.000 0.000
Mean 0.754 1.166 1.805 2.354 1.102 1.498 1.710 0.000
S.D. 0.416 0.617 0.628 1.431 0.679 1.122 1.097 0.000
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Figure 27. Enhancer synergism constructs, prim ary choroid plexus cells.
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Conclusions
Choroid plexus-specific expression of Igf2 is likely to be controlled by at least two 
distinct regulatory regions. One region with this function has been identified, the CCD 
(Ward et al. 1997; Jones et al. 2001; Charalambous et al.2004). Two small blocks of 
conserved sequence located within this region, the first o f which contains two sites of 
strong DNAse I hypersensitivity, are candidate c/s-regulatory elements for choroid 
plexus gene expression. This hypothesis was tested here by analysis o f CCD deletion 
Luciferase reporter constructs in transient assays. The existence of additional 
regulatory regions distinct from the CCD has been implicated by transgenic 
experiments, however their location is unknown (Jones et a l  2001). In this chapter, 
Luciferase reporter constructs containing conserved Igf2/H19 intergenic sequences, 
placed in cis to P3, were analysed in transient assays in an attempt to elucidate the 
role of these sequences as additional choroid plexus-specific enhancers.
To test the function o f these elements a primary choroid plexus culture system was set 
up. Primary cultures o f choroid plexus epithelium have been successfully established 
from a range of mammalian species (Crook 1981; Thomas 1992; Holm 1994; 
Ramanathan 1996; Villalobos et al. 1997). In the present study, primary cultures were 
established from the mouse using a protocol developed previously (Charalambous
2000). Two further modifications to this protocol, the incubation o f tissue in complete 
pre-warmed growth medium as opposed to PBS and a reduction in pronase 
concentration by 50%, appeared to increase the plating efficiency. It was not clear 
why these treatments were effective although it seems likely that cell survival is 
generally enhanced. Brains are held for periods exceeding 1 hour after animals are 
sacrificed while dissection takes place, thus incubation in growth medium creates a far 
better approximation o f the natural tissue environment than PBS. As such the serum 
component o f the medium provides an abundance of growth and attachment factors, 
thus enhancing both cell viability and plating. The reduction in pronase concentration 
may also have positively affected cell survival. During the disaggregation process it is 
possible that pronase activity renders a proportion of cells unable to attach, perhaps by 
destruction of surface adhesion molecules. It is also possible that pronase digestion at 
lower concentrations generates larger aggregates of epithelial cells that attach more 
effectively than smaller aggregates or single cells.
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The origin o f the cultured cells was confirmed with analyses of morphology and gene 
expression. Two principal cell-types were seen in the cultures. The first of these 
formed tight colonies and exhibited a polygonal, closely opposed ‘cobblestone’ 
morphology, all o f which are characteristic features of epithelial cells in culture. The 
remaining cell-types were dispersed amongst the epithelial colonies and were 
fibroblastic in nature. Gene expression analysis revealed that the cultures abundantly 
expressed Igf2 and TTR mRNA, both of which are diagnostic biochemical markers for 
the choroid plexus epithelium. It was also demonstrated that TTR protein was located 
only in the epithelial cells. A substantial component of the primary culture was likely 
to have originated from the choroid plexus epithelium. Cells of a fibroblastic 
morphology were also seen in the cultures. These cells did not express E-cadherin or 
TTR protein by immunofluorescence and were therefore unlikely to be derivatives of 
the choroid plexus epithelium. It seems more likely that these cells originated from 
the choroid plexus stroma.
Most of the cells presented morphological and biochemical properties of the choroid 
plexus epithelial tissue, however a number of stromal cells were also present. The 
type of culture system used in this study therefore cannot be considered homogeneous 
for the epithelial component. As has been shown in Chapter 3, the imprinting status of 
Igf2 is not continuous across the epithelial and stromal components of the choroid 
plexus. The regulatory elements involved might be predicted to behave differently 
dependent upon the cell-type. Such cell-type specific effects would not have been 
distinguished in this system therefore conclusions drawn from the transient assays 
cannot necessarily be directly extrapolated to the choroid plexus epithelium in vivo.
Various Luciferase reporter constructs were transiently expressed in the cultures to 
examine any tissue-specific enhancer activity that might be present within conserved 
sequences from the Igf2!H19 intergenic region. Surprisingly, rather than acting as an 
enhancer, the CCD conferred a reproducible and highly significant degree o f silencing 
upon P3 in cis with Luciferase reporter gene expression ratio of 0.243 ± 0.022 
(p=<0.001) from the H construct compared to basal levels provided P3 alone from the 
M construct. The silencing effect was not observed in HepG2 cells, therefore 
indicating that this activity may be restricted in a tissue-specific manner, although
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because of the low number of replicates (n=3) this conclusion should be treated with 
caution.
Two previous studies have described a tissue-specific silencing function within region 
1 of the CCD, which is active in skeletal muscle (Ainscough et al. 2000b; Jones et a l
2001). In the present study, reporter gene expression levels were consistently higher 
following transfection of the pCCD4 construct, which carried the region 1 deletion, 
compared with that of the H construct containing the non-deleted CCD, although this 
effect was not significant. Not withstanding, this observation could be consistent with 
the silencing activity observed within region 1 in vivo (Ainscough et al. 2000b).
Despite muscle-specific activity, a silencing function within the CCD active in 
choroid plexus tissue, as implicated by the present study is nonetheless surprising 
given the findings of two other transgenic studies where this region in fact conferred 
enhancer activity upon reporter genes in the choroid plexus (Ward et al. 1997; 
Charalambous et al.2004). In the former study, the constructs H and M produced 
opposite responses when integrated as transgenes to that observed in transient assays 
in the present study. Luciferase expression levels measured in choroid plexus tissue 
dissected from H-construct bearing lines were approximately 50-fold greater than 
basal levels provided by M-construct bearing lines (Ward et al. 1997). Taken with this 
evidence, data from the present study may indicate that the CCD can behave as an 
enhancer within an integrated context, but not upon extra-chromosomal plasmids.
Does CCD enhancer activity require a chromatin environment in order to function? 
Previous studies have demonstrated that transiently transfected plasmids become 
chromatinized to a certain extent and that histones can assemble on them. At the same 
time this acquisition of chromatin was incomplete and did not fully recapitulate the in 
vivo structure (Reeves 1985; Jeong 1994). The function of many c/s-acting elements 
involves complex interactions with higher order chromatin structure and it could be 
argued that chromatin organisation at the plasmid level may not fully support these 
functions in some cases. It is perhaps noteworthy that two sites o f strong 
hypersensitivity to DNase I have been identified within CCD region 1 (Koide 1994). 
That is, sequences within this region are able to locally affect the higher-order 
structure of chromatin. It is possible that enhancer activity at the CCD is dependent
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upon interactions with a defined chromatin structure that cannot properly condense 
upon extra-chromosomal plasmids.
The apparent requirement for integration into a chromosomal context, as transgenic 
studies seem to suggest, might indicate that the circular arrangement o f the plasmid 
environment (as opposed to the linear conformation of transgenes) generates 
interference between opposing regulatory activities at the CCD. That is, enhancer 
activity may have been subject to artifactual suppression by a silencer function in the 
transient assays, although how this would occur mechanistically is unclear. One 
explanation is that the close proximity of the CCD to P3 within the plasmid context, 
compared with their more distant separation at the endogenous locus, may have 
imposed an artificial silencing effect. Interestingly, the DMD (which also functions as 
a silencer at its endogenous locus) was found to impose such distance-dependent 
silencing upon the H I9 promoter in transient expression assays (Drewell et a l 2000) 
(Ginjala 2002). That is, the DMD conferred a second cryptic silencing activity. At 
present, such an effect cannot be excluded from the experiments in this study, 
although this could be addressed empirically by the creation of further constructs that 
contain various spacer fragments to increase the separation between P3 and the CCD.
The analysis described above and the findings of previous studies (Ward et al. 1997; 
Ainscough et a l  2000b; Jones et a l  2001)(Charalambous et a l  2004) support an 
argument that both positive and negative regulatory functions reside within the CCD 
region. The significance o f two opposing activities within this region is unclear. 
However, given the evidence that the CCD contains sequences sufficient to direct 
variegated expression (Charalambous et al. 2004)(Erhardt et a l 2003), it could be 
argued that these features are consistent with an involvement in regulating variegated 
Igf2 activation and/ or silencing in the choroid plexus epithelium. Indeed the apparent 
silencing imposed by the CCD upon P3 in cis could have reflected a CCD-mediated 
restriction in reporter gene expression to a fraction of the total number of cells 
transfected, i.e. to those that express Igf2. That is, the reporter gene was silenced in a 
subset of the cells transfected whilst in another subset its expression was activated.
Five conserved intergenic regions provided candidates for additional choroid plexus- 
specific enhancers at the Igf2/H19 locus. As such Luciferase reporter constructs
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containing these regions were transfected into primary choroid plexus cells although 
none elicited a significant enhancement of reporter gene expression over basal levels. 
Despite the small number of replicates it was concluded that none o f these elements 
were able to drive reporter gene expression in the primary cultures. In HepG2 cells the 
C2 construct produced a Luciferase expression ratio o f 1.94 ± 0.172 (p=<0.05) 
against basal levels (Figure 26). By contrast, in primary choroid plexus cells, 
although this construct consistently expressed at higher levels than basal, the data was 
not significant (Figures 25 and 27). This region may possess intrinsic enhancer 
activity, however the low number o f replicates in each experiment means that any 
conclusion drawn from this data should be treated with caution.
In isolation neither the CCD, nor any of the conserved intergenic regions were able to 
reproducibly drive reporter gene expression in primary choroid plexus epithelial cells. 
To examine potential synergistic enhancer activity between these regions, constructs 
containing various combinations of the CCD with C l and C2 regions were transfected 
into primary choroid plexus cells. Synergistic interactions o f statistical significance 
were not observed for any combination of the three fragments tested. Although not 
significant, the largest mean Luciferase expression ratio o f 2.35 ± 0.64 compared with 
basal levels was observed for the C1-C2 construct, suggesting that at least one or both 
of these regions may possess enhancer activity. Again, the replicate number was low. 
The C3-5 region was not analysed, as its conserved sub-regions had not been tested in 
isolation at this stage. A role for any of the conserved intergenic regions as choroid 
plexus-specific enhancers cannot be excluded at present, in particular given evidence 
that the CCD, which exhibits enhancer activity in vivo, is also unable to drive reporter 
gene expression in primary choroid plexus cells.
A formal possibility not considered by the experiments in this study is that additional 
choroid plexus enhancer activity lies within the Igf2 promoter 3 (P3) region. The 
transient expression data is consistent with this argument given that none of the 
constructs tested in primary choroid plexus cells demonstrated a significant increase 
in reporter gene expression (and in many cases showed a significant decrease) in 
comparison with the M construct containing P3 alone. Transgenes containing P3 are 
consistently expressed in the choroid plexus of transgenic mice and moreover a
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germline deletion that encompassed the CCD, but not P3, reduced but did not 
completely ablate Igf2 expression in this tissue (Ward et al. 1997; Jones et al. 2001; 
Charalambous et a l 2004; Kelly 2004). This hypothesis could be rapidly tested by 
analysis of additional constructs in which P3 is substituted for a heterologous 
promoter not normally active in the choroid plexus epithelium. The expression data 
presented in Chapter 3 suggests that the H I 9 promoter would be suitable for this 
purpose. Prospectively, the generation of further transgenic lines bearing P3-lacZ 
reporter constructs could also clarify the role of P3.
Developmentally, the choroid plexus epithelium and hepatocytes o f the liver arise 
from separate embryonic lineages, but intriguingly, are linked in the expression of 
many genes, particularly those with known roles in serum transport and in metabolism 
(Thomas 1989; Catala 1998; Chodobski 2001). Studies of the Transthyretin (TTR) 
gene have shown that expression from this locus in choroid plexus and liver utilises 
distinct regulatory regions (Yan 1990). With this in mind, two enhancer regions, the 
CCD and H19 endoderm enhancer region that respectively confer Igf2 expression in 
the choroid plexus and liver were investigated. Reporter gene expression levels from 
the A construct, containing the H19 endoderm enhancer region, did not differ 
significantly from basal levels following transfection into the primary choroid plexus 
cultures although consistent with previous work, this construct was highly expressed 
in the liver-derived HepG2 cell line (Yoo-Warren et al. 1988; Leighton et al. 1995; 
Ward et al. 1997). H I9 transgenes that included this region were reproducibly 
expressed in the choroid plexus, yet no decrease in H I 9 (or Igf2) expression was 
reported in the choroid plexus following deletion of this region (Brunkow 1991; 
Leighton et al. 1995). These results indicate that, similar to TTR, mechanisms 
governing Igf2 expression in choroid plexus and liver are separable.
In summary, and in agreement with data from transgenic studies (Ainscough et al. 
2000b; Erhardt et al. 2003) where the CCD was shown to act as a silencer in muscle 
lineages, this region also appeared to exert silencer activity upon P3 in a primary 
choroid plexus transient expression system (with caveats discussed). Potential roles 
for such silencer activity in this tissue are unclear, but might pertain to an involvement 
in variegated expression. Attempts to dissect this and other activities within the CCD 
using a transient system were unsuccessful. With this in mind, future work might
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involve a transgenic approach to address this issue. Ainscough et al. did not uncover 
any choroid plexus-specific enhancer activity following deletion of a lkb segment 
containing CCD region 1 (Ainscough et a l 2000b). Therefore, the second lkb segment 
containing region 2 is a strong candidate for the choroid plexus enhancer region. 
Prospectively, the creation o f a small germline deletion encompassing this region 
would be the most stringent means to test this proposal.
None of the conserved intergenic regions demonstrated clear enhancer activity in 
primary choroid plexus cells, suggesting either that they do not function as choroid 
plexus enhancers in vivo, or as has been shown for the CCD, a transient system is not 
a suitable means to investigate their activity. A transgenic approach should therefore 
be employed to test the function of these elements within the context o f transgenes. 
The use of the lacZ reporter gene would allow any tissue-specific activity to be 
resolved at many different developmental stages, thus providing a more 
comprehensive analysis o f these elements than was provided here by the transient 
assays. Additionally, the derivation of immortal choroid plexus epithelial cell lines 
(described in Chapter 5) may provide an alternative resource in which the function of 
these regions could be tested within stably integrated transgenes. Given its modest 
response in the transient assays, the C2 region would be a good candidate for this 
analysis. This region is highly conserved in mammals with a sequence identity o f 98% 
in human and mouse comparisons, suggesting that it will prove functionally 
significant.
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CHAPTER 5: GENERATION AND CHARACTERISATION OF IMMORTAL 
CHOROID PLEXUS EPITHELIAL CELL LINES
Introduction
Transgenic studies provide evidence that enhancer location plays a significant role in 
biallelic Igf2 expression in the choroid plexus (Ward et al. 1997; Jones et al. 2001; 
Charalambous et a l  2004). Epigenetic studies show that the differentially methylated 
regions located proximal to the Igf2 gene, DMR1 and DMR2, which confer 
methylation-dependent gene silencing or activation (Constancia et a l  2000; Eden et 
a l 2001; Murrell et a l 2001), are biallelically hypermethylated in the choroid plexus, 
suggesting that additional mechanisms are also important (Feil et a l 1994). The 
developmental expression analysis presented in Chapter 3 demonstrates that biallelic 
Igf2 expression does not occur throughout the choroid plexus, but is restricted to the 
epithelial compartment of this tissue, whilst imprinted expression occurs in the 
stroma. To date, no attempt has been made to analyse epigenetic modifications in 
isolated choroid plexus epithelium. The creation o f a culture system for choroid 
plexus epithelial cells would therefore assist in the identification o f cis- and trans- 
imprinting factors that mediate biallelic Igf2 expression in this tissue.
A method for culturing primary choroid plexus epithelial cells, described in Chapter 4 
of this work, was developed as a means to analyse the function of putative regulatory 
elements. It was also hoped that this method could be used to address the impact of 
DNA methylation and chromatin structure upon Igf2 transcription by treatment of the 
cultures with inhibitors of DNA methyl-transferase (Dnmt) and histone de-acetylase 
(HDAC) activity. However, these techniques require cells to be in an active state of 
proliferation, whereas the primary cultures do not proliferate and cannot be 
subcultured once plated. Moreover, these experiments would need extensive 
optimisation, requiring the sacrifice of large numbers of animals. The primary culture 
method was considered unsuitable for these reasons.
As discussed in Chapters 1 and 4, immortal choroid plexus epithelial cell lines have 
been established. However, such cell lines are scarce, with only three examples 
reported to date, one derived from the sheep and two from the rat (Torchio 1977; 
Kitazawa 2001; Zheng 2002). These cell lines are a superior choice as they are free
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from the many limitations of primary culture. First, they would be expected to 
proliferate rapidly in culture and may be routinely subcultured. Moreover, all were 
isolated via a cell cloning approach and are therefore assumed to represent 
homogeneous culture systems. Although not demonstrated formally, these cell lines 
would also be expected to express Igf2, reflecting that of the choroid plexus 
epithelium in vivo (Stylianopoulou et a l  1988b; DeChiara et al. 1991) and in primary 
choroid plexus cultures derived from these species (Holm 1994; Nilsson 1996). For 
numerous reasons, these cell lines were not used in the present study. The sheep cell 
line is known to be infected with the Maedi-Visna virus, its potential use therefore 
raising containment issues. Furthermore, this cell line has a fibroblastic phenotype, 
suggesting that it has undergone a degree of de-differentiation whilst in culture or was 
in fact derived from stromal cells (Torchio 1977). One of the rat cell lines was 
conditionally immortalised by a temperature sensitive (ts) allele o f SV40 T-antigen 
and must be cultured at 33°C (Kitazawa 2001). This aphysiological condition would 
cast doubt over any extrapolation of results to the in vivo environment. Finally, the 
locus under investigation in the present study originates from the mouse, whereas all 
available cell lines were derived from other species. Given that the genomic 
organisation and regulation o f the Igf2/H19 locus exhibits a degree of divergence 
between mammalian species (Schofield and Tate 1987; Overall 1997; Charalambous 
2000; Onyango et al. 2000; Jones et al. 2002; Ulaner 2003) it would be prudent to 
conduct any investigation within the context of a mouse system. Therefore, the 
principal aim o f the work described in this chapter was to establish an immortal 
choroid plexus epithelial cell line from the mouse as an in vitro model for biallelic 
Ig/2 expression.
A principal route to cell immortality involves the respective gain or loss-of-fimction 
in key cell cycle regulators encoded by proto-oncogenes and tumour supressor genes. 
The p53  gene encodes a transcription factor that regulates progression through the G l/ 
S phase cell cycle checkpoint and has been dubbed the ‘guardian o f the cell’. Mice 
that are homozygous for a p53 null mutation (p53'f') display an increased 
susceptibility to tissue sarcomas in particular those affecting the lymphoid tissues 
(Clarke 1993). The p53  gene therefore functions as a tumour supressor, by conferring 
cell growth restraint in a lineage specific manner. Consistent with this function,
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primary mouse embryonic fibroblasts (PMEFs) derived from P53'1' null mice are 
immortal and may be propagated into continuous cell lines (Kuerbitz 1992). 
Preliminary work done previously in the laboratory, suggests that in contrast to the 
observations in fibroblasts, primary choroid plexus epithelial cells carrying a p53v' 
null mutation may possess some survival advantage compared with WT cells of this 
type, but are not fully immortalised in culture (Charalambous 2000). Therefore, whilst 
loss of p53 function provides a direct route to immortalisation in some cell types, it 
appears to be insufficient for immortalisation of choroid plexus epithelial cells.
T-antigens are produced by a number of mammalian tumour-inducing viruses and are 
thought to act by binding and subverting the function of host cell tumour supressor 
genes. In this manner, T-antigens force terminally differentiated (and hence quiescent) 
host cells to express DNA replication proteins that the virus requires for its 
replication. In its natural host, the simian virus 40 (SV40) infects and perpetuates 
itself in differentiated kidney tissue. Upon infection the SV40 early promoter, which 
confers a high level of gene expression in a broad range o f cell types, directs the 
synthesis of three proteins, a large T-antigen (hereafter referred to as T-antigen) of 
708 amino acids and two small t-antigens (smt) of 175 and 135 amino acids, the 
function of which will not be discussed further. T-antigen is often sufficient for 
transformation in a large number of different cell types (Pipas 2001)(and references 
therein).
The principal transforming activity o f T-antigen is bipartite, located between amino 
acids 350-450 and 525-625, and governs interaction with the tumour supressor 
protein, p53. Mutants within this region of T-antigen that abrogate p53-binding are 
transformation defective in many cell types (Peden 1998). Genetic studies have shown 
that two additional transformation-related functions map to the amino-terminal 121 
amino acids of T-antigen. The first o f these corresponds to amino acids 105-114, 
which contains an LXCXE motif required for interaction with Retinoblastoma family 
tumour supressor proteins (DeCaprio 1988; Ewen 1989). Another transforming 
activity is located between amino acids 1-82 and corresponds to a J-domain, a feature 
that is functionally conserved and indeed originally identified within the Hsp40 family 
of chaperone proteins. This domain directs interaction with the Hsp70 chaperones, 
which have known roles in protein refolding and stability (Helmbrecht 2000; Garrido
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2003)(and references therein). Deletions within the J-domain o f T-antigen are 
transformation defective (Peden 1992). Interestingly, there is evidence that the J- 
domain may co-operate with the Retinoblastoma-interacting domain in an Hsp70- 
dependent manner to disrupt interactions between Retinoblastoma proteins and E2F 
transcription factors, although the precise mode of action is unclear (Stubdal 
1997)[Sullivan et al. 2000). Three independent domains o f T-antigen are therefore 
required for transformation in most cell types.
T-antigen overexpression has been used to immortalise continuous cell lines, indeed 
both of the existing rat choroid plexus cell lines were established using this approach 
(Kitazawa 2001; Zheng 2002) suggesting that it could also be successful in the mouse. 
The rat cell lines were induced to proliferate aberrantly and could be passaged 
indefinitely yet retained morphological and biochemical features consistent with their 
origin from the choroid plexus epithelium. Therefore T-antigen mediated 
immortalisation does not appear to unduly perturb the differentiated functions of this 
cell type. With this in mind a line of transgenic mice, the T 121 strain, which over­
express a T-antigen variant were obtained (Saenz Robles et al. 1994). This variant 
known as T 121 was created by introduction of an 11 amino acid missense mutation 
after codon 121 in the wild-type T-antigen coding sequence, such that the protein is 
truncated at this point. The resulting T]2 i protein therefore lacks the p53-binding 
domain, but retains the binding domain for Retinoblastoma proteins and the J-domain. 
The transgene is driven by the B-Lymphotrophic papovavirus early promoter, which 
directs T 121 expression exclusively to the choroid plexus epithelium and lymphocytes 
((Chen 1989) Figure 28). In this manner, T 121 selectively inactivates the function of 
Retinoblastoma proteins, but not p53  in the choroid plexus epithelium.
Studies utilising the T 121 line have elucidated the roles of T-antigen binding activities 
in cellular transformation. In mice, the choroid plexus epithelium normally exits from 
the cell cycle and becomes mitotically quiescent shortly after birth and remains so 
thereafter. Inactivation of Retinoblastoma proteins by T 121 induced aberrant cell 
proliferation and was sufficient for uniform tumourigenesis o f the choroid plexus 
epithelium, without a requirement for p53 mutations. Tumours induced in this manner
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Figure 28. Structure of the SV40 T121 transgene. A Structure of the 
wild type Sv40 large T-antigen gene is shown; the splice site that 
generates the small t-antigens is indicated. The structure of the LPV- 
SV40 Ti2[ transgene is also shown. The LPV early promoter which 
confers expression to the choroid plexus epithelium is shown as a 
shaded box. The insertion of 11 missense codons (*) following codon 
121 truncates the T-antigen protein at this position. B Structures of the 
WT and T121 proteins; the binding domains for Retinoblastoma proteins 
and for p53 are shown; the J-domain (interacting factors are unknown 
and are denoted with a question mark) is also indicated. T 121 lacks the 
p53 binding domain, but retains the amino terminal J-domain and the 








however were apoptotic and developed slowly, with death occurring at approximately 
8 months of age (Saenz Robles et al. 1994). Suppressed tumour progression in these 
animals was attributed to p53  function, as crossing the T 121 mice onto a p53''~ null 
background, thereby inactivating both p53 and Retinoblastoma, lead to significantly 
more rapid uniform tumourigenesis of the choroid plexus epithelium, with death 
occurring at around 4 weeks of age. Interestingly, when crossed onto a p53+/~ 
heterozygous background, T 121 induced phenotypically distinct focal tumourigenesis 
with an intermediate the end point, death occurring at approximately 8 weeks o f age 
(Symonds 1994). Tumour progression was thought to be dependent upon p53  in both 
cases, although its apparent latency in the latter instance probably reflecting the 
stochastic acquisition of mutations in the remaining functional p53  allele. That is, in 
T] 21 p53+l~ animals, the tumour foci are presumed to have arisen from individual 
progenitor cells in which p53 function had been completely lost. Taken together these 
experiments demonstrate that, while tumourigenesis of the choroid plexus epithelium 
can be induced following inactivation of Retinoblastoma, tumour progression is 
significantly accelerated following the combined inactivation of both Retinoblastoma 
and p53. Within this framework, it appeared that choroid plexus epithelial cells 
expressing T 121 in the presence of a p53-null mutation would provide suitable material 
from which to attempt derivation of a cell line.
To address imprinting mechanisms in a prospective choroid plexus epithelial cell line, 
a means to discriminate the parental alleles at Igf2 would be essential. This is 
conventionally achieved by deriving the cells from the progeny o f a cross between 
parents that exhibit DNA polymorphisms between the alleles. Two mouse strains 
were particularly suited to this purpose. The first o f these, the lacZDM Kl' strain 
(described in detail in Chapter 3) carries a lacZ reporter gene, prospectively allowing 
either quantitative or in situ gene expression analysis within an immortal culture 
system. Whilst providing an excellent visual marker for Igf2 expression, this strain 
would not provide a means for allele-specific epigenetic studies to be conducted in 
DMRs surrounding the Igf2/H19 locus. The use o f the second strain, the spretus upon 
distal chromosome 7, or SD7 strain was thought more suitable for this purpose. SD7 
mice are derived from an original Mus musculus versus Mus spretus outcross, with the 
progeny then repeatedly backcrossed onto the musculus background such that only the 
distal region o f chromosome 7 (containing the Igf2!H19 locus) from spretus has been
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retained. DNA polymorphisms specific to the spretus region have been described in 
Igf2 and H I 9 coding sequences and in the regulatory regions surrounding both genes 
(Fome et al. 1997; Hemberger 1998; Lopes et al. 2003). Both allele-specific 
expression and DNA methylation assays would therefore be possible in a cell line 
heterozygous for the SD7 chromosome.
The aim of the work in this chapter was therefore to derive a cell line from the choroid 
plexus epithelium, using the T 121 transgene as an immortalising agent and 
incorporating either the lacZD M Rl' or SD7 alleles to permit allele discrimination. 
Prospectively, a cell line o f this description would provide a resource for the in vitro 





The Igf2, H I 9 and Foxjl probes are described in Chapter 3. The TTR and GAPDH  
probes are described in Chapter 4. The CTCF probe is described in Chapter 3. The 
M sxl probe was described previously (Furuta 1997). The DMR1 probe was a 2.8kb 
EcoRl-BamHl fragment isolated from the G-construct plasmid described previously 
(Ward et a l  1997). The DMD probe was a 3.3kb Kpnl-Scal fragment isolated from 
the pICR plasmid described previously (Holmgren 2001). All probes for Northern and 
Southern analysis were isolated from their parent vectors by digestion with restriction 
enzymes and purification from agarose gels (see the relevant Chapter 2 sections). 
Probes were radioactively labelled prior to use (see Chapter 2 section describing 
synthesis of a -32P(dCTP)-labelled DNA probes). The use o f the Igf2 probe for the 
purposes o f in situ hybridisation is described in Table 1.
Plasmids
Transferrin (TFN)-DsRed reporter constructs were created as follows. The TF-CAT 
and pBS-TF plasmids were the respective sources of the 0.6kb and 3kb TFN 
promoters (Chaudhary 1998). The reporter constructs were based upon the pDsRedl - 
N1 plasmid (Clontech) which contains the DsRed reporter gene driven by the 
Cytomegalovirus (CMV) promoter. pDsRedl-Nl was digested with Vspl and NheI to 
excise the CMV promoter, the 3’recessed ends of the plasmid were removed by 
treatment with T4 DNA polymerase (see Chapter 2 section describing conversion of 
5’ and 3’ recessed ends to blunt ends) and then re-ligated to create the pDsRed 
plasmid.
To create the -3kbTFN-DsRed construct, a 3kb EcoRl-BamHl fragment containing the 
3kb TFN promoter from plasmid pBS-Tf was purified from an agarose gel and ligated 
into the EcoRl and BamHl sites of pDsRed.
To create the -0.6kbTFN-DsRed construct, a 0.75 kb Hindlll-Xhol fragment 
containing the 0.6kb TFN promoter from plasmid Tf-CAT was similarly purified and 
ligated directionally into the Hindlll and Sail sites of pDsRed. The constructs were 
sequenced to confirm the order and orientation of ligated fragments prior to use.
195
Antibodies
Transthyretin (TTR), Transferrin, pan-cytokeratin and E-cadherin antibodies used for 
immunofluorescence cytochemistry are listed in Table 13.








rabbit DAKO 1:300 4% (w/v) PFA
Pan-cytokeratin
a-mouse
mouse Santa Cruz 
Biotechnologies







1:100 1:1 (v/v) acetone: 
methanol
Table 13. Primary antibodies used for immunofluorescence cytochemistry. The
primary antibodies are shown in the far left column. The source species in which the 
antibodies were raised, the manufacturer, the dilutions at which they were applied and 
tissue fixation method employed are also shown.
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PCR Primers
Primer pairs specific to Ig/2 (exon3-4 containing transcripts) and to E-cadherin cDNA 
sequences, used for RT-PCR expression analysis are shown in Table 14. A primer 
pair to lacZ, used to detect transcripts from the lacZDMKT  allele is described (refer to 
Chapter 2 section describing PCR genotyping of transgenic mice). All primers were 
designed from published cDNA sequences obtained from the National Centre for 
Biotechnology Information (NCBI) Nucleotide database. Genetool primer design 








5’GGC CCT TTC CCT GTT CCC TAG AGA-3’ 
5’GCA AGA GCA AGT GGG AAC CCT GTC-3’
Table 14. Primers used for RT-PCR expression analysis.
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Results 
Generation of immortal choroid plexus epithelial cell lines
T-antigen mediated tumour induction
Tumours were induced in mice genetically by crossing T 121 homozygous mice with 
P53'1' knockout homozygous mice such that all progeny carried the genotype T 121 
p53+l'. For allele discrimination at Ig/2, further crosses were done to introduce either 
the lacZDM Rl' or SD7 allele as discussed in the Introduction to this chapter. In the 
case of lacZD M Rl', paternal transmission results in severe intra-uterine growth 
retardation with frequent neonatal death, whereas its maternal transmission produces 
no apparent phenotype, both o f which are consistent with observations in Igf2- 
knockout mice (DeChiara et a l  1991; Murrell et al. 2001). To avoid complex 
phenotypes arising in the offspring, it was decided to transmit the lacZDM Rl' 
mutation via the maternal germline. Therefore, to create T 121: p53+l'.lacZ D M R l triple 
mutant mice, matings were set up between lacZD M Rl' heterozygous females and T 121 
homozygous males. Double mutant Ti2i:/acZDMR2+/mat female animals were 
identified amongst the resulting progeny by PCR genotyping analysis (not shown, but 
see Chapter 2 section describing PCR genotyping). T 121 :/tfcZDMR2+/mat females were 
crossed with p53''' males, and T m'.p 5 3+l'.lacZDM Rl +/mat triple mutants identified 
amongst the progeny by PCR genotyping (Figure 29). From a litter of 13 animals, 3 
triple mutants were identified. To create the Ti2i:p53+/":SD7 mice, an identical 
protocol was followed with SD7 homozygous females substituted for those carrying 
lacZ D M R l. Time constraints prevented the derivation of cell lines from the 
Ti2i:p53+/’:SD7 mice, however tumours were induced in these animals, cells were 
isolated from them and frozen for future use. The experiment was continued with the 
triple mutant Tn\.p53+I'.lacZD M Rl +/mat animals. These were monitored daily and 
those showing evidence of choroid plexus tumour development (as judged by the 
appearance of a bulged cranium) were sacrificed and tumours removed by dissection. 
Tumours were observed to have arisen at multiple foci within the choroid plexus of 
the lateral ventricle in all cases, consistent with previous observations for the 
T 121 :p53+l' genotype (Symonds 1994). These tumours were disaggregated to release 
the cells for culture (see Chapter 2 section describing isolation and culture o f choroid 
plexus tumour tissue).
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Figure 29. PCR genotyping analysis, identification of T121: p53+l 
/acZDMR2+/mat mutants. Crude tissue lysates were made from a 4-week 
old litter derived from a p53'/_ x T 12]:/acZDMR2 +/mat cross and analysed 
by PCR using primers specific to the T121 transgene, to lacZ (lacZDM Rl' 
allele) and to the p53  locus. PCR reactions were analysed by gel 
electrophoresis where the presence of the T121 transgene, was indicated by 
a 170bp band (upper panel); the presence of the /acZDMR2" allele was 
indicated by a 206bp band (middle panel); in the p53 assay, wild-type and 
knockout alleles were discriminated by 600bp and 500bp bands 
respectively (lower panel) such that the presence of both bands denotes the 
p53+l~ genotype. The analysis identified animals 6, 8 and 11 as triple 
mutants (indicated by vertical arrows). The molecular weight marker (M) 
is a lOObp DNA ladder where the lower o f the two bright bands represents 
500bp.
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Isolation of clones by limiting dilution
Disaggregated tumour tissue was cultured for 5 days after which two cell types 
predominated, colonies of epithelial morphology, which were presumed to have 
originated from the choroid plexus epithelium, and extensive colonies of rapidly 
proliferating fibroblastic cells, presumed to be of stromal origin. The epithelial 
colonies were isolated from the cultures with the use of cloning rings (see Chapter 2 
section describing the cloning of cell lines by limiting dilution). In total, 4 colonies 
were successfully isolated in this manner and each distributed between 8 wells of a 
96-well plate, thus establishing 32 subclones. These were cultured for an additional 
two weeks, after which only 2 subclones had yielded homogeneous populations of 
well-differentiated cells of epithelial morphology. The remaining 30 clones had 
become variably populated with fibroblastic growth and were discarded.
To derive clonal cell populations for expansion into cell lines, the limiting dilution 
method was employed (see Chapter 2 section describing the cloning o f cell lines by 
limiting dilution). In theory, this involves the culture o f single isolated cells such that 
all cells derived from them can be considered identical. Single cell suspensions were 
prepared from homogeneous subclones isolated in the previous stage, their cell 
concentrations were estimated by counting small aliquots on a haemocytometer, then 
these were serially diluted to an appropriate concentration and dispensed into 96-well 
plates. The plates were inspected to identify those wells that contained 1 cell (all other 
wells were then excluded from the experiment) and were incubated under standard 
culture conditions. Inspection of the plates after 5 days revealed that cell growth had 
not occurred in any of the wells and in many cases the cells had not even attached to 
the plate. Further incubation of these plates for periods of 3 weeks or longer and 
repeated attempts did not reveal any evidence of cell growth.
Given the epithelial nature of cells under study, it was postulated that contacts 
between adjacent cells perform an important cell viability function thus isolated cells 
might be compromised in their ability to divide in culture. With this in mind, further 
limiting dilution experiments were done as described above, but using suspensions of 
small cell aggregates rather than single cells, where it was hoped that minimal cell­
cell contacts within aggregates could restore cell viability. A single 96-well plate was 
set up as before, but such that each well contained 1 cell aggregate. Inspection o f the
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plate after 5 days revealed expanding subclones in 14 wells. These subclones 
continued to expand with a further week in culture. As these subclones had not been 
established from single cells, the possibility remained that they were not clonal. Two 
of these subclones were therefore subjected to a second round of limiting dilution 
cloning from which a total of ten further subclones, termed CPlacZl-10 were derived. 
Four of these subclones CPlacZl, 2, 3 and 6 were successfully expanded into cell
lines during a six-week period by successive passage through 96-well, 24-well and 6-
2 • 2 well plates, then transferred into 25cm flasks and finally expanded into 75cm flasks.
During the expansion process, aliquots of each cell line were cryopreserved at each
passage.
Characterisation of immortal choroid plexus epithelial cell lines
Morphology
Closely opposed membrane junctions and ‘cobblestone’ morphology are 
differentiated features of the choroid plexus epithelial cells in culture (see Chapter 4). 
Examination of the cell lines by light microscopy revealed that this most important 
feature and been retained, thus suggesting that they originated from the choroid plexus 
epithelium. Figure 30 shows a field of live cells from the CPlacZ6 line, where the 
morphological features described above are evident. A view of live primary choroid 
plexus epithelial cells (originally presented in Chapter 4) is shown for comparison.
Genotype analysis
The genotype o f each cell line was confirmed by PCR. Genomic DNA was prepared 
from all cell lines (see Chapter 2 section describing isolation of high-purity genomic 
DNA from mouse tissues), lp l aliquots of the genomic DNA samples were amplified 
by PCR essentially as detailed earlier (see Chapter 2 section describing polymerase 
chain reaction) using primer pairs that allow discrimination o f the T 121 ,p53  and (Ig/2) 
lacZDMKZ  mutations (see Chapter 2 section that describes genotyping transgenic 
mice by PCR). Completed PCR reactions were analysed by gel electrophoresis 
(Figure 31). As expected all cell lines were found to be positive for the T 121 transgene 
and heterozygous for the lacZDM RT  allele. Interestingly, all o f the cell lines were 
found to carry the p53'!' genotype despite their original derivation from an animal that 
was heterozygous (p53+l~) for the p53 knockout allele (see Figure 29 for comparison).
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Therefore the choroid plexus cell lines (and presumably the tumour from which they 
were derived) appear to have undergone loss of heterozygosity at p53.
Growth
Successfully immortalised cell lines would be expected to proliferate at a greater rate 
than primary cells o f the same origin when placed in culture. The growth of CPlacZ2 
cells was compared against primary choroid plexus cultures derived from mice o f the 
following genotypes; WT; T]2 i, p53+,~; Tm  p53+l'. To generate mice of the T 121 
genotype, T 121 homozygous males were mated with Fi females. To generate mice of 
the p53+l' genotype, p53~/~ homozygous males were mated with Fi females. To 
generate mice of the T 121 p53+,~ genotype, T 121 homozygous males were mated with 
p53~/' females. Litters o f neonate mice bom from each cross were sacrificed and 
primary choroid plexus cultures prepared (see Chapter 2 section describing primary 
culture of choroid plexus epithelial cells). Viable cell number counts (see Chapter 2 
section describing growth curves) were collected daily over a 6 day period for the 
CPlacZ2 cells, which proliferate rapidly in culture and at 2-day intervals over a 12 day 
period for the primary choroid plexus cultures, which show a markedly lower rate of 
proliferation (Figure 32a). CPlacZ2 cells (which carried the T 121 p53‘/_ genotype) 
proliferated at a significantly greater rate than primary choroid plexus cultures 
prepared from T 121 p53+/’ or T 121 mice, providing evidence that inactivation of p53 
dramatically enhances the growth effects of T 121, consistent with observations in vivo 
(Symonds 1994). Non-linear regression analysis was used to calculate the mean 
doubling time of CPlacZ cells (Figure 32b). This was done by fitting an exponential 
curve to the viable cell count data, with a mean doubling time of 2.58 days calculated. 
Interestingly, the T 121 p53+l~ primary cultures proliferated at a significantly greater rate 
than cultures that carried either the T 121 or p53+l~ genotypes alone suggesting an 
additive effect upon growth. In addition, T 121 cultures displayed rate o f proliferation 
significantly greater than wild type cultures, consistent with in vivo observations.
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Figure 30. Comparison of CPlacZ cell lines and primary choroid 
plexus cultures, morphological analysis. The CPlacZ cell lines were 
examined by light microscopy. A CPlacZ6 cells exhibited a characteristic 
closely-opposed cobblestone morphology that is typically observed for 
epithelial cells in culture. The other cell lines derived following limiting 
dilution displayed an identical morphology (not shown). B A field of 
primary choroid plexus epithelial cells (previously shown in Figure 11) is 
shown for comparison. Magnifications x200.
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Figure 31. PCR genotyping analysis, CPlacZ cell lines. Genomic DNA 
was prepared from the cell lines and analysed by PCR using primers 
specific to the T 121 transgene, Igf2 intron 3/exon 4, to lacZ (lacZDM Kl' 
allele) and to the p53 locus (primer sequences are listed in the Chapter 2 
section that describes genotyping transgenic mice by PCR). PCR 
reactions were analysed by gel electrophoresis; in the T 121 assay, the 
presence o f the T121 transgene is indicated by a 170bp band; in the Igf2 
assay, the presence of the endogenous Ig/2 allele is indicated by the 
presence of a 206bp band; in the lacZ assay the presence o f the 
lacZDMR2~ allele is indicated by a 206bp band; in the p53 assay, wild- 
type and mutant alleles are discriminated by 600bp and 500bp bands 
respectively (lower panel) such that presence of both bands indicates the 
p53+l~ genotype. The analysis showed that all cell lines are positive for 
T121 are heterozygous for the lacZDMR.2' allele and have undergone loss 
of heterozygosity at the p53 locus to become p53~'~. The molecular weight 

























Figure 32a. Comparison of CPlacZ cell lines and primary choroid 
plexus cultures, cell growth in relation to T 12t expression and p53  
function. The growth of CPlacZ2 cells (T121 p53 '/') was compared against 
that of primary choroid plexus cultures carrying either the wild type (WT), 
T 121, p53+/' or T l2]p53+/~ genotypes by counting the viable cell number. 
Cell number is shown as the ratio of the control (cell number at time 0). 
Each data point is the mean of 4 independent replicates with each replicate 
counted twice. Error bars show the standard error of the mean (S.E.M.). 
The combination o f T 121 activity and loss of p53  function in CPlacZ2 cells 
leads to an increased rate of growth compared with T 121 alone, which 
imparts a modest increase in growth compared with wild-type cells 
(compare error bars).
Figure 32b. Quantitative growth of CPlacZ2 cells in culture. An
exponential curve was fitted to the viable cell number data for CPlacZ2 
(R2 = 0.9592). A mean doubling time of 2.58 days was predicted by non­
linear regression upon this curve. Cell number is shown as the ratio of the 
control (cell number at time 0). Each data point is the mean of 4 
independent replicates with each replicate counted twice. Error bars show 
the S.E.M.
Cell num ber/ratio of control
Time/ days
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Gene expression - Northern analysis
The expression of three genes, Transthyretin (777?) Foxjl and M sxl, were analysed to 
confirm the identity of the cell lines. The function and expression of TTR is described 
in Chapters 3 and 4. Foxjl encodes a winged helix domain-containing transcription 
factor, which is required to correctly specify the left-right body axis and for formation 
of ciliated epithelia (Brody 2000). Foxjl is expressed in the developing choroid 
plexus epithelium from e l0.5 of mouse development and continues to mark choroid 
plexus epithelial cells thereafter (Lim 1997). Foxjl therefore provided a good marker 
of differentiated choroid plexus epithelium. M sxl encodes a homeodomain protein 
with a prominent role in craniofacial development (Houzelstein 1997). M sxl 
expression occurs at several discrete sites in the developing brain including the 
choroid plexus epithelium and leptomeninges, Rathkes pouch, nasal recesses and 
streams of migrating cranial neural crest. In the presumptive choroid plexus 
epithelium, M sxl expression commences at el 1.5 and is maintained as the choroid 
plexus matures (MacKenzie 1991). M sxl therefore provided a third marker for this 
gene expression analysis. RNA was isolated from the 4 cell lines and from neonate 
choroid plexus tissue, which acted as a positive control (see Chapter 2 section 
describing isolation of total RNA). Total RNA isolated from kidney at 3 weeks of age, 
a tissue in which neither 777?, Foxjl or M sxl expression would be expected, served as 
a negative control. The RNA samples were blotted and sequentially hybridised with 
probes to TTR, Foxjl and M sxl (Figure 33). Abundant expression of TTR was seen in 
all cell lines except CPlacZ-2, which only showed a weak signal. Two TTR transcripts 
were observed, a lkb choroid plexus-specific transcript and 0.7kb transcript. Foxjl 
expression was variable between the cell lines with high levels of a 2.4kb transcript in 
CP/acZ-1, and slightly lower levels in all other lines with expression in CPlacZ-2 
almost absent. M sxl expression followed a similar trend with abundant expression of 
a 1.7kb transcript clearly visible in CPlacZ-1, lower levels in the other cell lines and 
expression again almost absent in CPlacZ-2. Hybridisation with a GAPDH  probe 
demonstrated approximately equal loading of RNA in each of the cell lines. With the 
exception o f CPlacZ2 where marker expression was either weak or absent, the cell 
lines have retained the expression of three choroid plexus epithelial markers, TTR, 
Foxjl and M sxl.
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Figure 33. Northern analysis of TTR, Foxjl and M sxl expression in 
CPlacZ cell lines. Total RNA prepared from the cell lines was blotted 
and successively hybridised with probes to the mouse TTR, Foxjl and 
M sxl genes. Total RNAs from week 3 kidney and from choroid plexus 
tissue were included as negative and positive controls for TTR 
expression respectively. Also shown is a separate probing for GAPDH  













Gene expression - Immunofluorescence
Gene expression was also examined at the protein level by immunofluorescence (see 
Chapter 2 section describing immunofluorescence cytochemistry) using antibodies to 
TTR and to three additional markers, Transferrin (TFN), Pan-cytokeratin and 
epithelial (E-) cadherin. TFN, a major serum protein, performs an important function 
in the serum transport of iron and its major sites of expression in rodents and humans 
are liver hepatocytes, choroid plexus epithelium, oligodendrocytes of the brain and 
Sertoli cells of the testis. TFN is thought to be expressed in the developing and mature 
choroid plexus epithelium in mice and therefore provides an additional marker for this 
tissue (Tu 1991; Chaudhary 1998)(and references therein). Cytokeratins form an 
integral component of intermediate filaments in all epithelia and occur in obligate 
heterodimeric pairs. Simple secretory epithelia, within which the choroid plexus 
epithelium is classified, are primarily characterised by the expression of the 
cytokeratin 8/cytokeratin 18 pair, but often acquire cytokeratin 7, 19 and 20 
expression as differentiation proceeds (Fuchs 1988; Owens 2003). The pan- 
cytokeratin antibody used here recognises all cytokeratins and would therefore be 
expected to positively stain choroid plexus epithelial cells. E-cadherin is found in all 
epithelia, including that of the choroid plexus, where it mediates homophilic cell-cell 
adhesion within specific membrane interfaces known as adherens junctions (Takeichi 
1991). Both cadherins and cytokeratins participate in the provision o f mechanical 
support that protects epithelial cells from external stress (Perez-Moreno 2003).
The CPlacZ cell lines were analysed using the same panel of primary antibodies. 
Results for the CPlacZ6 line, which were representative of observations made in the 
other cell lines, are shown. Primary choroid plexus epithelial cells analysed in parallel 
provided positive controls in all cases. Figure 34 shows cells that have been stained 
with a-TTR and a-TFN primary antibodies and the staining pattern visualised with a 
fluorescein-labelled secondary antibody. TTR protein was present at high levels in a 
perinuclear distribution in both the cell line and primary cells. TFN protein was 
detected in an uncharacteristic submembrane distribution (a perinuclear distribution is 
typical for TFN, as seen in the HepG2 cells shown in Figure 36) in CPlacZ cells and 
all other CPlacZ cell lines tested. Surprisingly, TFN was not detected in the primary 
cells although some positive staining was expected on the basis o f earlier work
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(Tsutsumi 1989; Tu 1991) and also the strong immunoreactivity seen with the same 
a-TFN antibody in sections of choroid plexus tissue presented in Chapter 3. Figure 
35 shows cells that have been stained with a-pan-cytokeratin and a-E-cadherin 
primary antibodies and the staining pattern visualised with a fluorescein-labelled 
secondary antibody. Neither of these proteins were obviously present in any of the 
cell lines, yet both were clearly present in primary choroid plexus epithelial cells with 
pan-cytokeratin staining localised to the cytoplasm of primary cells in a filamentous 
distribution, consistent with the distribution o f intermediate filaments and with E- 
cadherin localised almost exclusively to the plasma membrane, consistent with its 
known activity at cellular adherens junctions (Fuchs 1988; Takeichi 1991; Owens 
2003). Some evidence of E-cadherin immunoreactivity was seen in the perinuclear 
region of both CPlacZ cells and primary choroid plexus epithelial cells, possibly 
indicative of de novo synthesis of this protein.
In summary, the immunofluorescence analysis o f the CPlacZ cell lines clearly 
demonstrated the expression of TTR and possibly TFN, but did not provide 
convincing evidence for the expression of the epithelial cell markers, E-cadherin or 
cytokeratins. An additional positive control for this analysis was provided by 
comparison of the choroid plexus cell lines and primary culture data with hepatocytes, 
an epithelial cell type that is known to highly express the markers used in this analysis 
(Tosh 2002b; Tosh 2002a). The hepatocyte-derived HepG2 cell line was exploited for 
this purpose and stained with the same panel of primary antibodies as before. The 
staining patterns were visualised with a fluorescein-labelled secondary antibody as 
before (Figure 36). As expected all o f the markers were strongly expressed in HepG2 
cells, confirming the sensitivity o f the primary antibodies used in this analysis.
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Figure 34. Immunofluorescence: comparison of CPlacZ cell lines and 
primary choroid plexus cultures, hepatocyte/choroid plexus 
differentiation markers. Cells were fixed and stained for the presence of 
two serum proteins, Transthyretin (TTR) and Transferrin (TFN). Images 
under both FITC and DIC conditions were collected by laser scanning 
confocal microscopy (left and right columns respectively). These images 
were overlaid as shown in merge (middle column). A-F TTR expression, 
A-C CPlacZ6 line, strong positive staining was observed in a perinuclear 
distribution; D-F Primary choroid plexus cultures, strong positive staining 
was observed as in the cell lines. G-L TFN expression, G-I CPlacZ6 line, 
uncharacteristic staining was observed in membranes and in a diffuse 
pattern throughout the cells. J-L Primary choroid plexus cultures, no 
positive staining was observed. M-O Negative control, CPlacZ6 cells 
incubated with fluorescein-labelled a-mouse IgG secondary antibody. 
Scale bars show 10 pm.
a-rabbit IgG
Figure 35. Immunofluorescence: comparison of CPlacZ cell lines and 
primary choroid plexus cultures, epithelial cell differentiation 
markers. Cells were fixed and stained for the presence o f two generic 
epithelial cell proteins, Pan-cytokeratin and E-cadherin. Images under 
both FITC and DIC conditions were collected by laser scanning confocal 
microscopy (left and right columns respectively). These images were 
overlaid as shown in merge (middle column). A-F Pan-cytokeratin 
expression; A-C CPlacZ-6 line, no positive staining was observed; D-F 
Primary choroid plexus cultures, strong positive staining was observed in 
a filamentous cytoplasmic distribution. G-L E-cadherin expression; G-I 
CPlacZ-6 line; no staining was observed in a pattern consistent with the 
known membrane localisation of E-cadherin (see staining in primary 
cultures), but some faint perinuclear staining was visible. J-L Primary 
choroid plexus cultures, strong positive staining was observed in a plasma 
membrane distribution with clear perinuclear staining apparent in many 
cells (arrows). M-O Negative control, CPlacZ-6 cells incubated with 
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Figure 36. Immunofluorescence: analysis of HepG2 cells,
hepatocyte/choroid plexus differentiation markers. HepG2 cells were 
fixed and stained for the presence of four biochemical markers common 
to both differentiated hepatocytes and choroid plexus epithelial cells, 
TTR, TFN, Pan-cytokeratin and E-cadherin. Images under both FITC and 
DIC conditions were collected by laser scanning confocal microscopy 
(left and right columns respectively). These images were overlaid as 
shown in merge (middle column). A-C TTR expression, staining was 
observed in a perinuclear distribution. D-F TFN expression, staining was 
as seen for TTR. G-I Pan-cytokeratin expression, positive staining was 
seen in the cytoplasm in a filamentous distribution. J-L E-cadherin 
expression, positive staining was observed in the plasma membrane. M-O 
Negative control, HepG2 cells incubated with fluorescein labelled a - 
mouse IgG secondary antibody. Scale bars show 10 pm.
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Gene expression -RT-PCR analysis
The failure to uncover immunoreactive E-cadherin and pan-cytokeratin in the CPlacZ 
cell lines was inconsistent both with the strong epithelial morphology and expression 
of numerous differentiation markers displayed by these cells, which otherwise 
supported an origin from choroid plexus epithelium. Downregulation of E-cadherin 
expression is frequently observed in tumours and correlates with the invasive or 
metastatic state (reviewed in (Hazan 2004)). To ask whether aberrant silencing of E- 
cadherin gene expression could explain the apparent absence of E-cadherin protein in 
the CPlacZ cell lines, an RT-PCR approach was adopted to examine gene expression 
at the mRNA level. Complementary DNA (cDNA) was prepared from the CPlacZ cell 
lines and from neonate choroid plexus tissue, which acted as a positive control, then 
PCR amplified (see Chapter 2 section describing RT-PCR) using primers specific to a 
portion of the mouse E-cadherin cDNA sequence (see Table 14). This analysis 
(Figure 37) showed abundant expression of E-cadherin mRNA in two o f the cell 
lines, CPlacZ 1 and CPlacZ6, with much lower levels seen in CPlacZ2 and CPlacZ3 
cells. This finding was surprising given that immunoreactive E-cadherin could not be 
detected in any of these cell lines, suggesting a discrepancy between gene expression 
at the mRNA and protein level. The absence of E-cadherin protein, at least in 
CPlacZ 1 and CPlacZ6 cells, is therefore unlikely to be a consequence of gene 
silencing, instead implicating posttranslational factors in these observations.
TFN promoter trans-activation assays
TFN protein was seen in an uncharacteristic sub-membrane distribution in the CPlacZ 
cell lines and could not be found at all in primary choroid plexus epithelial cells when 
assayed by immunofluorescence. A cell transfection approach using TFTV-promoter 
reporter gene constructs was used previously to map c/s-elements involved in the 
tissue-specific expression of this gene (Chaudhary 1998). In an attempt to 
qualitatively demonstrate TFN gene expression in the CPlacZ cell lines, constructs 
containing either -0.6kb or -3kb TFN  promoter regions fused to the DsRed reporter 
gene (see Materials and Methods section at the beginning of this chapter) were 
transfected into CPlacZ6 cells (see Chapter 2 section describing transient transfection 
of choroid plexus epithelial cells). A CMV-promoter DsRed construct was transfected 
as a positive transfection control. To confirm an appropriate tissue-specific activation 
of these constructs, two control cell lines were included in this analysis. The liver-
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derived HepG2 cell line, in which high levels o f TFN protein are expressed (as 
demonstrated by immunofluorescence in this chapter) and primary choroid plexus 
epithelial cells provided positive controls. Mouse NIH:3T3 fibroblasts should not 
express TFN and were included as negative controls. Figure 38 shows reporter gene 
expression visualised under red fluorescence approximately 48 hours after 
transfection. Reporter gene expression was seen in CPlacZ6 cells and both control cell 
lines following transfection with the CMN-DsRed, indicating that the transfection had 
been successful. Reporter gene expression was seen from both the -0.6kb and -3kb 
TFN-DsRed constructs in the CPlacZ6 cells and in HepG2 cells although both 
constructs appeared to be expressed in a greater number o f cells and at higher levels in 
the HepG2 transfection. No evidence of reporter gene expression was seen following 
transfection of either construct into primary choroid plexus epithelial cells or 
NIH:3T3 cells (not shown).
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Figure 37. RT-PCR analysis of E-cadherin expression in CPlacZ cell 
lines. Complementary DNA (cDNA) was prepared from the cell lines and 
from neonate choroid plexus tissue and analysed by PCR using primers 
corresponding to a portion of the mouse E-cadherin cDNA. PCR reactions 
were analysed by gel electrophoresis. In the E-cadherin assay (upper 
panel), gene expression is indicated by a 520bp band. Analysis of y3-actin 
expression (lower panel) in the same samples shows the successful 
conversion of RNA to cDNA. Samples treated with and without reverse 
transcriptase are indicated as + and -  RT. The molecular weight marker 














Figure 38. TFN  promoter fraws-activation assays: comparison of 
CPIacZ cell lines and HepG2 cells. Two DsRed reporter constructs 
respectively containing -3kb and -0.6 kb upstream regions of the mouse 
TFN gene were transfected into CPlacZ6 cells. In addition, transfection of 
a CMV-DsRed construct provided a positive control. Images under both 
TRITC and DIC conditions were collected by laser scanning confocal 
microscopy (left and right columns respectively). These images were 
overlaid as shown in merge (middle column). A-I CPlacZ6 transfection; A- 
C -3kb TFN-DsRed construct; D-F -0.6kb TFN-DsRed construct; G-I 
CMN-DsRed. J-L HepG2 cells transfected with the 3kb TFN-DsRed 
construct. Neither o f the TFN-DsRed constructs were expressed following 
transfection into primary choroid plexus epithelial cells or the fibroblast 
NIH:3T3 cell line (not shown). Scale bars show 50 \xm.
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Gene expression at the lgf2IH19 locus
Northern analysis
Igf2 expression would be predicted in the CPlacZ cell lines given their probable origin 
from the choroid plexus epithelium (DeChiara et al. 1991; Svensson 1995)(and see 
Chapter 3), on the other hand H I9 expression would not be expected given its absence 
from the embryonic choroid plexus epithelium (see Chapter 3). Igf2IH19 expression 
was next examined by Northern analysis. RNA was isolated from the 4 cell lines and 
from e l2.5 embryos, which acted as a positive control for Igf2 expression (see 
Chapter 2 section describing isolation of total RNA). RNA extracted from kidney 
tissue at 3 weeks o f age provided a negative control. Although highly expressed in the 
embryonic kidney, both Ig/2 and HI9 expression are sharply downregulated 
postnatally and were expected to be absent from this tissue at this stage (Weber 2001). 
The RNA samples were blotted and sequentially hybridised with cDNA probes 
corresponding to Igf2 exon 6 and to H19 (Figure 39). Surprisingly, Igf2 mRNA was 
not detected in any o f the cell lines, though several transcripts were present in the 
positive control. This was surprising given work presented in Chapter 4, which 
showed abundant Igf2 expression in primary choroid plexus cultures. Low levels o f 
transcript were unexpectedly observed in the negative control, suggesting residual 
expression in this tissue. H19 RNA was not detected in any of the cell lines, although 
an abundant 2.5kb transcript was seen in the positive control. As seen for the Igf2 
hybridisation, low levels of H I9 RNA were present in the kidney sample expected to 
act as a negative control. GAPDH expression levels were similar in all lanes thereby 
excluding major differences in RNA loading as an influence upon the levels of Igf2 
and HI 9.
The question o f whether CTCF, a critical regulator of Igf2/H19 imprinting, is 
expressed in the choroid plexus epithelium was unsuccessfully addressed using an in 
situ hybridisation approach in Chapter 3. The derivation o f CPlacZ cell lines provided 
a opportunity to readdress this question. The Igf2/H19 blot was stripped and 
hybridised with a probe to CTCF (Figure 39) and revealed abundant expression of 
CTCF mRNA in all CPlacZ cell lines with comparable levels of a 3.8kb transcript 
visible in each case. CTCF  expression is therefore likely to occur in the choroid 
plexus epithelium.
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Figure 39. Northern analysis of /g/2, H19 and CTCF  expression in 
CPlacZ cell lines. Total RNA prepared from the cell lines were blotted 
and successively hybridised with probes to the mouse Igf2, H I 9 and 
CTCF genes. Total RNAs from week 3 kidney and from e l2.5 embryos 
were included as negative and positive controls for Igf2 and H I 9 
expression respectively. Also shown is a separate probing for GAPDH  
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RT-PCR analysis
Northern analysis failed to detect Igf2 expression in the CPlacZ cell lines, suggesting 
that expression was either below the detection threshold o f this technique or absent, 
and since these lines carry a maternally inherited lacZDMRl' allele, that this could 
reflect specific silencing of the paternal allele. Allele-specific RT-PCR analysis was 
performed next to determine the imprinting status of Igf2 in the cell lines using primer 
pairs specific to either the WT or lacZDMRl' alleles (see Materials and Methods 
section at the beginning of this chapter), thus discriminating transcripts of paternal 
and maternal origin. cDNA was prepared from the cell lines, and also from e l 0.5 WT 
and paternal transmission /acZDMR2'heterozygous embryos, which provided controls 
for the analysis, then PCR amplified (see Chapter 2 section describing RT-PCR) using 
primer pairs described (see Table 14). This analysis (Figure 40) showed transcripts 
from both WT and lacZDMRl' alleles to be present at low levels in all o f the cell 
lines.
Allele-specific Igf2 expression in situ
The expression data in Chapter 3 demonstrated that Igf2 expression is restricted to a 
subset of choroid plexus epithelial cells. Could the absence of Igf2 expression seen in 
the majority of the CPlacZ cell lines, following Northern and RT-PCR analysis, be 
explained by variegated Igf2 expression in these cells? An in situ approach seemed the 
most appropriate means to elucidate this question. This was done by separate analysis 
of expression from each of the parental alleles using the lacZDMRl' allele to 
discriminate maternal from paternal expression.
Igf2 mRNA in situ hybridisation (paternal-specific expression)
To examine paternal-specific Igf2 expression in situ, CPlacZ6 cells were fixed and 
hybridised with antisense and sense DIG-labelled RNA probes corresponding to exon 
6 of the Igf2 gene (see Chapter 2 section describing mRNA in situ hybridisation in 
cultured cells) with primary choroid plexus cultures analysed in parallel as positive 
controls for Igf2 expression (Figure 41). No evidence of Ig/2 expression was seen in 
CPlacZ cells, either in a cell subset or otherwise. By contrast, high levels of Ig/2 
expression were seen in the primary choroid plexus cultures, which assumed a clear 
perinuclear staining pattern in the epithelial cells and staining also evident in cells of 
non-epithelial morphology, presumed to have originated from the stromal
230
mesenchyme. The in situ hybridisation analysis together with the Northern and RT- 
PCR data suggest that paternal Igf2 expression is either weak or absent in the CPlacZ 
cell lines.
lacZDMR2' expression in situ (maternal-specific expression)
To examine any transcriptional activity originating from the lacZDMR2~ reporter gene 
(maternal Igf2 expression) in situ, CPlacZ6 cells were fixed and stained for p- 
galactosidase activity (see Chapter 2 section describing the detection of p- 
galactosidase activity in situ in cultured cells). Reporter gene expression was highly 
variegated, with stained cells evidently fewer in number than unstained cells (Figure 
41). This analysis demonstrated transcriptional activity from the mutant Igf2 maternal 
allele in the cell lines, which occurs in a variegated manner.
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Figure 40. Allele-specific RT-PCR analysis of Igf2 (lacZDM Rl ) 
expression in CPlacZ cell lines. Complementary DNA (cDNA) was 
prepared from the cell lines, and from e l0.5 WT and /acZDMR2pat/+ 
heterozygous embryos, which acted as controls then analysed by PCR 
for expression of the WT allele using primers spanning exons 3-4 of the 
Igf2 gene, and for expression of the lacZDMR' allele using primers to 
lacZ. PCR reactions were analysed by gel electrophoresis. Expression of 
the wild-type Igf2 allele (upper panel) is indicated by a 170bp band. 
Expression of the lacZD M Rl' allele (middle panel) is indicated by a 
206bp band (middle panel). The RT-PCR shows that low levels of 
transcript from both alleles are present in the cell lines. Analysis of p -  
actin expression (lower panel) in the same samples shows the successful 
conversion of RNA to cDNA in all cases. Samples treated with and 
without reverse transcriptase are indicated as + and -  RT. The molecular 
weight marker (M) is a lOObp DNA ladder where the lower o f the two 
bright bands represents 500bp.
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Figure 41. Allele-specific analysis of Igf2 (lacZDMR2 ) expression in 
situ, CPlacZ cell lines. A-D Paternal-specific expression was analysed by 
Igf2 in situ hybridisation. CPlacZ6 cells were hybridised with antisense 
(A) or sense (B) probes. Primary choroid plexus cultures provided 
positive controls for Ig/2 expression and are shown after hybridisation 
with antisense (C) or sense (D) probes. E-F Maternal-specific expression 
(lacZD M Rl' reporter gene) was analysed by staining for p-galactosidase 
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DNA methylation at the lgf2IH19 locus
The developmental expression analysis described in Chapter 3 has shown that biallelic 
Igf2 expression is confined to the choroid plexus epithelium. Could this escape from 
imprinted expression be explained by disruption o f allele-specific methylation 
patterns within Igf2/H19 DMRs within this tissue? Loss o f differential methylation 
has been previously observed in Ig/2 proximal DMRs both in the choroid plexus and 
in mutant mice that express Igf2 biallelically (Feil et al. 1994; Lopes et a l  2003). This 
question was indirectly addressed by examination of methylation at two regions, the 
DMD and Ig/2 DMR1 in the CPlacZ cell lines. Genomic DNA was prepared from the 
cell lines (see Chapter 2 section describing genomic DNA extraction from tissue) and 
digested with BamHl/Bglll. The DNA was further digested with the isoschizomer pair 
Hpall and Mspl where both enzymes cut within the same recognition sequence 
(CCGG). Hpall activity is blocked by CpG methylation whereas Mspl is insensitive, 
thus the methylation status o f CpG dinucleotides within these sites will determine the 
pattern of restriction fragments on a Southern blot dependent upon the enzyme used. 
Restriction maps o f the H I 9 DMD and Igf2 DMR1 genomic regions including the 
sites relevant to this study are respectively shown in Figures 42 and 43. HpalVMspl 
was predicted to cut at 5 sites within the DMD fragment, at 6 sites within the H I 9 
promoter-proximal fragment (Figure 42) and at 13 sites within the DMR1 fragment 
(Figure 43). Digested DNA samples were blotted and hybridised either with a probe 
encompassing the DMD and H I 9 promoter proximal region or a probe corresponding 
to DMR1 (see Chapter 2 section describing Southern analysis).
Methylation at the DMD and H19 promoter proximal region 
The cell lines displayed intermediate methylation of the DMD (Figure 44) as shown 
by a partial resistance to digestion by Hpall. A similar profile was observed in liver, 
where paternal-specific hypermethylation o f the DMD has been reported previously 
(Weber 2001), brain and choroid plexus controls. The H I9 promoter proximal region 
was also intermediately methylated in all o f the cell lines and control tissues. 
However, in the cell lines a slightly greater proportion of both regions appeared to be 
methylated compared with the liver control as exhibited by the levels of the 
unmethylated lkb fragments. Interestingly, in the cell lines the DMD appeared more 
highly methylated than the H I9 promoter proximal region relative to control tissues, 
where this pattern was in fact reversed (compare relative levels of the 2.5kb and
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2.38kb bands). Whether these patterns actually represent higher methylation levels at 
the DMD, or indeed lower methylation at the H I9 promoter proximal region in the 
cell lines compared with the control tissues cannot be judged, as the DNA was not 
equivalently loaded in all cases.
Methylation at DMR1
The cell lines displayed almost complete methylation of DMR1 (Figure 45) as shown 
by a high level o f resistance to digestion by Hpall. Indeed a large proportion of the 
DMR1 fragments were methylated at all 13 Hpall]Mspl sites covered by the probe 
(see restriction map shown in Figure 43), although the presence a faint band at 4.6 kb 
in all of the cell lines indicated that a small fraction were unmethylated at a single site. 
By comparison, DMR1 was intermediately methylated in liver, a site where paternal 
hypermethylation o f this region has been reported previously (Weber 2001) and in 
brain with a range of lower molecular weight fragments produced by digestion with 
Hpall. Choroid plexus DNA appeared to be highly methylated at DMR1 as shown by 
resistance to Hpall digestion, although unequal loading o f this sample prevents a 
comprehensive evaluation of this data.
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Figure 42. Restriction map of the H19 locus. Restriction map of the
lOkb genomic region containing the H I9 gene and proximal sequences. 
H I9 exons are shown as shaded boxes; open boxes show other features; 
hypersensitive sites 1 (HS1) and 2 (HS2); GC-rich repeat element (GCR). 
Arrows indicate positions of the DMD, the HI 9 promoter proximal region 
and the DMD probe. Restriction sites relevant to the methylation analysis 
are shown, Bglll, BamHl; lollipops represent sites of potential CpG 
methylation within Hpall/Mspl restriction sites. Digestion with 
Bglll/BamHl will produce 2.3 and 2.5kb fragments containing the DMD 
and promoter proximal region respectively, both of which are predicted to 











Figure 42. The HI 9 genomic region
BamHl BamHl
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Figure 43. Restriction map of the Igf2 locus. Restriction map of the 18kb
genomic region containing the Igf2 gene and proximal sequences. Igf2 
exons are shown as shaded boxes; other features include the /g/2-proximal 
differentially methylated regions, DMRO and DMR1. Restriction sites 
pertinent to the methylation analysis are shown, Bglll, BamHl; lollipops 
represent sites o f potential CpG methylation within HpalHMspl restriction 
sites. Digestion with BgtlHBamHl will produce a 4.8kb fragment 
containing the DMR1 region which is predicted to hybridise to the DMR1 
probe (indicated by lower arrow).
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Figure 44. Methylation analysis of the DMD and H19 promoter- 
proximal region in CPlacZ cell lines. The cell lines and three control 
tissues, neonate liver, brain and choroid plexus were analysed. Genomic 
DNA samples from each tissue were digested with BamHl-Bglll, BamHl- 
Bglll-Hpall or BamHl-Bgill-Mspl. Digested DNA samples were blotted 
and hybridised with a probe spanning the DMD and promoter proximal 
region. The predicted sizes of fragments resulting from these digests are 
represented in Figure 42. The DMD displayed intermediate (50%) 
methylation in all cell lines and controls, with a proportion of the total 
2.38kb fragment content protected in the Hpall digests. The H I9 
promoter proximal region {HI 9) was also intermediately methylated in all 
cell lines and controls with a proportion of the 2.5kb fragment protected 
in the Hpall digests in all cases. Levels of the 2.38kb DMD fragment 
predominated over the 2.5kb H I9 fragment in the cell lines compared to 
liver, brain and choroid plexus controls where this pattern was reversed. 
The ratio o f Hpall to Mspl digested fragments of lower molecular weight 
was slightly greater in the cell lines, except CplacZ6, compared with liver 
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Figure 45. Methylation analysis of Igf2  DMR1 in CPlacZ cell lines.
The cell lines and three control tissues, neonate liver, brain and choroid 
plexus were analysed. Genomic DNA samples from each tissue were 
digested with BamHl-Bglll, BamHl-Bglll-Hpall or BamHI-BglU-Mspl. 
Digested DNA samples were blotted and hybridised with a probe 
corresponding to DMR1. The predicted sizes of fragments resulting from 
these digests are represented in Figure 43. DMR1 appeared to be highly 
(near 100%) methylated in all o f the cell lines with a large proportion of 
the total 4.8kb fragment content protected in the Hpall digests. A small 
proportion of the total 4.8kb fragment content had been digested at a 
single site to give a 4.6kb fragment and at additional sites to give a range 
of 3-4kb fragments in all of the cell lines. DMR1 displayed intermediate 
(>50%) methylation levels in liver and brain controls, where the 4.8kb 
fragment had been completely digested by Hpall to give a range of 
fragments of 3-4kb and much lower molecular weight fragments of 0.5kb 
and 0.4kb. In the choroid plexus control, DMR1 appeared highly 
methylated, with a clear 4.6kb fragment and much fainter 3-4kb 
fragments visible in the Hpall digest, although unequal loading of this 
sample confounds comparison with the cell lines and controls.
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Conclusions
The primary aim of the work in this chapter was to establish an immortal cell line 
from the choroid plexus epithelium of the mouse as a means to investigate how the 
Igf2 gene escapes imprinting in this tissue. This was achieved by a genetic approach 
in which overexpression of the T-antigen-derived T 121 protein was used to inactivate 
Retinoblastoma family proteins and bring about tumourigenesis of the choroid plexus 
epithelium. Tumour tissue was isolated and ultimately four independent cell lines 
were successfully derived.
Successful derivation o f the cell lines appeared to be dependent upon inactivation of 
both Retinoblastoma and p53  gene products. The CPlacZ cell lines were ultimately 
derived from tumour foci induced in one T 121 p53+l~ /orcZDMR2+/mat‘ animal. 
Subsequent PCR analyses showed that whilst the founder animal was indeed 
heterozygous for the p53  knockout allele prior to tumour development, the cell lines 
(which were all derived from this animal) were p53  null. Consistent with previous 
observations (Symonds 1994), these results argue that the loss of p53 in this case is 
both the consequence of a secondary somatic mutation and the underlying cause of the 
tumour focus. Examination of the p53  status in non-transformed choroid plexus tissue 
adjoining the tumours, where preservation o f a single wild type p53  allele would have 
been predicted, would have substantiated these conclusions but was not done. 
Interestingly, the additional loss o f p53 was reflected in the growth rate of the cells, 
which was significantly higher than that observed for any of the primary cultures 
expressing T 121 in the presence o f functional p53. In conclusion, inactivation of both 
Retinoblastoma and p53  was required for the successful derivation of the CPlacZ cell 
lines.
This observation is interesting, particularly given the study by Saenz Robles et al. 
who reported that inactivation of Retinoblastoma proteins by T 121 was, in the absence 
of p53 mutations, sufficient for uniform tumourigenesis of the choroid plexus 
epithelium in vivo (Saenz Robles et al. 1994). In the present study, attempts to derive 
cell lines from cultured choroid plexus tissue dissected from neonatal mice of this 
genotype were unsuccessful as the epithelial cell fraction did not survive beyond a 
few passages and could not be cloned. Taken together, these observations argue that 
whilst T 121 is capable of transformation in vivo, it is not able to immortalise choroid
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plexus epithelial cells in vitro. Could this discrepancy have been a consequence of 
p55-dependent apoptosis? Observations made in vivo show that tumours induced by 
T 121 develop slowly and are highly apoptotic, yet upon a p53~'~ null background, 
where p53  dependent apoptosis is absent, this tumour induction is significantly 
accelerated (Saenz Robles et al. 1994; Symonds 1994). It is conceivable that the T 121- 
expressing choroid plexus epithelial cells lacked the growth potential required to 
properly establish and immortalise in vitro.
This issue was explored at the in vitro level by comparison o f the relative growth rates 
of primary choroid plexus cultures carrying T 121 in the presence or absence of a p53+l' 
knockout mutation (with the T 121 p53'!' genotype provided by the CPlacZ2 cell line) 
with wild type controls. This analysis revealed that in isolation, T 121 was able to 
induce a modest increase in cell proliferation compared with wild type controls in 
vitro. Interestingly, the p53+l~ mutation mediated a quantitatively similar increase in 
the overall proliferation rate compared with wild type controls. However, cultures 
carrying both mutations proliferated at a greater rate than those derived from either 
mutation alone, suggestive of an additive growth effect. Significantly, the 
proliferation rate o f CPlacZ2 cells, which carried the T 121 P53'1' genotype, was many 
times greater than that conferred upon primary cultures by T 121 alone, suggestive of a 
synergistic growth effect. Conclusions drawn from this data should be treated with 
caution as several factors complicate its interpretation. CPlacZ2 cells represent a 
homogenous population of epithelial cells whereas the primary cultures would have 
contained both epithelial and mesenchymal cell types, which the growth assay did not 
discriminate. In the primary cultures, growth effects may not have manifested 
uniformly (at least in some of the genotypes) and could equally be ascribed to 
disproportionate effects o f each mutation within these two cell types.
For example, in consideration of the T 121 and p53+l~ genotypes, different outcomes 
might be predicted. In T 121 mice, the LPV promoter directs T 121 expression 
specifically to the choroid plexus epithelium and lymphoid cells. The proliferation 
increase conferred upon the primary cultures by T 121 was therefore likely to be 
specific to the epithelial cell fraction. The same conclusion cannot be drawn for the 
p53+/~ genotype, as both cell types would be affected by this mutation. Moreover, 
fibroblasts o f this genotype are reported to share some characteristics o f p53~/m
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knockout fibroblasts, which are immortal. That is, p53+l' fibroblasts are ‘semi- 
immortal’ and possess an increased capacity for proliferation compared with the wild 
type. It seems possible therefore, that the growth rate o f the p53+l~ choroid plexus 
cultures could be explained by a similar effect in the mesenchymal fraction. By the 
same argument, the increased growth rate of T 121 p53+l~ cells compared with cells 
carrying either mutation alone cannot necessarily be explained by an interaction 
between both mutations within the same nucleus, as it could equally be due separate 
effects in the epithelial and mesenchymal fractions. Moreover, the observation that 
T 121 and p53+/~ mutations manifest an additive effect in double mutant (T 121 p53+l~) 
cells is consistent with the latter hypothesis. Perhaps more meaningful interpretations 
could have been made with the inclusion of cultures derived from T 121 p53''~ mice, 
however ethical considerations prohibited the creation o f such animals and hence, 
derivation of cells from them. To summarise, potentially independent effects in the 
epithelial and mesenchymal cell fractions prevent a clear conclusion, but the growth 
assay data suggests that, a finding that is consistent with observations in vivo, the p53 
null genotype significantly enhanced growth effects of T 121 conferred upon choroid 
plexus epithelial cells in vitro.
Clonality is an important feature of continuous cell lines and aims to provide 
reproducibility across multiple experiments. This is conventionally achieved by 
cloning a single progenitor cell such that a population of genetically identical cells are 
generated. In this instance, clones could not be derived from single cells with poor 
cell viability a probable determinant in this issue. Ultimately a compromise was 
sought where clones were eventually derived from small cell aggregates (containing 
20 cells or less) as opposed to single cells that are the convention. The cloning process 
was repeated to minimise the probability of variation within the clones prior to their 
expansion into the CPlacZ cell lines. Although unlikely, it remains a formal 
possibility that the cell lines contain two or more distinct lineages.
The limiting dilution method used in the present study has been successfully used to 
derive single cell clones from many tissues (Freshney 1987). It is conceivable that the 
failure to derive single clones from the choroid plexus epithelium reflects an intrinsic 
property o f this tissue. Reasons for the differences in cloning potential between single 
and aggregated cells were not obvious but suggest an involvement o f cell-cell contact.
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The epithelial nature o f these cells would favour maximal contact of plasma 
membranes with adjacent cells, a situation that isolated cells clearly would not 
achieve. Density dependent influences such as growth factor availability should also 
be considered. For similar reasons, many cell lines cease to proliferate when plated at 
low densities, growth signals produced by a dense population o f cells will rapidly 
equilibrate with the environment whereas those from a single isolated cells never will. 
By judicious application of exogenous growth factors and thus mimicking a cell-dense 
environment, it is often possible to ‘deceive’ cells into mitosis (Freshney 1987). 
Although not described in the results section of this chapter, alternative attempts were 
made to address this issue and involved the use o f elevated serum concentrations, 
epidermal growth factor supplementation, fibroblast growth-conditioned medium and 
mitomycin-C inactivated fibroblasts in feeder layers. However none of these 
alternative protocols proved successful. A point of possible relevance is that the 
lacZDMKT  mutation carried by the cell lines may have compromised their viability 
in some way. Additionally, Ig/2 transcripts could not be detected from the non­
disrupted paternal allele in any of the CPlacZ cell lines, when assayed by Northern 
analysis. Could an IGFII deficiency explain the poor cloning potential o f single cells? 
In the future this could be investigated by supplementation o f the cloning plates with 
exogenous IGFII. Prospectively, the derivation of a cell line that carries a copy of the 
Mus spretus-dQrived SD7 region, which is functionally wild type at Igf2, would also 
address this question.
During embryogenesis, differentiation of the choroid plexus epithelium from the 
embryonic neuroepithelium is signified by characteristic changes in cell morphology 
and the expression o f specific genes (Catala 1998). The identity o f the CPlacZ cell 
lines was investigated by asking whether their morphology and gene expression 
profile was consistent with the phenotype of the differentiated choroid plexus 
epithelium. The cell lines displayed the characteristic cobblestone morphology that 
typifies epithelial cells although these cells presented a smaller apical surface area 
than their primary counterparts possibly suggesting a less intimate association with 
the culture vessel. Gene expression was analysed both at the mRNA and protein level. 
The cell lines were shown to express many but not all o f the markers analysed, 
suggesting that a partial loss of the choroid plexus phenotype might have occurred. 
Northern analysis demonstrated the expression of three genes, TTR, FoxJl and M sxl
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in three of the four cell lines. These genes are robust markers for the choroid plexus 
epithelium and discriminate this layer from surrounding tissues in vivo (Murakami 
1987; MacKenzie 1991; Lim 1997). Expression of all three markers was severely 
reduced in CPlacZ2 cells compared with the other cell lines, suggesting that this cell 
line in particular had lost differentiated properties or perhaps reverted to a choroid 
plexus precursor phenotype.
To further characterise the cell lines, the expression o f TTR and that of three 
additional markers TFN, E-cadherin and Pan-cytokeratin, was examined at the protein 
level by immunofluorescence. Surprisingly, of these markers, only the presence of 
TTR was clearly demonstrated. O f the other markers, TFN was unexpectedly, yet 
consistently observed in an uncharacteristic sub-plasma membrane distribution, as 
opposed to the perinuclear distribution normally observed for this protein, as seen in 
the HepG2 cells here and previously (Tosh 2002b). Why TFN should be membrane 
localised, is unclear but could reflect the transformed state of the cell lines in some 
manner. Staining artefacts cannot be excluded from these observations, but are an 
unlikely cause given that the protocol used was identical to that successfully used to 
uncover immunoreactive TFN in HepG2 cells. Despite repeated attempts, TFN was 
never detected in primary choroid plexus controls, although its expression was 
expected on the premise of TFN immunoreactivity, revealed with the same primary 
antiserum batch in the choroid plexus epithelium at e l4.5 (see Chapter 3) and by 
Northern blot analysis in vivo and in vitro (Tsutsumi 1989; Tu 1991). The former of 
these studies demonstrated the presence of a 2.3kb choroid plexus-specific TFN 
transcript, in addition to the 2.5kb transcript found at all other sites o f expression. 
Distinct protein isoforms potentially encoded by this transcript might not have been 
detected by the primary antiserum used here and could explain the discrepancy 
between the cell lines and primary choroid plexus epithelial cells. A transfection 
approach involving TFN  promoter-DsRed constructs was attempted to resolve the 
issue of TFN expression. Both TFN promoters tested in this assay were activated in 
CPlacZ6 cells and HepG2 cells but not in primary choroid plexus epithelial cells thus 
corroborating the immunofluorescence data.
E-cadherin and cytokeratins, both of which are excellent differentiation markers for 
epithelial cells (Fuchs 1988; Takeichi 1991) did not appear to be expressed at the
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protein level in any o f the cell lines, although both were abundant in primary choroid 
plexus epithelial cells and HepG2 cells. This was particularly surprising, given the 
well-differentiated epithelial morphology of the cell lines and also other clear 
indications of choroid plexus epithelium origin. The normal expression of these 
markers in the primary choroid plexus epithelial cells eliminates failure of the 
protocol and instead suggests an involvement of the transformed state. Loss of 
function in the E-cadherin gene is well documented in cell transformation and tumour 
progression (Hazan 2004). Generally, cadherins mediate cell adhesion at adherens 
junctions via interactions with the actin-based cytoskeleton. Mutations in E-cadherin, 
by both genetic and epigenetic pathways, which downregulate or extinguish its 
expression, lead to the disruption of cell-cell adhesion. Within this framework, loss of 
E-cadherin expression is frequently correlated with the invasive or metastatic state in 
many instances o f cancer (Hirohashi 2003; Hazan 2004)(and references therein). 
Therefore, inactivation of E-cadherin function plays a significant role during 
tumourigenesis. RT-PCR analysis was performed to ask whether the absence o f E- 
cadherin protein reflected a general downregulation of E-cadherin gene expression in 
the CPlacZ cell lines and revealed that whilst this was likely to be the case for two of 
the cell lines in which little or no expression could be detected, relatively high levels 
of E-cadherin mRNA were found in the two remaining cell lines, thus implicating 
posttranslational factors in the absence of the protein in these examples. It is 
conceivable that changes in E-cadherin expression at the mRNA and protein levels 
could reflect, or might have been required for acquisition o f the transformed state by 
the cell lines.
Could a similar argument be put forward to account for the loss o f pan-cytokeratin 
expression? Clinical studies provide evidence that cytokeratin expression is in fact 
maintained virtually all human choroid plexus tumours (Rickert 2001). Nonetheless, 
the absence o f this important marker suggests that the cell lines have lost a specific 
differentiated function. Interestingly, normal epithelial cells show transient 
disassembly of cytokeratin-based intermediate filaments during mitosis (Lane 1982). 
Therefore, with a very high proportion of cells undergoing mitosis almost 
continuously, it could be argued that the cytokeratin-based intermediate filament 
network is established only transiently, or not at all in the cell lines. Although 
speculative at present, an involvement of cytokeratins (and possibly E-cadherin) in
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cytoskeletal reorganisation would be consistent with the altered morphology of the 
cell lines, where the cells appeared much smaller and less flattened compared with 
primary choroid plexus epithelial cells. It is also possible that cytokeratin gene 
expression has been affected specifically at the protein level, as seems to be the case 
for E-cadherin, at least in some o f the cell lines. Though not done in the present study, 
RT-PCR or Northern analysis o f cytokeratin genes known to be expressed in the 
choroid plexus epithelium could resolve this question.
Mitotic quiescence is a major differentiated feature of the choroid plexus epithelium 
in vivo (Saenz Robles et al. 1994), therefore by forcing these cells into proliferation 
by the genetic inactivation of tumour supressor genes, it is perhaps unsurprising that 
normal gene expression patterns have been disrupted. Similar findings have been 
reported in another example of T-antigen mediated immortalisation, where 
dedifferentiation o f a rat hepatocyte cell line was observed (Kim 2000). This loss of 
phenotype was correlated with a high passage number (>50), which the authors 
attributed to the acquisition o f secondary somatic mutations during this extended 
culture period. However, the CPlacZ cell lines were kept within a maximum of 10-15 
passages for all experiments described, thus it seems less likely that passage number 
would have substantially influenced differentiation markers in this case. Examination 
of the parent tumour tissue, from which the cell lines originate, using the same panel 
of markers might have elucidated this point, however this was not done.
Interestingly, in neither o f the two previous descriptions o f choroid plexus epithelial 
cell lines, both immortalised with T-antigen, do the authors report dedifferentiation 
even at greater than 100 passages (Kitazawa 2001; Zheng 2002). It should be noted 
however that in these studies, the expression of only a single marker, TTR, was 
examined, whereas in the present analysis, a broader panel o f markers was assessed. 
Indeed in the present study, TTR was one of the markers analysed whose expression 
had been retained by the cell lines. Although speculative, it is possible that the partial 
loss of phenotype in the cell lines represents a default state imposed by the 
compulsive cell proliferation induced by T 121 activity. The domain structure of T- 
antigen is discussed in the Introduction to this chapter. The J-domain, which is 
retained by the T 121 protein, is known to mediate interactions with the Hsp70 
chaperones, which have well-established roles in protein refolding and stability
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(Helmbrecht 2000; Garrido 2003)(and references therein). The apparent absence of 
protein expression (E-cadherin and pan-cytokeratin) and altered subcellular 
localisation (TFN) of some of the markers in the cell lines could potentially be a 
consequence of T 121 J-domain activity, by interference with chaperone function. 
Though speculative, J-domain activity could explain the discrepancy between gene 
expression at the mRNA and protein level observed for E-cadherin and possibly pan- 
cytokeratin. It is concluded that three of the four CPlacZ cell lines have retained many 
aspects of the choroid plexus epithelial phenotype and provide useful in vitro models 
for this tissue. By contrast, the almost complete absence o f marker gene expression in 
the CPlacZ2 cell line, suggests a more global loss of phenotype is likely to have 
occurred in this example.
As discussed in Chapter 1, recent genetic evidence has established a pivotal role for 
BMP-signalling in the specification and differentiation of the choroid plexus 
epithelium (Bulchand 2001; Hebert 2002; Hebert 2003). In this work embryos 
carrying a telencephalon-specific deletion within the Bm pr-la  gene, which encodes 
the BMP-type IA receptor, fail to develop the choroid plexus in the lateral ventricles 
of the brain (Hebert 2002). In these mutants, choroid plexus epithelial precursors 
lacked the expression o f tissue-specific markers, showed reduced expression of M sxl, 
a BMP-responsive dorsal midline marker and remained in a proliferative state. BMP 
signalling is therefore required to correctly specify and differentiate the choroid 
plexus. Interestingly, in the present study, Northern analysis revealed that expression 
of M sxl though present, was somewhat reduced in some of the CPlacZ cell lines 
compared with wild-type choroid plexus tissue, thus suggesting that BMP signalling 
may be compromised. With this in mind, it would be interesting to ask whether 
augmentation o f BMP-signalling could promote differentiation and re-establish the 
choroid plexus phenotype in the CPlacZ cell lines? An earlier study has demonstrated 
that either BMP2 or BMP4 protein soaked beads were able to promote expression of 
M sxl and inhibit cell proliferation in cultured telencephalon explants (Furuta 1997). 
This work suggests the exogenous delivery of BMP proteins as a potential method by 
which BMP-signalling could be stimulated in the cell lines. With the goal of a 
robustly differentiated in vitro model for choroid plexus epithelium in mind, 
experiments o f this nature should be pursued in future work.
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The principal aim o f this chapter was to establish choroid plexus epithelial cell lines 
as in vitro models for biallelic Igf2 expression. Indeed, biallelic Igf2 expression would 
be predicted in cell lines derived from the choroid plexus epithelium, upon the basis 
of observations made in vivo (DeChiara et al, 1991) therefore it was necessary to 
demonstrate this important criterion in the CPlacZ cell lines. Unexpectedly, Northern 
analysis failed to detect Igf2 expression from the non-disrupted paternal allele, 
suggesting either that expression levels were below the detection threshold of this 
technique, or since the cells carried a maternally inherited lacZDM RZ  allele, that the 
paternal allele had been silenced by an unknown mechanism. Allele-specific RT-PCR 
analysis, using primers that discriminate the wild type and lacZD M Rl' sequences 
revealed evidence of weak expression from both paternal and maternal alleles. That is, 
biallelic Ig/2 expression, albeit at low levels, was observed in the cell lines.
Allele-specific analysis of Igf2 expression in situ demonstrated transcription of the 
maternally inherited lacZD M Kl' reporter gene allele, as evidenced by in situ staining 
for p-galactosidase activity. Remarkably, reporter gene activity was clearly restricted 
to a scattered cell population in all o f the cell lines, thus mimicking the variegated 
expression profile o f the choroid plexus epithelium in vivo (Charalambous et a l  2004). 
In situ hybridisation using an Ig/2 probe, to examine transcriptional activity from the 
paternal allele did not uncover any clear expression in a cell subset or otherwise, 
though abundant Ig/2 expression was seen in primary choroid plexus epithelial cells 
analysed in parallel. Whilst the RT-PCR analysis provided evidence o f biallelic Ig/2 
expression in the cell lines, the in situ analysis superficially describes monoallelic 
expression occurring specifically from the maternal allele. However the absolute gene 
expression levels from each allele cannot be formally related, as the various methods 
used to interrogate these factors are not directly comparative.
Interestingly, this data could reflect an unconfirmed observation made in the 
developmental expression assays (see Chapter 3), where a greater proportion of 
choroid plexus epithelial cells were seen to express the /acZDMR2' reporter gene 
upon maternal transmission. Expression of the paternal allele in a very small number 
o f cells, as appears to be the case in the choroid plexus epithelium in vivo, could have 
been missed, even with the in situ approach used here. The issue o f whether Ig/2
254
expression predominating from the maternal allele actually occurs in the choroid 
plexus epithelium could be stringently addressed in the future by examination of 
expressed polymorphisms in similar cell lines carrying the Mus spretus-derived SD7 
chromosome. H19 expression was not detected in the cell lines by Northern analysis, 
a finding that was expected given the absence of H I 9 expression from the choroid 
plexus epithelium in vivo (Charalambous et a/.2004)(and Chapter 3), though sensitive 
RT-PCR analysis that would have confirmed this observation was not done. As 
already discussed, the cell lines showed clear evidence of variegated reporter gene 
expression as observed in vivo (Charalambous et a/.2004)(and Chapter 3). Whether 
this variegated expression pattern has arisen as consequence o f clonal heterogeneity 
within the cell lines or whether a cell autonomous mechanism is involved remains 
unanswered. Time constraints prevented further work on this very interesting feature, 
but potentially the conservation of variegated Igf2 expression in the CPlacZ cell lines 
would provide a useful system for further analysis. The investigation o f candidate 
genes in the Notch signalling pathway (see Chapter 3) could be extended to the cell 
lines. As such an RNA interference (RNAi) approach could be employed in vitro to 
assess the function of these molecules in the context of variegated expression.
Differential methylation upon CpG dinucleotides at imprinted loci is widely 
documented and discussed at length in Chapter 1. Primary imprinting control of the 
Igf2IH19 locus is centred upon a differentially methylated domain (DMD) that lies in 
the 5’ flank of the H I 9 gene and in the unmethylated state, functions as an insulator to 
prevent activation of Igf2 by distal enhancers. The insulator function of the DMD is 
dependent upon the zinc-finger protein CTCF, which binds to specific sites within this 
region in a methylation-sensitive manner (Thorvaldsen et al. 1998; Bell 2000; Hark et 
al. 2000; Kaffer 2000; Kanduri 2000a). Recent genetic evidence demonstrates that 
CTCF binding is required to maintain the unmethylated state o f the DMD during 
development (Schoenherr et a l  2003; Fedoriw et al. 2004; Pant 2004).
One of the most significant questions posed by the present study was to ask whether 
epigenetic modifications at the DMD underlie the deregulation imprinting at Igf2/H19 
in the choroid plexus epithelium? That is, could aberrant methylation of the maternal 
DMD allele and/or the absence of CTCF protein explain biallelic Ig/2 expression (and 
biallelic H I9 silencing) in this tissue? These questions were tackled indirectly by
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analysis o f the CPlacZ cell lines. Northern analysis revealed the abundant expression 
of CTCF mRNA in all o f the cell lines suggesting that the protein would also be 
present. Time constraints prevented Western blot analysis that would have 
corroborated the Northern analysis. Prospectively, the examination of allele-specific 
CTCF binding at the DMD within the context of the cell lines could better define the 
role of this protein as an epigenetic regulator in the choroid plexus epithelium.
CpG methylation was examined at several HpalUMspl sites within the DMD and also 
in the associated H I 9 promoter proximal region, in the cell lines using a methylation- 
sensitive Southern blotting approach. Both regions were partially (approximately 
50%) methylated in all of the cell lines with this pattern assumed to represent 
differential methylation. Two lines of evidence support this assumption. First, 
paternal-specific hypermethylation of the DMD is consistently observed throughout 
development in a wide range o f tissues (Tremblay et a l  1997; Weber 2001). 
Secondly, a similar degree o f partial methylation was observed at the DMD in the 
neonate liver controls, a tissue where its robust differential methylation has been 
previously shown (Weber 2001). Though allele-specific analysis would be required to 
formally exclude other possibilities, the present data argue that the DMD is 
differentially methylated in a tissue where non-imprinted expression occurs, the 
choroid plexus epithelium.
In addition to the DMD, other regions of differential methylation, DMR1 and DMR2, 
have been identified proximal to Ig/2 that display hypermethylation upon the 
predominantly expressed paternal Igf2 allele in many mesodermal and endodermal 
tissues (Sasaki et a l  1992; Weber 2001). These regions possess methylation- 
dependent silencing or activating functions respectively (Constancia et a l  2000; Eden 
et a l 2001; Murrell et a l 2001) and therefore provide the basis o f secondary 
imprinting controls that act upon Ig/2. More recent work has shown that methylation 
within these regions is dependent upon and acquired in a manner consistent with that 
of the DMD lying in cis, and has led to the proposal that these DMRs fall under the 
control of the DMD in a hierarchical manner (Lopes et a l  2003).
Earlier work demonstrated that Ig/2 proximal DMRs are highly methylated upon both 
parental alleles in the choroid plexus providing evidence of an epigenetic basis to
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biallelic Igf2 expression in this tissue (Feil et al. 1994). Strikingly, almost complete 
methylation of DMR1 was observed in the cell lines, thus indicating almost absolute 
hypermethylation of both alleles in a manner consistent with this work (Feil et al. 
1994). At the same time, measurements made in intact choroid plexus tissue (which 
would have contained both epithelium and stroma) observed somewhat lower 
methylation levels within this region suggesting that its hypermethylation is likely to 
be specific to the choroid plexus epithelium, but not the stroma. These observations 
are consistent with the developmental expression analysis (see Chapter 3) where Igf2 
expression was found to be biallelic in the choroid plexus epithelium, but imprinted in 
the stroma. The cell line methylation data provides compelling evidence that 
epigenetic modification (the acquisition of maternal hypermethylation) o f DMR1 is 
associated with biallelic Igf2 expression in this tissue. Importantly, when considered 
with the analysis o f the DMD, which appeared to be differentially methylated in the 
cell lines, it seems likely that this modification o f DMR1 occurs by a DMD- 
independent mechanism.
In consideration of the DMR1 methylation data, a surprising outcome was the lack of 
concordance between the parental-origin specific expression and methylation of Igf2 
in the cell lines. Hypermethylation within the DMR1 region is usually associated with 
the transcriptionally active Igf2 allele and its hypomethylation with silencing (Sasaki 
et al. 1992; Constancia et al. 2000; Eden et al. 2001; Weber 2001). In the cell lines 
DMR1 appeared to be highly methylated upon both alleles, yet only low levels of 
expression could be detected from either allele. That is, DMR1 methylation and Igf2 
expression are negatively correlated in the cell lines. Examination o f methylation at 
other sites within the Igf2 gene might further elucidate this discrepancy and exclude 
other possibilities such as linear spreading of methylation into adjacent regulatory 
elements. DMR2 or the promoter regions would be good candidates for this analysis. 
A concern is that the partial loss o f phenotype in the cell lines, as indicated by gene 
expression analysis, has also impacted upon transcriptional regulation and/or 
epigenetic modifications at the Igf2/H19 locus, although that methylation patterns 
observed within DMR1 and the DMD are consistent with those seen previously is 
encouraging (Feil et al. 1994; Yang 2003). Nonetheless, in general terms aberrant 
epigenetic modifications leading to the inappropriate expression or silencing of genes 
are frequent events in vitro. Similar effects in the CPlacZ cell lines cannot be
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excluded at present, which means that any extrapolation of the methylation data 
should be made with caution.
The DMR hierarchy proposal asserts that the DMD protects Igf2 proximal DMRs 
lying in cis, from de novo methylation and thus maintains their maternal 
hypomethylated state (Lopes et al. 2003). While this is likely to be the case in the 
majority of tissues, the findings o f the present study and of earlier work (Feil et a l 
1994) argue against such DMD-centred control in the choroid plexus epithelium. In 
the wake o f the DMR hierarchy proposal, it could be argued that mechanisms 
conferring DMD-mediated protection are either absent, or in some way surmounted in 
the choroid plexus epithelium. Lopes et al. posit the involvement of regional 
chromatin dynamics in mediating DMR interactions and propose a chromatin-looping 
model by which the DMD and Igf2 proximal DMRs might associate, via the 
vertebrate insulator CTCF and other proteins, to form a single nucleo-protein 
complex. Future work might attempt to address the possibility o f such interactions by 
performing chromatin immuno-precipitation (ChIP) assays in choroid plexus 
epithelial tissue. The choroid plexus epithelial cell lines created in the present study 
would provide a good resource for this analysis. Comparative ChIP analysis using the 
choroid plexus cell lines against a second cell line in which imprinted Ig/2 expression 
is maintained, could reveal much about potential mechanisms that regulate DMR 
interactions. Along these lines, it might also be interesting to ask whether DMD- 
independent controls operate within additional sites of biallelic Ig/2 expression in the 
brain, the capillary endothelium and leptomeninges. Indeed, a method for isolating 
capillary endothelium from rat brain parenchymal tissue has been described (Li 
2001a). This technique could be adapted to isolate brain endothelial tissue for 
methylation and ChIP analysis.
A criticism of the methylation analysis presented in this study is that it lacks allele- 
specificity; instead gross methylation levels from both alleles were measured 
inclusively. This is particularly relevant to the DMD analysis, where partial 
methylation was interpreted as differential- and hence, paternal-specific methylation 
for reasons discussed. Although unlikely, these findings could represent mosaic 
methylation patterns upon both alleles. In this instance, allele-specific methylation 
assays were not possible in the CPlacZ cell lines as there was no means o f
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discriminating the alleles at either DMR1 or the DMD. Nonetheless, such assays 
should be done to corroborate the conclusions of this chapter. This awaits the 
derivation o f further choroid plexus epithelial cell lines carrying the Mus spretus 
derived SD7 chromosome. In this system, restriction fragment length polymorphisms 
that exist between the Mus musculus and Mus spretus alleles will be identified and 
used to interrogate parental-origin specific methylation marks both at DMD and the 
DMR1. A further limitation of the analysis here is that it only considered methylation 
at CpG dinucleotides within Hpall/Mspl sites, with the status of these sites assumed 
representative o f other CpG sites in the surrounding genomic DNA. This is 
particularly relevant to DMR1, where the magnitude o f differential methylation has 
been shown to vary between specific CpG sites within this region (Fome et al. 1997; 
Weber 2001). Further work utilising a bisulphite mutagenesis approach, which can 
determine methylation frequencies within all CpG dinucleotides of a given genomic 
region, might further elucidate findings o f this study.
In summary, immortal cell lines have been successfully established from the choroid 
plexus epithelium of the mouse. Three of the four cell lines established bear a close 
resemblance to the parent tissue by criteria of morphology and the expression of 
marker genes, though the expression of epithelial cell markers E-cadherin, 
cytokeratins and possibly other genes may have been perturbed in response to the 
transformed state o f the cells. Biallelic Igf2 expression was not clearly demonstrated 
in the cells though, encouragingly, other hallmarks of Igf2/H19 expression described 
within the choroid plexus epithelium in vivo, that is, variegated reporter gene 
expression and biallelic silencing of H I 9 appear to have been conserved. 
Asymmetrical methylation patterns were observed at Igf2/H19, where biallelic 
hypermethylation of DMR1 was seen in the presence of differential methylation at the 
DMD in cis. This epigenotype suggests that a DMD-independent modification o f the 





The Igf2 and H I9 genes are expressed in multiple tissues during embryonic 
development and are subject to genomic imprinting. Both genes are regulated by an 
imprinting control region (ICR) that is situated within a differentially methylated 
domain (DMD) 2-4kb 5’ of H I9 (Tremblay et al. 1997; Thorvaldsen et al. 1998). The 
DMD exists in two epigenetic states, dependent upon its parental origin. Following 
transmission through the paternal germline, it is hypermethylated, adopts a closed 
chromatin conformation and is required to initiate but not maintain silencing of the 
H I9 gene. After maternal transmission, it is almost entirely devoid o f methylation, 
exists in an open chromatin conformation and is required to both initiate and maintain 
silencing o f Igf2 in cis (Tremblay et al. 1997; Thorvaldsen et al. 1998; Drewell et al. 
2000; Srivastava 2000). The DMD contains a chromatin boundary or insulator 
element that acts to block the interaction of Igf2 promoters with enhancers that lie 3’ 
of this region with insulator activity dependent upon the protein CTCF, which binds 
in a methylation-sensitive manner (Bell 2000; Hark et al. 2000; Holmgren 2001; 
Schoenherr et al. 2003; Fedoriw et al. 2004; Pant 2004). Consistent with the insulator 
model, which predicts that enhancers active in imprinted tissues will be situated 3’ of 
the DMD, both endoderm and mesoderm-specific enhancer regions have been 
identified 3’ of H I 9 (Leighton et al. 1995; Ishihara and Jinno 2000; Kaffer 2000; 
Davies et al. 2002).
Ig/2 escapes imprinted regulation and is biallelically expressed in the exchange tissues 
of the brain, the choroid plexus and leptomeninges, in mice and humans (DeChiara et 
al. 1991; Ohlsson et al. 1994; Svensson 1995). A greater understanding of the 
molecular mechanisms involved in this mode of expression has been sought, as Ig/2 
frequently undergoes loss of imprinting in human overgrowth disorders and cancer. 
Regulatory elements that confer Ig/2 expression in these tissues would be predicted to 
lie 5’ o f the DMD and therefore not be affected by insulator activity. Consistent with 
this expectation, at least one enhancer driving expression in the choroid plexus and 
leptomeninges is located within the Igf2/H19 centrally conserved domain (CCD) 
situated approximately 32kb 5’ of the DMD (Ward et al. 1997; Jones et al. 2001; 
Charalambous et al. 2004). Importantly, the CCD can also drive expression in a subset
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of tissues where Ig/2 is imprinted suggesting that enhancer location alone cannot fully 
explain biallelic Ig/2 expression in the exchange tissues of the brain (Charalambous et 
al. 2004). Differentially methylated regions situated proximal to Ig/2 are 
hypermethylated upon both alleles in the choroid plexus, suggestive o f an additional 
mechanism that could mediate biallelic expression in this tissue (Feil et al. 1994; 
Constancia et al. 2000; Eden et al. 2001).
The choroid plexus arises from two distinct embryonic lineages. The epithelium 
originates from the neural tube, whereas the stroma is derived from cephalic 
mesoderm (Catala 1998). In the present study, allele-specific analysis to determine the 
imprinting status of Igf2 in situ , which made use o f the lacZDMKT  reporter gene 
knock-in mutant, revealed strikingly different expression profiles between the 
epithelial and stromal components of this tissue. Igf2 {lacZDMKl') expression was 
initiated in the presumptive choroid plexus epithelium between e9.5 and e l0.5 of 
development and was biallelic from its onset. Biallelic expression continued in the 
mature choroid plexus epithelium consistent with previous work, though in the stroma 
Igf2 was imprinted, with expression from the paternal allele at all stages examined, 
contrary to earlier reports o f biallelic expression in this component (DeChiara et al. 
1991; Svensson 1995). Igf2 in situ hybridisation experiments verified these 
observations. H19 was biallelically silenced in the choroid plexus epithelium, but 
maintained imprinting in the stroma with exclusive maternal expression. In the adult 
brain, biallelic Igf2 expression was observed in the choroid plexus epithelium, 
although the stromal expression had almost completely disappeared, possibly 
reflecting the situation in other imprinted tissues, where expression o f this gene is 
downregulated after birth. These observations appear to reflect the dual embryonic 
origin of the choroid plexus and strengthen the argument that Igf2/H19 expression is 
governed by distinct mechanisms in the two components of this tissue.
Regulatory elements that confer expression in the choroid plexus epithelium are 
situated 5’ to the DMD, within the CCD region and provide the basis of biallelic Ig/2 
expression at this site (Jones et al. 2001; Charalambous et a/.2004). Silencing of the 
H I9 gene in this tissue could also be consistent with its location on the opposite side 
of the DMD (to Igf2), where the insulator potentially blocks an interaction between 
the H19 promoter and the CCD. In support of this proposal, no change in the level of
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H I9 RNA was reported in the choroid plexus following deletion o f the CCD (Jones et 
al. 2001). Imprinted expression of both genes in the stroma invokes elements situated 
3’ to the DMD. Consistent with this expectation, mesodermal enhancers (that would 
be predicted to confer expression in the stroma), are located 3’ of the H I 9 gene 
(Ainscough et al. 1997; Ishihara and Jinno 2000; Kaffer 2000; Davies et al. 2002). In 
apparent contradiction to the insulator model, the CCD has also been shown to drive 
reporter gene expression in a subset of mesodermal tissues that includes the choroid 
plexus stroma (Charalambous et al. 2004). Transgenic experiments indicate that this 
activity may be specific to Igf2 as no change in H I9 expression was reported in the 
choroid plexus following deletion of the CCD, again possibly reflecting the presence 
of the insulator within the intervening region (Jones et al. 2001). The CCD therefore 
drives Igf2, but probably not H I 9 expression, in both the stroma (imprinted) and 
epithelium (non-imprinted).
Other sites o f biallelic Igf2 expression were identified in the brain, most notably the 
capillary endothelium. Expression in this tissue was imprinted at early stages with 
expression from both parental alleles evident later in gestation, which continued in the 
adult brain. Regulatory elements driving Igf2 expression in capillary endothelium 
have not been formally defined, although the mesodermal origin of this tissue 
implicates enhancers situated 3’ of the DMD, or possibly the restricted mesoderm- 
specific activity observed at the CCD (Charalambous et al.2004). Speculatively, the 
transition from imprinted to non-imprinted expression observed in developing 
capillaries, is suggestive of a switch between regulatory mechanisms involving 
distinct enhancer regions.
Given the extensive network of brain capillary endothelium, it seems likely that this 
tissue provides a third major source of biologically available IGFII peptide in the 
brain, complementing that provided by the choroid plexus and leptomeninges. A 
definitive function has yet to be ascribed to Igf2 in the CNS and with this in mind it 
may be no coincidence that the major sites of its brain expression are in tissues with 
exchange or barrier function.
Igf2 (lacZDMR2‘) expression was observed in a finely scattered distribution in the 
choroid plexus epithelium. This variegated pattern was seen at the onset of Igf2
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expression in the presumptive choroid plexus epithelium at e l 0.5 and at all other 
stages examined. By contrast, uniform expression of Transthyretin (TTR) and several 
other differentiated markers was observed throughout this tissue. Therefore, two cell- 
subpopulations respectively defined by the presence or absence of Igf2 expression 
exist in the choroid plexus epithelium.
It would be of interest to identify cis-elements and the associated trans-factors 
controlling this mode of expression. Recent studies suggest the participation of the 
CCD in this role. In transgenic mice, the CCD reproducibly conferred variegated 
expression upon Igf2 Promoter3 (P3)-lacZ reporter genes in the choroid plexus 
epithelium, thus reflecting that of the endogenous Igf2 gene (Charalambous et 
<3 /. 2004). Remarkably, analysis o f the mouse CCD in transgenic Drosophila 
demonstrated that the variegation/silencing functions of this region are conserved, 
with the polycomb group (PcG) genes Enhancer o f  zeste (E[z]) and Posterior sex 
combs (Psc) involved in mediating this activity (Erhardt et al. 2003). The CCD (and 
possibly P3) must therefore contain the sequences sufficient to direct this pattern of 
expression within the choroid plexus epithelium in vivo. It would be interesting to ask 
if mammalian E[z] and Psc homologues perform analogous roles in the mouse, by 
mediating the variegation and silencing functions of the CCD at the Igf2IH19 locus. 
Indeed the absence o f genome methylation in Drosophila and the hypomethylated 
state of the CCD reported previously in the mouse, suggests that repression conferred 
by this region in both species may be mediated by a conserved, methylation- 
independent mechanism (Koide 1994; Lyko et a l  1999).
There was good reason to suspect an involvement o f Delta and Notch genes in the 
specification o f putative subpopulations within the choroid plexus epithelium. Notch 
signalling has an established role in generating asymmetric cell fates within lineages 
of identical cells during embryogenesis (discussed in the Introduction to Chapter 3). 
Mammalian Notch receptors and the cognate ligands encoded by Delta genes are 
widely expressed in the primitive neuroectoderm layer from which the CNS and 
associated structures, including the choroid plexi later arise. RT-PCR analysis showed 
expression o f all Notch and most Delta genes in whole neonate choroid plexus tissue. 
In situ hybridisation analysis was performed to examine the distribution of 
Delta/Notch expression in the embryonic choroid plexus epithelium, but technical
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difficulties prevented a comprehensive evaluation of these genes in this tissue. At 
present, the role o f Notch signalling in the choroid plexus epithelium remains 
unresolved.
Transient expression assays
It was o f interest to define the minimal sequences within the CCD that confer biallelic 
expression in the choroid plexus epithelium. One approach to the localisation of 
functional elements is to search for conserved sequences between divergent species. 
Earlier work that utilised this approach identified two stretches of conserved 
sequence, region 1 and region 2, within the 2kb CCD region, where region 1 coincides 
with three sites o f strong DNasel hypersensitivity (Koide 1994). Deletion of the 5’ 
most lkb of the CCD, which removed region 1 and the hypersensitive sites had no 
apparent effect upon Ig/2 expression in the brain, but resulted in reactivation of the 
maternal Igf2 allele in tissues with a significant skeletal muscle component after e l7.5 
of development (Ainscough et al. 2000b). That is, region 1 contains a muscle-specific 
silencer element that is active in late embryogenesis. A function for the second lkb of 
the CCD containing region 2 has not been described, but could possibly contain the 
elusive choroid plexus enhancer element.
An in vitro approach was taken to further delineate regulatory elements controlling 
Igf2 expression. Primary choroid plexus cultures were established and shown to 
present appropriate morphological features and express diagnostic marker genes. 
These cultures were subsequently used in transient expression assays to analyse Igf2 
?3-Luciferase constructs, which either carried the full length CCD or smaller 
fragments from which region 1 or region 2 had been deleted. Consistent with previous 
work where the CCD could not drive reporter gene expression above the level of a 
control construct in vitro, no tissue-specific enhancer activity was seen in the primary 
cultures (Charalambous 2000). Instead the CCD conferred a large and significant 
silencing effect upon P3. Although not statistically significant, deletion of region 1 
from this construct resulted in a partial but reproducible loss o f this silencing, possibly 
consistent with the silencer activity reported previously for region 1 in vivo 
(Ainscough et al. 2000b; Jones et a l  2001). Taken together with previous transgenic 
and transient analyses of the CCD, data from the present study argues that this region 
can behave as an enhancer when integrated into the genomic environment, but not in
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the extra-chromosomal context (Ward et al. 1997; Charalambous 2000; Jones et al. 
2001; Charalambous et al. 2004). This hypothesis remains to be tested in the in vitro 
cell culture system (CPlacZ cells) by analysis of stably integrated transgenes.
Does region 2 o f the CCD contain the choroid plexus enhancer? Given the failure of 
the transient system to dissect activities within the CCD, future studies should involve 
a transgenic approach. The creation of a small germline deletion encompassing region 
2 would be the most stringent means to address this issue.
Are other elements besides the CCD required for Igf2 expression in the choroid 
plexus? Deletion of the CCD led to a reduction in Igf2 mRNA levels, but did not 
eliminate expression from the choroid plexus, which argues for the existence of at 
least one additional regulatory region with activity in this tissue (Jones et al. 2001). 
The present study made use of comparative sequence analysis of a 1Mb region 
encompassing the Igf2IH19 locus in human and mouse, which identified a number of 
conserved non-coding sequences, five of which were located within the Igf2/Hl9  
intergenic region and did not correspond to known elements (Onyango et al. 2000). 
These sequences, C1-C5, were inserted into V2>-Luciferase reporter constructs and 
transfected into primary choroid plexus cultures to examine any tissue-specific 
enhancer activity, although none were found to drive reporter gene expression above 
the levels o f the M construct, containing Ig/2 P3 alone.
Could cryptic enhancer activity implicated in the study by Jones et al. reside at P3? 
Transgenes containing P3 consistently confer expression in the choroid plexus, 
providing evidence in support of this proposal (Ward et al. 1997; Charalambous 2000; 
Charalambous et al.2004; Kelly 2004). Transient expression data from the present 
study could also be consistent with this hypothesis as none of the constructs tested 
significantly increased reporter gene expression levels above that of the M construct, 
containing P3 alone. However it is unclear whether silencing conferred by the CCD 
upon P3 in vitro genuinely represents that observed in vivo (Ainscough et al. 2000b) 
or a second aberrant activity, thus complicating any interpretation of the transient 
data. Prospectively, the generation of further transgenic lines bearing P3-lacZ reporter 
constructs would provide a more appropriate means to clarify the role of P3. In
265
conclusion, the CCD represents the only brain/choroid plexus enhancer element 
formally identified at the Igf2IH19 locus to date.
Immortal choroid plexus epithelial cell lines
Igf2 expression is biallelic in the choroid plexus epithelium and imprinted in the 
stroma. This may reflect the distinct embryonic origin of the two tissues and suggests 
that epigenetic marks may be differently established in these cell types (Catala 1998). 
Indeed biallelic hypermethylation of the differentially methylated regions proximal to 
Igf2, DMR1 and DMR2, has been described previously following analysis of whole 
choroid plexus, yet the same study provided evidence that the H I9 promoter-proximal 
region is only 50% methylated, consistent with a profile of differential (paternal- 
specific) methylation similar to that normally observed in imprinted tissues (Feil et al. 
1994). Feil et al. did not address the methylation status o f the DMD in the choroid 
plexus, raising the question of whether differential methylation of this region is 
maintained in this tissue.
It was therefore of interest to separately examine epigenetic modifications in the 
choroid plexus epithelium. Primary choroid plexus cultures were not suited to this 
analysis, as they contained both epithelial and stromal cell types. In addition these 
cells did not proliferate once explanted in culture and could not be passaged, thus 
further limiting their use. Therefore a strategy was devised to derive an immortal cell 
line from the choroid plexus epithelium. Transgenic mice of the T 121 strain were 
obtained, which over-express a T-antigen variant. This T 121 protein binds and 
inactivates Retinoblastoma but not p53 such that its expression in these animals 
induces aberrant cell proliferation and tumourigenesis of the choroid plexus 
epithelium (Saenz Robles et a l 1994). However, this activity alone was not sufficient 
to allow derivation of cell lines, therefore the absence of p53 binding activity in T 121 
was /nms-complemented by crossing the mice onto a p53+l~ knockout background, 
creating T 121 :p53+/~ mice, which have a significantly increased rate o f choroid plexus 
tumour development. Tumour tissue taken from these animals was the source from 
which four choroid plexus epithelial cell lines were derived.
Genetic analysis showed these cell lines to be p53  null, consistent with loss of the 
single wild-type p53  copy carried by the founder animal. This was reflected in the
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growth rate o f the cell lines (essentially of the T n \p 5 3 '1' genotype), which proliferated 
at a significantly greater rate than primary cultures expressing T 121 in the presence of 
functional p53. The cell growth data thus indicates that combined inactivation of both 
Retinoblastoma and p53  are required to fully immortalise the choroid plexus 
epithelium in vitro.
The identity of the cell lines was confirmed by analysis of morphology and gene 
expression. All of the cell lines presented the polygonal closely opposed morphology 
that is characteristic o f epithelial cells, consistent with their origin from the choroid 
plexus epithelium. Three out of four cell lines expressed marker genes consistent with 
their origin from the choroid plexus epithelium but none of the cell lines appeared to 
express the epithelial cell markers E-cadherin and pan-cytokeratin at the protein level, 
possibly indicating the downregulation of these genes in response to the transformed 
state induced in these cells. One of the cell lines, CPlacZ2, exhibited a marked 
reduction in the expression of all genes analysed indicating that a global loss of 
phenotype had occurred in this case. Biallelic Igf2 expression could not be clearly 
demonstrated in the cell lines though, biallelic silencing of H I 9 appears to have been 
maintained. Good evidence for expression of the maternal Igf2 allele was found in situ 
as judged by staining for activity of the lacZDMR2' reporter gene allele. This 
expression was variegated and thus reflected the pattern of expression seen in the 
choroid plexus epithelium in vivo (Charalambous et al. 2004).
Once the identity of the cell lines had been examined and largely confirmed, DNA 
methylation analysis was performed as an indirect means to assess epigenotypes at the 
Igf2/H19 locus in the choroid plexus epithelium. The DMD and H I9 promoter- 
proximal region were found to be approximately 50% methylated in the cell lines and 
in whole choroid plexus consistent with the previous analysis o f the H I9 promoter 
(Feil et al. 1994). These observations indicate that differential methylation of the 
alleles occurs at the DMD in both components of the choroid plexus. The protein 
CTCF is essential for the maintenance of differential methylation at the DMD 
postzygotically, where binding of this protein prevents de novo methylation of the 
maternal allele (Schoenherr et al. 2003; Fedoriw et al. 2004; Pant 2004). In agreement 
with these studies, abundant CTCF mRNA expression was demonstrated in all o f the 
cell lines. By contrast, DMR1 was almost 100% methylated in the cell lines,
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consistent with biallelic hypermethylation of this region. Methylation levels were 
significantly lower at this region in whole choroid plexus. Together these results 
suggest that DMR1 acquires distinct epigenotypes in the epithelial and stromal 
components of the choroid plexus, with biallelic hypermethylation of DMR1 
predominating in the epithelium.
In imprinted tissues, differential marking within Igf2 proximal DMRs is dependent 
upon and acquired in a manner consistent with that o f the DMD lying in cis, and has 
led to the proposal that these DMRs fall under the control o f the DMD in a 
hierarchical manner (Lopes et al. 2003). The DMD therefore protects Igf2 proximal 
DMRs from de novo methylation on the maternal allele. Recent evidence suggests that 
the mechanism conferring this protection may involve the physical association of the 
DMD and DMR1 on the maternal chromosome via a chromatin loop, with the protein 
CTCF implicated in mediating this interaction (Murrell 2004). In vitro analysis of the 
choroid plexus epithelium (CPlacZ cell lines) in the present study showed that the 
maternal allele is hypermethylated at DMR1 in the presence of the DMD in the 
hypomethylated state lying in cis. That is, parental-origin specific methylation at these 
DMRs is dissociated in the choroid plexus epithelium. In the wake of the chromatin- 
looping proposal, it could be argued that interactions normally existing between these 
regions at imprinted sites may be decoupled in this tissue (Murrell 2004). How this 
might occur mechanistically is unclear, but it is possible that the local chromatin 
environment in differentiated choroid plexus epithelial cells is not permissive for 
DMR interactions at Igf2/H19.
In summary, two mechanisms are proposed to mediate biallelic Igf2 expression in the 
choroid plexus epithelium (Figure 46). First, the identification o f at least one 
enhancer within the CCD region that drives expression in the choroid plexus 
epithelium provides a fundamental mechanism for biallelic Ig/2 expression in this 
tissue (Ward et al. 1997; Jones et al. 2001; Charalambous et al.2004). Enhancers 
governing expression in imprinted tissues are located 3' o f the DMD and access Igf2 
exclusively on the paternal allele as a consequence of insulator activity. The CCD is 
located 5' to DMD and therefore gains access to Igf2 promoters upon both alleles, as 
presumably the insulator does not affect it. Second, biallelic hypermethylation of Igf2 
proximal DMRs may be permissive for biallelic expression, presumably by excluding
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Figure 46. Proposed mechanisms of biallelic Igf2 expression in the 
choroid plexus epithelium. The Igf2 and H I9 genes are shown as open 
boxes (not to scale), regions of differential methylation between the 
parental alleles are shown as filled boxes, from left to right, DMR1, 
DMR2, DMD, H I9 promoter proximal region; lollipops above these 
regions indicate hypermethylation. Enhancers are shown as ovals, from 
left to right, the CCD, endoderm enhancers, mesoderm enhancers. Where 
present the curved arrows indicate interactions between enhancers and 
promoters; curved flat-ended lines indicate silencing or enhancer 
blocking activity. A Igf2 expression in the choroid plexus epithelium is 
mediated by enhancers at the CCD and by biallelic methylation of 
proximal DMRs which abrogates binding of repressor proteins such as 
GCF2. H I9 is silenced in this tissue by hypermethylation of the DMD and 
promoter proximal region on the paternal allele and by insulator activity 
(associated with hypomethylation of the DMD) which may block an 
interaction with the CCD on the maternal allele. B In the choroid plexus 
stroma and a subset o f mesodermal tissues the CCD drives Ig/2 
expression as the proximal DMRs are paternally methylated. 
Hypomethylation o f these DMRs on the maternal allele allows repressor 
proteins to bind and prevent activation of Igf2 by the CCD. Maternal- 
specific H19 expression in the stroma may not be mediated by the CCD 
but instead governed by the distal enhancers.
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protein factors with a silencing function (DMR1) or recruiting those that activate gene 
expression (DMR2) respectively (Eden et al. 2001; Murrell et al. 2001). 
Hypomethylation of maternal allele at these DMRs is probably required in a subset of 
mesodermal tissues to prevent activation of Igf2 by the CCD (Charalambous et 
al.2004). Biallelic silencing of H I9 in the epithelium is consistent with paternal- 
specific methylation of its promoter region and by maternal-specific insulator activity 
both o f which could prevent its activation by the CCD.
Future work
Choroid plexus epithelial cells provide the structural basis o f the blood-cerebrospinal 
fluid (CSF) barrier and play important roles in regulating the delivery of biologically 
important molecules, including therapeutic compounds, to the brain. In vitro models 
that mimic the barrier and transport properties of this tissue are widely sought as a 
means to assess the delivery of novel drug compounds to the CNS, potentially 
lessening the need for laboratory animals (Ghersi-Egea 2001; Haselbach et al. 2001; 
Speake 2001)(and references therein). Morphological and biochemical analyses 
performed in the present study suggest that the CPlacZ cell lines could provide such 
in vitro models for the characterization of choroid plexus function. It would be 
necessary to determine whether cultured CPlacZ cells can reproduce functional 
properties o f the choroid plexus epithelium, for example the polarized ion fluxes 
associated with CSF secretion. A preliminary means to address this question would be 
to culture CPlacZ cells in specialized trans-well apparatus and look for any directional 
fluid movement across the cell monolayer that would be indicative of functional CSF 
production. This approach has been successfully used in both primary and immortal 
choroid plexus epithelial culture systems (Haselbach et al. 2001; Zheng 2002). 
Analysis of such functional markers of the choroid plexus phenotype, it is envisaged, 
could further confirm the identity of the CPlacZ cells, thus complementing the 
morphological and biochemical data already described in this study.
Biallelic methylation o f the Igf2 proximal DMRs is observed in association with 
biallelic Ig/2 expression in the choroid plexus epithelium. Whether these epigenetic 
marks are the determinant factors or the consequence o f biallelic expression in this 
tissue remains unanswered. Could the imprinting o f Igf2 be manipulated by 
experimentally removing CpG methylation at this locus? This could be addressed in
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the CPlacZ cell lines by treatment with the DNA methyltransferase inhibitor, 5’-aza- 
2’-deoxycytidine (aza-C) and the lacZDMR2' reporter gene used to differentiate the 
pareital origin of transcripts. However, as there would be no means of discriminating 
the alleles for the purposes of methylation analysis, this would be better suited to a 
similar cell line carrying one copy of the Mus spretus-derived SD7 chromosome. 
DNA polymorphisms that exist between the musculus and spretus sub-species have 
beer described in Igf2 and H I 9 coding sequences and in the DMRs surrounding both 
genes (Fome et al. 1997; Hemberger 1998; Lopes et al. 2003; Murrell 2004). Both 
allele-specific expression and DNA methylation assays would therefore be possible in 
such a cell line following global demethylation with aza-C treatment. Live tumour 
tissue has been successfully explanted from a single T\i\\p53+I~\§D1+I' animal and 
cryopreserved. The derivation of cell lines carrying the SD7 region awaits cloning of 
the epithelial cell fraction from this tissue.
Biallelic Igf2 expression commences at an early stage in the specification of the 
choroid plexus epithelium (see Chapter 3). Are the epigenetic marks associated with 
this mode of expression established in a synchronistic manner? The CPlacZ cell lines 
created in this study represent the choroid plexus epithelium at a postnatal stage of 
development. Whilst it is likely that the methylation patterns observed in these cell 
lines reflect those present in the mature tissue, they do not describe the ontogeny of 
epigenetic marks during the formation of the choroid plexus epithelium or indeed 
within the lineage of neuroepithelial cells that generate this tissue. This could be 
investigated by the derivation of further cell lines using presumptive and 
differeitiating choroid plexus epithelial tissue explanted from different embryonic 
stages. Lines o f Ti2i:/?53+/':SD7+/' mice would provide a useful resource for this 
purpose Examination o f the epigenetic modifications at Igf2/H19 in this context 
could further elucidate the mechanisms by which the DMD-centred control at this 
locus is surmounted in the choroid plexus epithelium. The pursuit o f studies utilising 
this approach may provide a greater understanding of the molecular events that lead to 
loss ofimprinting mutations in overgrowth and cancer.
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A bstract
The insulin-like growth factor 2 (Igf2) gene encodes a potent growth factor that is expressed in multiple tissues during embryonic 
development. Expression at this locus is mediated by genomic imprinting. In the developing endodermal tissues, imprinting o f  Igf2 is 
mediated by the interaction o f  a set o f  enhancers downstream o f the linked H I 9 gene with a differentially methylated domain (DMD) that lies 
approximately 2 - 4  kb upstream o f  H 19 that has a boundary or insulator function in the hypomethylated state. In the remainder o f tissues that 
express Igf2 and H I9, the cis elements that drive their correct expression and imprinting are not well understood. In addition, enhancers 
driving expression o f Igf2 in the choroid plexus and leptomeninges, tissues where the gene is thought not to be imprinted, have not been 
isolated. Here we show that biallelic (non-imprinted) expression within the choroid plexus is restricted to the epithelium, and we provide 
evidence that a conserved intergenic region functions as an enhancer for Igf2 both in tissues where the gene is imprinted, and where Igf2 is 
biallelically expressed. The presence o f  an enhancer for imprinted tissues in the intergenic region argues for the existence o f imprinting 
controls distinct from the DMD, which may be provided by differential methylation at sites proximal to Igf2.
© 2004 Elsevier Inc. All rights reserved.
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sites; YAC, yeast artificial chromosome; DMR, differentially methylated 
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Introduction
The centrally conserved domain (CCD) was initially 
characterized by Koide et al. (1994) as a GC-rich, relatively 
unmethylated region approximately 32 kb upstream of the 
mouse H I9 gene. This region was found to contain DNasel 
hypersensitive sites (HSS) as well as a high degree of 
sequence conservation between mammals, a strong indica­
tion that this region is functional. Subsequent analysis (Ain- 
scough et al., 2000) showed that this region can be subdivided 
into two domains based on comparisons with human se­
quence (see Fig. lc , shaded areas). Region 1 shares 86% 
identity between mouse and human sequences over approx­
imately 100 bp and contains the previously mapped HSS. 
Region 2 displays 87% identity between the two species over 
approximately 200 bp. Region 1 has been analyzed in the 
context of a yeast artificial chromosome (YAC) transgene that 
contains 130 kb of the mouse genomic region spanning from 
approximately 5 kb upstream of the first exon of insulin-like 
growth factor 2 (Igf2) to approximately 35 kb downstream of
0012-1606/$ - see front matter © 2004 Elsevier Inc. All rights reserved, 
doi: 10.1016/j.ydbio.2004.04.022
M. Charalambous et al. /  Developmental Biology 271 (2004) 488-497




lg f2  gene ii
- 7 T - d >
C C 0
"77* - f e w ----------0 0 —
H 19 gene endodermal
enhancers




|P 3 |! LacZ CCD
E  U  P
1..-" ' 1
P \  E
Region 1 Region 2
2 kb
Fig. 1. The !gf2/H19  gene locus and P3-LacZ-CCD transgene construct, (a) The relative positions o f the lgf2  and H I9  genes within the 100 kb genomic region 
are indicated by their position along the horizontal line. Exons are indicated by filled boxes and regulatory elements by open boxes. Vertical arrows above the 
line indicate regions o f  DNasel hypersensitivity. Horizontal arrows show the direction o f  transcription from the four lgf2  promoters (PO, PI, P2, and P3) and the 
single H19 promoter. Regions that exhibit differential levels o f  methylation between parental alleles (DM Rs, DMD, and H19  promoter-proximal region) are 
indicated by solid horizontal lines, (b) Structure o f  the P3-LaeZ-CCD transgene (Construct C). Ig/2 promoter 3 was cloned upstream o f  the E. coli LacZ  coding 
sequence, and the 2 kb CCD region was inserted immediately downstream, (c) The CCD in detail. The 2 kb CCD regions contains two regions o f  strong 
sequence conservation with the human locus, Regions 1 and 2 (see text). The CCD deletion in the YAC experiment (Ainscough et al., 2000) referred to in the 
text is the 5' 1 kb £coRI (E )-F i/I  (P) interval containing Region 1.
the H19 gene. With the intact YAC transgene, imprinting is 
maintained of both an Ig/2-LacZ  fusion gene and HI 9, and 
transgenic mice display expression o f both genes in the 
majority o f tissues where Ig/2  and H I 9 are normally 
expressed (Ainscough et al., 1997). In transgenic mice where 
1 kb of the intergenic region, including Region 1 but not 
Region 2, was deleted from the same YAC, the maternal allele 
of LacZ was reactivated in late gestation in a subset of skeletal 
muscle cells, most notably those of the tongue (Ainscough et 
al.. 2000). Region 1 therefore contains a maternal allele- 
specific, tissue-specific silencer that is active in late gestation. 
The role o f Region 2 has not been elucidated, though 
evidence from transgenic and germline knock out experi­
ments suggests that it may contain the exchange tissue 
enhancers (Jones et al., 2001; Ward et al., 1997).
Imprinting of the Ig/2 gene in endodermal tissues is 
thought to be mediated by the interaction of tissue-specific 
enhancer elements with a differentially methylated domain 
(DMD) 2 - 4  kb upstream o f the H19 gene (for relative 
positions, see Fig. 1). On the maternal allele, where the 
DMD is unmethylated, it functions as a boundary to prevent 
the access o f downstream enhancers to the lgf2  gene. This 
boundary function is mediated by the protein CTCF (Bell and 
Felsenfeld, 2000; Hark et al., 2000; Kanduri et al., 2000; Pant 
et al., 2003; Szabo et al., 2000). On the paternal allele,
methylation of the DMD prevents CTCF binding; therefore, 
the Ig/2 promoters and the downstream enhancers are able to 
interact. If the DMD provides the sole imprinting element for 
Ig/2, a prediction would be that the enhancers that drive 
imprinted Igf2 expression would lie on the opposite side of 
the boundary. Indeed, a region that can drive gene expression 
in skeletal muscle, where Igf2 is abundantly expressed and 
imprinted, has recently been mapped as lying approximately 
28 -30  kb downstream of the HI 9 gene, on the predicted side 
of the boundary (Kaffer et al., 2000), and is one of many 
putative enhancers in this region (Davies et al., 2002; Ishihara 
et al., 2000). However, the existence of several regions of 
differential methylation proximal to Ig/2 (DMRO, DMR1, 
DMR2, see Fig. 1) that display methylation-dependent, 
tissue-specific silencer activity (Constancia et al., 2000; Eden 
et al., 2001; Murrell et al., 2001) argues that the DMD may 
not directly mediate the imprinting of Ig/2 in all tissues.
The CCD lies between the Ig/2 gene and the DMD and 
consequently the CCD should not be affected by the 
boundary element that prevents the interaction of Ig/2 with 
more distant enhancers. We therefore considered the CCD 
as a good candidate for driving expression in the tissues 
where Ig/2 is biallelically expressed, the choroid plexus 
and leptomeninges. To test this hypothesis, we have created 
transgenic mice that carry the CCD in the context of a
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LacZ  reporter construct. A s expected, these mice express 
the reporter gene in the exchange tissues o f  the brain. We 
show that within the choroid plexus endogenous, Ig/2 
expression is imprinted in the stromal compartment (with 
the paternal allele active) but non-imprinted in the epithe­
lium (both alleles expressed), and that this is opposite to 
the pattern o f  H I 9 expression (with the maternal allele 
expressed in the stroma and both alleles silent in epitheli­
um). The CCD was able to drive transgene expression in 
both stromal and epithelial components o f  the choroid 
plexus in a pattern very similar to that o f  endogenous 
Igf2 expression. In addition, the CCD was able to repro- 
ducibly drive gene expression in further tissues o f  meso­
dermal or neural crest origin that are consistent with the 
known expression pattern o f  Ig/2. The presence o f  an 
enhancer for Ig/2 proximal to the boundary, in addition 
to the existence o f  tissue-specific silencers upstream o f  the 
Igf2 gene, suggests that a second mechanism  acts to 
imprint this gene in a subset o f  tissues.
Methods
Mice
The LacZD M R 2~  m ice were maintained on an Fi 
(CBA x C57BL6/J) background. To derive embryos for 
allele-specific expression analysis, male and female mice 
heterozygous for the LacZD M K2~  mutation were mated 
with F] partners. To distinguish LacZDM R2-  heterozy­
gous embryos from wild-type littermates, yolk sacs were 
collected and crude lysates were made by heating in 50 
mM NaOH at 100°C for 10 min. Lysates were analyzed 
for the presence o f  the LacZ  reporter by PCR using 
primers internal to the LacZ  gene: 407, 5' ATG AAC  
GGT CTG GTC TTT GC-3' and 408, 5' ACA TCC AGA  
GGC ACT TCA CC-3'. The H I 9  knockout strain, desig­
nated H I9A3, was previously described, together with 
methods for distinguishing the wild-type and knockout 
alleles (Ripoche et al., 1997).
Transgenesis
The ?3-LacZ-CCD  construct C (see Fig. 1) contained a 
3.6 kb coding region o f  the bacterial (3-galactosidase (Lac 
Z) gene driven from Igf2 promoter 3 (Ig/2 P3, as de­
scribed in Caricasole and Ward, 1993). The CCD frag­
ment, placed immediately 3' to the LacZ  gene, was a 2 kb 
EcoRI fragment (pA-4, as detailed in Koide et al., 1994). 
Cloning steps were performed in the Bluescript II SK+ 
vector, according to standard techniques (Sambrook et al., 
1989).
Transgenic mouse lines were constructed as follows: 
Linear construct DNA (1 pg/m l) was purified from vector 
sequences and microinjected into one pronucleus o f  an FI 
(C57BL/6JxCBA/Ca) zygote, using standard techniques
(Hogan et al., 1986). Injected embryos were transferred into 
the oviduct o f  pseudopregnant MF1 females. Lines were 
established and maintained by breeding the transgenics with 
FI partners.
Founders were identified by PCR o f  sequences unique to 
the Igf2 ?3-L acZ -C C D  transgene (primers lgf2  P3: 5' 
CTGTGAGAACCTTCCAGCCTTTTC 3' and LacZ: 5' 
CAAGG CG ATTAAGTTGGG TAACG CC 3') and con­
firmed by Southern blotting o f  tail genomic DNA with a 
probe generated from the transgene construct, according to 
standard techniques. Copy number was estimated on South­
ern blots by titrating D N A  from hemizygous transgenic 
animals, with reference to an endogenous band detected 
using CCD sequences within the transgene probe.
Tissue processing
Embryos and tissues were analyzed for LacZ  expression 
according to Ainscough et al. (2000), with the following 
modifications: Samples were incubated in X-Gal or BLU- 
GAL (Melford Laboratories Ltd) staining solution for l b -  
24 h, washed with PBS, then fixed overnight in 4%  
paraformaldehyde in PBS (PFA) and stored in 70% ethanol. 
Paraformaldehyde fixed material from both LacZ  analysis 
and obtained for in situ hybridization analysis was pro­
cessed according to standard techniques as described pre­
viously (Charalambous et al., 2003).
Probes and antibodies
The H I 9 in situ hybridization probe was a 346 bp 
fragment spanning exons 3 - 4  o f  the mouse H I9 cDNA, 
amplified by PCR using the following primers: 416; 5'AAT 
GAG TTT CTA GGG AGG GAG G-3' and 417; 5'GGA  
A A A  GTG A AA  GAA CAG ACG G-3', then cloned into 
the pGEM-T easy vector. Sense and antisense transcripts 
were obtained for this gene and for Ig/2, as described 
previously (Charalambous et al., 2003). Transthyretin 
(TTR) was detected in tissue sections using a rabbit poly­
clonal antiserum (DAKO) at a dilution o f  1:100. Immuno- 
histochem istry and m R NA  in situ hybridizations were 
performed essentially as detailed in Charalambous et al. 
(2003).
Results
Generation o f  P3-LacZ-CCD  transgenic mice
To test the CCD function, w e created a transgene 
construct containing the LacZ  gene driven by Igf2 promoter 
3 (P3), in cis to the CCD (construct C, see Fig. 1). Previous 
experiments have shown that Ig/2  P3 alone cannot drive 
reproducible tissue-specific expression o f  a reporter gene 
(Ishihara et al., 2000; Ward et al., 1997). Construct C (P3- 
LacZ-CCD ) D N A  was used to generate five transgenic
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founder animals, designated Connie, Columbo, Cornelius, 
Christian, and Clive, all o f which were shown by PCR and 
Southern blotting to transmit the transgene (data not 
shown). Founder animals were mated to generate an FI 
generation of males and females hemizygous for the trans­
gene, and these animals were backcrossed onto stock 
(CBA/C57BL6) mice to yield the embryos used in this 
study. Embryos were assayed for the expression of |3- 
galactosidase by an in situ assay at various embryonic 
and neonatal stages. Within each line, no differences in 
spatial patterns of gene expression, or obvious differences 
in the level o f gene expression, were observed following 
the transmission of the transgene from either males or 
females at any developmental stage examined (not shown). 
This is consistent with the absence o f parental allele- 
specific methylation or DNasel hypersensitivity in the 
CCD (Koide et al., 1994).
P3-LacZ-CCD reporter transgenes are expressed in tissues 
where Ig/2 is biallelically expressed
Four of five lines demonstrated a detectable level of 
gene expression from embryonic day 12.5 (el2.5). In the 
Clive line, the transgene appears to have been silenced by 
a position effect. As expected, the remaining lines dis­
played reporter gene expression in the choroid plexus and 
leptomeninges from their formation at e l2.5. Embryos 
from the Connie line expressed the transgene at very 
low levels, and not all individuals positive for the trans­
gene demonstrated detectable levels o f expression. The 
Connie line was therefore excluded from further analysis. 
By e l4.5, the Columbo, Cornelius, and Christian lines all 
expressed the transgene reproducibly in the third, fourth, 
and lateral ventricle choroid plexus, as well as in the 
leptomeninges of the brain, and surrounding the spinal 
cord (Fig. 2a). Expression of the reporter gene in the 
choroid plexus and leptom eninges was m aintained 
throughout embryonic development and persisted after 
birth (Figs. 2b- d), consistent with the previously reported 
endogenous Igf2 expression pattern (Stylianpoulou et al., 
1988b).
The choroid plexus develops from more than one cell 
population. It is comprised of a stromal stalk that extends 
into the ventricular cavities o f the brain, surrounded by the 
columnar choroid plexus epithelium. The stroma develops 
from the same mesenchymal cell population as will form 
the pia mater of the leptomeninges, some of which may be 
derived from the neural crest (Catala, 1998; Davson, 1967). 
At approximately e l0.5 in the mouse, mesenchymal cells 
overlying the neuroepithelium expand and become highly 
populated with vasculature. This expansion into the ven­
tricles forms a stromal stalk that retains its ependymal 
lining. The ependyma is the innermost layer of the neuro­
epithelium that lines the ventricles of the brain and the 
spinal cord. Concomitant with the expansion and invagi­
nation of the stroma, the ependyma in this region also
le
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Fig. 2. Expression o f  the P3-LacZ-CCD  transgene construct mirrors that o f 
lg/2  in the brain, (a) Bisected embryo at e l 4.5 o f  the Columbo line, 
focusing on the area surrounding the fourth ventricle o f  the brain. The 
choroid plexus (cp) is expressing the reporter gene, as are the connecting 
leptomeninges (le) surrounding the brain. The leptomeninges that enclose 
the neural tube also express the transgene. Some additional gene 
expression is seen in the pons (p), which is limited to the Columbo line 
and thought to be due to a position effect o f transgene integration, (b) 
Dissected fourth ventricle choroid plexus at 10 days post-partum from the 
Columbo line. Gene expression can clearly be seen in the connective 
stromal tissue (s) as well as in a subset o f epithelial (ep) cells, (c and d) 
Whole brain from the individual shown in b. Gene expression is confined 
to the meningeal layers surrounding the brain and its cavities, ( e -h )  A 
comparison o f  reporter gene expression from the Columbo line, and Igf2 
mRNA localization at e l 5.5. (e, g) Show in situ hybridization to the fourth 
ventricle choroid plexus with an antisense lg/2  probe at 100x and 200 x 
magnification, respectively, (f, h) Show reporter gene expression in the 
fourth ventricle at the same magnification. Both lg/2  and reporter gene 
expression is abundant in the stroma and leptomeninges, and is less 
abundant and mosaic in the choroid plexus epithelium.
expands, becoming highly convoluted by el2.5. The mor­
phology of the cells changes from low cuboidal to a high 
cylindrical epithelium with an apical brush border (Davson, 
1967), the choroid plexus epithelium.
The expression pattern of the reporter gene was com­
pared in detail with that o f Igf2 mRNA at mid-gestation. In 
the fourth ventricle of the brain, both Igf2 and the reporter 
gene were expressed at high levels in the stromal stalk of the 
choroid plexus, and in the underlying pia mater and arach­
noid mater layers o f the leptomeninges (Figs. 2e, f). At 
higher magnification (Figs. 2g, h), a lower level of reporter
492 M. Charalambous et al. /  Developmental Biology 271 (2004) 488—497
gene and Igf2 expression can be detected in a scattered cell 
distribution in the outer epithelial layer o f the choroid 
plexus. Therefore, reporter constructs mirror the expression 
o f  Ig/2 in both the fine distribution of gene expression 
within the exchange tissues, and in the maintenance of gene 
expression in these tissues after birth.
Igf2 is biallelically expressed in the choroid plexus 
epithelium, but imprinted in the stroma
Expression of Igf2 has been previously reported in both 




Fig. 3. Igf2 demonstrates both monoallelic and biallelic expression in the choroid plexus. Reporter gene expression (blue stain) from the Ig/2 LacZDM R2  
allele is detectable from both parental alleles at developmental stages spanning the course o f choroid plexus development. (A) At e l0 .5 , paternal expression of 
the reporter is present in both a scattered population o f  ependymal cells (the presumptive choroid plexus epithelium, ep) and in the overlying mesenchyme (the 
presumptive choroid plexus stroma, s). (B) At the same stage, reporter gene expression from the maternal allele is present in a similar scattered population of 
ependymal cells, but absent from the overlying mesenchyme. Expression was not detected before e l0 .5 , either following maternal or paternal transmission of 
the Ig/2 LacZDMR2~ allele. (D, G) At e l 2.5 to e l 4.5, reporter gene expression from the paternal allele is detectable in both the epithelium and in the stroma. 
(E, H) However, following maternal transmission o f  Z.acZDMR2~, reporter gene expression is detected in the epithelium, but never in the stroma. A similar 
pattern o f  parental allele-specific gene expression was observed by in situ hybridization for the wild-type Ig/2  allele in LacZD M R2~  heterozygotes (not shown). 
(C, F, and I) An antibody recognizing transthyretin (TTR) protein was used as a marker o f  developing choroid plexus tissue and shows uniform expression of 
TTR (brown stain) throughout the plexus epithelium at all stages examined. (J) H19 mRNA can be readily detected in the choroid plexus stroma, but not in the 
epithelium, o f a wild-type embryo at e l 4.5. (K) Following maternal transmission o f  the H I9A 3  allele, H19  gene expression cannot be detected in either 
compartment o f the choroid plexus. Tissue sections were counter-stained with either nuclear fast red (A, B, D, E, G, and H) or M ayer’s hematoxylin (C, F, and 
I), and images were captured at a magnification o f  either 400 x (A -I) or 200x (J, K).
et al., 1988b). However, whether the gene is biallelically 
expressed in both compartments has never been resolved 
(Svensson et al., 1995). In addition, it is not known whether 
the expression o f the gene is initially parent-of-origin 
specific in this organ, becoming biallelic as development 
proceeds, or expressed from both alleles from the onset of 
development.
To answer these questions, we made use of a previously 
described allele o f Igf2 in which exons 4 - 6  (including 
D M R 2) are rep laced  w ith a L acZ  casse tte . This 
LacZDM K2~ allele faithfully recapitulates the expression 
of Igf2 (Murrell et al., 2001). We followed the expression of
Paternal Maternal
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the reporter in the fourth ventricle choroid plexus o f  
embryos from e9.5 to e l4 .5  to ask whether Igf2 is expressed 
from the earliest formation o f  the organ in both epithelial 
and stromal compartments. In addition, w e were able to 
determine the imprinting status o f  Igf2 in both compart­
ments by exam ining em bryos that had inherited the 
LacZDM K2~  allele uniparentally. Before e l 0.5, we could 
not detect reporter gene expression in either ependymal cells 
or in the underlying mesenchyme, follow ing maternal or 
paternal transmission o f  LacZDMR.2~  (not shown). At 
e l 0.5, paternal gene expression was detected in both the 
mesenchyme and in a subset o f  the overlying ependymal 
cells o f  the presumptive choroid plexus (Fig. 3a). At the 
same stage, expression from the maternal allele was detect­
able only in the ependyma (Fig. 3b). Subsequently, pater­
nally  derived gene expression  w as abundant in the 
developing stroma (Figs. 3d, g), whereas the maternally 
derived reporter gene expression could not be detected in 
this region (Figs. 3e, h). Gene expression from both parental 
alleles was detected in the choroid plexus epithelium. In 
contrast, H I 9 mRNA was detected in the stroma but not the 
epithelium o f  a wild-type embryo at e l4 .5  (Fig. 3j), and was 
absent from both cell types in embryos with maternal 
transmission o f  an H19A3  knockout allele (Fig. 3k). To 
confirm that Igf2 expression is associated with the choroid 
plexus, particularly at earlier stages when the characteristic- 
folded morphology o f  this organ has not been established, 
we have used an antibody that recognizes transthyretin 
(TTR). Within the brain, TTR expression was confined to 
the presumptive and definitive choroid plexus epithelium, 
with expression commencing at around e l0 .5  when the 
plexus epithelial cells differentiate from the neuroepithe­
lium. This expression pattern is consistent with the previous 
description o f  TTR as a marker o f  choroid plexus epithelium 
(Murakami et al., 1987). It is noted that TTR expression is 
uniform throughout the epithelium, in contrast with the 
variegated expression o f  Igf2 in this tissue.
We conclude that Igf2 is expressed in both the epithelial 
and stromal compartments o f  the choroid plexus from the 
onset o f  its development. Ig/2  is imprinted (paternally 
expressed) in stromal cells, but biallelically expressed in 
the choroid plexus epithelium. H I9  has a reciprocal expres­
sion pattern in the choroid plexus with expression from the 
maternally derived allele in the stroma and with both alleles 
silent in the epithelium. The CCD was thus able to drive 
reporter gene expression in a region where Igf2 is bialleli­
cally expressed, as predicted, but also in a region where the 
gene is imprinted.
P3-LacZ-CCD reporter transgenes are expressed in further 
tissues where Ig/2 is imprinted
Further exam ination  o f  C C D -bearing transgen ics  
revealed gene expression in som e additional embryonic 
tissues. The three high expressing lines (Columbo, Corne­
lius, and Christian) demonstrated reproducible patterns o f
gene expression in structures derived from the mesoderm 
and the neural crest (summarized in Table 1), as well as 
several line-specific sites o f  expression that are a presumed 
consequence o f  the transgene insertion sites (position  
effects).
At e9.5, all three lines showed staining in the mesen­
chyme at the site o f  the head fold, in the developing eye, 
and in the branchial arches. A subset o f  the condensing 
paraxial mesoderm was stained, as was the urogenital 
ridge (Fig. 4b). By e l0 .5 , a high level o f  staining was 
observed in the somites at their dorsolateral edge, in the 
mesenchyme surrounding the myencephalon including that 
which condenses to form the pia and arachnoid mem­
branes o f  the leptomeninges (Rugh, 1990; Stylianpoulou et 
al., 1988a), as w ell as in the mesenchyme surrounding the 
neural tube (Fig. 4c). The mesonephros maintained ex­
pression o f  the reporter gene, and the developing eye was 
clearly stained. A t e l 2.5 (Fig. 4f), expression in the 
paraxial mesoderm had declined and was present only in 
the most posterior somites. Gene expression was wide-
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Connie 2 - 4 48 none detected choroid plexus
Columbo >20 25
Cornelius 2 - 4 52
Christian >20 34
oculomotor nerve, 











of the limbs) 
cartilage o f the 
digits, tubules 
o f the kidney, 
dermis o f the skin
Clive 1 - 2 24 none detected
(fourth ventricle) 
leptomeninges 
(roof of midbrain 
and surrounding 
the third ventricle, 
and surrounding 
the neural tube), 
choroid plexus 
(of the third, 
fourth, and 
lateral ventricles), 
lens of eye, 
tongue muscle, 
mesenchyme of 
the head and 
neck tubules of 
the ear (eustacian 
tubules and lateral 
and posterior 
semicircular 




For each o f the P3-LacZ-CCD transgenic lines, an estimation o f transgene 
copy is given and also the number o f embryos examined for expression of 
the LacZ  reporter. Common sites o f expression are those regions where the 
transgenes were expressed in the majority o f lines. Position-dependent sites 
o f expression were those unique to a transgenic line.
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Fig. 4. Expression o f  the C construct in tissues where Igf2  is imprinted. Representative embryos from the Columbo line are shown at e9.5 (b), e l0 .5  (c), el 2.5 
(e, f), and at e l4 .5  (g) with reference to Ig/2  expression at elO (a) and e l2 .5  (d). In the early embryo (a -c ) ,  the transgene is expressed in the head mesenchyme 
(me), in the branchial arches (ba), in a subset o f  the somitic mesoderm (so), and in the eye (ey). By e l 2.5 (d - f ) ,  this expression has become refined to the 
ependyma o f  the brain (me), the lens o f  the eye (ey), several regions o f facial mesenchyme, to the posterior somites (dm), and the mesonephros (not shown). In 
later development (g), facial mesenchymal expression is resolved into specific areas including the tongue (to), the nasal epithelium (ne), and the ear (not 
shown).
spread in the condensing ependyma of the brain and was 
present in the choroid plexus as it forms in the fourth 
ventricle. Cranial structures such as the eustachian tubules 
and semicircular canals o f the ear, and the nasal mesen­
chyme and epithelium began to express the transgene at 
this stage, as did the intrinsic muscle o f the tongue (Fig. 
4e). Expression was maintained in the mesonephros and in 
the eye (not shown). At el4 .5 , gene expression was lost 
from the derivatives of the somites. The tongue muscle, 
nasal epithelium and mesenchyme, ear and neck cartilage 
expressed the transgene (Fig. 4g). The mesonephros has 
degenerated at this stage, but one o f its derivatives, the 
ureter, displayed reporter gene expression (not shown). 
The choroid plexus and meninges surrounding the brain 
and spinal cord continued to express the transgene, and we 
note that within the choroid plexus epithelium expression 
is restricted to a subset o f cells, as is expression of 
endogenous lgf2 (see Fig. 3). After e l4.5, gene expression 
declined in all tissues except the exchange tissues of the 
brain (Fig. 2c).
In summary, reproducible expression patterns were seen 
in three transgenic mouse lines containing the C construct, 
representing three independent integration events. This 
expression pattern represents a subset o f the tissues in which 
Igf2 is expressed during mouse development (see Figs. 4a, 
d). Furthermore, in all the tissues described above (with the 
exception of the exchange tissues of the brain), the majority 
of Ig/2 transcripts are generated from the paternal allele of 
the gene. The CCD is therefore acting as an enhancer both
in tissues where Igf2 is imprinted and where it is biallelically 
expressed.
Discussion
We have established that Ig/2 expression is biallelic from 
the earliest stages at which it can be detected (e l0.5) in the 
presum ptive choroid plexus epithelium . In contrast, 
imprinted (patemal-allele) expression is seen from the onset 
in choroid plexus stroma. We propose that this reflects the 
different origins of these two tissues (Catala, 1998; Davson, 
1967), and that epigenetic marks may be differently estab­
lished in these lineages (see Fig. 5). Biallelic methylation of 
the differentially methylated regions proximal to Igf2 
(DMR1 and DMR2) has been reported previously following 
analysis o f whole choroid plexus, and the same report 
indicated that the H I9 promoter exhibits only 50% methyl­
ation, consistent with differential allelic marking of this 
region (Feil et al., 1994). The methylation status of the 
DMD in this tissue remains unknown, and no attempt has 
yet been made to separately analyze methylation in the 
stromal and epithelial compartments. However, it is possible 
that within the choroid plexus, biallelic methylation of Igf2 
DMRs is restricted to the epithelium, and that this local 
hypermethylation is permissive for Ig/2 expression.
The results of our transgenic experiments using the Igf2 
P3-LacZ-CCD construct demonstrate that the CCD can act as 
a regional enhancer of a reporter gene during mouse devel-
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Fig. 5. Proposed model o f Igf2 expression mediated by enhancer activity o f 
the CCD. The Igf2 and H19 genes (gray boxes, not to scale) are shown 
relative to areas that may be differentially methylated between parental alleles 
[black boxes, from left to right Igf2 DMR1 and DMR2, the DMD (2 boxes) 
and H I9 promoter-proximal region; black lollipops above the boxes indicates 
regions o f  methylation] and enhancers (shown as gray ovals, from left, CCD, 
endodermal enhancers and mesodermal enhancers). Curved arrows indicate 
interactions between enhancers and promoters, (a) In the choroid plexus 
epithelium, the CCD may drive IgJ2 expression from the paternal allele and 
the maternal allele, as DMR1 methylation prevents the binding o f lg/2- 
promoter silencing factors such as GCF. H19  is not expressed in the choroid 
plexus epithelium, perhaps due to the methylation o f  its promoter (though 
this has yet to be established; see text), (b) In other tissues where the CCD is 
active (i.e., CP stroma, somites, tongue, eye), the Igf2 promoter can be 
accessed on the paternal allele, due to methylation at DM R1. On the maternal 
allele, loss o f DMR1 methylation allows the binding o f  silencing factors that 
prevent CCD enhancer activity. In addition, lack o f  methylation o f  the DMD 
on the maternal allele allows the binding o f  the boundary protein CTCF, 
and thus blocks the lgJ2 promoter from access by the distal enhancers.
opment in tissues where Ig/2 is expressed both biallelically 
(the choroid plexus epithelium) and monoallelically (the 
stroma of the choroid plexus and also discrete sites outside 
of the brain). It is important to note that the Ig/2 P3-LacZ- 
CCD transgenes did not exhibit any differences in expression 
when transmitted from either males or females, indicating 
that the isolated CCD is not sufficient to direct imprinted 
expression, a fact that is consistent with the absence from this 
region of any parental allele-specific methylation or DNasel 
hypersensitivity (Koide et al., 1994). The enhancer for 
choroid plexus expression has previously been predicted to 
lie within the interval between Ig/2 and H19, both from 
transgenic experiments with CCD reporter constructs (Ward
et al., 1997), and from a 12 kb deletion, including the CCD, 
which showed reduced expression in the choroid plexus 
(Jones et al., 2001). The knockout study by Jones et al. 
(2001) did not report a reduction in levels of gene expression 
in any tissues other than the choroid plexus; however, the 
study measured gene expression quantitatively on dissected 
organs. Our study shows expression of the reporter gene in 
discrete tissues and developmental stages that could easily be 
missed by the previous approach. Likewise, deletion of the 5' 
1 kb (including Region 1) of the CCD from a YAC transgene 
did not result in the loss o f gene expression in any of the 
tissues that we report, and instead, CCD Region 1 was 
associated with a tissue-specific silencer function (Ain­
scough et al., 2000). Consequently, we propose that the 
enhancer region most likely lies in the second 1 kb of the 
CCD that includes Region 2 (see Fig. 1). This must be 
confirmed by testing smaller reporter constructs to exclude 
alternative explanations, such as the presence of redundant 
enhancers that may have obscured the role of Region 1 in the 
YAC experiments. Within the choroid plexus epithelium, the 
CCD directed transgene expression in a mosaic fashion to 
only a subset o f cells, mimicking the endogenous Ig/2 
expression pattern in this tissue. Interestingly, the silencer 
function o f the mouse CCD was found to be conserved when 
it was tested in transgenic Drosophila and conferred varie­
gated silencing on the mini-white reporter gene, with silenc­
ing dependent upon two polycomb-group proteins (Erhardt 
et al., 2003). This suggests a mechanism by which enhancer 
and silencer elements within the CCD might interact to bring 
about variegated expression of Ig/2 within the choroid plexus 
epithelium.
We propose that a mesodermal or neural crest enhancer 
element lies at the CCD, driving the imprinted expression of 
Ig/2 independently of the Ig/2/H19 boundary element. The 
Ig/2 DMRs have been shown to play a role in the imprinting 
of Ig/2 in the mesoderm (Constancia et al.. 2000; Eden et al., 
2001; Weber et al., 2001). DMR1 contains several CpG 
dinucleotides that are hypomethylated on the maternally 
derived chromosome, and hypermethylated on the paternally 
derived chromosome (Brandeis et al., 1993; Feil et al., 1994; 
Sasaki et al., 1992). Differences in the levels o f methylation 
between parental chromosomes are most marked in tissues 
with a substantial mesodermal component (Weber et al., 
2001). A deletion encompassing DMR1, when maternally 
inherited, leads to a detectable derepression of the maternal 
Ig/2 allele from e l2 in whole embryos, and from e l6 in 
individual mesodermal tissues (Constancia et al., 2000). The 
authors suggest that DMR1 contains an allele-specific silenc­
er that represses the maternal allele in the mesoderm. An 
additional methylation-sensitive silencer has been mapped 
within DMR1, but its action is not thought to be tissue- 
specific (Eden et al., 2001). It would be o f interest to ascertain 
if DMR1 can silence gene activity in the subset of meso­
dermal tissues stained in transgenic mice carrying the P3- 
LacZ-CCD  reporter construct. The presence of enhancers 
located upstream of the DMD boundary, combined with
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differential methylation at Igf2 DMR1 and DM R2, could 
provide the basis o f  correct imprinted expression o f  Ig/2 in 
som e non-endodermal tissues, including the choroid plexus 
epithelium (see Fig. 5).
It has been shown recently that methylation o f  the DMRs 
at this locus is coordinated in a hierarchical fashion (Lopes et 
al., 2003). Mutations in the DM D, when transmitted mater­
nally, result in loss o f  differential methylation o f  both DMR1 
and DMR2. Both alleles become highly methylated. More­
over, a maternally transmitted deletion encompassing DMR1 
leads to a greater level o f  methylation o f  DMR2. Thus, e x ­
acting elements are present in the DM D and upstream o f  Ig/2 
that act to protect the DMRs from methylation. This work 
confirms earlier experiments show ing that Igf2-proximal 
DMR methylation is dependent upon DM D sequences (Fome 
et al., 1997), but also highlights that perturbations o f  DMR 1 
could lead to the relaxation o f  Igf2 imprinting independently 
o f  the DM D. The DM Rs proxim al to Igf2 provide an 
additional level o f  imprinting control. In combination with 
enhancers proximal to the DM D boundary, these local DMRs 
may provide control o f  Igf2 imprinting that is independent o f  
the DM D (Fig. 5). We propose that such an enhancer region 
lies at the CCD and functions to drive imprinted expression o f  
Igf2 in a small subset o f  tissues o f  mesodermal and neural 
crest origin. Other enhancer sequences may also lie within the 
interval between the Igf2 promoter and the DM D boundary 
(D rewell et al., 2002). The presence o f  /g/2-proxim al 
enhancers suggests that a distinct mechanism o f  Ig/2  imprint­
ing has arisen in two subsets o f  tissues where the gene is 
expressed. Mutations in this DM D-independent mechanism  
o f Ig/2 imprinting may account for some o f  the cases o f  
Beckwith-W iedemann syndrome, in which loss o f  imprint­
ing o f  Ig/2 occurs with no modification o f  methylation at the 
DMD (Engel et al., 2000).
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